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ABSTRACT 
 Glycosylation modulates the range and specificity of interactions among 
glycoproteins and their binding partners. This is important in influenza A virus (IAV) 
biology because binding of host immune molecules depends on glycosylation of viral 
surface proteins such as hemagglutinin (HA). Circulating viruses mutate rapidly in 
response to pressure from the host immune system. As proteins mutate, the virus 
glycosylation patterns change.  The consequence is that viruses evolve to evade host 
immune responses, which renders vaccines ineffective. Glycan biosynthesis is a non-
template driven process, governed by stoichiometric and steric relationships between the 
enzymatic machinery for glycosylation and the protein being glycosylated. Consequently, 
protein glycosylation is heterogeneous, thereby making structural analysis and 
elucidation of precise biological functions extremely challenging. The lack of structural 
information has been a limiting factor in understanding the exact mechanisms of glycan-
mediated interactions of the IAV with host immune-lectins. Genetic sequencing methods 
allow prediction of glycosylation sites along the protein backbone but are unable to 
  ix 
provide exact phenotypic information regarding site occupancy. Crystallography methods 
are also unable to determine the glycan structures beyond the core residues due to the 
flexible nature of carbohydrates. This dissertation centers on the development of 
chromatography and mass spectrometry methods for characterization of site-specific 
glycosylation in complex glycoproteins and application of these methods to IAV 
glycomics and glycoproteomics. We combined the site-specific glycosylation information 
generated using mass spectrometry with information from biochemical assays and 
structural modeling studies to identify key glycosylation sites mediating interactions of 
HA with immune lectin surfactant protein-D (SP-D). We also identified the structural 
features that control glycan processing at these sites, particularly those involving glycan 
maturation from high-mannose to complex-type, which, in turn, regulate interactions with 
SP-D. The work presented in this dissertation contributes significantly to the 
improvement of analytical and bioinformatics methods in glycan and glycoprotein 
analysis using mass spectrometry and greatly advances the understanding of the structural 
features regulating glycan microheterogeneity on HA and its interactions with host 
immune lectins. 
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Chapter 1: Introduction 
 
1.1 Glycobiology 
Glycobiology, the study of processes mediated by carbohydrates in biological 
systems, encompasses glycan biosynthesis and the roles of glycosylated molecules in 
health and disease. Glycans are ubiquitous in living organisms as free carbohydrates, 
lipid- and protein-linked.  In addition to being the primary source for energy storage in 
most organisms, carbohydrates play important roles in defining the structural and 
biochemical properties of glycoconjugates. While the total number of native gene 
products coded by an organism’s genome is well-defined, the presence of glycosylation 
greatly expands the range of phenotypes and functions of gene products.  
Glycans define biological processes in two different ways: first, by modulating 
the structural properties of the protein to which they are attached, and second, by 
modulating interactions with binding partners. Glycans alter structural stability and 
confer proteolytic resistance to the proteins they decorate. The large size of branched 
oligosaccharides also shields functionally important regions of proteins against immune 
molecule or pathogen binding.  Thus, the partners to which a glycoprotein binds depend 
to a large degree on binding between glycans and lectin domain-containing proteins.  All 
animal cells have a surface layer of glycans and glycoconjugates coating them, known as 
the “glycocalyx”, which defines cell-cell interactions and also mediates highly specific 
interactions with pathogens [134,163,540,541,542,547,643].  In tissue, cells are 
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surrounded by an extracellular matrix consisting of carbohydrates, glycoproteins, 
proteoglycans and collagens. 
Glycans are made up of monosaccharides, joined together into linear or branched 
oligosaccharides (2-20 units) or polysaccharides (>20 units). The glycosidic bonds that 
join these monosaccharides are formed between the hemiacetal group of the anomeric 
carbon of one monosaccharide and a hydroxyl group of another monosaccharide. Thus, 
the glycan biopolymers usually contain reducing and non-reducing ends, with the 
reducing sugar bearing a free anomeric center that is not involved in a glycosidic bond. 
The reducing end with an aldehyde functional group is often used as a handle for glycan 
tagging and enrichment, as described in the following sections.  
In contrast to the biosynthesis of DNA, RNA and proteins, which are all template 
driven processes, synthesis of glycans is controlled by interactions of substrates with the 
glycosylation machinery consisting of a series of enzymes (glycosyltransferases and 
glycosidases) in the endoplasmic reticulum (ER) and the Golgi apparatus. The factors 
that affect protein glycosylation include conformational access to the enzymes, enzyme 
and substrate concentrations, the physiochemical characteristics of the glycoprotein being 
processed, and the tissue or cell-type-specific properties of the secretory pathway. As a 
result, glycosylation as a rule is heterogeneous in structure and therefore function. While 
this makes the study of glycosylation extremely challenging, it also makes this one of the 
most interesting processes in nature [494,543].  
Glycan heterogeneity exists at two levels: macroheterogeneity refers to the 
presence or absence of glycans at putative glycosylation sites; microheterogeneity refers 
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to the different glycoforms that are present at a particular site in a population of 
glycoproteins. Both macro- and microheterogeneity are important in defining the 
interactions of the glycoconjugates. Together, the overall glycan composition and specific 
motifs present dictate the range of lectin domain-containing binding partners. Such 
interactions are especially important in tissue patterning, recruitment of hormones, 
signaling proteins, infection of a cell by pathogens and recognition of antigens for 
immune response.  
Alterations in these glycan distributions can be correlated with deviations from 
the normal or healthy state to a disease state. The lack of template and proof-reading 
mechanisms renders glycan biosynthesis susceptible to environmental influences; 
glycosylation is therefore spatially and temporally regulated. Consequently, glycans serve 
as sensitive biomarkers for pathological conditions ranging from metabolic diseases to 
cancer.  Due to this, the development of glycan and glycoprotein analysis methods has 
received much attention in the last decade. The following sections describe an overview 
of the N-linked glycan biosynthetic pathway and the roles of glycosylation in Influenza.  
1.1.1 N-Glycan Biosynthesis 
Glycans are added to proteins co-translationally, as nascent polypeptide chains are 
extruded into the ER lumen. Asparagine-linked N-glycans are attached to a sequon 
characterized by the presence of an Asn-Xxx-Ser/Thr (where Xxx ≠ Pro), also 
abbreviated as N-X-S/T. N-glycan biosynthesis begins by addition of a GlcNAc-P 
(Phosphate) from UDP-GlcNAc in the cytoplasm to dolichol-P, which generates Dol-P-
P-GlcNAc. This structure is extended to Dol-P-P-GlcNAc2-Man5 and then flipped to the 
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luminal side of the ER by enzymes known as flippases. There, four more mannose and 
three glucose residues are added to the immature glycan to build up the final composition 
Glc3Man9GlcNAc2. The glucose residues are recognized by chaperones calnexin and 
calreticulin, and act as a handle during protein folding quality control in the ER. The 
terminal glucose residues and one to two mannose residues must be trimmed by α-
glucosidases I and II and ER α-mannosidase I, respectively, before the folded 
glycoprotein can be transferred to the Golgi apparatus. As a result, most glycoproteins 
entering the Golgi have a glycan composition of Man7-8GlcNAc2 [5,60,96,119,134,494]. 
 
Figure 1:  Schematic of N-linked glycan biosynthesis showing the Golgi compartments and the different classes 
of N-glycans: paucimannose-, high-mannose-, hybrid-, bisected-, and complex-type.  
Abbreviations: oligosaccharyltransferase, OT; the α-glucosidases, GI, GII; the β-N-
acetylglucosaminyltransferases, TI, TII, TIII, TIV, TV, T(i), T(I); the α1,2mannosidases, MI, α1,3/6mannosidases MII, 
MIII;β1,4-galactosyltransferases (Gal-T), α-fucosyltransferases (Fuc-T), α-sialyltransferases (ST). The terminal 
sequences are added to both N- and O-linked glycans by β1,4Gal-T; β1,3GlcNAc-T(i); β1,6GlcNAc-T(I); α2,3ST, 
α1,3Fuc-T. A number of substrate-product relationships govern N-glycan biosynthesis. Briefly, the GlcNAc-TI product 
is required for substrate recognition by α-mannosidase II and GlcNAc-TII, and necessary for biosynthesis of the 
complex-type glycans. GlcNAc-TIII substitutes the core β-mannose residue, re-directs the pathway into ‘‘bisected 
glycans,’’ and blocks any subsequent he action of α-mannosidase II and GlcNAc-TII. The lactosamine antenna initiated 
by GlcNAc-TV is preferentially substituted by β1,3GlcNAc-T(i), and elongated to produce polylactosamine 
(i.e.,Galβ1–4GlcNAcβ1–3 repeating units of 2 to .10 in length) and Lewis antigens. Polylactosamine synthesis is also 
affected by β1,3GlcNAc-T(i) activity, glycoprotein transit time in the trans-Golgi, and competition by chain-
terminating enzymes including α1,2Fuc-Tand α2,6SA-T. Thus, control of polylactosamine and Lewis antigen 
expression appears to be, in large measure, a consequence of substrate preference, enzyme competition and tissue-
specific regulation of glycosyltransferases. Adapted from [119]; used with permission. Copyright © 1999 John 
Wiley & Sons, Inc. 
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In the cis-Golgi apparatus, trimming of the mannose units produces a 
Man5GlcNAc2 structure for most proteins before they can be further processed to 
complex and hybrid-type N-glycans, as shown in Figure 1. Once in the medial-Golgi, the 
Man5GlcNAc2 structure may be further elaborated by GlcNAcT-I addition of a GlcNAc 
residue to the C-2 position of core α1-3-linked Man. This structure can be trimmed by α-
mannosidase II to remove the terminal α1-3Man and α1-6Man, leaving behind a 
GlcNAcMan3GlcNAc2 structure. Upon removal of the two mannose units, another 
GlcNAc residue is added to the C-2 of the α1-6-linked Man in the core by GlcNAcT-II, 
resulting in the precursor structure for bi-antennary complex-type glycans. In the absence 
of α-mannosidase II activity, the α1-3Man and α1-6Man are left intact and are not further 
acted upon by the glycosylation machinery, leaving behind a Man5GlcNAc2 structure. 
However, in cases of incomplete α-mannosidase II activity, a Man4GlcNac2 structure is 
formed that acts as the precursor for hybrid type N-glycans.  Paucimannose glycan 
structures (Man3-4GlcNAc2) can also be formed, usually as a result of GlcNAc residue 
removal from GlcNAcMan3-4GlcNAc2, by a Golgi hexosaminidase after α-mannosidase 
activity. Further branching of complex type N-glycans to tri- and tetra-antennary 
structures is carried out by GlcNAcT-IV and GlcNAcT-V, at the C-4 of the core mannose 
α1-3 and C-6 of core mannose α1-6, respectively. GlcNAcT-VI can initiate another 
branch at C-4 of the core-mannose α1-3 and a bisecting-GlcNAc residue can be attached 
to the β-mannose of the core by GlcNAcT-III.  
After the branching is completed in the medial-Golgi, the elongation and addition 
of terminal glycan residues occurs in the trans-Golgi. The trimannosyl core can be 
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modified by addition of a fucose residue to the GlcNAc adjacent to the asparagine. FucT-
VIII adds the fucose in α1-3 linkage (in plants), in α1-6 linkage (in vertebrates) and in 
α1-3 or α1-6 linkage (in invertebrates). Plants can have a β1-2 linked xylose present as a 
modification to the core.  
Typical elongation of the branches involves addition of β-linked galactose to the 
GlcNAc, to form a Galβ1-3GlcNAc or Galβ1-4GlcNAc sequence, known as type-1 or 
type-2 N-acetyllactosamine sequences, respectively (commonly known as LacNAc). 
Sometimes, sequential additions of LacNAc repeats can form a polyLacNAc structure. A 
less common structure, resulting from the addition of a β-linked GalNAc to the terminal 
GlcNAc forms a LacdiNAc structure. N-Glycan branches typically terminate by addition 
of sialic acids by sialyltransferases, with the possibility of other modifications such as 
Fuc, Gal, GalNAc and sulfates to the branches. Sialic acids (NeuAc or NeuGc) are 
generally α-linked to the galactose units. While many other modifications and 
substituents have been reported, the above described features are most common in N-
glycan biosynthesis and sufficient for the explanation of concepts spanning the scope of 
this thesis.  
1.1.2 Influenza virus glycobiology 
Influenza is responsible for an annual average of 36,000 deaths in the US alone 
and about ten times as many worldwide. The primary causative agent for influenza, the 
Influenza A virus (IAV), consists of eight single-stranded RNA segments that code for 
eleven proteins. Of these eleven, there are two coat surface glycoproteins; hemagglutinin 
(HA) and neuraminidase (NA), as shown in Figure 2. Hemagglutinin is a roughly bulb-
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shaped trimeric protein with between 6 and 12 N-glycosylation sites that serves many 
important functions, including glycan mediated attachment to host cell-surface receptors, 
membrane fusion and internalization of the virus genetic payload for infection of the host 
cell. Most importantly, HA displays the immunodominant antigens on the virus. HA is 
almost 10 times more abundant than NA on the surface of IAV and is therefore the 
primary target for the host immune system. NA is important for cleaving sialic acid 
residues on the host cell surface to allow release of newly formed virions from the 
infected cell. HA and NA evolution is one of the mechanisms by which the virus 
responds to the selection pressures from the host immune system. The evolutionary 
process, also known as antigenic drift, involves changes in glycosylation at or near the 
antigenic sites on the surface of viral hemagglutinin. Because glycans can act as shields 
against the host antibodies, the IAV circulating in the human population evolves to gain 
N-linked glycosylation sequons around the antigenic sites on the HA head region. 
Genetic sequencing studies have shown that new strains entering a host population 
typically have a low sequon number on the HA head region; however, as they circulate 
seasonally, they acquire mutations in the protein backbone to change HA antigenicity by 
adding more glycosylation sequons [439,508]. On one hand, this glycosylation protects 
the HA protein from host antibodies [86,117,118,466,516]; on the other, increased high 
mannose N-glycosylation potentiates binding of lectins of the innate immune system, 
including surfactant Protein-D (SP-D) and mannose-Binding Lectin (MBL) that can 
neutralize IAV by binding HA glycans [81,109,545,564]. Thus, the virus strives to 
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maintain fitness by balancing addition or removal of glycosylation sequons, in the 
presence of selective pressures from the host adaptive and innate immune molecules.  
 
 
Figure 2: Model of the Influenza A virus 
 
The innate immune system is the first line of defense against microbial pathogens.  
Collagen domain-containing C-type lectins (collectins) are soluble glycoproteins of the 
innate immune system that bind glycoconjugates on the surfaces of microbial pathogens.  
Collectin binding triggers microbial elimination through aggregation, complement 
activation, and/or activation of phagocytosis, the effects of which are to clear virus from 
the lungs [469,518,565]. The collectin surfactant protein-D is expressed constitutively by 
aveolar type II pneumocyte cells and non-ciliated bronchiolar cells (Clara cells) as a 
cruciform-shaped four-armed dodecameric  glycoprotein, in which each arm represents a 
collagenous trimeric subunit that is covalently linked with three other subunits via the 
cysteine-rich N-terminal domain of the polypeptide [105].  Trimerization is initiated by a 
short 'neck' region of 33 amino acids that generates the formation of an α-helical coiled 
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coil domain  and drives collagen trimerization further towards the N-terminus [243]. The 
C-terminus of each subunit clusters three calcium-dependent C-type lectin domains 
(Carbohydrate Recognition Domains, CRDs) that facilitate multivalent, high-affinity 
interactions with patterns of glycans expressed on the surface of pathogens including 
IAV. This categorizes SP-D as a β-inhibitor, a class of IAV inhibitors that share the 
ability to target viral carbohydrates in a calcium-dependent manner. SP-D molecules bind 
mannose residues of HA glycans, thereby acting as opsonins that modulate phagocytic 
neutrophils and macrophages against IAV [215].  IAV escaping from SP-D binding may 
be neutralized by antibodies in hosts previously exposed to a similar IAV strain, 
constituting an adaptive immune response. 
It has been shown that porcine SP-D (pSP-D) possesses two unique structural 
features in its CRD that result in substantially stronger anti-IAV activity as compared to 
the antiviral activity of SP-Ds from other animal species, including human SP-D (hSP-D) 
[137]. The IAV HA has a sialic acid binding receptor that allows binding to sialylated 
host cell-surface receptor glycoproteins. This interaction is specific to sialic-acid linkage 
type and defines the host-specificity of an Influenza strain. Avian hosts predominantly 
display α-2,3 linked sialosides in their upper respiratory tract, while humans have α-2,6 
linked sialosides in their upper respiratory tracts. This restricts the infection of these 
species by viruses that have a preference towards binding the respective sialylated 
glycans. This receptor specificity has been used by many research groups, as a tool for 
characterizing IAV strains and understanding virus-protein interactions 
[194,428,489,503,505]. Such studies are typically performed on glycan arrays where 
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fluorescently labeled virions or viral proteins are allowed to interact with a variety of 
immobilized glycans with defined structures. Porcine SP-D has a sialylated N-linked 
glycan in its CRD that facilitates a dual mechanism of interaction with IAV and that 
makes pSP-D unique amongst SP-Ds from different species in being a β-inhibitor as well 
as a γ-inhibitor against IAV infections. β-inhibitors are calcium-dependent lectins that 
bind carbohydrates on pathogen surface leading to aggregation and neutralization, while γ 
inhibitors (calcium-independent) have sialylated glycans that block the sialic acid binding 
receptor on HA, thereby preventing the interaction of the virus with host cell-surface 
receptors. Studies with pSP-D isolated from porcine bronchoalveolar lavage have 
suggested that this N-linked glycan is fully sialylated with α(2,6)-linked terminal SAs 
[538] and is responsible for the interactions between pSP-D and IAVs. In addition, it was 
shown that the type of SA-linkage present on pSP-D is important for inhibition of IAV 
strains that have a corresponding receptor-binding specificity [538]. The adaptive 
changes that affect glycan binding specificity of a virus would therefore also affect its 
neutralization by a pSP-D.  
Genetic sequencing studies can only predict the presence or absence of sequons, 
positions at which glycosylation could modulate the interactions of the virus with the host 
immune molecules. Such information has been used to model HA glycosylation by using 
a chitobiose core at the sequons [117,520,561,571]. However, crystallographic studies are 
unable to identify exact structural information pertaining to the carbohydrates linked to 
the protein backbone for both pSP-D and HA. This lack of glycan structural information 
prevents a systematic study of these interactions in a site-specific manner. Fortunately, 
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recent technological advancements in mass spectrometry have enabled site-specific 
glycosylation profiling. The information from mass spectrometry can be used for 
elucidating the specific interactions that mediate IAV neutralization by innate immune 
molecules like SP-D and how glycan macro- and micro-heterogeneity affects these 
interactions. 
 
1.2 Glycan and Glycoconjugate analysis using mass spectrometry 
Glycan and glycoprotein mass spectrometry includes a range of analytical 
methods that can be used to attain structural information from carbohydrates and 
glycoconjugates. There are many levels at which these biopolymers can be probed and 
each requires a specific set of methods to be used, ranging from the type of sample 
preparation and cleanup to the type of instrumentation required and the specific 
informatics tools that are necessary to deal with the data generated. While a complete 
review of the methods utilized for analysis of glycans and glycoconjugates would be 
impractical within the thesis, this section provides an overview of the most popular 
strategies in glycan and glycoprotein analysis. Figure 3 exhibits a generic flow of steps 
involved in mass spectrometry analysis and each step is elaborated upon, in the context of 
glycan and glycoconjugates samples, in the following sub-sections.  
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Figure 3: A workflow showing steps involved in mass spectral analysis combined with online and offline 
separation methods  
(Courtesy of Prof. Catherine E. Costello) 
 
1.2.1 Glycan sample preparation 
Glycans attached to proteins are released either enzymatically or chemically, 
depending on the glycan type (linkage to protein) and the scale of desired experiment. N-
Linked glycans can be released from asparagine residues on the protein backbones rather 
conveniently, using the enzyme peptidyl-N-glycosidase F (PNGase F), which typically 
releases all vertebrate N-glycans.  Invertebrate and plant glycans may contain α-2,3 
linked fucose on the core GlcNAc, a motif that prevents PNGase F release.  PNGaseA, on 
the other hand can be used to release all N-glycans, including those with a core fucose, 
provided that the protein is first proteolytically digested.  There are several classes of O-
glycosylation and no single glycoside acts on all; for many types, no glycosidase is 
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available.  For mucin-type O-glycans, the O-glycanase enzyme releases Galβ1-3GalNAc, 
but not when this epitope is elaborated by monosaccharide substitution.  As a result, 
mucin-type O-glycans are released by chemical means, most commonly by a reductive β-
elimination reaction, first described by Carlson [70], which has been further modified and 
adapted by several groups [96,258,465]. Sodium borohydride is used as a reducing agent, 
to prevent the peeling reaction that can degrade the free reducing end generated by β-
elimination, and converts the terminus to a glycan alditol. Glycosaminoglycans are also 
typically O-linked to proteins and are released  by reductive β-elimination [95], after 
solubilization of tissue using guanidine-HCl or after digestion of the protein using 
proteases like pronase or papain. Another method for glycan release is hydrazinolysis, 
which causes complete release of both N- and O-linked glycans from proteins. This 
reaction can lead to loss of acetyl groups attached to the carbohydrate and therefore must 
be followed by a reacetylation step [310,311,416]. An advantage to the use of mild 
hydrazinolysis is the ability to completely regenerate the reducing end of the glycan by 
mild hydrolysis with mineral or Lewis acid, such as copper acetate [533]. The conditions 
used for release of the O-glycans degrade the protein/peptide backbone. 
1.2.1.1 Glycan derivatization 
Chemical derivatization of glycans is common for improving liquid 
chromatography and mass spectrometry analyses. Carbohydrates with a free reducing end 
present a reactive aldehyde functional group, which can be modified with a variety of 
linkers to improve analytical properties. Reducing-end tagging offers multiple advantages 
to glycan analysis, including increasing hydrophobicity for better reversed-phase 
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chromatographic retention, enabling optical detection, allowing quantification using 
tandem MS, ability to multiplex samples, etc. In addition, the available hydroxyl groups 
on the oligosaccharides can be modified by per-O-alkylation, such as permethylation, or 
per-O-esterification, e.g., peracetylation, to alter the liquid and gas-phase properties of 
glycans for enhanced sensitivity, enrichment, separation and detailed structural analysis 
by mass spectrometry [8,401]. Glycan labeling strategies have been discussed in detail in 
various reviews and research articles [279,383,384,450]. Figure 4, shows the most 
widely-used glycan derivatization schemes.  
 
Figure 4: Commonly used glycan derivatization schemes 
 
1.2.1.2 Reductive amination 
Released glycans can be reductively aminated to add reducing end tags, where a 
primary amine group-containing tag reacts with the aldehyde on the free reducing end of 
the glycan to form a Schiff base or imine, which is then reduced in the presence of a 
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reducing agent such as sodium cyanoborohydride to a stable secondary amine. The most 
commonly used reagents for reductive amination are 2-AA (anthranilic acid), 2-AP (2-
aminopyridine) and 2-AB (2-aminobenzamide), all of which are fluorophores that enable 
optical detection and quantification of the glycans using HPLC-based methods [25]. The 
labeled glycans can also be analyzed by mass spectrometry when coupled to online 
chromatographic separations [26,48,219,268]. The primary advantage of using these tags 
is the ability to get absolute quantification of glycan species by measuring optical 
response of the fluorescent tags against standards of known quantities. There are many 
variants of this approach that have been published by academic groups; some of these 
have been commercialized for glycan analysis. One of the first stable-isotope coded 
reductive amination tags for glycomics experiments was introduced by Bowman and Zaia 
[57,58]. These tags utilize mild reductive amination conditions and provide high labeling 
yields. Recently, isobaric aldehyde-reactive tags (iARTs) were used for reductive 
amination-based labeling, identification and relative quantification of N-glycans from the 
gp120 glycoprotein of human immunodeficiency virus [599]. 
1.2.1.3 Hydrazide labeling, oxazolone labeling, carbamate chemistry and aminoxy 
TMT labeling 
Another tagging approach, described by Walker et al. [559], utilizes isotopically 
labeled hydrazide tags. These tags add a hydrophobic linker group to the glycan, which 
enables chromatographic separation of these glycans using reversed-phase 
chromatography. The tags also allow correction of any bias in quantification from isotope 
overlap by inclusion of internal standards labeled with light and heavy versions of the 
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tag. These tags are available commercially as the Individuality Normalization when 
Labeling with Isotopic Glycan Hydrazide Tags (INLIGHT) from Cambridge Isotope 
Laboratories, Tewksbury, MA. All of these tags add a hydrophobic group to the glycans, 
thereby also improving the ionization efficiency. Reaction of the carbonyl group of 
glycan reducing end aldehyde with an amine group results in formation of a hydrazone 
[313,558,600]. Conversion of glycans to phenylhydrazones has been shown to improve 
sensitivity in mass spectrometry-based analyses [315]. In addition to labeling the glycan 
for increasing hydrophobicity or with isobaric tags such as INLIGHT, hydrazide 
chemistry-based labels can also be used for glycan purification. One advantage of this 
chemistry is that it does not require addition of salts such as sodium borohydride, thus 
making it much cleaner and more adaptable to mass spectrometry based workflows. 
Lowering the pH allows hydrolysis of the hydrazine for facile release of the glycans. 
Hydrazide functionalized beads or biotin have been used in many studies for solid-phase 
glycan capture [597].  
Cai et al. recently reported an oxazolone chemistry-based strategy for isotope-
coded glycan tagging [64]. In this study, isotopically labeled amino acids were 
conjugated to glycans by reductive amination. The primary advantage here was the wide-
availability of isotopically labeled amino acids, which makes this approach broadly 
accessible. Amine-reactive tandem mass tags (TMT) are widely used in proteomics 
analyses with great multiplexing and relative quantification capacity 
[94,364,447,456,526]. A carbonyl-reactive version of the TMT is available for tagging 
unreduced glycans. Hahne et al. compared aminoxy- and hydrazide-functionalized TMT 
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and concluded that the aminoxy-TMT outperformed the hydrazide version [206]. This 
reagent is also available commercially for glycan tagging and multiplexing for mass 
spectrometry analysis.  
Another convenient glycan tag is the Rapifluor MS that has been developed by 
Waters Corporation. As shown in Figure 4, this tag combines an NHS-carbamate reactive 
group that reacts with N-glycosylamines with a quinoline fluorophore for optical 
detection and a tertiary amine group that improves MS response by enhancing ionization 
of the tagged glycans [316]. A similar derivatization chemistry has been used by Gong et 
al. for labeling glycans with isotopically coded TMT tags to enable multiplexing [184]. 
Shuang and coworkers have reported a quaternary amine-containing isobaric tag 
for quantitative glycomics (QUANTITY) [598]. While both the tertiary amine structure 
in aminoxy-TMT and the quaternary amine structure in QUANTITY fragment more 
easily during collisional dissociation compared to the glycosidic bonds, the quaternary 
amine is more labile than the tertiary amine structure and therefore QUANTITY 
generates a stronger reporter ion signal that can be used for relative quantification of 
multiplexed glycans. 
1.2.1.4 Permethylation 
Permethylation is the most widely used and arguably the most useful 
derivatization technique in glycan analysis. Native glycans are difficult to analyze by 
mass spectrometry owing to their hydrophilicity, which results in poor ionization 
efficiencies and MS sensitivity lower than the more hydrophobic compounds. The most 
widely available dissociation mode, CAD, typically yields glycosidic bond fragments for 
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native glycans and except in the negative mode analyses, where more extensive cross-
ring fragmentation is observed and is also helpful in keeping sialic acids stable [98,129]. 
Permethylation converts the hydroxyl (-OH) groups on glycans to O-CH3, thus making 
the glycans more hydrophobic and easier to desolvate. This reduces the bias from 
differences in ionization efficiencies for better quantification. Collisional dissociation of 
permethylated oligosaccharides has been shown to generate more cross-ring fragments 
compared to native glycans, thus improving the ability to assign linkages between 
different monosaccharides and also reduces gas-phase rearrangement of ions that is seen 
in tandem MS of native or reducing end labeled glycans [222,622]. Notably, gas-phase 
rearrangement may occur in high energy CAD of permethylated glycans and can be 
minimized in native glycans by metal-adduction and utilization of free radicals 
[120,323,586,587]. Permethylation also stabilizes sialic acid residues to enable positive 
mode analysis and tandem MS of sialylated glycans. Combined with isotopic labeling, 
permethylation can be used as an effective strategy to identify structural features like 
sulfation on glycans [320].  
Isobaric labeling can be achieved by permethylation as shown by Atwood and 
colleagues [31].  The use of 
13
CH3I and 
12
CH2DI, introduces the very small mass 
difference of 0.002922 Da, which generates derivatives that can be resolved when 
multiple sites are labeled. In addition to multiplexed analysis and quantification, 
permethylation also enables generation of useful fragments for structural analysis of the 
derivatized glycans. Kang et al. have described an approach for comparative glycomic 
profiling using quantitative permethylation and stable-isotope labeling [283]. The most 
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commonly used method for permethylation is a liquid-phase approach developed 
originally by Ciucanu and Kerek [90] and improved by Ciucanu and Costello [89], which 
involves incubation of glycans with sodium hydroxide dissolved in DMSO (dimethyl 
sulfoxide) and methyl iodide, followed by a liquid-liquid extraction of the derivatized 
oligosaccharides using chloroform and water. While this procedure is simple and well-
established, solid-phase permethylation strategies have also been adopted in recent years 
for derivatization of glycans from small sample amounts . Solid-phase permethylation 
requires packaging of sodium hydroxide particles or beads into spin-columns or 
capillaries, followed by passing a solution of the glycan sample dissolved in DMSO and 
methyl iodide through the columns or capillaries. Residual salts from both liquid and 
solid-phase permethylation procedures can be removed easily, using reversed-phase spin 
columns or online with reversed-phase liquid chromatography by using a trapping 
column where the glycans can be washed and concentrated. Commonly, for glycans 
containing a free reducing end, the glycan sample is reduced prior to permethylation in 
order to open the reducing end monosaccharide to avoid chromatographic separation of 
the α and β anomers and to introduce a mass shift that facilitates discrimination of 
reducing and non-reducing end fragments. Glycans are reduced to oligosaccharide 
alditols using sodium cyanoborohydride or an ammonia-borane complex [7,162]. The 
symmetry between reducing and non-reducing end fragments and certain internal 
fragments can be further resolved by carrying out the reduction in the presence of 
isotopically labeled reagents like sodium borodeuteride [383]. A number of LC-MS/MS 
platforms have been developed for the analysis of permethylated glycan alditols [7,98]. 
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1.2.1.5 Metabolic/enzymatic labeling of glycans to enable click-chemistry 
Another approach for glycan labeling that has recently gained interest is the use of 
metabolic or enzymatic labeling followed by click-chemistry [448]. Both copper- 
catalyzed and copper-free azide-alkyne cycloadditions are relatively easy to perform and 
produce high yields. Monosaccharide analogs with azido functional groups can be used in 
cell culture for incorporation into glycans as they are being synthesized by the 
glycosylation machinery. Azido sugars are recognized by glycosylation enzymes and 
incorporated into glycans and glycoproteins. The azido sugars can then be probed using 
tags with alkyne groups. The efficiency of this method depends on the efficiency and 
specificity of the glycosylation machinery to accept the azido monosaccharides and then 
incorporate them into oligosaccharides in the ER and the Golgi apparatus.  
Woo and colleagues recently developed a platform for targeted glycoproteomics 
using this metabolic labeling approach [578]. They used alkyne-functionalized isobaric 
tags with a cleavable biotin linker that enabled both the enrichment of the glycoproteins 
or glycopeptides and, after removal of the biotin linker, their subsequent analysis by LC-
MS. Linkage-specific enzymes can also be used to probe specific motifs in glycans, by 
incorporating azido-labeled monosaccharides, as has been shown by Wu et al. [583]. 
When combined with powerful LC-MS workflows, these methods greatly improve the 
ability to identify features associated with glycans in normal and altered physiology and 
lead to understanding the biological pathways.  
  21 
1.2.1.6 Sialic acid derivatization 
Sialic acid residues are prone to dissociation during ionization, especially in 
MALDI-MS. In addition to glycan permethylation, sialic acids can be selectively 
modified to stabilize them in MALDI mass spectral analyses. Powell and Harvey have 
described a methyl esterification strategy for sialic acid stabilization [423]. This method 
is relatively straightforward and requires incubation of released glycans with DMSO and 
iodomethane. Another reagent, 3-Methyl-1-p-tolyltriazene, has been used for efficient 
solid-phase methyl-esterification of sialic acids [381]. More recently, the Wuhrer group 
have devised an approach where sialic acid esterification leads to stabilization of these 
labile monosaccharides and also enables discrimination of Gal-α-2,3 and Gal-α-2,6 linked 
neuraminic acids. This method utilizes 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide 
(EDC) and 1-hydroxybenzotriazole (HOBt) in presence of ethanol and ethyl-
esterification or lactonization of α-2,6 or α-2,3 linked sialic acids, respectively. As shown 
in Figure 5, the mass shifts associated with these modifications allow easy identification 
and relative quantification of differently linked sialosides, in addition to stabilizing these 
glycans for positive mode MALDI-MS. Applications of this method for analysis of 
sialylated glycans will be discussed in subsequent chapters. 
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Figure 5: Chemical derivatization scheme for neutralization of carboxylic acid groups and differentiation of 
sialic acid linkages, as described by Reiding et al.[438] 
Adapted from [438];used with permission. Copyright © 2014, American Chemical Society 
 
1.2.2 Glycopeptide sample preparation 
Sample preparation for glycopeptide analysis or glycoproteomics is similar to that 
for proteomics. A bottom-up analysis entails reduction and alkylation of cysteine residues 
followed by proteolysis of proteins or glycoproteins and then analyzing the peptides and 
glycopeptides by LC-MS. Glycopeptides can be analyzed directly as part of a complex 
mixture of peptides and glycopeptides. The presence of a hydrophilic glycan hampers 
efficient desolvation and ionization of glycosylated peptides and results in lower response 
in mass spectrometry, compared to the non-glycosylated peptides. Additionally, glycan 
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heterogeneity divides the glycopeptide signal into many channels corresponding to 
multiple glycoforms. To prevent masking of the glycopeptide signal and obtain deeper 
coverage of glycan microheterogeneity, it is preferable to enrich or separate 
glycopeptides from non-glycosylated peptides prior to mass spectrometry. Glycopeptide 
enrichment can be performed using SPE or LC based methods that will be described in 
the following section. 
 
1.2.3 Glycan and glycopeptide enrichment and pre-ionization separation  
As the performance of MS instruments improves steadily both in speed and 
sensitivity, the depth and throughput in analyses is limited by front-end separations [481]. 
Advancement in separation methods is therefore imperative for bringing proteomics and 
glycomics to the same level of throughput as genomics analyses. Improved separations 
are necessitated by the heterogeneity in molecular phenotypes caused by glycosylation, 
where one gene product can have dozens of proteoforms. The range of molecular forms 
multiplies exponentially with the presence of glycosylation on a protein, because this 
modification brings more heterogeneity in terms of presence or absence at a site and the 
population of glycoforms that can occupy a site. Therefore to improve analysis by mass 
spectrometry, separation of differently modified or glycosylated forms, is necessary. 
Liquid-chromatography is an indispensable separations method for analytical 
separation and fractionation of compounds in mixtures. A variety of stationary-phases 
enable orthogonal separation of mixtures. Depending on the solvent system required for 
mobile phases, the chromatography mode may or may not be compatible for separations 
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online with mass spectrometry. Owing to the hydrophilic nature, branching and the 
presence or absence of acidic substituents of glycans, their separations are most 
efficiently performed using HILIC (Hydrophilic Interaction Liquid Chromatography), 
ion-exchange or PGC (Porous Graphitized Carbon) modes [88,271,413,468,496,584]. 
Additionally, SEC (Size Exclusion Chromatography) can be used to resolve glycans 
based on their size [611,617]. While reversed-phase chromatography is not well-suited 
for the separation of native glycans, glycans labeled with hydrophobic linkers or 
permethylated glycans can be analyzed using RPLC (Reversed-phase Liquid 
Chromatography) modes, particularly with ion-pairing agents [7]. A comparison of 
different chromatography modes for glycan separation has been reported in literature 
[358,376]. 
1.2.3.1 HILIC 
Hydrophilic interaction liquid chromatography takes advantage of polar stationary 
phases, including silica, amine- or hydroxy-based or zwitterionic resins and a mobile 
phase that contains a mixture of water and an organic solvent such as acetonitrile [11]. 
Ammonium salts are most commonly used to enhance resolution in MS-friendly mobile 
phases. The presence of polar groups on the surface of the column leads to creation of an 
aqueous layer, into which the hydrophilic analytes partition. A binary gradient starting 
with a higher concentration of the organic solvent is typically used for loading and 
adsorption of the hydrophilic analytes. An increasing aqueous composition in the mobile 
phase allows gradual elution of the glycans, in the order of increasing hydrophilicity – 
larger and highly charged glycans typically elute later than small and neutral 
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oligosaccharides [584]. HILIC works well for separation of hydrophilic compounds from 
hydrophobic compounds but generally offers lower resolution, broader peak shapes 
compared to other chromatography modes like PGC and reversed-phase, and is unable to 
resolve isomeric glycans, as shown in Figure 6. HILIC is therefore a preferred method for 
glycan and glycopeptide enrichment prior to RPLC-MS 
[16,68,293,321,390,412,468,523]. With online HILIC-MS of peptides and glycopeptides, 
non-glycosylated peptides elute earlier, while the glycosylated species elute later. 
Glycopeptide separation using HILIC is mostly glycan-centric and the resolution is much 
lower compared to reversed-phase methods [254,612]. Another disadvantage of using 
HILIC for glycopeptide LC-MS is that the presence of salts (typically ammonium) in the 
mobile phase causes formation of adducts during ionization, and these make the mass 
spectra more convoluted and decrease the sensitivity and speed of analysis, due to signal 
splitting and time wasted on data-dependent tandem MS of adducted species. Therefore, 
HILIC-enrichment using LC or solid-phase extraction (SPE) methods precedes 
glycopeptide analysis using reversed-phase LC-MS [293,468]. While HILIC-based 
methods still lag behind reversed-phase in terms of resolution, recently introduced 
zwitterionic HILIC stationary phases such as ZIC-HILIC offer much better resolution 
than Amide-based HILIC stationary-phases, so that the results are comparable to the 
resolution achieved on graphitized carbon columns [170,358]. With the advent of newer 
stationary phases, which contain both HILIC and weak anion exchange (WAX) 
properties such as the Thermo Scientific’s GlycanPac™ AXH-1 columns, better 
resolution, mixed-mode separation of acidic oligosaccharides can be achieved. A similar 
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column (AXR-1) that combines reversed-phase and WAX characteristics can be used for 
separation for glycans with a hydrophobic tag or a linker or glycopeptides with acidic 
glycans. A reasonable concern with HILIC-based approaches is the solubility of the 
analyte in the high-organic starting conditions. Additionally, HILIC LC columns take 
longer to equilibrate, making the method less attractive for high-throughput analyses, 
whereas HILIC SPE is widely used in high-throughput workflows.  
 
Figure 6: Overlaid extracted-ion chromatograms showing separation of released N-glycans from human α1-acid 
glycoprotein by HILIC-MS.  
Glycan compositions are abbreviated as [HexNAc; Hex; dHex; NeuAc]. 
1.2.3.2 Porous Graphitized Carbon 
A particular advantage of using PGC is its ability to resolve glycan isomers 
[286,287,408,409,609]. Because glycan retention on PGC stationary phases is a 
combination of hydrophobic, polar and ionic interactions [146,407], PGC has been 
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successfully used for separation of both native and permethylated oligosaccharides 
[98,130]. In addition to offline liquid chromatography separation and online LC-MS of 
glycans and glycopeptides, PGC is also commonly used in SPE cartridges for extraction, 
enrichment and desalting of oligosaccharides from complex samples [410]. Pabst et al. 
have performed a systematic study cataloging the retention times of isomeric glycan 
standards using PGC-MS and then populated a library for analysis of glycans in unknown 
mixtures [408]. The principles governing PGC separation of oligosaccharides and its 
applications have been reviewed in detail by Ruhaak and colleagues [451]. Hong et al. 
have described a PGC LC-MS workflow for glycopeptide quantification using a MRM 
(Multiple Reaction Monitoring) assay [242]. Alley et al. have compared the performance 
of RPLC and PGC for glycopeptide analysis and noted that while the performance of the 
two chromatography modes is equivalent, some hydrophilic glycopeptides are better 
retained on PGC compared to RPLC [10].  
PGC LC methods can be conveniently coupled with UV detection of labeled 
glycans or online MS detection in the positive or negative mode. Molesworth and 
colleagues observed that it is important to keep the carbon column electrically isolated 
from the MS source to prevent polarization of the carbon material, which could prevent 
elution of acidic oligosaccharides [382]. After comparing multiple solvent systems for a 
range of oligosaccharides, an acidic eluent with pH 3.0 (30-65 mM ammonium formate) 
or lower was found to allow better retention and elution of all sialylated, sulfated or 
uronic acid containing oligosaccharides. However, for attaining a more sensitive analysis, 
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a higher pH and lower salt concentration, such as 10 mM ammonium carbonate, provided 
the highest sensitivity and elution power for a broad range of analytes.  
PGC has been shown to have wide applicability for analysis of both N- and O-
linked oligosaccharides, including sulfated and sialylated glycans [35,305]. Combining 
PGC with tandem MS allows simultaneous separation and characterization of glycan 
isomers, using diagnostic fragment ions [145]. This enables high-throughput 
characterization of glycan structures in complex mixtures of oligosaccharides, which can 
be extremely useful in identifying glycosylation changes associated with various 
biological processes and pathologies [6,143,452,499,527]. PGC has a few shortcomings 
in its susceptibility to salt buildup from samples that cause polarization of the stationary-
phase and loss of reproducibility. The column must therefore be stripped periodically to 
remove the adsorbed material and recover performance. In addition, analyte recovery 
diminishes with increase in the number of acidic glycan substitutents. 
1.2.3.3 Reversed-phase liquid chromatography (RPLC) 
Reversed-phase chromatography is the most commonly used chromatography 
mode in biomolecule analysis. Reversed-phase stationary phases retain and resolve 
molecules based on their hydrophobicity by interaction or adsorption to alkyl chains of 
varying length for use with different compounds. The greatest advantage of using RPLC 
is the ease of coupling with mass spectrometers. Typical reversed-phase setups use MS 
friendly solvent systems for gradient elution of analytes. In addition to obviating the need 
for salts in the mobile-phase, RPLC also allows online desalting or washing of the 
samples thereby making resulting mass spectra cleaner and adduct-free. While RPLC is 
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the preferred mode for analysis of biopolymers like peptides, proteins and lipids, glycans 
are not retained well by reversed-phase columns due to their hydrophilic nature. 
However, addition of a hydrophobic tag or permethylation of glycans, as described in the 
previous sections, allows their retention and separation by RPLC 
[7,98,123,320,557,558,559]. Addition of ion-pairing agents such as trifluoroacetic acid 
improves the retention and separation of glycans and glycopeptides on reversed-phase 
columns but causes ion suppression [24,312]. Elevated temperatures have also been 
shown to improve chromatographic resolution of permethylated glycans on reversed-
phase columns [628].  
The above mentioned features make reversed-phase chromatography the most 
elegant method for glycopeptide analysis by LC-MS. Contrary to HILIC, where the 
separation is glycan-centric, glycopeptides are primarily retained and separated on RPLC 
columns by virtue of their peptide backbones. However, the glycan moieties also interact 
to an extent with either the un-bonded silica in the stationary-phase or in other cases 
where reversed-phase columns have polar modified stationary-phases, such as the 
Polaris
TM
 stationary-phase from Agilent Technologies. This allows mixed-mode 
separation of glycopeptides, where glycopeptides with the same peptide backbone cluster 
together on the chromatogram and are separated to some extent based on their attached 
glycan moieties. The polar character allows longer retention of larger and sialylated 
glycoforms, as shown in Figure 7. Other mixed-mode stationary phases, such as Thermo 
Scientific’s GlycanPac™ AXR-1, combine reversed-phase and WAX properties, thereby 
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allowing better glycoforms separation, particularly for sulfated and sialylated 
glycopeptides. 
While RPLC offers unmatched resolution for glycopeptide analysis, enrichment 
of glycopeptides prior to LC-MS is important for improving depth of glycopeptide 
analysis. This is because non-glycosylated peptides desolvate more easily than 
glycosylated peptides upon ionization and produce a much stronger signal, which masks 
the signal from co-eluting glycopeptides. Additionally, the heterogeneity of glycoforms 
splits the signal from glycosylated peptides into many channels, effectively reducing the 
signal-to-noise of glycopeptide peaks. These factors prevent comprehensive glycopeptide 
analysis in the presence of unglycosylated peptides. HILIC and PGC are therefore 
typically used for offline glycopeptide enrichment prior to RPLC-MS analysis. We have 
also developed a workflow for online enrichment of glycosylated peptides, using HILIC, 
prior to reversed-phase separation coupled with tandem MS analysis [293]. 
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Figure 7: Overlaid extracted-ion chromatograms showing separation of the different glycoforms of a Human α1-
acid glycopeptide QDQCIYNTTYLNVQR by C18 reversed-phase LC-MS 
Glycan compositions are abbreviated as [HexNAc; Hex; dHex; NeuAc]. 
1.2.3.4 Size exclusion chromatography (SEC) 
Size exclusion or gel filtration chromatography offers a mode of separation 
orthogonal to the above discussed modes, including PGC, HILIC and RPLC. Unlike 
HILIC, PGC or RPLC, in SEC analytes do not interact with the stationary phase based on 
their hydropathy. Instead molecules are resolved based on their size or molecular weight, 
typically under isocratic mobile phase delivery conditions. Larger analytes are unable to 
enter the pores or channels in the column packing material and are therefore excluded or 
elute earlier. The smaller analytes get trapped within the porous architecture of the SEC 
column and thus elute later. This allows facile separation of glycan polymers based on 
the degree of polymerization (dp). Isobaric saccharides with the same saccharide 
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composition can have different branching patterns, leading to multiple topologies, which 
cannot be efficiently resolved by SEC. However, linear polysaccharides such as GAGs 
(Glycosaminoglycans) typically consist of a heterogeneous mixture with high 
polydispersity. SEC becomes extremely useful for resolving the components in such 
mixtures because the components largely differ by size or the degree of polymerization. 
These separations can be performed online with mass spectrometry detection 
[228,608,609]. A major disadvantage of SEC is that it dilutes the sample, leading to 
lowered detection sensitivity. Therefore, SEC is sometimes performed offline using very 
long columns that offer higher resolution but dilute out the sample to levels lower than 
the detection limits of mass spectrometers. Development of UPLC SEC columns has now 
improved size-based separation both in terms of peak capacity and speed, such that very 
complex mixtures of linear polysaccharides can be resolved online with mass detection 
[611]. However, SEC uses a low salt content for minimizing interactions with stationary-
phase and keeping analytes soluble by maintaining mobile-phase pH, these salts can 
cause ion-adduction, making the mass spectra difficult to analyze. We have demonstrated 
the application of an online ion-suppressor cell that exchanges cations in the mobile-
phase with protons to prevent gas-phase adduction of analyte ions and generates cleaner, 
more interpretable spectra [611]. Sephadex (Dextran) based size exclusion columns, 
available from GE Healthcare
TM
, are commonly used for desalting glycan preparations. 
SEC can also be used for glycopeptide enrichment and separation from non-
glycosylated peptides, because of the added size of the glycan on the peptide backbone 
[12]. While this is not the most efficient separation method and does not offer high 
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chromatographic resolution, it can resolve non-glycosylated, singly glycosylated and 
multiply glycosylated peptides. SEC can be interfaced with MS to ascertain the elution 
profiles of glycosylated peptides or glycans of different sizes and then offline 
fractionation can be performed, as shown in Figure 53, followed by RPLC-MS of the 
enriched fractions of interest. 
1.2.3.5 Lectin Affinity chromatography 
Lectin-affinity chromatography (LAC) is driven by carbohydrate-protein 
interactions [329]. Lectins bind oligosaccharides and thus glycoproteins/glycopeptides by 
varying degrees of specificity. This property can be used to enrich or separate glycans 
and glycoconjugates based on their saccharide compositions, structures or biologically 
relevant motifs [112]. The most commonly used lectins that offer broad specificities for 
glycan and glycopeptide enrichment are ConA (concanavalin A), which binds to alpha-
mannose units and WGA (wheat germ agglutinin) that binds N-acetylglucosamine and to 
some extent sialic acid [112,160,280]. O-linked glycans and glycopeptides/glycoproteins 
can be selectively enriched using Jacalin, a lectin that binds the O-linked core 
disaccharide 1-β-galactopyranosyl-3-(α-2-acetamido-2-deoxygalactopyranoside) [245]. 
Lectins are most commonly immobilized on Sepharose for glycan/glycopeptide 
enrichment in SPE formats. While, lectins can be used individually for isolating a 
particular glycan or glycoconjugate population, for isolating all glycoforms from a 
complex biological sample, a multi-lectin affinity column (M-LAC) can be used where 
lectins with different glycan specificities are packed together [560,601,602]. Similar to 
other enrichment and analysis workflows, lectin affinity-enriched glycans and 
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glycopeptides are further desalted and analyzed using an appropriate LC-MS method 
[165]. Zhu et al. have compared the characteristics of various lectins for glycopeptide 
enrichment and fractionation combined with IMS-MS analyses [631,633]. Commercially 
available lectins are generally used for purification of common glycan compositions and 
motifs but in theory any biologically occurring lectin can be expressed or purified and 
then immobilized for mimicking biological interactions between biomolecules and 
capturing or resolving proteins of interest. 
Other chromatography modes such as ion exchange that utilize high salt content 
cannot be directly interfaced with MS but can be used for orthogonal glycan and 
glycopeptide fractionation prior to LC-MS. A recent study by Totten et al. evaluates the 
performance of multiple chromatography methods for glycopeptide separation and 
enrichment [528]. The study found great value in performing electrostatic repulsion 
hydrophilic interaction liquid chromatography using strong anion exchange solid-phase 
extraction (SAX-ERLIC) over other methods for improving the depth in glycopeptide 
analysis. Capillary electrophoresis (CE) has recently gained popularity for glycan and 
glycopeptide analysis due to availability of improved MS interfaces and is discussed in 
Chapter 5. 
1.2.4 Mass Spectrometry analysis of glycans and glycopeptides 
Optical measurements are easy to combine with LC-based oligosaccharide and 
glycoconjugate separations but offer little insight into the composition and structure of 
the glycan or glycoconjugate and minimal capacity to differentiate co-eluting 
compounds. Accurate mass measurements and tandem mass spectrometry provide the 
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fields of glycomics and glycoproteomics with detailed compositional and structural 
analyses. While other analytical tools such as nuclear magnetic resonance (NMR) 
spectroscopy enable comprehensive structural analysis of biomolecules, the relatively 
low sensitivity of such methods and their inability to combine with online separation 
methods like nano-LC and CE, limits their use for analysis of complex biological 
samples. Mass spectrometry offers unparalleled sensitivity and specificity for 
unambiguous characterization of biomolecules. Tandem MS provides further resolution 
of isobaric analytes by dissociating them in the gas phase and then analyzing the 
fragments. Modern mass spectrometers are also able to combine gas-phase separation 
with mass detection, using Ion-Mobility Spectrometry (IMS), which takes advantage of 
differences in their cross-sections to resolve isomers and conformers that cannot be 
resolved by chromatography.  
1.2.4.1 Sample introduction/ionization 
Sample analysis by mass spectrometry requires ionization of the analytes. While 
many ionization methods exist for introduction of analytes into mass spectrometers, only 
electrospray Ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) 
are commonly used for analysis of oligosaccharides and glycopeptides [234,608,610]. A 
MALDI source typically employs a UV (e.g. nitrogen, 337 nm or Nd:YAG third 
harmonic, 355 nm) or an IR (Er:YAG, 2.94 μm) laser to liberate the analyte dried with a 
chemical matrix that absorbs at the laser wavelength. The energy from the laser pulse 
leads to photoexcitation and photoionization of the solid matrix and transfer of a proton 
to co-crystallized analyte molecules [221,230]. To prevent thermal disintegration of the 
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analyte, the laser is only pulsed for a short period of time which makes this ionization 
most suitable for use with a Time-of-Flight (TOF) mass analyzer. UV-MALDI ionization 
predominantly generates singly charged ions, with more highly charged ions observed in 
abundance only for large molecules such as intact proteins; multiply charged ions are 
common in IR-MALDI mass spectra. MALDI provides high spatial resolution in the 
plane of the sample stage and is relatively forgiving of contaminants in the sample. Thus, 
it is well suited for imaging mass spectrometry directly analysis of biological samples 
such as tissue sections. However, MALDI-Mass Spectrometry (MALDI-MS) cannot be 
combined with online separation methods such as liquid chromatography. Since analytes 
in a mixture are ionized together by MALDI, differences in ionization efficiencies and 
abundances of analytes favor sampling of molecules that ionize well and are abundant in 
a complex mixture. Pre-fractionation can help circumvent this limitation to a certain 
extent.  
On-line LC-MS is the preferred method for analysis of complex mixtures of 
analytes, particularly those coming from biological matrices. Liquid chromatographs are 
interfaced with mass spectrometers using a continuous ionization source that allows 
introduction of analytes into the mass spectrometer as they elute from the column. ESI 
allows ionization of the sample from a continuous stream of analytes at atmospheric 
pressure. As analyte droplets emerge from the tip of a conductive sprayer or a capillary, 
an electric potential is applied between the capillary orifice and the mass spectrometer 
inlet, along with a drying gas that facilitates rapid evaporation of the solvent. As the 
solvent droplets evaporate, the charge concentration builds-up, leading to increased 
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Coulombic repulsions and division of the droplets carrying the analyte into smaller 
droplets and eventual release of the charged analyte into the gas phase [148]. While 
charged analyte molecules are drawn into the mass spectrometer under the influence of 
the electric field, the neutrals are not captured and solvent droplets dry off by application 
of a heated drying or curtain gas. In general, a combination of organic and aqueous 
solvents is used, which improves electrospray by decreasing surface tension, while 
maintaining the solvent conditions necessary for keeping the analyte soluble. For proteins 
and peptides, modifiers such as formic and acetic acid are also used in both static 
electrospray or as part of LC mobile phases to improve protonation.  
Nano-ESI sources that operate at nanoliter flowrates provide much higher 
sensitivity and typically do not require application of a heated sheath gas to the source, 
owing to the low solvent volumes [570]. Unfortunately, these advantages to true nano-
ESI are only observed for flow rates less than 50 nL/min. Because it remains impractical 
to interface on-line chromatography at such flowrates, sub-microliter per minute ESI 
sources operate as reduced scale conventional electrospray, not as true nano-ESI. Such 
devices have been integrated onto microfluidic separation devices such as the Agilent 
HPLC chip and the microfluidic-CE device (ZipChip) from 908 Devices 
[256,293,437,495]. Other convenient systems such as the Advion Triversa Nanomate are 
available for easy coupling of liquid chromatography to mass spectrometry using nano-
ESI [291].  
In contrast to MALDI, ESI generates abundant multiply charged ions, which 
allows analysis of biomolecules with higher neutral masses using a limited m/z analysis 
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range. The distribution of multiple charge states makes the mass spectra more complex 
than singly-charged mass spectra due to possible overlap of isotopic clusters and presence 
of multiple charge states. Both MALDI and ESI can be used in positive and negative 
modes for sample introduction but ESI is generally softer and therefore more appropriate 
for labile molecules such as oligosaccharides and glycopeptides. Even so, careful 
attention must be paid to the ESI source conditions to avoid loss of one or more labile 
sialic acid residues. Unless vibrational cooling is employed [265], MALDI can be 
reliably employed for sialylated glycans only after permethylation or use of other 
derivatization to stabilize the labile sialic acids [98,202,384,438], 
1.2.4.2 MS analysis 
Mass spectrometers consist of a series of ion-optical guides that direct beams or 
packets of ions towards a detector. Mass analyzers resolve analyte ions based on their 
mass-to-charge ratios (m/z). A variety of detectors are available on modern mass 
spectrometers that deliver varying detection or acquisition speed, mass resolution, mass 
accuracy, sensitivity and dynamic range. Irrespective of the mode of detection, all mass 
analyzers generate a spectrum with mass-to-charge (m/z) ratios of all ions detected.  
The limits to acquisition speed or the rate at which mass spectra are acquired are a 
function of the physics of the mass analyzer. The realized mass resolution depends 
largely on the mode of operation of the mass spectrometer such as the choice of 
acquisition speed, acquisition m/z range, etc. and to a degree on the electronics involved 
in digitizing and converting the signal. The mass accuracy is measured as the deviation of 
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measured mass of an analyte from the theoretical mass of that analyte and is generally 
expressed in parts-per-million.  
 
 𝑴𝒂𝒔𝒔 𝒂𝒄𝒄𝒖𝒓𝒂𝒄𝒚 𝒐𝒓 𝒎𝒂𝒔𝒔 𝒆𝒓𝒓𝒐𝒓 (𝒑𝒑𝒎) =
(𝒎𝒆𝒂𝒔𝒖𝒓𝒆𝒅 𝒎/𝒛 −  𝒕𝒉𝒆𝒐𝒓𝒆𝒕𝒊𝒄𝒂𝒍 𝒎/𝒛)
𝒎𝒆𝒂𝒔𝒖𝒓𝒆𝒅 𝒎/𝒛
× 𝟏𝟎𝟔 Equation 1 
 
Mass resolving power is the ability of a mass analyzer to discriminate or separate 
masses that are very close to each other. Ion signals in mass spectra appear as normally 
distributed peaks. Mass resolving power is defined by IUPAC in terms of the overlap (or 
'valley') between two peaks [641]. For two peaks of equal height, masses m1 and m2, 
when there is overlap between the two peaks to a stated percentage of either peak height 
(10% is recommended), then the resolving power is defined as: 
 
𝑹 =
𝒎𝟏
𝒎𝟏 − 𝒎𝟐 
 =
𝒎
∆𝒎
=
𝒎
∆(𝒎/𝒛)
 
Equation 2 
It should be noted that manufacturers’ quotations of resolving power or resolution 
are often given with a 50% valley definition. For mass analyzers such as FT-ICR and 
Orbitraps, resolving power is a function of m/z value, so the m/z value must be included 
in the quotation of mass resolution. 
The percentage overlap (or 'valley') concerned must always be stated. To calculate 
resolution from a single peak in a given spectrum, the peak width at half maximum is 
used as Δm. 
Sensitivity and dynamic range of a mass analyzer define the lower limits of 
detection and the range of signal intensity that can be measured by the mass 
spectrometer. Sensitivity is the smallest amount of sample that can be used to generate a 
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signal discernible from the background noise and sometimes also referred to as the lowest 
limit of detection. This is different from the lowest limit of quantitation, which is the 
smallest amount of a sample needed to produce a robustly quantifiable signal. The 
sensitivity or limits of detection are typically defined in number of moles. Dynamic range 
on the other hand defines the difference between the highest and lowest analyte signal 
that can be measured together (usually in orders of magnitude of difference between the 
highest and lowest signals).  
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1.2.4.3 Types of mass analyzers 
The most commonly used mass analyzers in biological mass spectrometry are 
described in brief below. Each mass analyzer has specific applicability and offers features 
for specific analyzer types as described in the following section.  
Analyzer MS 
Acquisition 
speed 
Resolving 
power 
(m/z 1000) 
Mass 
accuracy 
Upper limit 
of m/z range 
Dynamic 
range 
Time-of-
flight 
50 Hz 20,000 (Linear) 
40,000 
(Reflectron) 
< 5ppm Unlimited 10
4
 
Quadrupole 10 Hz 2000 100 ppm 4,000 10
5
 
Orbitrap 18-22 Hz 
(for High-
field 
Orbitraps) 
50,000 – 10000 
*** 
1-5 ppm 3,000 
(Up to m/z 
8,000 on the 
Biopharma 
extended 
mass range 
instrument) 
10
4
 
Ion-trap 50-60 Hz 4000 100 ppm m/z 4000  10
3
-10
4
 
FTICR-MS 10 Hz 500,000 *  < 1-2 
ppm 
3,000 
(typical) 
Can be 
extended up 
to 5,000 **  
10
4
 
Table 1: Comparison of different types of mass analyzers [127,235,349,354,462,562,577] 
*varies with acquisition speed, transient length and magnetic field strength 
**While the analyzer can detect higher masses, the limit is imposed by transfer optics and the pressure 
in the ICR cell. Also, resolving power decreases significantly at higher m/z.  
*** Depends on the acquisition speed. Resolving power (R) decreases less significantly with increased 
m/z in Orbitrap compared to FTICR. For FTICR, R α 1/(m/z), while for Orbitrap R α 1/√ (m/z) 
1.2.4.3.1 Time-of-flight detector 
As its name suggests, a time-of-flight or TOF mass analyzer measures the time 
taken by ions to fly through a “flight tube” of defined length and uses that information to 
measure the m/z value of the ions. The flight tube is a field free region into which the ions 
with the same charge state are injected with a constant kinetic energy. As a result, the 
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velocity of ions and their time-of-flight are a function of mass and charge, as described 
by the equations below [193].  
 
𝑲𝒊𝒏𝒆𝒕𝒊𝒄 𝒆𝒏𝒆𝒓𝒈𝒚, 𝑲𝑬 =
𝟏
𝟐
𝒎𝒗𝟐 = 𝒒𝑼 = 𝒛𝒆𝑼 
Equation 3 
 
 
𝑣 = √
2𝑒𝑈
𝑚/𝑧
 
Equation 4 
 
 
𝒕 =
𝑳
𝒗
=
𝑳
√
𝟐𝒆𝑼
𝒎/𝒛
 
Equation 5 
 
where, m = mass of the ion 
v = velocity of the ion in the flight tube 
z = number of charges on the ion 
U= Ion acceleration potential 
e = elementary charge (1.602×10
−19
 coulombs) 
L = length of the flight tube 
t = time of flight  
A TOF instrument detects all ions pulsed into the analyzer at a given time. Thus, 
TOF analyzers are well suited for analysis of ions generated by the pulsed MALDI 
process. Electrospray generates a continuous beam of ions that must be compacted and 
pulsed into the TOF analyzer. TOF analyzers record all arriving signals and therefore 
sample a higher percent of the ions generated than quadrupole or ion-trap analyzers using 
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ESI. TOF instruments also have a duty-cycle advantage over trap instruments and can 
therefore reach MS acquisition speeds as high as 50 Hz on commercial instruments, 
which makes them the preferred analyzer for LC-MS and MALDI-MS. Resolution in 
TOF-MS is limited primarily by the length of the flight tube as well as by the temporal, 
spatial and kinetic energy spreads of the ion-packets, which can cause peak broadening. 
Reflectron TOF detectors can improve resolution by effectively increasing the length of 
the flight path, without having to increase the physical length of the flight tube, and more 
importantly by correcting the kinetic energy spread of ion packets. Additionally, delayed 
pulsed ion extraction can decrease the dispersion of ion packets at the detector, further 
improving the resolving power [62,350,544]. The detection system must be very fast 
(kHz) in high resolution TOF systems, in order to maintain the resolution provided by the 
analyzer. 
1.2.4.3.2 Quadrupole mass analyzer or Quadrupole mass filter 
Ideal quadrupole mass analyzers (Q) are made up of four parallel, hyperbolic rods 
assembled in a square configuration. In practice, cylindrical rods are often used. The 
opposite pairs of rods are connected electrically by a direct current (DC) potential with 
negative and positive polarities applied to the two different pairs. The two pairs of rods 
also have a radio frequency (RF) alternating current applied to them and are always 180 
degrees out of phase. As ions travel along the center of the Q, parallel to the rods, the DC 
voltages destabilize the ions, while the application of RF maintains ions of certain m/z 
along the ion path [352,353]. The combination of RF and DC fields causes the ions to 
oscillate perpendicular to the length of the rods. The RF and DC current values can be 
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selected such that only ions of certain m/z can be stabilized and traverse the entire length 
of the quadrupole, while all other ions collide with the rods and remain undetected. The 
Q can therefore be used as a mass filter where specific potentials allow the transmission 
of ions of a selected m/z that can be detected by a downstream detector in hybrid 
instruments such as QQQ, Q-TOF, Q-Orbitrap and Q-FTICR. The range of m/z values 
that is allowed to pass through the Q can be very wide or very narrow. While the 
quadrupole mass analyzer suffers from low mass accuracy, low resolution and limited 
mass range, the combination of the quadrupole as a mass filter with higher resolution 
mass analyzers such as TOF, Orbitrap and FTICR enables high-resolution/accurate mass 
(HR/AM) measurements [142]. This also facilitates selective fragmentation of analyte 
molecules in the gas phase and analysis of its fragments by tandem MS, which is 
discussed in more detailed in later sections. Triple quadrupole mass analyzers (QQQ) are 
extremely useful in monitoring pairs of precursor and fragment ions with enhanced 
specificity and sensitivity, using multiple reaction monitoring (MRM) assays [20]. 
1.2.4.3.3 Ion trap mass analyzer 
Ion traps are mass analyzers that use RF oscillating electric fields to store and 
analyze ions. Ion traps are categorized into 3-D quadrupole ion traps (QIT) or 2-D QIT or 
linear ion traps (LIT). The QIT operates with a 3-D quadrupole field by using a pair of 
opposing hyperbolic electrodes as end caps along with a ring electrode, as opposed to a 
quadrupole mass filter that uses four hyperbolic or cylindrical rods. QITs can have very 
high scan rates as the time to fill up the trap and acquire a spectrum is very short. 
However, the trapping efficiencies and dynamic range are limited due to the small 
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volume of the trapping region. This can also lead to poor spectral quality and mass 
accuracy from increased charge density [352,353]. The LIT achieves trapping by utilizing 
four sectioned quadrupole rods ending in lenses that trap ions radially by applying a RF 
potential between the rods and a DC potential at the end sections that confines the ions 
axially. Linear ion traps remedy the limitations of QIT by achieving higher ion storage 
capacity and minimizing space-charge effects. Mass measurements in ion-trap 
instruments are performed by ramping the RF field and measuring the amplitude that 
leads to ejection of ions based on their m/z [131,204]. While ion-trap instruments can 
achieve high scan rates, resolution depends heavily upon scan time and mass accuracy, 
even with increasing scan time, remains poor. The greatest advantage of using ion-trap 
instruments is that the ions can be stored and then excited inside the trap analyzers to 
achieve tandem MS and sequential MS/MS (MS
n
). Furthermore, ion trap mass analyzers 
enable gas-phase ion-ion reactions that require analyte ions to be stored with reagent ions 
for varying periods of time. Such reactions and MS
n
 experiments cannot be performed in 
beam-type instruments. Ion traps can be used in combination with other mass analyzers 
such as Orbitrap or TOF to achieve high mass accuracy and resolution, following ion-ion 
reactions or in tandem MS [65,349]. 
1.2.4.3.4 Fourier Transform Ion Cyclotron Resonance (FTICR) Mass Analyzer  
FTICR mass spectrometers are the most versatile instruments and provide the 
highest resolution and mass accuracy among the mass analyzers available today. FTICR-
MS is based on ion cyclotron resonance theory, which was first developed and evaluated 
for studying the fundamental properties of an atom by Lawrence and Edlefsen [317] and 
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Sommer et al. were the first to apply this technology in ICR mass spectrometry [232]. 
Marshall and Comisarow were the first to integrate Fourier Transform in ICR 
spectrometry [92,93]. Since then, instrumentation development and applications in 
FTICR-MS have increased exponentially. This section provides an overview of the 
fundamental principles of FTICR-MS, which have been covered in great detail in articles 
by Marshall et al. and by Amster [354,13]  
There are four primary components in all FTICR-MS instruments: a high-field-
strength magnet; an analyzer cell; an ultra-high vacuum system; a data system for data 
acquisition and processing. The first component is a magnet, most commonly a 
superconducting magnet. The newer FTICR-MS instruments all have solenoidal 
superconducting magnets that offer stronger magnetic fields and enable achievement of 
higher performance. All magnets have a cylindrical bore to allow incorporation of the 
analyzer cell.  
A cubic analyzer was the first to be developed and is still used today. This cell 
comprises of six plates in a cubic arrangement, such that one opposing pair of plates 
(trapping plates) is orthogonal to the direction of the magnetic field and the remaining 
two opposing pairs lie parallel to the field. The trapping plates or the trapping electrodes 
enable axial trapping of ions and have small openings in them to allow introduction of 
analyte ions and electrons into the cell, whereas the other two pairs of plates are used for 
ion excitation and ion detection. Another cell design known as the open-ended cylindrical 
cell also has six electrodes that perform similar to those in a cubic analyzer cell but form 
a cylinder-like shape. The two ends of the cylinder are the trapping electrodes that are 
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perpendicular to the magnetic field, with the principal axis of the cylinder aligning with 
the magnetic field. The core of the cylinder is divided into four electrodes that allow 
excitation and detection of charged particles. A dynamically harmonized FTICR cell with 
specially shaped electrodes was recently introduced by Nikolaev and coworkers 
[55,309,396]. This new cell design utilizes specially shaped electrodes for compensation 
of inhomogeneity of the magnetic field, which makes the cell field hyperbolic after being 
averaged along the cyclotron motion trajectories. This results in long durations of 
synchronous ion motion and higher resolving power than other cell types. 
The ultra-high vacuum system is present to maintain an extremely low pressure in 
the instrument (the order of 10
-9 
to 10
-10
 Torr), which is critical to achieve high mass 
resolution. This is because collisions between any gaseous particles and the analyte ions 
can lead to rapid decay of the transient signal, resulting in a lower resolution. A 
sophisticated data acquisition and analysis system is the fourth feature of an FTICR-MS 
instrument that includes a frequency synthesizer, delay pulse generator, broadband R.F. 
amplifier and preamplifier, a fast transient digitizer and an electronic system to 
coordinate all of the devices during the data acquisition, as well as to process and analyze 
the data. 
The ion motion in the analyzer cell is governed by a combination of electric and 
magnetic fields as described by the equation below.  
 𝐹 = 𝑞𝐸 +  𝑞(𝑣 ⊗ 𝐵) 
 
Equation 6 
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The electric field E, allows trapping of the ions between the trapping plates, while 
the ion motion in a direction perpendicular to the electric field is guided by a Lorentz 
force F, generated by the uniform magnetic field B. As a result, the cyclotron motion is 
defined by the following equation in the absence of the axial trapping field: 
 
𝐹 = 𝑚𝑎 = 𝑚𝑣𝜔 =  
𝑚𝑣2
𝑟
= 𝑞(𝑣 ⊗ 𝐵) 
 
Equation 7 
 
 
𝑟 =
𝑚𝑣
𝑞𝑏
 
 
Equation 8 
Where the Lorentz force (F) acts upon an ion of mass m and charge q, inside a 
uniform magnetic field B to move it along a circular path of radius r, with velocity v. 
Angular frequency is defined by, ω = v/r and cyclotron frequency fc = ω/2π. Therefore, 
the cyclotron frequency can be calculated as: 
 
𝑓𝑐 =
𝑞𝐵
2𝜋m
 
 
Equation 9 
Thus, measuring the cyclotron frequency, in a uniform magnetic field allows 
calculation of the mass-to-charge ratio, m/q or m/z.  
The electric field required for trapping of the ions inside the cell leads to a 
magnetron motion, which doesn’t provide any useful information regarding the mass-to-
charge ratio of the ions. Magnetron motion, represented by the equation below, is 
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undesirable because it causes radial diffusion of the ions and adversely affects mass 
accuracy. 
 
𝑓𝑚 =
𝛼𝑉
𝜋𝑎2B
 
 
Equation 10 
where, fm is the magnetron frequency, α is the geometry factor for the analyzer 
cell, a is the distance between the trapping electrodes and V is the trapping potential or 
electric field necessary to store the ions during analysis. 
Ion detection is achieved by applying a broadband excitation or a range of 
frequencies to excite all ions in that cyclotron frequency range. This is done by applying 
a rapid frequency sweep, which allows all ions in that range to be excited into large 
cyclotron orbits of the same radius and different cyclotron frequencies. When multiple 
ions are detected simultaneously with a broadband sweep, the resulting image current is a 
composite of sinusoids of different frequencies and amplitudes. The frequency 
components of the signal are isolated by applying a Fourier transform to the time domain 
transient. A calibration formula derived from the cyclotron equation allows conversion of 
the frequency spectrum to a mass spectrum. While, any portion of the transient provides 
information on the same set of ions, the mass resolving power is directly proportional to 
the length of transient recorded. This is described by the equation below, where R is the 
resolving power and T is the duration of the transient: 
 
𝑅 =
𝑓𝑐𝑇
2
 
 
Equation 11 
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The ultra-high resolution and capabilities for electron-based activation of ions in 
FTICR instruments have led to their frequent application to biopolymer structural studies 
and have been key in the development of top-down proteomics and detailed glycan 
characterization strategies [76,257,467,605,622,637,638]. The different dissociation 
modes used in protein, glycan and glycoconjugate analysis are discussed in later sections. 
Unfortunately, the high resolving power and versatility in dissociation techniques in 
FTICR-MS comes at the expense of data acquisition time. This prevents efficient 
coupling of these instruments to LC or CE separations. Further, the presence of many 
components in hybrid FTICR-MS instruments and the selectivity of the ion optics can 
result in low sensitivity compared to other mass spectrometers. Some of these limitations 
have been overcome in Orbitrap Mass Spectrometers that combine high-resolution with 
high acquisition speed and sensitivity, and this has led to their wide adoption for analysis 
of complex biological samples. 
1.2.4.3.5 Orbitrap Mass Analyzer 
Orbital trapping was demonstrated by Kingdon in the early 1900s but the Orbitrap 
mass analyzer was developed into a commercial instrument by Alexander Makarov more 
recently by solving the problem of efficiently injecting ions into it using a C-trap [295]. 
While Orbitrap mass spectra are also generated via Fourier transform of the transient 
signal, Orbitrap analyzers trap ions electrostatically [348], (i.e., without the requirement 
for a high-field magnet) making them considerably less expensive than FTICR analyzers. 
The Orbitrap analyzer consists of an outer barrel-like electrode and a coaxial inner 
spindle-shaped electrode. The outer electrode is separated into two equal halves separated 
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by a very fine gap. Ions orbit the inner electrode in elliptical trajectories and also move 
along the axis of the inner electrode in a harmonic motion. The ions are injected 
tangentially into the electric field between the two electrodes, which is ramped to 
compress the ions towards the inner electrode, until they reach the desired orbit inside the 
trap [250]. The ions move at different axial frequencies (ω) based on their m/z. The ion 
axial motion in the outer electrodes induces an image current, which is acquired as a 
time-domain transient and Fourier Transformed to produce a frequency spectrum. 
Frequencies are converted to m/z by the equation below [417,639]. 
 
𝜔 = (
𝑘𝑧
𝑚
)
1
2
 
 
Equation 12 
where, ω is the axial oscillation frequency, m and z are the mass and charge of the 
ion, respectively. k is the field curvature, determined by the exact shape of the electrodes 
and the applied potential. Orbitrap instruments have quickly gained popularity due to 
their superior performance in terms of speed and sensitivity as well as the high resolution 
and high mass accuracy achievable. 
The commercial Orbitrap instruments are fitted with a curved RF-only quadrupole 
ion trap (C-trap), which compresses and injects ion packets for analysis by rapidly 
ramping RF and DC voltages across the C-trap. Hybrid Orbitrap instruments use either an 
LIT upstream of the Orbitrap for mass isolation and dissociation of precursor ions by CID 
or ETD or a quadrupole, in conjunction with a Higher energy collisional dissociation 
(HCD) cell for collisional dissociation [349], or both [474].  
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1.2.5 Tandem Mass Spectrometry 
Tandem mass spectrometry entails isolation of a designated m/z range followed 
by ion activation, dissociation, and analysis of the resulting product ions [367]. The 
analyte ions or precursor ions can be measured intact first, followed by ion activation by 
one of the methods described in the following subsections, and mass analysis of the 
resulting fragment ions.  
Peptide fragments follow a nomenclature adapted from what was first proposed 
by Roepstorff and Fohlman [444]. Fragment ions containing the N-terminus are named a-
, b- or c-type based on the position, as shown in Figure 8. Similarly, product ions 
containing the C-terminus are named x-, y- or z-type. The numbering denotes the bond 
cleaved counting from the N or the C-terminus.  
 
Figure 8: Nomenclature for peptide backbone fragments generated from gas phase ions 
Similar to peptide fragmentation, a fragment nomenclature system for glycans 
was introduced by Domon and Costello [129]. Analogous to peptide fragmentation, 
fragments containing either end of the oligosaccharide (reducing or non-reducing end) 
are categorized as A-, B- and C-type (non-reducing end) or X-, Y- and Z-type (reducing 
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end) with a numbering system that indicates the position of the bond or residue at which 
cleavage occurred, as shown in Figure 9. While, B-, Y-, C- and Z-type ions are all 
generated by glycosidic bond fragmentation, A- and X-type ions are cross-ring fragments 
and therefore assigned with additional two numbers that denote the two bonds in a 
pyranose ring that were cleaved. The bonds are numbered from 0 to 5, starting with the 
O-C1 bond. For branched oligosaccharides, Greek letters (α, β, γ) are used to annotate the 
branches or antennae. The largest branch is designated as α, the next largest as β and so 
on for subsequent branches in decreasing order of size. If primary branches are further 
branched, superscript primes are used with Greek letters to indicate the order of 
branching, such as α’, β’ and α’’, β’’ for primary and secondary branches, respectively. 
 
Figure 9: Domon and Costello nomenclature for glycan fragmentation 
Reproduced from [129], with permission. Copyright © 1988, Glycoconjugate Journal 
 
1.2.5.1 Collisionally-activated dissociation or Collision-induced dissociation (CAD or 
CID) 
Collisionally-activated dissociation activates precursor ions by exciting them in a 
dissociation cell that is filled with a neutral gas such as nitrogen, argon or helium. 
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Repeated collisions lead to vibrational excitation of the precursor ions and the bonds 
dissociate in the order of their decreasing fragility, leading to generation of fragment or 
product ions. CAD is the most commonly used dissociation mode on modern mass 
spectrometers. It allows quick and efficient fragmentation that enables fast spectral 
acquisition and deeper coverage in LC-MS/MS experiments compared to other 
dissociation modes. Collisional activation can be broadly categorized into resonant-
excitation and beam-type. Resonant-excitation dissociation is achieved in ion trapping 
instruments, where product ions cool rapidly, thus limiting the extent of dissociation. 
Beam-type CAD product ions, on the other hand, undergo further collisions with gas, 
resulting in a higher extent of dissociation [261,365].  
Collisional dissociation was the first dissociation method applied for the 
purposeof peptide sequencing and PTM identification by mass spectrometry; it is still 
widely used today for peptide and PTM identification (211–213). Collisional-dissociation 
of peptides primarily yields b- and y-type ions, which are useful for peptide sequencing. 
One disadvantage of using CAD is that any PTMs that are linked to the peptide backbone 
with a bond more fragile than the peptide amide bond (e.g. sulfation, phosphorylation, O-
GlcNAc, etc.) may be lost in this process and only the unmodified peptide backbone can 
be determined from the tandem MS [415]. Another disadvantage is that, for large 
proteins, collisional activation only produces fragments near the N- and C-terminus while 
the central part of the protein remains poorly covered [76].  
Glycan fragmentation by collisional-dissociation primarily yields glycosidic bond 
fragments, with cross-ring fragments in lower abundances [324]. More comprehensive 
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cross-ring fragmentation can be achieved by manipulating ion charge states, using metal 
ion adduction, or inducing high-energy (kV) dissociation, at the cost of higher analysis 
complexity.  
1.2.5.2 Electron-activated dissociation (ExD) 
Electron-activated dissociation is a broad term used to refer to a number of 
dissociation modes including electron capture dissociation (ECD), hot electron capture 
dissociation (hECD), electron transfer dissociation (ETD), negative electron transfer 
dissociation (NETD), electron detachment dissociation (EDD) and electronic excitation 
dissociation (EED) [33,97,378,488,589,636]. 
The ETD process combines ion-ion chemistry with tandem mass spectrometry 
[513]. In ETD, multiply charged analyte ions are reacted with radical anions, generated in 
a chemical ionization source, to transfer electrons to the precursor cations, and results in 
the formation of an odd-electron hypervalent species that dissociates by a non-ergodic 
process. ETD reactions are typically performed in analyzers that allow trapping of the 
precursor ions with reagent radical anions, such as those from anthracene and 
fluoranthene. Ion trap instruments only allow resonant-excitation of the precursors and 
suffer from an m/z range cutoff that limits acquisition in the low m/z range, depending on 
the RF trapping field magnitude. Newer instrument and dissociation cell designs now 
enable ETD and beam-type collisional dissociation to be performed in the same 
multipurpose dissociation cell [446]. This enables combination of collisional and 
electron-based dissociation for better sequence coverage on large proteins and glycans 
[161,331].  
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Negative electron transfer dissociation (NETD) is a variant of ETD used for 
negative mode analysis, where reagent cation radicals are reacted with precursor anions 
to induce dissociation. It is an extremely useful fragmentation mode for generating 
complementary information on analytes that do not ionize efficiently or fragment too 
extensively in the positive mode due to their acidic nature, including acidic glycans and 
ribonucleotides, as well as acidic peptides [257,366,442,453,576].  
Electron capture dissociation (ECD) is achieved by directing a beam of low-
energy electrons into a region containing multiply-charged analyte cations. While the 
exact mechanism of peptide fragmentation by ECD is still under debate, the overall 
reaction is driven by electron capture by the analyte polycations, followed by charge 
reduction and generation of an excited radical species that rapidly decays by bond 
cleavage to generate the fragment ions. Peptide fragmentation by ECD and ETD 
predominantly produces N-Cα bond cleavage. As a result, ECD and ETD primarily 
generate c- and z-type ions; some secondary fragmentation from side chain losses may be 
seen and are more common in ECD than ETD [553,637].  
ETD and ECD generate more complete coverage for large proteins and 
informative cross-ring fragments for glycans [76,208,255,327,630,637]. Because these 
dissociation modes do not involve vibrational excitation, fragile PTMs often remain 
intact during ECD/ETD and their linkage site can be identified in the product ion spectra 
[370,380,567,637].   
Increasing the electron energy during ECD fragmentation can lead to extensive 
secondary fragmentation, including amino acid side chain losses from z• ions and 
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formation of w ions. Additionally, b- and y-type ions may be seen. This type of 
fragmentation is termed hotECD (hECD) and has been shown to be useful in 
discriminating isomeric amino-acids such as norvaline from valine and leucine from 
isoleucine [298,299,568,606]. 
Further increasing the electron energy above what is needed for hECD can lead to 
a completely different dissociation process known as Electronic Excitation Dissociation 
(EED) [605]. For glycans, EED results from formation of a distonic ion due to electron 
detachment from an oxygen atom. This is followed by electron recapture to generate a 
diradical that rapidly undergoes fragmentation. The advantage of using EED is the 
generation of extensive fragmentation without charge-reduction, which minimizes the 
precursor charge state dependence that ETD and ECD suffer from. EED also produces 
significantly more structural information than ECD and ETD and is compatible with 
analysis of glycans ionized with a wide range of charge carriers. 
Electron Detachment Dissociation (EDD) is the negative mode complement of 
ECD that utilizes higher-energy electrons (>10 eV). EDD is initiated by electron 
detachment from a multiply charged analyte anion, which produces an anionic radical 
that subsequently undergoes radical-induced fragmentation to generate a variety of 
product ions [63]. Similar to NETD, this fragmentation mode has been shown to be 
extremely useful in analysis of acidic analytes, including proteins, peptides and acidic 
glycans such as GAGs, without the loss of labile groups or side chains [3,492,574,575].  
Until recently, most electron-based activation methods could only be 
implemented in FTICR mass spectrometers because a strong magnetic field is required to 
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contain the electrons for activation of precursor ions. The application and dissemination 
of these methods was therefore limited due to the expensive FTICR instrumentation 
whose relatively lower scan speed and lower sensitivity hindered their effective 
implementation during high-throughput LC-scale experiments; however, Voinov et al. 
have recently demonstrated electron activated dissociation of biomolecules on QQQ and 
Q-TOF instruments fitted with a radio-frequency-free electromagnetostatic cell 
[550,552,553]. 
1.2.5.3 Photodissociation 
Photodissociation is an alternative method for ion activation and fragmentation, 
which offers higher selectivity than collisional and electron-based dissociation methods. 
This is because bond cleavages are specific to the wavelength of light used and the 
absorption spectrum of particular bonds. Two commonly used photodissociation modes 
are classified by the wavelength ranges they operate in: IRMPD (Infrared multiphoton 
dissociation) and UVPD (Ultraviolet photodissociation). While photodissociation is not 
widely available on commercial MS instruments, a number of academic research groups 
have used it for biopolymer characterization. IRMPD is often combined with CAD or 
ExD for supplemental activation, to achieve more extensive fragmentation. 
Photodissociation is typically implemented in instruments where ions can be trapped for 
some period of time, so that they can be exposed to photon irradiation. Without making 
major modifications to the mass spectrometer, a window is added to the instrument to 
allow introduction of a laser beam. A quartz window may be used for transmission of 
near UV light (e.g. 355 nm). UVPD (e.g., 193 nm) requires the use of a LiF or MgF2 
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window, IRMPD by CO2 (10.6 µm) typically uses a ZnSe window. Photodissociation 
requires the analyte ion to have a suitable chromophore to allow photon absorption and 
ion excitation. Ly and Julian have summarized the use of UV lasers of different 
wavelengths in tandem MS [341]. In cases where the laser is not directly absorbed by the 
analyte, a chromophore may be attached covalently or non-covalently. IRMPD is 
typically used in conjunction with other dissociation modes such as ETD and facilitates 
better dissociation by pre-activating the ion. This involves unfolding of the precursor ion 
by irradiation leading to electron acceptor sites getting exposed for better ExD 
fragmentation. Many research groups have explored the use of UVPD and IRMPD in 
glycomics and proteomics, some of which are discussed in the following sections 
[124,125,303,318,344,442,446,480,492].  
1.2.6 Ion-mobility-Mass Spectrometry 
Ion-mobility spectrometry (IMS) is a method that provides an additional 
dimension of separation and structural information for gas-phase analytes. Ion-mobility 
techniques are broadly characterized into three different modes: time dispersive; space-
dispersive and ion-confinement with selective release [361]. The different types of IMS 
techniques have been described in detail elsewhere [54,149,285,361,369,426,644]. IMS 
provides an extra dimension of separation for ions in complex biological mixtures and 
can be easily combined with liquid-chromatography and mass analysis. Combination of 
IMS with MS allows analysis of both molecular compositions and structural 
conformations in a single experiment, with tandem MS adding additional sequence and 
structure information to the already resolved conformations. This section reviews the 
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basic concepts and instrumentation used in IM-MS (Ion mobility-mass spectrometry) of 
biomolecules, while work focused on applications of IM-MS to biomolecular separations 
is discussed in later sections and in Chapter 5.  
1.2.6.1 Drift-tube Ion Mobility Spectrometry (DTIMS) 
A drift-tube ion mobility device is the most common IMS instrumentation, widely 
used in chemical detectors for security applications. In a DTIMS system, ions travel with 
constant velocities vd under a uniform electric field E through a drift tube filled with a 
buffer gas.  
 𝑣𝑑 = 𝐾𝐸 
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Equation 14 
Where K is the mobility of the ion. L is the length of the drift tube, tD is the drift 
time of the ion, and V is the voltage drop across the drift tube. The mobility of an ion is 
often reported as its reduced mobility (K0) at standard temperature and pressure, which 
can be calculated from K by: 
 
𝐾0 =
𝑝
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×
273.15
𝑇
× 𝐾  
 
Equation 15 
Where p and T are the pressure and temperature of the buffer gas, respectively. 
Substituting for K, 
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Equation 16 
The collision-cross-section (Ω), abbreviated as CCS, of an ion can be calculated 
from its measured drift time and mobility, as follows:  
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Equation 17 
Where z is the ion charge, N is the number density of the gas used, mi is the mass 
of the ion, mb is the mass of the buffer gas molecule and kb is the Boltzmann constant. 
The mobility resolving power R, for all temporally dispersive ion-mobility 
devices, is calculated as the drift time divided by the peak width at half-maxima (w): 
 
𝑅 =
𝑡𝐷
𝑤
 
 
Equation 18 
Commercial DTIMS instruments deliver a resolving power of about 50-60, while 
certain custom-built instruments have been shown to have resolving power higher than 
100 [172,176,285,515,535,591]. 
1.2.6.2 Traveling wave ion mobility spectrometry 
A traveling wave ion mobility spectrometry (TWIMS) device comprises a series 
of electrodes that form a stacked ring ion guide. RF voltages with opposite phases are 
applied to the adjacent electrodes in the ion guide and this induces a wave pattern of 
voltages, known as a traveling wave (T-wave) [169,424,519]. The T-wave creates a 
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transient potential to move ions through the TWIMS device under static pressure of an 
inert buffer gas. While higher-mobility ions can keep up with the wave and therefore 
travel faster through the ion guide, lower-mobility ions fall over the apex of the traveling 
wave peak and are therefore slower to arrive at the end of the mobility device. In addition 
to the RF potential used to create the T-wave and push the ions through the ion guide, a 
second RF voltage component is applied to confine the ions radially. The TWIMS device 
is available on commercial mass spectrometers (Synapt) from Waters Corporation. 
While, the calibration of DTIMS is straightforward, the TWIMS device requires 
extensive calculations. Due to the absence of a physical model for TWIMS, the mobilities 
and CCS values of analytes must be extracted using empirical calibration performed 
using a set of analytes or calibrants, for which CCS values have been determined using 
DTIMS or another mobility device [484]. 
1.2.6.3 Trapped ion mobility spectrometry 
Trapped ion mobility spectrometry (TIMS) is another technique for separating 
gas-phase ions based on their size-to-charge ratio[152,153,229,377,485]. This method 
utilizes an electric field to stabilize ions against the flow of a carrier gas that pushes ions 
towards the analyzer. A TIMS ion funnel consists of an entrance funnel, a mobility 
analyzer and an exit funnel. Radial confinement of ions is achieved by applying the same 
RF potential to the electrodes in all three regions of the TIMS device. The adjacent plates 
in the entrance and exit funnels have an RF potential applied to them, which is 180⁰ out-
of-phase. The RF phase between adjacent plates in the analyzer region is constantly 
alternating [175]. The entrance funnel traps and focuses ion packets that are periodically 
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pulsed into the analyzer region, where a laminar gas flow directs the ions from the 
entrance funnel towards the exit funnel. A scanning electric field is used to retard the 
motion of ions towards the exit funnel and, with the appropriate combination of electric 
field strength E and carrier gas velocity vG, the net axial velocity of an ion of mobility K 
becomes zero, thus the ion is trapped in the analyzer region: 
 𝑣𝑖𝑜𝑛 = 𝐾𝐸 +  𝑣𝐺 = 0 
 
Equation 19 
A gradual decrease in the electric field strength by reducing the voltage difference 
(∆V) between the entrance and exit funnels allows sequential release of trapped ions of 
increasing mobilities [377,377,425]. Mass analyzers can be combined with TIMS devices 
to record spectra of ions as they sequentially elute from the mobility device.  
A variation of the TIMS device, known as selected accumulation TIMS (SA-
TIMS) has been recently introduced that allows selective storage or trapping of ions of 
desired mobility. In SA-TIMS, the axial electric field gradient is modified to include a 
steep ramp near the entrance that stops lower-mobility ions from entering the mobility 
analyzer, and a small barrier near the exit that does not retain higher-mobility ions; thus 
only ions with the mobility of interest are selectively accumulated in the TIMS analyzer. 
SA-TIMS allows combination of TIMS with mass analyzers and dissociation modes that 
require ion-trapping such as ExD on FTICR-MS [426].  
1.2.6.4 High-field asymmetric waveform ion mobility spectrometry 
DTIMS instruments use a low-field potential for mobility separations, where drift 
velocity is proportional to the electric field applied but the mobility is independent of the 
  64 
electric field. When higher electric fields are applied, the drift velocity is no longer 
proportional to the electric field strength but the mobility becomes dependent on the 
electric field applied. High-field asymmetric waveform ion mobility spectrometry 
(FAIMS) utilizes the difference in mobility of an ion in the high-field and low-field limits 
as a mechanism for gas-phase separation of ions [191,421,441].  
FAIMS uses an electric field applied between a pair of electrodes perpendicular to 
the flow of the carrier gas, such that it induces axial motion of the ions through the 
mobility device. One of the two electrodes is kept at ground potential and an asymmetric 
waveform is applied to the other. The asymmetric waveform consists of a shorter 
duration high-voltage component and a longer duration low-voltage component, of 
opposing polarities. The peak voltage of the asymmetric waveform is known as the 
dispersion voltage. For a majority of ions, the mobility in the high field is different from 
the mobility in the low field, resulting in a net transversal displacement from their 
original positions [191,192]. To eliminate this transversal displacement, a DC 
compensation voltage is applied. The ratio of high-field mobility to low-field mobility is 
unique for each ion in a mixture. As a result, a unique compensation voltage is required 
to transmit each ionic species in the FAIMS device. When the compensation voltage is 
set for transmission of one ion in a mixture, all other ions drift towards one of the 
electrodes and get neutralized, thus allowing the FAIMS device to act as a mobility filter. 
A compensation voltage scanning mode can be used to generate a FAIMS mobility 
spectrum, where ions of different mobilities get transmitted sequentially through the 
mobility device. 
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While other types of IMS instrumentation exists, the above described techniques 
are most commonly used for gas-phase separation of biomolecular ions. Our own work 
involving application of DTIMS to glycan and glycoconjugate separation is described in 
Chapter 5. 
 
1.2.7 A review of mass spectrometry applications in glycan and glycopeptide analysis 
Glycans and proteins are two different classes of biopolymers that have very 
different biochemical properties. While proteomics and glycomics present their own 
challenges in deep characterization, the level of complexity scales exponentially when 
these two biopolymers are combined to form glycoproteins with heterogeneous 
glycosylation. This section describes the state-of-the-art methodologies in achieving 
different levels of characterization of both released glycans and glycopeptides using mass 
spectrometry. 
Comprehensive glycoproteomics analysis is many problems combined into one. 
This is because detailed characterization of the entire protein backbone and the 
decorating glycan(s) requires many different experiments. The methods to be used are 
dictated by the type and level of information that is desired to meet the needs in 
biological hypotheses - an overall glycomics profile may be sufficient in some cases, 
while detailed linkage information is necessary in others. Generally, the ability to 
characterize glycoproteins and glycans in a high-throughput manner decreases as deeper, 
more specific analyses become necessary. This decline in throughput is offset by 
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advancement in analytical workflows and improvement in instrumentation and 
informatics tools.  
Biological hypotheses often focus on a specific set of biomolecules and their 
functions in normal and altered states. While omics level experiments measure the 
properties of a system at the level of all detectable proteins and glycans, the resulting 
information needs to be probed at varying levels of granularity for pinpointing the 
involvement of candidate biomolecules in health and disease. Naturally, more specific 
and detailed information can be obtained from a sample that has been enriched for a 
specific subset of proteins and glycoproteins based upon the hypothesis. Biochemical 
methods employed in fractionating, enriching and purifying glycoproteins from different 
matrices, cellular compartments or based on their physiochemical properties or affinity 
towards binding partners are generally well-established and previously reviewed 
[79,80,253,343,607,623].  
Regardless of the method and stringency used in glycoprotein purification, 
contaminating proteins and glycoproteins are always present. It is therefore important to 
first establish the level of purity. With the assumption that proteomics workflows are 
more sensitive that glycoproteomics, a bottom-up proteomics experiment with or without 
deglycosylation helps account for all proteins and glycoproteins present in the sample, 
including targets and contaminants. Because glycosylated peptides are more difficult to 
analyze due to their poorer ionization efficiency and diverse glycoforms, deglycosylated 
proteomics enhances the ability to characterize the underlying peptide backbones. This is 
limited to N-linked glycopeptides, where the glycan can be removed using PNGase F, 
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without destroying the peptide backbone. The PNGase F release also induces a mass shift 
of 0.98 Da by converting the previously glycosylated asparagine to an aspartic acid. This 
mass shift can be used to account for the glycan site occupancy (macroheterogeneity) at 
that site [291,498,507,607]. The observed mass shift can be enhanced if the enzymatic 
deglycosylation is performed in the presence of H2
18
O, allowing incorporation of the 
heavier oxygen at the previous site of glycosylation [291,337,478,618]. Incorporation of 
an 
18
O isotope also reduces false positives arising from in-vivo Asn deamidation. 
However, it is important to ensure that trypsin or other serine proteases have been 
inactivated prior to deglycosylation in presence of H2
18
O, to prevent artefactual labeling 
on peptide C-termini [23]. Also, spontaneous deamidation of asparagine residues in the 
presence of the heavier water can lead to labeling of the unmodified peptides, thereby 
confounding the data [291]. In addition to providing a measure of site-occupancy, 
proteomics of deglycosylated peptides also allows determination of all molecular forms 
of the peptide backbone present in the sample, along with any other PTMs present on the 
peptides apart from N-glycans [291,292]. For O-linked glycoproteins or glycopeptides, 
the level of information that a proteomics experiment yields may be limited to 
identification of all proteins present in the sample, since O-glycans cannot be removed 
without destroying the peptide backbone without using a series of enzymatic steps, and 
few relevant O-glycosidases are commercially available. Due to the multiplicity of 
molecular forms in a heterogeneous glycan population, it may not always be feasible to 
assign all peptide backbones and PTMs on glycosylated peptides.  
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Proteomic characterization is well-established and usually involves C18 reversed-
phase LC-MS/MS with data-dependent acquisition (DDA). The mass spectrometer is 
programmed to select and fragment the most abundant analytes as they elute from the 
chromatograph [37,181,277,385]. The data are typically subjected to a proteomics 
database search for identification of proteins and peptidoforms present in the sample.  
1.2.7.1 Glycan mass spectrometry 
Once a biological sample has been characterized for proteins present and their 
respective proteoforms or peptidoforms, the total pool of glycans can be determined by 
analyzing released glycans. Glycans can be released from proteins as described in 
previous sections and further resolved by chromatography. Online LC-MS can be used to 
get an overall profile of glycan compositions using single stage MS. While native glycans 
may be analyzed in the positive mode, it is generally preferred that negative mode be 
used to prevent protonation and minimize loss of acidic moieties such as sialic acids and 
sulfate groups. LC-MS is the preferred method for glycan profiling. As described in 
earlier sections, reversed-phase chromatography can be used for glycan separation only 
when the glycans are peralkylated or are conjugated with a hydrophobic tag, frequently at 
the reducing end. Reversed-phase chromatography methods for LC-MS of derivatized 
glycans have been reviewed recently by Vreeker & Wuhrer [554]. The Wuhrer group has 
also developed numerous workflows for glycan profiling using MALDI-MS, which also 
involve linkage specific chemical derivatization and automation for high-throughput 
glycan profiling with sialic acid linkage discrimination [202,438,483]. They have also 
developed a data analysis pipeline for glycan assignment and relative quantitation from 
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MALDI-MS data and showed that relative quantification results from MALDI-MS and 
LC-MS are comparable [269].  
The Mechref group has thoroughly explored the use of reversed phase LC-MS for 
glycomics and compared its performance with MALDI-MS for glycan analysis. They 
have demonstrated online trapping for desalting of permethylated glycans and use of 
higher temperatures for improving chromatographic resolution for permethylated glycan 
alditols [123,130,251,252,628]. They assert that while MALDI-MS is convenient and 
provides good coverage on glycoforms, it doesn’t match the sensitivity of RPLC-ESI-MS 
for glycan profiling. Furthermore, they have shown that RPLC performed at elevated 
temperature produces better and narrower peak shapes and higher resolution, sufficient to 
separate glycan structural isomers, but their method could not separate linkage-specific 
isomers. Quantitative mass spectrometry-based methods for glycan profiling have been 
reviewed by Mechref [371]. These strategies involve labeling of released glycans using 
one of the methods described in the previous sections and then using either single-stage 
or tandem MS for label-free or label-based quantification. 
While glycan profiling experiments are valuable in estimating the range of 
glycoforms and their relative abundances, the assignments often suffer from ambiguity in 
isobaric glycan compositions and structures. Further, false compositional assignments 
cannot be eliminated in the absence of glycan fragmentation. Tandem MS of 
oligosaccharides adds much value to glycan analysis both in terms of overall glycan 
profiling and confirming assignments, and detailed glycan structure analysis [15,323]. 
Permethylation of glycans enables LC-MS in the positive mode without any loss of acidic 
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residues. Tandem MS of permethylated glycans also yields more useful information for 
structural assignment compared to native glycans. Most recently, Zhou et al. have 
described the use of PGC LC-MS/MS for isomer characterization of permethylated N-
glycan alditols [627]. They demonstrated the ability to resolve core and terminal 
fucosylation by chromatography and confirmed the assignments based on tandem MS.  
PGC LC-MS is also used in many laboratories for analysis of native glycans. 
Everest-Dass et al. compiled a library of tandem mass spectra from glycan alditols 
analyzed using PGC-MS/MS on an ion-trap instrument using CAD [145]. They 
characterized over 200 N- and O-glycan structures generated by sequential treatment with 
exoglycosidases and used diagnostic ions for glycosidic and cross-ring fragments to 
discriminate isomers. Negative mode LC-MS is also commonly used in native glycan 
profiling experiments, particularly for acidic glycans including sialylated 
oligosaccharides and sulfated glycosaminoglycans [256,286,287,322,495,496]. While 
collisional activation in the positive mode generates primarily glycosidic bond cleavages, 
in the negative mode it can yield more cross-ring fragments that are informative towards 
structure elucidation. This is particularly the case when acidic groups are deprotonated or 
paired with a metal cation.  Metal-adduction in the positive mode also enhances the 
ability to generate cross-ring fragments using collisional dissociation, compared to 
protonated oligosaccharides [220,238]. Ni and colleagues used ammonium fluoride in the 
mobile-phase for PGC LC-MS to form pseudomolecular oligosaccharide anions that yield 
useful product ions, including C-type glycosidic fragments, A-type cross-ring cleavages 
and gas-phase reaction products such as D- and E-type ions, which are useful for detailed 
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structural characterization of the glycan [395]. Additives to improve mass spectrometric 
ion responses and fragmentation patterns of oligosaccharides can also be added post-
column continuously or pulsed into the electrospray to minimize salt build-up in the 
source [256,496]. Yu and colleagues have explored CAD on MALDI-Q-TOF and 
MALDI-TOF-TOF for permethylated glycan tandem MS and show that, while a Q-TOF 
instrument affords only glycosidic bond fragments generated by lower energy CID, TOF-
TOF MS/MS provides high collisional energies to generate abundant cross-ring 
fragments for glycan sequencing [604]. Unfortunately, many of the more abundant cross-
ring fragments are 
1,5
Xn product ions which can be generated from any linkage isomer, 
and are therefore provide little structural information. 
Another method for analyzing detailed glycan structure is sequential tandem MS 
(MS
n
). The Reinhold group has thoroughly investigated the use of MS
n
 for glycan 
structure elucidation [28,29,30,273,273].  Sequential tandem MS can only be performed 
in ion-trap instruments where multi-stage dissociation can be performed efficiently on 
precursors and resulting fragments.  Ion trap instruments are also extremely valuable for 
combining CID and ETD fragmentation in MS
n
 experiments to generate complementary 
information on the same precursors. Han and Costello analyzed the structure of milk 
oligosaccharides using CID, ETD and sequential MS/MS on an ion-trap instrument, even 
including sequential ETD and CID steps, in either order [208]. Their results showed an 
abundance of cross-ring fragments in ETD spectra and the fragment ion assignments 
were verified using MS
3
 and stable isotope labelling at the reducing end, with or without 
reduction.  
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Although sequential tandem MS has its advantages in producing detailed 
structural information, the process is extremely low throughput and requires relatively 
large quantities of pure starting material for long periods of continuous infusion. This 
also hinders the coupling of the MS
n
 approach to chromatography and limits its use in 
omics-scale experiments. In addition, manual involvement and expert knowledge are 
necessary for selecting fragments appropriate for sequential tandem MS and the data 
acquisition and analysis are difficult to automate.  In addition, there is concern in the 
community that product ion identification is ambiguous in the absence of high mass 
resolution and mass accuracy, although the use of stable isotopic labels and verification 
with parallel analyses performed on FTICR instruments can mitigate potential ambiguity. 
Electron activated dissociation of glycans is greatly advantageous over single 
stage collisional activation for tandem MS. While ECD of large branched 
oligosaccharides can require supplemental activation such as IRMPD to yield efficient 
fragmentation, higher energy electrons in hECD can generate extensive glycan 
fragmentation without supplemental activation [2]. Zhao et al. have compared CAD and 
hECD of branched permethylated oligosaccharides on an ESI-FTICR mass spectrometer 
[622]. The study showed that the two fragmentation modes generate complementary 
structural information, in terms of the types of ions generated. While CAD generated 
abundant B- and Y-type glyosidic fragments, hECD generated predominantly C and Z 
ions. CAD also generated A-type cross ring fragments and hECD produced paired A and 
X ions that helped assign linkages positions.  Devakumar and colleagues have also used 
ultraviolet photodissociation (UVPD) using a 157-nm laser to identify structural isomers 
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in permethylated glycans [124,125].  The authors showed that photofragmentation 
generates more A-type cross ring fragments compared to CID. Ko and Brodbelt have 
used a 193-nm UV laser for photoactivation of sialylated glycans in the negative mode to 
attain extensive A- and X-type cleavages for sialylated glycans [303]. They note that 
operation in the negative mode also alleviates the need to permethylate glycans [61].  
Another method for producing rich glycan structural information is Electronic 
Excitation Dissociation (EED), which can yield extensive cross-ring fragmentation 
without any charge reduction [605]. Electron Detachment Dissociation (EDD) allows 
negative mode fragmentation of oligosaccharides, which has been shown to be more 
extensive than both CAD and IRMPD [3]. This has enabled negative mode fragmentation 
of acidic oligosaccharides such as GAGs, to generate detailed structural information 
[575]. In addition to EDD, NETD (Negative Electron Transfer Dissociation) has also 
shown promising results in attaining structurally informative fragments for highly 
sulfated glycans in the negative ion mode [257,576]. Overall, electron activated 
dissociation modes can provide comprehensive structural information that can be 
combined with chromatographic separations for better coverage. As ExD becomes 
available on faster, more sensitive instruments such as the systems being developed by 
Voinov et al. [550,551,552,553], online LC-MS methods with ExD will become more 
accessible to researchers in glycoanalytics.  
Even with the best chromatographic resolution and most efficient tandem MS 
methodologies, it is difficult to characterize glycans that are present in biological 
samples. Glycans in nature are always heterogeneous in terms of compositions and fine 
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structure, including branching, positions of substituents and linkages. Structural isomers 
can be separated to a limited extent by chromatographic and offline purification methods 
and these co-eluting isobaric molecules generate chimeric spectra where the exact 
structural features remain unresolved. Ion-mobility spectrometry is becoming 
increasingly powerful in resolving isobaric molecules with structural and conformational 
differences. With the addition of ion-mobility devices to mass spectrometers, it has 
become possible to resolve isomeric glycans prior to MS and tandem MS measurements. 
The first commercial IMS-MS instrument, the Waters Synapt TWIMS-Q-IM-TOF, 
became available in 2006. Since then, newer generations of the Synapt instrument have 
been released and the latest addition to the family of commercial IM-Q-TOF instruments 
is the Agilent 6560 drift tube IMS (DTIMS) IM-QTOF.  
In 2013, Pagel and Harvey measured the CCS (Collision Cross Section) values of 
many sodiated N-glycans using both nitrogen and helium on a TWIMS system [411]. 
They also performed in-source fragmentation and measured CCS values of both the 
native glycans and fragments thereof, to correlate trends in varying 
compositions/structures with CCS values. They were able to resolve structural isomers, 
of the same glycan composition (bi-antennary disialylated N-glycan), from fetuin, 
thyroglobulin and ovalbumin. Plasencia et al. have analyzed permethylated N-linked 
glycan structural isomers from Ovalbumin using a home-built modular DTIMS-TOF 
system [419]. Such data from glycan IMS studies are being populated into an online 
database, GlycoMob, cataloging CCS values for different glycans [506]. As the size of 
this database grows, these CCS values can be used for confirming glycan identities in 
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discovery glycomics experiments [237]. Ion-mobility separation has also been used for 
resolving linear glycosaminoglycan oligosaccharides that have different conformations 
due to differences in sulfation patterns [463,475].  Zheng et al. have studied the 
separation of glycan isomers adducted with metal ions in both positive and negative 
modes, using DTIMS [625]. Their results show that the presence of metal ions has a 
significant impact on glycan conformations and this helps improve gas-phase separations. 
Hofmann and colleagues recently performed relative quantification of configurational 
trisaccharide isomers in a mixture, using a TWIMS-Q-TOF system [236]. The Clemmer 
group has characterized isomers of the Man7 glycan from bovine ribonuclease B after 
permethylation, using a modified DT-IMS-LTQ instrument with a 1 meter long drift tube, 
where they were able to select mobility separated glycan isomers using a selection gate at 
the end of the drift tube [632]. Mobility selected ions were dissociated in the linear ion 
trap using collisional activation. Glaskin et al. have reported the incorporation of an ECD 
cell into the Agilent 6560 IM-QTOF MS and its use for oligosaccharide analysis 
[99,178]. Such combination of ion-mobility and tandem MS can be extremely useful for 
separation and identification of glycan structural isomers. Pu and co-workers have 
demonstrated the power of combining ExD with ion-mobility separation on a hybrid Qh-
FTICR mass spectrometer, modified with a front-end selective accumulation-trapped ion 
mobility spectrometry (SA-TIMS) device [426]. SA-TIMS provides higher resolution 
than the drift-tube and traveling wave devices. Combined with high resolution mass 
spectrometry and extensive structural information from ExD, this method provides 
unambiguous assignment of glycan structures from a mixture of isomers. Together with 
  76 
liquid and gas-phase separations, tandem MS of glycans has made a great impact in 
revealing structural complexities of glycans in biological systems and enabled large scale 
glycan profiling and comprehensive characterization studies. 
 
1.2.7.2 Glycopeptide mass spectrometry 
Complete structural elucidation of glycoproteins requires analysis of site-specific 
glycosylation to model the functions of glycosylated proteins and to understand their 
biological functions. Released glycan analysis by MS-based approaches yields useful 
information for compositional and structural assignments but does not provide 
information on the linkage of glycans to proteins. Addition of glycosylation sites to 
proteins enhances the heterogeneity of protein molecular forms exponentially, due to the 
added heterogeneity of glycan molecular forms. This adds considerable challenges in 
both acquisition and interpretation of site-specific glycosylation data.  
The glycan micro- and macro-heterogeneity are primarily regulated by the 
glycosylation enzymatic machinery and its accessibility to the site(s) of glycosylation 
[4,210,291]. Since glycan synthesis is a non-template driven process, it is difficult to 
predict the exact compositions or structures present at each glycosylation site. Because 
each glycosylation site can have a variety of glycoforms decorating it, addition of 
glycosylation sites quickly balloons the range of possible glycoproteoforms from the 
combined heterogeneity at each site. This complexity is further exacerbated by the 
presence of other PTMs on the protein and the difficulties in studying glycosylation as a 
PTM, as described in the previous sections.  
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Typical proteomics experiments entail enrichment, sample cleanup, proteolysis 
and LC-MS analysis, followed by database searching for identification and then 
quantification, when necessary. Glycoproteomics differs from typical proteomics 
experiments in many ways, due to the inherent differences in the physiochemical 
properties of glycosylated peptides. The first step in all protein mass spectrometry studies 
is sample acquisition and preparation. This includes collection of biological samples such 
as tissue, biofluids or cultured cells and then appropriate treatment for analytical 
workflows. For a discovery or targeted proteomics experiment, a simple cleanup 
followed by proteolysis and desalting may suffice; a glycoproteomics experiment can be 
performed the same way but it is generally better to add an enrichment step for 
glycoconjugates to prevent masking of signal from non-glycosylated species. The 
enrichment methods used are typically selected based on the goals of the experiment. It is 
important to select an enrichment method that would minimize any bias in enrichment of 
different glycoforms, particularly if quantitative analyses are desirable. Typically, SPE 
methodologies are more convenient, robust and high-throughput for sample enrichment 
or fractionation compared to LC based fractionation, unless fine resolution of 
biomolecules over a long gradient is needed. Methods like HILIC provide the best overall 
enrichment of glycosylated proteins and peptides, without any major bias toward 
glycoforms. For more selective enrichment of particular glycoforms or glycan 
substructures/motifs, a lectin-based approach is preferable. Ion-exchange fractionation 
methods are very useful for isolating acidic glycans and glycopeptides (sulfated and 
sialylated species) from neutral glycoconjugates. In addition to offline glycopeptide 
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enrichment approaches, online enrichment of glycopeptides has also been demonstrated. 
We have designed a method for online HILIC enrichment of glycopeptides prior to 
reversed-phase separation and nanoESI on a microfluidics HPLC chip device from 
Agilent Technologies [293]. Reversed-phase separation remains the most efficient 
chromatography mode for glycopeptide LC-MS. Details of chromatographic separation 
methods have been discussed in the previous sections. 
Confident glycopeptide identification using mass spectrometry requires a tandem 
MS step [122]. This is because the combinations of theoretical glycan and peptide 
molecular forms against which data are searched typically contain multiple ambiguous 
matches even when high resolution/accurate mass measurements are used. Furthermore, 
in the absence of tandem MS, it is not feasible to assign the exact locations of PTMs or to 
de novo sequence peptides that are not present in a theoretical search space. Before the 
development of hybrid mass spectrometers capable of delivering higher energy beam-
type CAD, such as Q-TOF and Orbitrap instruments, collisional activation primarily 
generated glycan fragments and little or no peptide backbone coverage was present in the 
tandem mass spectra [579,585]. While this approach provides some information on the 
glycan composition and topology, in most cases, the peptide backbone has to be inferred 
from the residual mass after the glycan composition has been identified. This was still an 
error-prone process, since peptide backbone intact mass could have many more possible 
combinations given the number of amino acids and PTMs that can be combined together.  
One method that allows sequencing of the peptide backbone using low-energy 
resonant CAD uses MS
3
 of the glycopeptide Y1 ion (341–343). Such experiments can 
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only be performed on ion trap and ion trap-Orbitrap instruments.  The only other way to 
confirm a peptide match was to perform ETD to get peptide backbone fragmentation with 
the glycan still attached to the peptide backbone fragments [121,634]. ETD fragmentation 
is slower than CAD due to the reaction time required to initiate radical-mediated 
dissociation. While ETD performance has improved dramatically, particularly on newer 
generations of the Orbitrap instruments, it still lags behind CAD in terms of speed and 
sensitivity [248]. Furthermore, efficient ETD experiments can only be performed on the 
more expensive high-end hybrid Orbitrap instrumentation, thus limiting access among the 
research community. 
Fortunately, in the last few years CAD has gained popularity for glycopeptide 
analysis. We and others have shown that peptide backbone sequencing is possible using 
higher-energy collisional-activation (CAD or HCD) of glycopeptides [18,293]. This has 
enabled confident glycopeptide analysis by single-stage CAD tandem MS, using low-cost 
Q-TOF and Q-Orbitrap instruments. Such methods can be easily disseminated for data-
dependent acquisition of high-confidence glycoproteomics data [291]. While CAD works 
well for identification of singly-glycosylated glycopeptides, it has serious limitations in 
the ability to characterize multiply glycosylated peptides. Because glycosidic bonds are 
more labile than peptide bonds, vibrational energy provided by collisional activation 
results in complete obliteration of the glycans before the peptide backbone starts to 
fragment significantly. As a result, in higher energy CAD spectra where the peptide 
backbone can be sequenced, the glycan composition must be inferred from the residual 
mass of the precursor. This becomes challenging when analyzing multiply glycosylated 
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peptides for the following reasons. First, the abundances of peptide backbone dissociation 
ion for multiply glycosylated peptides are low with CAD. Second, the composition of 
individual glycan modifications remains unknown. Third, the exact location(s) of glycan 
attachment(s) remains ambiguous. Unless the glycosylation sites can be separated by the 
use of proteolytic enzymes, such glycopeptides can only be assigned confidently using 
ExD, most commonly ETD. The use of ExD for glycans and glycopeptides is discussed 
in Chapter 5. The Brodbelt group is also exploring the use of UVPD for glycopeptide 
analysis. They had earlier compared the use of CAD with UVPD for glycopeptide 
fragmentation, using a 193-nm laser in a trap instrument [303]. They showed that 
negative mode UVPD generated more extensive fragmentation for both the peptide and 
the glycan compared to positive mode UVPD or CAD in positive or negative modes. 
More recently, they have presented the negative mode UVPD results on acidic 
glycopeptides from kappa Casein glycoprotein and an Acinetobacter baumannii 
Ompa/MotB glycoprotein [344]. In both cases, UVPD produced abundant a- and x-type 
peptide backbone fragments that retained the labile glycan modifications. In addition, 
useful B/Y- and C/Z-type glycan fragments were observed, along with some cross-ring 
fragments that helped sequence the glycan attached.  
Because glycopeptide glycoforms cannot be fully resolved using online LC-MS, 
ion mobility is increasingly being used in glycopeptide analysis. IMS adds the much 
needed peak capacity for resolving glycoforms and achieving a deeper coverage of the 
glycoproteome. Li and co-workers studied the correlation in FAIMS trendlines with 
different charge states of glycopeptides from α1-acid glycoprotein (AGP) and 
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Antithrombin III and compared them with non-glycosylated peptides in both positive and 
negative modes. They were able to detect isomeric mobility peaks for specific 
glycopeptides [325]. The glycosylated peptides were well separated from any non-
glycosylated peptides. Such separation allows better identification of the glycoconjugates 
without interference from the more abundant peptides. Ion-mobility separation has also 
been applied to analysis of intact monoclonal antibodies and tryptic glycopeptides from 
the antibody. Olivova et al. analyzed the glycan heterogeneity in a monoclonal antibody 
by LC-ESI-IM-MS where the light and heavy chains were well-resolved in the gas phase. 
They also performed LC-ESI-IM-MS with two step-collisional dissociation of the 
glycopeptides to generate both glycan and peptide information [404]. Creese and Cooper 
have used FAIMS to separate and identify isomeric glycopeptides [104]. They analyzed 
two O-GalNAc linked glycopeptides with the same peptide backbones, only differing in 
the location of the O-GalNAc-linked using LC-FAIMS-MS. The glycopeptides co-eluted 
from the chromatograph but were partially separated in the gas-phase. The the locations 
of the GalNAc residues in the mobility-separated isomers were identified by tandem MS 
using ETD, which preserved the glycan modification during fragmentation. Glycoscience 
researchers are now starting to apply ion-mobility MS to yield information on 
biologically-relevant motifs. A recent study by Hinneburg and colleagues demonstrated 
the ability to resolve isomeric glycopeptides based on differences in N-acetylneuraminic 
acid linkages [231]. Our own work has focused on cataloging the collision-cross sections 
of a variety of glycans and glycopeptides to populate a database that can be used for 
  82 
inferring the glycan compositions in large-scale glycoproteomics and glycomics studies 
employing IMS. The details of this work are presented in Chapter 5. 
Improvement in glycoproteomics technologies has propelled biological studies in 
the last few years to the point where deep coverage of glycoform heterogeneity is now 
feasible. As the identification coverage increases, the focus is now shifting to being able 
to perform quantitative glycoproteomics. Recent studies have demonstrated relative 
quantitation of site-specific glycopepetide glycoforms [116,291,319,592,593,603]. 
Thaysen-Andersen et al. have summarized the recent glycoproteomics studies with the 
level of quantification achieved in a recent review [524]. We and others have described 
the available strategies and computational tools in both glycopeptide identification and 
quantification [113,248,249]. Data-dependent acquisition is the most commonly used 
acquisition method in LC-MS based proteomics and glycoproteomics, where precursors 
are isolated and fragmented based on their ion abundances. This method is limited by the 
duty cycle of the mass spectrometer in use and only samples the most abundant species. 
Additionally, the amount of time spent fragmenting each precursor is inconsistent 
because of variations in the ion abundances, chromatographic-peak shapes and changes in 
background. With increasing instrument speed, it is now possible to sample the entire 
mass range in small increments, without isolating specific precursor ions, by repeatedly 
cycling through sequential isolation windows – these methods are collectively referred to 
as Data Independent Acquisition (DIA) methods  [164,333,414]. This has enabled better 
coverage of all molecular forms present in the proteome/glycoproteome. Most 
importantly, every peak gets sampled consistently, so there is no bias in tandem MS-
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based quantitation. Liu et al. have compared the quantitative power of SWATH-MS 
(sequential window acquisition of all theoretical fragment-ion spectra) with SRM 
(selected reaction monitoring), which is regarded as the gold standard in quantitative 
mass spectrometry, for N-linked glycoprotein analysis [336]. SWATH measurements had 
slightly lower sensitivity for quantification but its reproducibility was comparable to 
SRM. However, a much larger number of peptides and glycopeptides could be quantified 
using SWATH-MS. SWATH and other DIA methods also obviate the need to create a 
targeted assay and yield information that can be used for both identification and 
quantification. The same group also applied the SWATH-MS acquisition method for 
glycoproteomics analysis of prostate cancer tissues and identified potential biomarkers 
for tumor aggressiveness [335]. Xu and colleagues have used SWATH-MS as a novel 
approach for N-glycosylation site occupancy measurement [595]. Sanda and Goldman 
have presented a workflow for DIA of IgG glycoforms from unfractionated human 
plasma samples [459]. They optimized CAD conditions for quantitative measurement of 
Y-ions resulting from saccharide unit losses and showed that this approach enhances 
sensitivity of label-free glycoform measurement in a complex sample. 
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Chapter 2: Development of LC-MS/MS methods for direct analysis of site-specific 
glycosylation in complex glycopeptide and peptide mixtures 
(Part of this work is published in [293]) 
 
2.1 Introduction  
Occurring through a series of regulated biosynthetic events in the endoplasmic 
reticulum and Golgi apparatus, the extent of glycosylation of mature proteins depends on 
numerous factors. Thus, the glycan structures assembled onto a given protein core are 
regulated according to cell type, developmental stage and spatial considerations.  It is 
therefore not surprising that distinct glycoprotein glycosylation patterns characterize 
normal versus disease states [53,449,532].  As has been described in a recent report by 
the National Research Council [391], methods for study of glycoprotein structures are 
essential to progress in biomedicine. Many glycoproteins have several sites of 
glycosylation, each with a range of glycoforms.  Glycoproteins pose analytical challenges 
based both on their chemical properties and the nature of the information produced.  
Thus, analytical methods used for proteomics and glycomics do not suffice for analysis of 
glycoproteins [323].    
Mass spectrometry workflows for discovery and targeted proteomics are 
applicable to post-translational modifications (PTM) with defined molecular weight 
values, including phosphorylation, acetylation, methylation, ubiquitination and β-O-
GlcNAcylation [87,264].  Such workflows have been applied to analysis of protein N-
glycosylation site occupancy only following enzymatic release of glycans [296]. Thus, 
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because complex glycosylation is beyond the scope of traditional proteomics workflows, 
there is a paucity of information regarding the structures of N-glycans that occupy each 
protein site [522].  In order to address this problem, algorithms that allow users to define 
an unlimited number of peptide modifications have been developed [43]. 
In order to determine the site-specific glycosylation structure of mature 
glycoproteins, it is necessary to acquire accurate proteolytic peptide maps that include the 
range of glycan structures present at each glycosylated amino acid. In practice, accurate 
determination of the site specific glycan structures present on complex glycoproteins 
(those containing more than one glycosylation site) requires purified starting material. 
This is demonstrated by a recent interlaboratory study [321] in which prostate specific 
antigen, a glycoprotein with a single site of N-glycosylation was analyzed. Although there 
was a consensus in the interlaboratory results regarding the distribution of the most 
abundant N-glycan compositions present, it was clear that a more complex glycoprotein 
would pose serious challenges to investigators using analytical methods in current 
practice. The reason for this is that glycosylation multiplies the number of molecular 
forms of each glycosylated peptide by more than 10-fold. In addition, the most-often used 
reversed phase chromatography methods in proteomics workflows lack an enrichment 
step and therefore do not perform well for mapping glycopeptides from glycoproteins that 
contain several glycosylation sites.   
Glycosylated proteins and peptides ionize poorly relative to non-glycosylated 
molecules. In order to produce confident identification of peptide backbone and glycan 
composition, it is desirable to analyze intact glycopeptides.  Intact analysis eliminates the 
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possibility of false positive identifications that result from detection of deglycosylated 
peptides as surrogates for glycopeptides. Specifically, peptides that become deamidated, 
either through chemical or enzymatic processes, may be confused with formerly 
glycosylated peptides [413]. On the other hand, direct MS analysis of glycopeptides is 
made challenging by their aforementioned heterogeneity and poor ionization properties. 
Fortunately, hydrophilic interaction liquid chromatography (HILIC) has proven effective 
for enrichment of glycopeptides based on the hydrophilic glycan moiety [390,405,585]. 
However, these enrichment strategies, often in the form of solid-phase extraction (SPE) 
cartridges, add a number of steps to the sample preparation workflow. We conceived that 
it would be possible to integrate HILIC enrichment of glycopeptides directly to the 
reversed phase separation. 
A glycoprotein may contain several sites of glycosylation, each of which is 
heterogeneous. As a consequence of glycoform diversity and signal suppression from 
nonglycosylated peptides that ionize more efficiently, typical reversed-phase LC-MS and 
bottom-up proteomics database searching workflows do not perform well for 
identification of site-specific glycosylation for complex glycoproteins. We present an 
LC-MS system for enrichment, separation, and analysis of glycopeptides from complex 
glycoproteins (>4 N-glycosylation sequons) in a single step. This system uses an online 
HILIC enrichment trap prior to reversed-phase C18-MS analysis. We demonstrated the 
effectiveness of the system using a set of glycoproteins including human transferrin (2 
sequons), human α1-acid glycoprotein (5 sequons), and influenza A virus hemagglutinin 
(9 sequons). The online enrichment renders glycopeptides the most abundant ions 
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detected, thereby facilitating the generation of high-quality data-dependent tandem mass 
spectra. The tandem mass spectra exhibited product ions from both glycan and peptide 
backbone dissociation for a majority of the glycopeptides tested using collisionally 
activated dissociation that served to confidently assign site-specific glycosylation. We 
demonstrated the value of our system to define site-specific glycosylation using a 
hemagglutinin containing 9 N-glycosylation sequons from a single HILIC-C18-MS 
acquisition. HILIC has been directly interfaced to revered phase separation in previous 
reports for 2D separations [52,572]. In these cases, significant dilution of the fractions is 
necessary in order to ensure proper sample binding on the second dimension phase. This 
complication arises from the fact that HILIC separations typically begin in high percent 
organic mobile phase and reversed phased separations in high percent aqueous mobile 
phase.  The design of a platform to automate HILIC enrichment followed by reversed 
phase separation is considerably simpler in architecture than a 2D HILIC-reversed phase 
separation. 
 We found that HILIC enrichment could be performed online with reversed phase 
separation so long as the enrichment column volume was kept sufficiently small 
compared to the separation column volume. Here, we present the use of on-line HILIC 
enrichment prior to C18 analytical separation with MS detection (HILIC-C18-MS). 
While we used a microfluidic chromatography chip to perform the experiments, such 
online enrichment and separation arrangement can be achieved using any HPLC system 
with appropriate valves for flow control and plumbing for low dead volume.  Using this 
system, the most abundant ions detected corresponded to glycopeptides.  
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As has been pointed out by Desaire and Hua [122], it is difficult to assign 
glycopeptides based solely on MS data, even with the use of high resolution Fourier 
transform-MS instruments with high mass accuracy. As the number of glycosylation 
sites, variable modifications and peptide miscleavages increase, the usefulness of high-
resolution MS data becomes limited in analyzing complex glycoproteins. A tandem mass 
spectrometry step therefore becomes necessary, in order to map glycopeptides with 
confidence. A recent review of software tools for glycopeptide analysis also highlights 
the importance of tandem fragmentation data for high-confidence glycopeptide 
assignments [113]. Thus, the need to improve quality of glycopeptide tandem mass 
spectra acquired during LC-MS (liquid chromatography-mass spectrometry) experiments 
also drove the present work. Beam-type collision-activated dissociation (CAD) of 
glycopeptides produces abundant oxonium ions, the m/z values of which serve as useful 
indicators of glycosylation [9,71]. Under typical CAD conditions, ions produced from 
dissociation of the peptide backbone are not detected [362]. As a result, separate electron 
activated dissociation (ExD) methods are often used to produce abundant peptide 
backbone dissociation while leaving the glycan intact [75]. The on-line HILIC-C18-MS 
system we describe increases the abundances of glycopeptide precursor ions and is in 
principle applicable to any tandem MS dissociation method.   
Using elevated collision energies, we observed peptide backbone fragments from 
glycopeptides, in addition to oxonium ions and intact peptide ions with varying numbers 
of saccharide units attached (stub glycopeptides). An and colleagues [18], who used 
elevated collision energies to fragment all ions entering the mass spectrometer without 
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ion isolation/selection (known as MS
E
) have also reported glycopeptide backbone 
fragmentation and others have reported similar glycopeptide backbone fragmentation 
using higher energy collisional (C-trap) dissociation (HCD) [468,471]. We demonstrate 
that HILIC-C18-MS enriches proteolytic glycopeptides from complex glycoproteins 
efficiently and thereby improves the ability to acquire data-dependent MS/MS on these 
molecules. As a result, the use of HILIC-C18-MS/MS generated significantly greater 
informational value than did C18-MS/MS.  We demonstrated this method by analyzing 
glycoproteins including human transferrin and human α1 acid glycoprotein (AGP) and 
influenza A virus (IAV) hemagglutinin (HA). HA is a viral coat protein that is heavily 
glycosylated with the number of glycosylation sites varying between 5 and 12, depending 
on the strain. It binds sialylated glycoproteins present in host airway epithelia to facilitate 
infection and presents as a target for both innate and adaptive host response.  HA 
glycosylation therefore represents an attractive target for researchers studying the 
pathogenicity of IAV [1,18,301,392,517].  
 
2.2 Experimental Section 
2.2.1 Materials and Methods 
Human transferrin and human α1-acid glycoprotein were purchased from Sigma-
Aldrich, St. Louis, MO. Recombinant HA1 from A/USSR/90/1977 (H1N1) (amino acid 
18-345) (Genebank #: ABD60933), was purchased from Immune Technology Corp., 
New York. Sequencing grade trypsin was purchased from Promega Corp., Madison, WI. 
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LC-MS grade solvents were purchased from Fisher Scientific, Pittsburgh, PA. All other 
chemicals and reagents were purchased from Sigma-Aldrich, unless otherwise stated.  
Glycoproteins were subjected to reduction (dithiothreitol), alkylation 
(iodoacetamide) and overnight tryptic digestion in the presence of 2,2,2-trifluoroethanol 
(5%) as denaturant, and ammonium bicarbonate (100 mM) as pH buffer.  Reactions were 
stopped by heating at 95⁰ C for 5 min.  The masses of resulting peptides were analyzed 
using a Bruker Ultraflextreme MALDI MS (Bruker Daltonics, Billerica, MA) using 2,5-
dihydroxybenzoic acid (DHB) as matrix. The samples were then dried down in a 
centrifugal evaporator.  
Dry tryptic digests were reconstituted in a 1:1 mixture of water and acetonitrile 
with 0.1% formic acid to a 1 mg/mL concentration. The samples were then diluted in the 
appropriate loading conditions for C18 or HILIC-C18 analysis to approximately 100 
fmol/µL and injected into the LC/MS system using the Agilent 1200 series autosampler. 
All analyses were performed on an Agilent 1200 series LC system capable of delivering 
nanoliter flow rates coupled to an Agilent 6550 ion-funnel quadrupole time-of-flight (Q-
TOF) mass spectrometer, equipped with a chip-cube ionization source (Agilent 
Technologies, Santa Clara, CA), in the positive ion mode.  
Approximately, 1 µg and 0.1 µg of the total proteolytic digests were injected 
without any cleanup for analyses on HILIC-C18 or C18 chip-LC/MS, respectively. 
Lower amounts of total material were loaded onto the C18 chip because in the absence of 
enrichment, the non-glycosylated peptides led to signal saturation. The Agilent HPLC 
chip consisted of laser ablated channels that were packed with appropriate stationary 
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phases.  The C18 chip used was a commercially available Polaris-HR-Chip-3C18 chip 
(Agilent Technologies, Santa Clara, CA) with a 75µm X 150mm separation/analytical 
column and a 360nL enrichment column, both packed with 3µm particle size and 180Å 
pore size, Agilent Polaris C18-A stationary phase.  The HILIC-C18 hybrid chip consisted 
of a 75µm X 150mm analytical column packed with 5µm particle size and Polaris C18-A 
stationary phase and a 40nL enrichment column, packed with Amide-80 stationary phase 
(Tosoh Biosciences, Montgomeryville, PA), 5µm particle size and 80Å pore size.  This 
chip is available from the vendor as a custom order.  A binary pump with microliter flow 
rates was used as the “loading pump” to deliver sample and solvent to the 
trapping/enrichment column and a nanoscale pump was used as the “gradient pump” to 
deliver the gradient once the trapping and analytical columns were inline, as shown in 
Figure 10.  
 
Figure 10: Schematic showing trapping and analysis configurations of a HILIC-C18 HPLC-chip for 
glycopeptide analysis 
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The HPLC mobile phases for the C18 chip were as follows: Solvent A was 99% 
water, 1% acetonitrile modified with 0.1% formic acid. Solvent B was 99% acetonitrile, 
1% water modified with 0.1% formic acid. The enrichment column was equilibrated 
using the loading pump which was constantly pumping 98% solvent A and 2% solvent B 
as loading conditions. The sample was washed on the enrichment column with 4µL of the 
loading condition solvent and then the 6 port valve was switched to bring the enrichment 
column in-line with the analytical column. The analytical pump was used to deliver the 
solvent after the valve switched. 98% solvent A was pumped for the first 10 minutes after 
a gradient was started from 98% solvent A to 15% solvent A over 30 min. The solvent 
conditions were then changed to 5% solvent A in the next 2 min and kept constant for 5 
min thereafter to wash the columns. The columns were brought back to the starting 
condition, 98% solvent A, in 3 min and then equilibrated for 5 min.  
For the HILIC-C18 chip, the HPLC conditions were as follows. Solvent A was 
99% water, 1% acetonitrile with 0.1% formic acid. Solvent B was 99% acetonitrile, 1% 
water with 0.1% formic acid. A premixed special loading solvent, 80% acetonitrile, 20% 
water, modified with 0.1% trifluoroacetic acid, was delivered using the loading pump in 
this case as the loading condition. The samples were loaded and washed on the trapping 
column using the loading pump with 4µL of the special loading solvent. These high 
organic conditions were used to allow binding of the glycosylated peptides to the HILIC 
trapping column which the non-glycosylated peptides were washed away to waste. The 
analytical column was equilibrated with the regular mobile phases at 98% solvent A. 
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After the washing step was complete, the trapping column was brought in-line with the 
analytical column and the setup received flow from the nanoscale analytical pump, which 
delivered 98% solvent A for the first 10 min. These high-aqueous conditions allowed 
elution of the glycosylated peptides from the HILIC trapping column and binding to the 
C18 reversed phase analytical column. After this a gradient was delivered by the 
analytical pump to resolve and elute the glycopeptides from the C18 analytical column. 
The gradient was similar to that used in the C18 chip setup. Mobile phase was changed 
from 98% solvent A to 15% solvent A over 30 min. The solvent conditions were then 
changed to 5% solvent A in the next 2 min and kept constant for 5 min thereafter to wash 
the columns. The columns were brought back to the starting condition, 98% solvent A, in 
3 min and then equilibrated for 5 min. 
Both HPLC chips (C18 and HILIC-C18) consisted of an integrated nano-ESI 
source, to allow sample introduction into the mass spectrometer. The MS and tandem MS 
conditions used for both C18 and HILIC-C18 runs were the same.  Data dependent 
tandem mass spectra were acquired for the first 40 minutes of the run. Top 5 most 
abundant, multiply charged precursor ions were selected for fragmentation with dynamic 
exclusion enabled after 10 spectra for each precursor. MS spectra were acquired in the 
m/z 200-2000 range and MS/MS spectra in the m/z 50-3000 range. MS and MS/MS 
spectra were acquired at rates of 4 and 1 spectra/s, respectively. An isolation width of 4 
m/z was used. Nitrogen was used as the collision gas and collision energy varied with 
precursor m/z. The collision energy was determined dynamically as a linear function of 
precursor m/z, with a slope of 5 and offset of -4.8 to yield peptide backbone fragments. 
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For only glycan dissociation, a lower collision energy can be used, also calculated using 
the precursor m/z, with a slope of 0.9 and offset of 2. Data were acquired in the positive 
ion mode with source capillary voltage set at 2150 V for the first 40 minutes of the run. 
Drying gas flow was 13 l/min for the first 25 minutes and 11 l/min, thereafter with gas 
temperature set at 225 ⁰C throughout the run. Data files were acquired using Agilent 
MassHunter Workstation Data Acquisition software and analyzed using Agilent 
MassHunter Qualitative Analysis software package.  
2.2.2 LC-MS data analysis 
For automated data analysis, entire LC-MS data files were deconvoluted using 
DeconTools [266]. Deconvoluted data were matched and scored against theoretical 
peptide and glycopeptide neutral mass lists, using GlycReSoft
 
[359], with a 10 ppm mass 
tolerance. For quantitative evaluation of the ability to perform tandem MS on 
glycopeptides, LC-MS data files were also searched for precursor ions, which produced 
oxonium ions. The search was performed using software written in-house that generates a 
list with the total number of precursor ions in an LC-MS/MS data file and precursors that 
produce oxonium ions.  Data files were searched for the following oxonium ion masses 
[624] with a 0.01 unit mass tolerance: m/z 204.08635, 186.07539, 168.065, 138.05423, 
366.13942, 274.0920 and 292.1026. Only the precursor ions that produced 3 or more of 
the listed oxonium ions were identified as glycopeptide precursor ions. The number of 
unique glycopeptide precursors selected for data dependent tandem MS were determined 
in this way and compared among HILIC-C18 and C18 data. 
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Tandem mass spectra were analyzed both manually and using a prototype 
software tool, written in-house, to confirm peptide backbone fragment ions and glycan 
compositions for manually assigned glycopeptides. Theoretical peptide fragment ion 
masses were calculated and matched, using a 20 ppm mass error tolerance. For manual 
matching of tandem MS peaks a minimum signal threshold of 5 counts was used.  
 
2.3 Results and Discussion 
2.3.1 Glycopeptide identification based on accurate intact mass 
We compared the usefulness of LC-MS data acquired using HILIC-C18-MS 
versus C18-MS for profiling glycoprotein proteolytic peptides.  For this purpose, the 
neutral mass values extracted from the data sets were searched against a set of theoretical 
glycopeptide masses, with a 10 ppm mass-error tolerance. The theoretical masses 
consisted of the protein proteolytic peptides with up to two missed cleavage sites.  
Masses for those peptides containing an N-glycosylation sequon were calculated as a set 
of glycosylation variants using N-glycosylation compositions ranging from core N-glycan 
structures to penta-antennary complex-type N-glycans containing N-acetylneuraminic 
acid and high-mannose N-glycans. The GlycReSoft program [359] was used to match and 
score deconvoluted masses from an LC-MS experiment against this list of theoretical 
compound accurate masses. Because the complexity in glycopeptide data increases with 
the number of glycosylation sites, intact mass assignments suffer from ambiguous 
matches and false positives that cannot be verified in the absence of tandem MS.  
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We acquired LC-MS profiling data for three glycoproteins with a range of 
complexities. Transferrin is known to have two N-linked glycosylation sites with 
complex N-glycans and the glycan heterogeneity for this protein is fairly limited with 
[5,4,0,2,0] [Hex, HexNAc, dHex, NeuAc, NeuGc] contributing to over 90% of the glycan 
distribution [596]. Thus, this glycoprotein presents low complexity, which makes the 
search space small and minimizes the chances for false positives and ambiguous 
assignments. AGP, by contrast, has five known N-linked glycosylation sites [530] with 
multiple genetic variants and a more diverse set of complex glycans that make this a 
relatively more complex glycoprotein. Recombinant hemagglutinin from 
A/USSR/90/1977 (H1N1), referred to herein as HA, was the most complex of the three 
glycoproteins analyzed, with 9 consensus glycosylation sites.   In addition, theoretical 
tryptic cleavage of HA produced 2 peptides that presented more than one putative 
glycosylation site on a single peptide. Thus, expected ambiguity and false positives 
scaled with increasing number of glycosylation sites in transferrin, AGP and HA. The 
number of theoretical glycopeptide compositions used for each glycoprotein is given in 
Table 2. 
We observed a significantly higher number of glycopeptide matches using HILIC-
C18 LC-MS data over C18 LC-MS data, for all glycoproteins tested. Table 2 shows the 
number of glycopeptides and peptides identified based on intact glycopeptide masses.  
Even with the limited the possibility of false matches when searching solely based on 
theoretical masses, it was evident that HILIC-C18 enriched glycopeptides efficiently. 
  97 
Data were acquired as analytical triplicates and peptide/glycopeptide compositions found 
in all three replicates were considered matches. 
2.3.2 Oxonium ion distributions 
In order to confirm the ion compositions from the MS data, we used data-
dependent LC-tandem mass spectrometry.  Collisional dissociation of glycopeptides leads 
to formation of oxonium ions that are useful as features for identifying glycopeptides in a 
LC-MS/MS chromatograms [71].  We therefore used the absence of oxonium ions to 
disqualify a precursor ion as glycopeptide.  Based on this rationale, we compared the 
abundances of oxonium ions in extracted ion chromatograms (EICs) of glycopeptides 
observed using C18-MS/MS versus HILIC-C18-MS/MS data. Figure 11 compares the 
HexNAc oxonium ion (m/z 204) EIC with the BPC (base peak chromatogram) for 
hemagglutinin. When using HILIC-C18, we observed that the abundances of the 
HexNAc (m/z 204) oxonium ion profile were similar to those of the BPC, consistent with 
the fact that most of the detected ions corresponded to glycopeptides. For the C18 LC-
MS experiments, the abundances of HexNAc oxonium ion were 10-fold lower than the 
BPC, indicating that most of the detected ions corresponded to unglycosylated peptides. 
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Figure 11: Comparison of tryptic glycopeptide abundances using (A) HILIC-C18-MS and (B) C18-MS   
Each panel shows the base peak chromatogram (BPC) and the extracted ion chromatogram (EIC) 
for the HexNAc oxonium ion (m/z 204.08).   BPC and EIC are shown using the same Y-scale. 
 
Using C18-MS, unmodified peptides were the most abundant ions selected by the 
acquisition software for tandem MS based on abundance.  By contrast, for HILIC-C18 
data, glycopeptides were the most abundant ions present and were selected automatically 
for tandem MS.  The oxonium ion distributions were consistent with the results obtained 
from the LC-MS data, shown in Table 2, indicating the contribution of glycopeptides to 
total ion abundances in C18 and HILIC-C18 runs.  
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Glycoprotein Transferrin AGP Hemagglutinin 
Number of theoretical 
peptides + glycopeptides 
1576 4009 57358 
Total number 
of non-
glycosylated 
peptides 
identified (MS1 
only) 
HILIC
-C18 
2 2 4 
C18 77 19 39 
Number of theoretical 
glycopeptides (search 
space) 
1230 3936 56886 
Number of 
ambiguous 
matches (more 
than one match) 
HILIC
-C18 
6 16 725 
C18 5 23 278 
Total number 
of glycopeptides 
identified (MS1 
only) 
HILIC-
C18 
54 155 1220 
C18 38 141 530 
Total % 
relative 
abundance of 
glycopeptides 
HILIC
-C18 
97.67% 99.93% 99.97% 
C18 0.86% 3.40% 2.52% 
Table 2: Total number of identified peptides and glycopeptides from LC-MS data sets, using GlycReSoft (MS 
only) 
Only the glycopeptides/peptides found in all three replicate data were included. Relative abundances were 
calculated as a percentage of total abundances of all identified compounds. Note: Deamidation was considered as 
a variable modification only in the case of HA. 
 
Oxonium ions detected early in the chromatogram using HILIC-C18-MS resulted 
from a small fraction of the enriched glycopeptides from the HILIC trapping column 
getting washed away with the dead volume containing high organic mobile phase. This 
was a fixed and unbiased loss that accounted for less than 2% of the total sample 
abundance and did not affect the relative abundances of the compounds being retained on 
the C18 analytical columns.  
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Figure 12: Comparison of percent of precursor ions that generate diagnostic oxonium ions between HILIC-C18-
MS (green) and C18-MS (red) 
Results are shown for the glycoproteins labeled on the X axis.   
 
Figure 12 shows the percent of precursor ions identified as glycopeptides based 
on formation of oxonium ions in data dependent LC-MS/MS runs using HILIC-C18-MS 
versus C18-MS.  We concluded that use of HILIC-C18-MS resulted in significant 
increase in the ability to analyze glycopeptides using data-dependent LC-MS/MS. These 
data demonstrate that the HILIC-C18-MS increased abundances of glycopeptides relative 
to unglycosylated peptides and thus the quality of data dependent LC-tandem MS data. 
The improved data quality increased confidence in assignments and decreased false 
identifications.   
Two AGP glycopeptides (ENGTISR/ENGTVSR and NEEYNK) were detected 
only using HILIC-C18-MS. This was due to the fact that tryptic cleavage of AGP 
produces glycopeptides that are only 5 to 7 amino acids long and are not retained during 
the trapping step when using C18-MS.  These glycopeptides were trapped on the HILIC 
  101 
enrichment column when using HILIC-C18-MS and eluted soon after the solvent-front 
on the analytical chromatogram, which allowed them to undergo MS and MS/MS 
analysis. The C18 trapping step can be eliminated to retain any shorter glycopeptides in a 
sample. However, in our experience an on-line trapping step is useful means of 
elimination of salts and other contaminants while minimizing manual manipulation.   
2.3.3 Tandem MS of glycopeptides 
While the presence of oxonium ions from dissociation of glycosidic bonds is a 
useful feature, the formation of peptide backbone product ions is necessary for 
unambiguous assignment of the peptide sequence and glycan composition.  We therefore 
investigated the extent to which the increased glycopeptide precursor ion abundances 
obtained using HILIC-C18-MS improved the quality of the resulting glycopeptide 
tandem mass spectra. Collisional dissociation using typical conditions for peptide tandem 
MS results in formation of abundant ions from dissociation of the glycan with those from 
peptide backbone dissociation often not detected. In the interest of maximizing the 
information produced from a CAD LC-MS/MS experiment, we investigated use of higher 
collision energies for glycopeptides. Figure 13 shows an example of glycopeptide tandem 
mass spectra from a hemagglutinin glycopeptide; collision energies were calculated as 
per the equations described in the methods section. As expected, glycopeptide 
dissociation produced abundant oxonium ions in the low m/z range that confirmed the 
presence of monosaccharides in the precursor ion composition. In addition, peptide 
backbone product ions were detected that enabled direct identification of the peptide. 
This information increased confidence in true matches and decreased those in incorrect 
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matches.  This was important in cases where more than one theoretical glycopeptide 
matched an observed mass value. Complete peptide backbone or parts of the peptide 
backbone could be sequenced for glycopeptide precursors as shown in the annotated 
spectra. Intact peptide and glycopeptides+saccharide (referred to as stub glycopeptide) 
ions were also detected in the higher m/z range of the spectra that matched the masses of 
peptide with N-glycan core structures. The presence of intact peptide or stub glycopeptide 
ions significantly increased confidence of assignments over those made from MS-only 
data.  In the majority of LC-tandem mass spectra, ions corresponding to peptide 
backbone product ions plus a HexNAc residue were detected, which confirmed the site of 
glycosylation. 
 
Figure 13: Tandem mass spectrum of Hemagglutinin glycopeptide precursor ion 1013.7474 [M+3H]3+, 
identified as NGSYPNLSK-[5,4,1,1,0] 
Glycopeptide identifier is listed as Peptide-[a,b,c,d,e], where: a = number of Hexoses; b = number of N-
acetylhexosamines; c = number of Deoxyhexoses; d = number of N-acetylneuraminic acids; e = number of N-
glycolylneuraminic acids. 
 
Although, the relative abundance of a glycopeptide precursor ion had an effect on 
the quality of tandem MS by affecting the ability to select the ion in a data-dependent 
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LC-MS/MS experiment, the absolute abundance did not appear to play a role in 
generation of useful fragment ions for confident assignment of the glycopeptides. In 
order to demonstrate that the detection of peptide backbone product ions was a universal 
phenomenon, we analyzed glycopeptides with different peptide backbones and varying 
absolute abundances, from each of the three glycoproteins studied. Table 3 summarizes 
the types of product ions observed using HILC-C18 vs. C18 LC-tandem MS.  
 
  
1
0
4
 
 
Table 3: Summary of glycopeptide tandem mass spectra for intact-mass matched compounds 
The features used in identification are listed in the table as yes/present () or no/absent (x).  Abundances refer to the composite values of all charge states identified and 
matched for a given glycopeptide, presented as a percent of the total volume of all matched compounds. The absolute precursor ion abundances were determined from 
extracted ion chromatograms. Peptide backbone coverage was reported as percent product ions detected of total possible peptide product ions. Glycopeptide 
compositions in red indicate false/incorrect match. Glycopeptide nomenclature has been described in the text. Detailed mass tables confirming glycopeptide assignments 
have been presented with the supplemental information in [293].   Glycopeptide identifiers are listed as Peptide-[a,b,c,d,e], where: a = number of Hexoses; b = number of 
N-acetylhexosamines; c = number of Deoxyhexoses; d = number of N-acetylneuraminic acids; e = number of N-glycolylneuraminic acids 
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For all glycopeptides assignments that were confirmed by tandem MS, the 
following criteria were used (1) intact glycopeptide mass match; (2) presence of oxonium 
ions; (3) presence of either an abundant protonated peptide ion and/or a peptide + 
HexNAc ion; (4) presence of significant peptide backbone product ion coverage. It is 
significant that some of the glycopeptide compositions that were assigned to high 
abundance precursor ions based on intact mass that also produced oxonium ions, were 
rejected (shown in red font) because the tandem MS stub glycopeptide or peptide y-ions 
were not consistent with the assignment. This emphasizes the need for tandem MS on 
glycopeptides for confident assignments. Although the ions shown in Table 3 were quite 
abundant in the mixtures analyzed, many were not selected for data dependent tandem 
MS when using C18-MS due to the presence of more abundant non-glycosylated 
peptides. In addition, GlycReSoft failed to find and match some of these compositions in 
C18 data, which was probably due to very low abundances or presence of overlapping 
isotopic peaks.  HILIC-C18-MS improved the abundances of glycopeptides relative to 
non-glycosylated peptides, which allowed these ions to be matched by the GlycReSoft 
software. Data-dependent acquisition of tandem mass spectra led to systematic 
identification of these glycopeptides and allowed confident assignments due to the 
presence of peptide backbone product ions. The abundant product ions containing stub 
glycopeptides and oxonium ions were useful for confirming peptide identities.   
Results for transferrin. Transferrin presents two glycosylation sites, with the most 
abundant N-linked glycan of composition [5,4,0,2,0] at each of those two sequons. In 
agreement with this, glycopeptides  QQQHLFGSNVTDCSGNFCLFR-[5,4,0,2,0] and 
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CGLVPVLAENYNK-[5,4,0,2,0] could be identified using tandem MS in both HILIC-
C18 and C18 analyses. Other transferrin glycopeptides, although identified by 
GlycReSoft in the C18 LC-MS data, did not get selected for data dependent tandem MS 
due to presence of abundant non-glycosylated peptides. However, these glycopeptides 
underwent tandem MS and could be confidently assigned in case of HILIC-C18. 
Results for α1-acid glycoprotein.  Compared to transferrin which has only two 
glycosylation sites and limited glycan heterogeneity, AGP is more complex with five 
different glycosylation sites and differences in peptide backbone arising from genetic 
variants. The HILIC-C18 method was significantly more effective at acquiring data 
dependent tandem mass spectra of sufficient quality to enable identification of the peptide 
backbone. We observed formation of useful peptide backbone ions, even for precursor 
ions with moderate abundances (~1-2x10
5
 counts). Tandem mass spectra were useful in 
discriminating single amino acid genetic variants , for example, in Table 3, two AGP 
glycopeptides have similar peptide sequences, ENGTVSR and ENGTISR, for which we 
observed complete peptide sequences in the glycopeptide tandem mass spectra of 
precursors 1070.6586 (4+) and 1074.1627 (4+).  These peptides were not retained using 
the C18-MS system.  
Results for influenza A virus hemagglutinin.  HA presents a considerably greater 
analytical challenge than AGP.  Due to the presence of 9 putative glycosylation sites with 
a wide distribution of possible glycan compositions at each site, the number of theoretical 
glycopeptides (the search space) was more than 10-fold greater than that of AGP, as 
shown in Table 2. In addition, the number of glycopeptide glycoforms detected was 
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greater, and as a result of higher glycoform heterogeneity the corresponding relative 
abundances of each glycopeptide precursor ion were generally lower, than those observed 
for transferrin and AGP.  In Table 3, we compared 5 different glycopeptide compositions 
that were identified by GlycReSoft in both HILIC-C18 and C18 data from HA analyses. 
Out of the five glycopeptides assigned by intact mass, only one, NGSYPNLSK-
[5,4,1,1,0], underwent tandem MS with C18 analysis. However, in case of HILIC-C18, 
useful tandem MS data were acquired on all 5 glycopeptides, leading to formation of not 
only peptide backbone ions but also backbone ions with an attached HexNAc, facilitating 
identification of the glycosylation site. This was important in case of NGSYPNLSK-
[5,4,1,1,0], where two glycosylation sequons NGS and NLS were present on the same 
glycopeptide; HILIC-C18 tandem MS data allowed us to identify NLS as the occupied 
sequon as shown in Figure 13. Tandem MS was also useful in identifying other 
modifications. For example, the exact site of deamidation could be identified in case of 
HA glycopeptide NVTVTHSVNLLEDSHNGK(1-Deamidation)-[7,6,1,3,0]. 
As shown in Table 2, measurement of glycopeptide mass did not suffice to 
identify the peptide and glycan composition because of the size of the search space. Thus, 
observed masses consistent with more than one glycopeptide were not uncommon. We 
showed that tandem MS could be used to resolve ambiguities. As shown in Table 3, HA 
precursor ion m/z 1339.1270 (5+) matched three different compositions 
SWSYIAETPNSENGTCYPGYFADYEELR-[7,6,1,3,0], NGSYPNLSKSYVNNKEK (1 
deamidation)-[14,8,0,3,0] and NGSYPNLSKSYVNNK (2 deamidation)-[12,13,3,0,0], 
within a 10 ppm mass error tolerance. Peptide backbone and stub glycopeptide ions 
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proved useful in assigning SWSYIAETPNSENGTCYPGYFADYEELR-[7,6,1,3,0] as the 
correct composition. In case of AGP, SVQEIQATFFYFTPNK-[7,6,0,4,0] or 
QNQCFYNSSYLNVQRENGTVSR-[6,6,0,2,0] also corresponded to the same precursor 
mass 1088.2441 (5+) and SVQEIQATFFYFTPNK-[7,6,0,4,0] was assigned as the 
correct composition based on tandem MS data. The fact that HILIC-C18-MS resulted in 
relative precursor ion abundances sufficient to allow selection for tandem MS and 
consequently, make these assignments, demonstrates the value of this approach. 
2.3.4 Confident site-specific glycan profiling: 
We used the glycopeptides assignments to construct a site specific glycosylation 
map for HA and AGP (Figure 14).  Glycan compositions were classified based on the 
number of HexNAc units, as high-mannose (2 HexNAc), bi-antennary (3 or 4 HexNAc), 
tri-antennary (5 HexNAc), tetra-antennary (6 HexNAc) and penta-antennary (7 
HexNAc). Only glycopeptides identified with at least 40% peptide backbone coverage 
from tandem MS data were included in the glycan profile maps. In some cases, 
particularly for HA, two putative glycosylation sites appeared on a single tryptic peptide. 
The peptide backbone fragment ions with an attached HexNAc helped resolve the 
ambiguity in such cases by helping to identify the occupied site. Such site-specific glycan 
profile assignments were possible only when using HILIC-C18-MS/MS whereby at least 
7 times more glycopeptides underwent tandem-MS, from evaluation of precursors 
generating oxonium ions. It is evident from the data that the usefulness of HILIC-C18-
MS scales with the number of glycosylation sites and glycopeptides in the theoretical 
search space. For transferrin, where the glycopeptide and glycoform diversity is very 
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limited, the C18 and HILIC-C18 platforms yield similar results. However, with AGP and 
hemagglutinin there is an obvious improvement in data quality with the use of HILIC-
C18 over C18.  We made these assignments using assumptions regarding the protein 
sequences, glycosylation sites, glycoform distributions and post-translational 
modifications. It is therefore possible that modified peptides not included in our 
assumptions exist.  Since the goal of this study was to compare performances of the 
HILIC-C18 and C18 systems, our glycopeptide analyses sufficed to reach clear 
conclusions despite the absence of exhaustive discovery-mode proteomics data 
interpretation. 
 
Figure 14 Site-specific glycan profile of hemagglutinin from influenza A virus (top) And Human AGP (bottom) 
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2.4 Conclusions: 
We assert that even for purified glycoproteins, a tandem MS step is necessary in 
order to confidently assign glycopeptide compositions with respect to peptide and glycan. 
Because the traditional data-dependent mass spectrometry algorithms used in proteomics 
select the most abundant precursor ions, most glycopeptides are not selected for tandem 
MS when using C18 chromatography.  We therefore developed a method in which 
glycopeptides are enriched using a HILIC trapping column on-line prior to a C18 
analytical column. Using this method, we observed that glycopeptides were the most 
abundant ions in the data sets and therefore preferentially selected for data-dependent 
LC-MS/MS.  The HILIC trapping column provides efficient enrichment of glycopeptides. 
The C18 analytical column provides high chromatographic resolution. Thus, we 
demonstrated that online enrichment and separation can be conveniently performed 
without manual sample manipulation. This combination enables facile glycopeptide 
enrichment, separation and analysis with online LC-MS/MS using a commercially 
available instrument system.    
CAD-based tandem MS of glycopeptides is useful for determining peptide 
sequence and glycan composition; it does not determine glycan structure in detail.  We 
found that by programming the MS system to acquire CAD tandem MS using elevated 
collision energy, we observed peptide backbone product ions for the majority of the 
glycopeptides selected for tandem MS. Even for the lowest abundance glycopeptide 
precursor ions so selected, we observed glycan modified peptide stubs that were useful 
for confirming the mass of the peptide moiety. These tandem mass spectra improve the 
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informational value of an LC-MS/MS experiment, from the point-of-view of 
glycopeptide analysis.  In principle, however, use of on-line enrichment of glycopeptides 
with HILIC-C18-MS will improve tandem MS results for any dissociation method.   
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Chapter 3: Development of data-analysis workflows for glycoproteomics and 
glycomics 
(Part of this work is published in [292]) 
 
3.1 Introduction: the need for tailored bioinformatics workflows in 
glycoproteomics and glycomics 
Proteomics methods have focused on the analysis of PTMs with single, defined 
mass shifts, including phosphorylation, acetylation, methylation and ubiquitination 
[32,87,122,621]. Glycosylation does not fit into the traditional proteomics paradigm 
because, owing to its microheterogeneity, the peptide mass cannot be accurately and 
unambiguously predicted from the molecular mass [122]. In addition, the molecular 
weight heterogeneity is multiplied by the presence of other modifications, including 
mutations, oxidations, deamidations, dehydrations, incomplete and/or unexpected 
proteolytic cleavages.  Therefore, tailored bioinformatics algorithms are needed to assign 
glycopeptide mass spectral data with confidence.  
As an example, consider the tryptic peptide sequence 
QNQC(Carbamidomethyl)FYNSSYLNVQR from α1-acid glycoprotein 2 
http://www.uniprot.org/uniprot/P19652 [346,537], which contains a single N-
glycosylation site. We do not have information on the actual frequency of Asparagine (N) 
deamidation for this protein. Therefore, we have to rely on the assumption that 
deamidation can occur on N not occupied by a glycan, and there are two Ns in this 
sequence excluding the one in the glycosylation sequon. Deamidation can occur 
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spontaneously, so we cannot a priori designate where it may occur, so if we are 
constructing a theoretical database, we must include all combinations. The number of 
peptidoforms from variable deamidation is  ∑ (2
𝑖
)2𝑖=0  . There are 4 theoretical 
peptidoforms from deamidation alone. Next we combine these peptidoforms with some 
library of glycan compositions. Assuming a list of 200 N-glycan compositions, which 
may be considered conservatively small, we have to consider 4 * 200 = 800 
glycopeptides for a single tryptic peptide with one missed cleavage and one glycosite. If 
we use the target-decoy method [139,635], that means we must search at least 800 decoy 
glycopeptides as well. We don’t even expect many of those cases to be real in any case, 
but we must dedicate compute time and statistical power to analyze them. As the above 
example shows, it is possible to estimate the search space for a glycopeptide by making 
assumptions regarding the multiplicity of molecular forms present.  This method of 
describing peptidoforms using only subjective information we refer to as naïve.  Such 
assumptions can lead to erroneous data interpretations as shown by Knudsen et al. [302]. 
In order to minimize the margin for error, we want to make as few assumptions 
about the contents of our sample as possible. The set of theoretical glycopeptides, known 
as a search space, consists of the peptide sequences, multiplied by number of possible 
glycan structures, multiplied by any other structural/chemical variants (such as 
oxidations, deamidations, etc.).  Ideally we would like to use the mass spectral data to 
calculate confidence values for the search space so as to identify the site-specific 
glycosylation present. In order to do this, the search space must be defined accurately.   
The best way to define the proteins present in the sample is to measure the proteome.  
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Likewise, analytical measurement of the released glycome is the best way to determine 
the glycans present. Methods for measuring proteomes and glycomes of glycoprotein 
samples are mature and available for use by the same mass spectrometry instruments 
used for glycoprotein analysis. To what extent do these data domains improve the 
confidence whereby site specific glycosylation can be assigned? This chapter describes 
our bioinformatics workflow and examines the effectiveness of glycoproteomics under 
scenarios where the search space is defined based on naïve assumptions versus using 
glycomics and proteomics data and the effects of increasing matrix complexity on data 
acquisition and interpretation.    
Bottom-up proteomics experiments generally contain peptide precursor ions that 
have low charge states (+2 or +3) that during tandem MS tend to produce singly charged 
product ions. These ions can be matched against a theoretical database without the need 
to determine charge states. As a result, assignment of charge states in proteomics data is 
not critical. Most proteomics database search programs attempt to identify isotopic 
clusters and then match the theoretical fragment ions to the monoisotopic peak (A ion) in 
the cluster. Occasionally, incorrect assignment of the A+1 peak as the monoisotopic peak 
can also be confused as presence of deamidation or another modification that adds about 
1 unit to the mass of the peptide. While it is not clear how commercial proteomics 
software packages deal with the issue of charge state deconvolution, many popular open-
source software tools identify charge states by measuring the spacing between isotopic 
peaks but do not take into account the isotopic pattern fit [140,157,294,563]. 
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Glycopeptides generally have higher charge states than unglycosylated peptides. 
As a result, they generate abundant multiply charged fragment ions, as shown in Figure 
15. Furthermore, overlapping peak clusters can often lead to misassignment of the 
monoisotopic peak or the charge state. As shown in Section 5.3, polydisperse mixtures of 
oligosaccharides can generate overlapping ion clusters. Also, presence of sulfation on 
glycans can complicate spectra and makes even manual assignment of monoisotopic 
peaks challenging. It therefore becomes important to deconvolute and deisotope glycan 
and glycopeptide mass spectra before automated peak matching can be performed. Our 
glycoproteomics workflow described in this chapter utilizes an averagine model for 
deconvolution that models the isotopic patterns based on an average elemental 
composition for that class of analytes, as described by Senko and implemented by Horn 
[244,473].  
 
Figure 15: Tandem MS of IAV glycopeptide ILDGKN(N-Glycosylation)CTLIDALLGDPHCDGFQNEK Hex5 
HexNAc2 assigned by GlycReSoft, showing multiply charged fragment ions 
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For mixtures of sulfated oligosaccharides, an averagine model is not sufficient, 
since the varying number of sulfates skews the isotopic pattern beyond what can be 
modeled using an average composition. For sulfated oligosaccharides, we therefore used 
a targeted pattern-fitting approach, where theoretical isotopic patterns were calculated 
using an implementation of the BRAIN algorithm for all theoretical compounds. Both 
mass and the isotopic pattern were used in matching the mass spectra, as described in 
Section 5.3 and elsewhere[128,611].  
 
3.2 Methods 
All the work described in this section was carried out under the guidance of Prof. 
Joseph Zaia. Mass spectrometry data were acquired by Kshitij Khatri. Joshua A. Klein 
developed the software tools including the GlycReSoft pipeline used in glycoproteomics 
data analysis. Data analysis and interpretation were performed by Joshua A. Klein and 
Kshitij Khatri.  
Standard human serum glycoproteins were purchased from Sigma-Aldrich (St. 
Louis, MO). Glycoproteins were reduced with dithithreitol and alkylated using 
iodoacetamide. The samples were then subjected to tryptic digestion and individual 
glycoprotein tryptic digests were mixed to generate samples of scaling complexity levels 
as below: 
α1-acid glycoprotein (AGP) (Complexity level 1) 
Glycoprotein mix 3: AGP + transferrin + fetuin 
Glycoprotein mix 4: AGP+ transferrin + fetuin + haptoglobin 
 117 
 
Glycoprotein mix 5: AGP + transferrin + fetuin + haptoglobin + α2-macroglobulin 
 
The highest complexity level analyzed was AGP in pooled human serum (Sigma-
Aldrich, St. Louis, MO). Since, serum contains very high abundances of albumin and 
immunoglobulin G (IgG), it was necessary to deplete these resident proteins to observe 
coverage on the glycoproteins of interest [21,135,613]. Albumin and IgG were depleted 
using ProteoExtract® Albumin/IgG Removal Kit (EMD Millipore, Billerica MA). 
Depleted serum and glycoprotein mixes were subjected to sample preparation and 
analysis using a multi-pronged approach, as described elsewhere [291].  
3.2.1 Proteomics analyses 
Tryptic samples were deglycosylated using peptide N-glycosidase F (PNGase F, 
New England Biolabs, Ipswich MA) and subjected to triplicate C18 LC-MS/MS analyses 
using a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jose, CA) equipped 
with an Advion NanoMate (Advion Inc., Ithaca, NY)  nanoESI source, coupled to a 
Waters NanoAcquity nanoLC system. A Waters Xbridge™ reversed-phase column (150 
μm × 100 mm) with 1.7 μm BEH C18 resin and a Waters trap column (180 μm × 20 mm) 
packed with 5 μm Symmetry™ C18 stationary phase, were used for online desalting and 
separation of the proteomics samples. The mass spectrometer was programmed to acquire 
data-dependent tandem MS, using instrument parameters described previously [291]. 
Glycoproteins used in complex mixtures were analyzed both individually and as mixtures 
of increasing complexity. 
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3.2.2 Glycomics analyses 
N-Linked glycans were released from tryptic digests using PNGase F. Released 
glycans were separated from deglycosylated peptides using C18 reversed-phase spin 
columns (Thermo Pierce, Rockford IL). Glycans were desalted using PD MiniTrap G-10 
columns (GE Healthcare, Piscataway NJ), as per the manufacturer’s instructions. Glycan 
samples were analyzed, in triplicate, using HILIC-MS using an Agilent 6520 LC-MS 
system with a chip-cube nanoESI source, as described previously [496].  
3.2.3 Glycoproteomics analyses 
Tryptic digests of glycoprotein mixes and depleted serum were analyzed using a 
previously described chip LC-MS platform [293]. Glycopeptide enrichment was 
performed online using a HILIC trapping column followed by C18 reversed-phase 
separation and data-dependent tandem MS analysis using collisional-dissociation.  
3.2.4 Proteomics data analysis 
Proteomics data were analyzed using Peaks Studio 7.5 [615] (Bioinformatics 
Solutions Inc., Waterloo ON). Triplicate data files for individual samples were combined 
in Peaks Spider Searches, which combine database, error-tolerant PTM searching, and de 
novo sequencing. Data were searched against a Uniprot protein database, using a 
precursor mass tolerance of 10 ppm and a product ion mass tolerance of 0.1 Da. A 
maximum of 2 missed cleavages per peptide were specified; carbamidomethylation at 
cysteine was used as a fixed modification and deamidation (Asn, Gln), oxidation (Met), 
acetylation (Lys and N-terminus), Na
+
 adduction (Asp, Glu, C-term), and 
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pyroglutamination (Gln at N-terminus) were used as variable modifications in the 
database searches. The PTM search examined the data for presence of 484 variable 
modifications from the Unimod database [103] and possible mutations leading to amino 
acid substitutions. The results from combination of database, PTM and de novo searches 
were accepted at a false discovery rate (FDR) threshold of 0.1%. Peptides with spectrum 
matches of -10 log p values 15 or higher were used for downstream processing and 
building a glycoproteomics database. 
3.2.5 LC-MS/MS Data Preprocessing 
3.2.5.1 LC-MS Deconvolution and Relative Quantitation with Decon2LS 
LC-MS data are pre-processed in the MS
1
 dimension using 
Decon2LS/DeconTools [266], determining charge state, monoisotopic mass, isotopic 
cluster continuity, and total abundance integration. This data is used for gross 
composition matching, and in downstream analysis for relative quantitation. 
3.2.5.2 MS/MS Deconvolution with BUPID/ MasSPIKE 
MS/MS data taken from the LC-MS run were preprocessed using an 
implementation of MasSPIKE [288] implemented for BUPID [525]. MasSPIKE provided 
substantially more sensitive deconvolution of tandem MS, allowing detection of low 
abundance fragment ion peaks indicative of residually glycosylated peptide backbone 
fragments [293]. 
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3.2.6 Glycomics data analysis 
Glycomics data were deconvoluted and deisotoped using DeconTools (version 
1.0.5501) [244,266]. Scan-specific monoisotopic peaklists from LC-MS analyses were 
matched against a combinatorically generated glycan composition database, using the 
following parameters: 
 
 
Monosaccharide lower and upper bounds: 
Hexose  3 - 10 
HexNAc  2 - 8 
Fucose (deoxyhexose) 0 - 5 
NeuAc   0 - 4 
 
Rules: 
Fucose (dHex) <= HexNAc – 1 
NeuAc <= HexNAc – 2 
 
Database generation and matching were performed using a 10 ppm mass error 
tolerance using GlycReSoft [359]. 
LC-MS data preprocessed by Decon2LS were clustered using a method similar to 
that reported previously [359], described in Method 1. The sorted order invariant ensures 
that the most abundant peak will be the seed mass for a group, which is expected to have 
the most accurate mass. These peak clusters were merged following a new algorithm to 
capture scan density, signal to noise ratio, charge state multiplicity, monoisotopic mass, 
and isotopic cluster consistency. 
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SequentialNeutralMassClusteringByDescendingIntensity(MSPeaks, GroupMassErrorTolerance): 
Clusters := ∅ 
SortedMSPeaks := SortByIntensityDescending(MSPeaks) 
For each Peak in SortedMSPeaks: 
 PeakGroup := FindNearestMass(Peak, Clusters, GroupMassErrorTolerance) 
 If PeakGroup != 𝑛𝑢𝑙𝑙: 
  AddToGroup(Peak, PeakGroup) 
 Else: 
  CreateNewGroup(Peak, Clusters) 
Return Clusters 
 
Method 1: Sequential Clustering 
3.2.6.1 MS1 Database Search 
After clustering MS peaks and computing cluster features, clusters were 
compared against a hypothesis database as constructed above. Each entry in the 
hypothesis database was searched against the peak group clusters, selecting matches 
which are within some ppm error tolerance threshold 𝑡, for our tests, 10 ppm. Adduction 
and incomplete derivatization can cause a glycan precursor mass to shift by fixed 
amounts, which are taken into account 
3.2.6.2 Peak Group Evaluation 
We converted peak groups into feature vectors comprised of charge state count, 
scan density, scan count, total volume, A to A+2 peak intensity estimate error, centroid 
scan estimate error, and average signal to noise. We then constructed a label vector to 
reflect the match label, and fit a logistic regression model to find peak group parameters 
which distinguish groups that match the hypothesis database, and those that do not. We 
then score all peak groups with this model, independent of whether or not they matched a 
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database entry. Because MS
1
 information alone is insufficient for identification, this 
model application does not predict the quality of a match, but a peak group’s likeness to 
peak groups which matched database entries. This metric evaluates the completeness of 
the database, intended to identify peak groups which look like real compositions but that 
were not found in the database. 
3.2.7 Glycoproteomics data analysis 
A naïve glycopeptide hypothesis is a database of glycopeptides from an in-silico 
enzymatic digest with up to 𝑘 missed cleavages of one or more reference sequences of 
putative glycoproteins with all combinations of selected post-translational modifications, 
combined with one or more N-Glycan compositions. We used pyteomics [182] to provide 
our dictionary of proteolytic enzymes. Post-translational modifications may either be 
fixed, guaranteed to be present, or variable, occurring or not at each viable site as defined 
by a subset of rules selected from database such as Unimod [103]or ProteinProspector’s 
MS-Digest [32]. If a glycopeptide has more than one glycosylation site, combinations of 
glycans are considered, up to a limit of 𝑔 glycosylations on a single peptide. A hypothesis 
is only constructed for MS
1
 compositions, so exact placement of variable modifications 
and glycosylations need not be determined exactly. Only unique glycopeptides are 
considered for each reference protein. 
After construction, the hypothesis is searched against clustered LC-MS data as for 
glycomics. The results are used to construct an MS
2
 hypothesis. 
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3.2.7.1 MS1 Informed Hypothesis Building 
An informed hypothesis begins with an mzIdentML file [278] and a library of 
glycan compositions, like a hypothesis or database search results set from a glycomics 
experiment. Each protein and associated peptidoforms are extracted from the mzIdentML 
file, filtered for just those which contain glycosylation sites following biosynthetic-rules, 
user specifications or other experimental information and then all combinations of 
peptidoforms and glycans are generated as in the naïve case. Because post-translational 
modifications and their locations have already been identified, no position information is 
removed. This may cause the informed hypothesis to be larger than the naïve hypothesis 
at the MS1 level, but each match at this level will translate to exactly one sequence 
searched at MS2 instead one or more. As in the naïve case, the informed MS1 hypothesis 
is evaluated in the same way. 
3.2.7.2 MS2 Naïve Hypothesis Building 
After having performed MS
1
 database searches, an MS2 hypothesis can be 
constructed. Each hit glycopeptide composition with present but un-localized PTMs is 
expanded into a set of glycopeptide sequences where PTM locations are exactly 
specified. This results in a combinatorial expansion of glycopeptide sequences, many of 
which may be indistinguishable without high coverage. This process included positioning 
the glycosylation attachment site(s) for each isoform. We generated theoretical peptide b 
and y ion series for each sequence, as well as precursor stub ions and oxonium ions. A 
precursor stub ion is composed of the mass of the intact peptide backbone with portions 
of the N-glycan core attached. Oxonium ions are low mass diagnostic saccharide ions 
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generated by fragmentation of the glycan units on glycoconjugates during collisional 
dissociation, analogous to immonium ions generated by peptide dissociation. 
3.2.7.3 MS2 Informed Hypothesis Building 
Each glycopeptide matched at the MS1 level from an informed hypothesis is 
translated to exactly one glycopeptide sequence. Informed databases for integrated omics 
were generated as described previously [291], except that the only glycans which were 
included from the glycomics analysis had an aggregated abundance greater than twice the 
mean abundance of all glycan matches.. Tandem mass spectra were identified by first 
recalculating the precursor ion monoisotopic mass and charge, followed by a database 
search procedure with a precursor mass tolerance of 10 ppm. For each glycopeptide 
which fell within the acceptable mass range, theoretical product ions for b, y, b plus 
HexNAc, y plus HexNAc, and intact peptide plus incremental losses of saccharide units 
(known as “stub ions”, were assigned. The tandem spectra were deconvolved and peaks 
were matched for each theoretical product ion with an error tolerance of 10 ppm, 
constructing a glycopeptide-spectrum match (GSM). 
3.2.7.4 MS2 Database Search 
For each sequence in the hypothesis, for each tandem spectrum whose precursor 
neutral mass is within 𝑡1  ppm mass error window, we compute fragment matches. 
Theoretical fragment masses are compared against the neutral masses for each tandem 
spectrum peak with an error tolerance of 𝑡2 ppm. For our datasets, 𝑡1 = 10, 𝑡2 = 20. We 
first search for oxonium ions, evidence that the scan included a glycopeptide, and if none 
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are found, no further matching is performed. Multiple glycopeptides regularly match the 
same spectrum, as in proteomics, so spectral evidence is assigned to the best matching 
cases. Under the simple scoring model, this is just the set of glycopeptides which match 
the most peaks in the spectrum. 
3.2.7.5 MS2 Scoring 
Under a simple scoring regime, which does not assume any instrument-specific 
information, we built the score for each glycopeptide match from the set of all spectrum 
matches assigned to it. We computed three scores and combined them into a single 
summary 𝑀𝑆2 𝑆𝑐𝑜𝑟𝑒 following user parameterized weights depending upon the amount 
of backbone information that was expected, as shown in Method 2. 
For each GSM, a score based upon peptide backbone coverage and presence of 
stub ions was computed and scaled to be between 0.0 and 1.0. For each spectrum where 
multiple glycopeptides could be assigned, all GSMs tied for the highest score were added 
to a results set. 
For each experiment, a forward-sequence (target) and a reverse-sequence-with-
valid-sequon (decoy) database was searched, and a q-value without PIT as described by 
Käll et al. [281], was computed for the paired result sets. Target spectra which had a q-
value < 0.05 were selected for inclusion in the final reported results.  
All of the glycomics and glycoproteomics data analysis, including database 
generation, matching and FDR estimation was performed using components of a 
prototype GlycReSoft data analysis pipeline, developed by Joshua A. Klein.  
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MeanCoverage(Glycopeptide, MatchedFragments): 
bIonSeries := {0 for 𝑖 in [1, Length(Glycopeptide)]} 
yIonSeries := {0 for 𝑖 in [1, Length(Glycopeptide)]} 
 
For each Fragment in MatchedFragments: 
 If IonSeries(Fragment) == 𝑏: 
  bIonSeries[SequenceIndex(Fragment)] = 1 
 Else If IonSeries(Fragment) == 𝑦: 
  yIonSeries[SequenceIndex(Fragment)] = 1 
Coverage := bIonSeries + Reversed(yIonSeries) 
MeanCoverage := Sum({
log 2 1+Coverage [𝑖]
log 2 1.5∗ 𝐋𝐞𝐧𝐠𝐭𝐡(Glycopeptide )
 for 𝑖 in [1, Length(Glycopeptide)]}) 
Return MeanCoverage 
 
 
MeanHexNAcCoverage(Glycopeptide, MatchedFragments): 
bSeriesObserved := 0 
ySeriesObserved := 0 
 
For each Fragment in MatchedFragments: 
 If IonSeries(Fragment) == 𝑏 && Glycosylated(Fragment): 
  bSeriesObserved += 1 
 Else If IonSeries(Fragment) == 𝑦 && Glycosylated(Fragment): 
  ySeriesObserved += 1 
 
bSeriesEnumerated := Length(TheoreticalGlycopeptideSeries(Glycopeptide, 𝑏)) 
ySeriesEnumerated := Length(TheoreticalGlycopeptideSeries(Glycopeptide, 𝑦)) 
 
MeanHexNAcCoverage := 
bSeriesObserved  + ySeriesObserved
bSeriesEnumerated  + ySeriesEnumerated
 
Return MeanHexNAcCoverage 
 
 
MS2Score(Glycopeptide, MatchedFragments): 
MeanCoverage := MeanCoverage(Glycopeptide, MatchedFragments) 
MeanHexNAcCoverage := MeanHexNAcCoverage(Glycopeptide, MatchedFragments) 
 
BackboneScore := (MeanCoverage * 𝐵𝑎𝑐𝑘𝐵𝑜𝑛𝑒𝑊𝑒𝑖𝑔ℎ𝑡) + (MeanHexNAcCoverage * 
𝐺𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑𝑊𝑒𝑖𝑔ℎ𝑡) 
 
BackboneFactor := 1 − 𝑆𝑡𝑢𝑏𝐼𝑜𝑛𝑊𝑒𝑖𝑔ℎ𝑡  
StubIonScore := Min(CountStubIonsObserved(MatchedFragments) / 3.0, 3) 
 
MS2Score := (BackboneScore * BackboneFactor) + (StubIonScore * 𝑆𝑡𝑢𝑏𝐼𝑜𝑛𝑊𝑒𝑖𝑔ℎ𝑡) 
Return MS2Score  
Method 2: Glycopeptide MS2 scoring scheme 
We implemented a false discovery rate (FDR) estimate using the target decoy 
method [139,635] using a reversed target sequence decoy database, comparing 
𝑀𝑆2𝑆𝑐𝑜𝑟𝑒 between target and decoy. In order to preserve as much biological context as 
possible, the N-glycan sequon in each decoy sequence retained its original orientation. 
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For example, a target sequence YPVLN(HexNAc)VTMPNNGK becomes 
GNNPMN(HexNAc)VTLVPYK. This produces deterministic, if reduced entropy decoys, 
which is desirable for reproducibility [197]. To accommodate for the assumption that the 
majority of the sequences in even a small combinatorial database are unlikely to be 
present, we used a “percent incorrect target” adjustment to the Target Decoy ratio 
calculation and also reported a q-value for each glycopeptide match as described by Käll 
and colleagues [281].  
 
3.3 Results 
The complexity of a sample mixture has implications for both the analytics and 
informatics methods used in data acquisition and data analysis. Assumptions about 
sample complexity or purity can have serious consequences on the quality of data and 
information generated. Because population heterogeneity is inherent in glycoconjugates, 
the number of glycosylated molecular forms propagates quickly with added heterogeneity 
from bottom-up sample preparation methods and presence of other PTMs. Additional 
proteins or glycoproteins in the sample matrix will impact the analytical and informatics 
performance.  Therefore, we assessed the effects of sample matrix complexity on 
analytical methods and informatics. We also demonstrated how integration of different 
data domains improves estimation of complexity and keeps false discovery rates in 
check.  
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3.3.1 Effects of assumptions about glycoprotein search space 
Typical assumptions in glycoprotein characterization are related to sample purity. 
Most search spaces do not account for presence of contaminating proteins/glycoproteins 
in the sample analyzed. For biotherapeutic formulations, these contaminants are often 
components of the culture system used for production of the biomolecule.  For biological 
samples derived from animals or plants, co-purified molecules from the sample matrix 
are commonly present.  Commercially available standard glycoproteins are commonly 
used for method development and validation and are usually assumed to be pure; 
however, while the target glycoprotein may be the most abundant molecule present in the 
preparations, it is not safe to assume that it is the only (glyco)protein present. We 
assessed purity of commercially available AGP and transferrin glycoprotein standards 
using proteomics. Figure 16A shows the total number of proteins identified in a 
proteomics analysis of each purified glycoprotein. While all standard glycoproteins 
originated from serum or plasma, each has its own unique subset of contaminants, which 
are co-purified despite the enrichment and purification steps. 
3.3.2 Evaluation of search space construction methods: naïve versus informed 
In addition to contaminating proteins present in the sample, presence of PTMs, 
non-specific cleavages or missed-cleavages in bottom-up sample preparation methods 
can also confound the data analysis. In the absence of a proteomics experiment, it is 
almost impossible to gauge the number and type of protein variants in the sample. 
Traditional proteomics search methods require the user to specify a list of modifications 
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and proteolytic cleavage types to be considered, which also limits the search space to 
assumptions [141].  
The degree to which the naïve approach estimates accurately the false discovery 
rate (FDR) depends on the assumptions; unfortunately, in the absence of data, there is no 
way of evaluating the correctness of these assumptions.  As a result, the naïve method 
may over- or under-estimate search space size.  Underestimation arises when a 
glycoprotein is incorrectly assumed to be pure.  This situation leads to false confidence in 
the results when FDR is calculated for glycopeptides derived from the pure glycoprotein.  
The presence of contaminating glycoproteins in the sample means that the search space is 
in reality much larger than assumed and that the FDR calculated from the assumed search 
space underestimates the rate of false identifications.   
Overestimation of search space size is a result of including too many 
glycoproteins and glycoforms in the search space and may lead to inability to 
differentiate true from false identifications; in such cases many high quality tandem mass 
spectra will have spurious matches against components in the search space.   In summary, 
the validity of an FDR calculation depends on the assumptions of search space size.  To 
the extent that the search space accurately estimates sample complexity, the FDR 
correctly expresses the confidence of glycopeptide assignments. 
Error-tolerant searches and de novo sequencing tools have gained popularity in 
proteomics [102,351,509,615]. These allow the user to analyze data without bias from 
pre-defined search parameters to maximize coverage of the proteome with respect to the 
different molecular forms present. Glycosylation adds a large molecular weight and 
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considerable macro and micro-heterogeneity, in addition to other non-glycan 
modifications present on proteins or peptides. Glycosylation also introduces glycosidic 
product ions in tandem MS, not found for unglycosylated peptides, complicating the 
identification process. As a result proteomics search engines that perform error-tolerant 
searches are unable to handle complex glycosylation as a modification. For similar 
reasons, emerging software tools that are capable of assigning glycopeptide compositions 
are unable to perform large error-tolerant searches for other PTMs and therefore rely on 
user specified search spaces. We assert that the most efficient circumvention to this 
problem is to use the identifications from proteomics data to inform the search space for 
glycoproteomics.  
To prove this, we used mzIdentML proteomics search results from a combination 
of error-tolerant and de novo searches and the confidently identified peptide molecular 
forms to build a search space for all possible glycopeptidoforms present in our samples. 
Similarly, to define our glycoform search space, we performed glycomics searches on our 
released glycan pools and iteratively combined the results with the proteomics 
identifications that contained glycosylation sites. Figure 16 compares the sizes for a naïve 
search space (B), built for glycoprotein mixture 3 based on assumptions about 
glycoproteins and PTMs present versus an informed search space (C), built using the 
proteomics search results to define the range of glycoproteins and PTMs present in the 
sample and a further constrained informed search space (D) that included glycomics data. 
Strikingly, the proteomics and glycomics informed search space in panel D has less than 
half the number of total theoretical glycopeptides compared to the naïve search space in 
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panel B. While proteomics information helps identify all contaminating glycoproteins in 
the sample, it can lead to an explosion of the search space size, which can render the 
glycopeptide search process inefficient; glycomics helps restrict the number of 
glycoforms to those that are actually detected in the glycomics analyses. It is therefore 
important to use both proteomics and glycomics in glycopeptide search space 
construction. 
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Figure 16: Glycoproteomics search space 
(A) Venn diagram showing number and overlap of proteins identified from proteomics analyses of individual 
serum glycoproteins and albumin and IgG depleted serum. Only proteins identified at a 1% FDR with 2 or more 
unique peptides identified were included. Comparison of a naïve search space (B) with proteomics informed (C) 
and proteomics + glycomics informed (D) search spaces for glycoprotein mixture 3. X-axes show the Swissprot 
identifiers for glycoproteins included in the hypotheses and Y-axis shows number of glycopeptides per 
glycoprotein considered.   Glycoprotein standards AGP (A1AG), fetuin (FETUA) and transferrin (TRFE) are 
shown on the left-most side of the X-axes. 
 
 133 
 
3.3.3 The site-specific glycoproteomes of transferrin and α1-acid glycoprotein 
Figure 17 shows the base-peak chromatogram (A) for size-enriched glycopeptides 
from commercially sourced human transferrin.  Chromatographic peaks corresponding to 
glycopeptides were identified based on the extracted ion chromatogram for the HexNAc 
and Hex-HexNAc oxonium ions (B and C). We interpreted the glycopeptide tandem mass 
spectra using a search space containing putative transferrin glycopeptides; this analysis 
identified three of the EIC peaks as transferrin glycopeptides.  Next, we acquired 
proteomics data on the PNGase F deglycosylated sample and found that hemopexin, a 
protein with five N-glycosylation sequons, was in the sample, in addition to transferrin.  
When we added hemopexin to the search space, we identified abundant chromatographic 
peaks corresponding to hemopexin glycopeptides. 
 
Figure 17: Base peak chromatogram of enriched transferrin glycopeptides stacked over extracted ion 
chromatograms for saccharide oxonium ions, generated by MS/MS, indicating the presence of glycopeptides in 
the eluting peaks 
α1-Acid glycoprotein contains two protein isoforms with five sequons, each 
[293,398,530:1-]. To construct a naïve glycopeptide search space, we allowed 0-2 missed 
tryptic cleavage sites, methionine oxidation, and 0-1 sites of deamidation for asparagine-
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containing glycopeptides.  Table 4 shows the naïve search space size calculated assuming 
pure AGP, AGP plus haptoglobin, and AGP plus haptoglobin plus transferrin. We then 
compared the results from our informed versus naïve search spaces. 
The search space size ballooned 10-fold for the three protein mixture relative to 
the hypothetically pure AGP protein. We acquired proteomics data for human α1-acid 
glycoprotein (AGP) and found that in addition to the two expected isoforms, the sample 
contained haptoglobin, a protein that contains four N-glycosylation sequons, among the 
top scoring identified glycoproteins.   For both AGP and haptoglobin, there are a large 
number of hypothetical glycopeptides.  Tryptic haptoglobin has glycopeptides containing 
two sequons, thus the high mass and large number of hypothetical haptoglobin 
glycopeptides.   
Sample Naïve Search 
Space Size 
Informed Search 
Space Size 
Naïve Pure AGP 14,577 2,000 
Naïve Contaminated AGP 
(AGP + Haptoglobin) 
45,371 2,085 
Naïve AGP + Transferrin 
(AGP + Haptoglobin + 
Transferrin) 
115,910 25,850 
Table 4: Search space sizes for AGP and AGP mixed with transferrin when calculated with assumptions about 
proteoforms and glycoforms (naïve) and using data from proteomics and glycomics experiments 
 
Because of the sample complexity, we compared the ability to assign 
glycopeptide tandem mass spectra for a naïve search space versus a search space 
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informed by proteomics and released glycan glycomics (Figure 18A). The glycomics 
results for AGP are presented in Figure 19.    
 
 
Figure 18: Comparison of the performance of naïve versus informed search spaces for an AGP glycoproteomics 
result. 
 (A) Number of glycopeptide matches over a range of confidence thresholds (q-value) based on glycoproteomics 
searches followed by FDR calculation by decoy database searches. Colored lines represent different hypotheses 
as indicated in the legend. (B) A comparison of number of glycopeptides and decoys matches for naïve and 
informed search spaces at different MS2 score thresholds. 
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Figure 19: Glycomics results for α1-acid glycoprotein 
 
Figure 18B, compares glycoproteomics search results using naïve versus informed 
hypotheses.  The height of the curve at the red bar tells us how many predictions were 
accepted at our confidence threshold. The informed hypothesis retains substantially more 
predictions above the confidence threshold, compared to the naive 
hypothesis.   Therefore, use of a search space informed by proteomics and glycomics data 
boosts our ability to assign glycopeptides from tandem mass spectral data with 
confidence.  The profile of site specific AGP glycosylation informed by proteomics and 
glycomics is shown in Figure 21. 
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3.3.4 Confidence in assignment of site-specific glycosylation of an analyte of interest in 
an increasingly complex matrix.   
Most glycoproteomics experiments rely on data dependent acquisition that is 
directly affected by the complexity of the sample matrix. With increase in matrix 
complexity the ability of the analytical methods to interrogate the analyte of interest 
decreases. The mass spectrometer may not be able to detect glycopeptides from the 
glycoprotein of interest depending on the relative abundance of the impurities and the 
dynamic range of the instrument. Moreover, even when the glycopeptides of interest are 
within the dynamic range, data-dependent acquisition methods spend less time on 
collecting tandem MS on these analytes in presence of contaminating 
glycopeptides/peptides.  
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Figure 20: Effects of increasing sample complexity on analytical methods  
(A) Base peak chromatograms (MS only) for samples with different levels of complexity. (B) Extracted ion 
chromatograms showing the abundance of an AGP glycopeptide (LVPVPITNATLDR-Hex6, HexNAc5, NeuAc3) 
in the different complexity levels. (C) The average number of tandem mass spectra acquired per precursor 
across samples of different complexity. (D) Distributions of precursors selected for tandem MS across a LC-
tandem MS experiment for samples with scaling complexity levels. 
 
We constructed mixtures with scaling complexity by mixing together fixed 
quantities of different glycoprotein samples. Figure 20 shows how data quality for the 
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AGP glycopeptides of interest deteriorates when complexity increases. Figure 20A shows 
overlaid base peak chromatograms for AGP alone, glycoprotein mix 3, glycoprotein mix 
5 and serum (see the Experimental section for mixture definitions). With each complexity 
level, the chromatogram is visibly more crowded. The non-AGP glycopeptides in the 
sample can easily lead to saturation of the column binding capacity leading to a decrease 
in intensity of the glycoprotein/peptides of interest, as seen in Figure 20B. This could be 
a problem when trying to get quantitative LC-MS data, since sample matrix complexity 
could affect the dynamic range of the assay at both the column binding capacity and mass 
spectrometer detection levels. Figure 20D shows how the precursors were selected for 
tandem MS as sample complexity grows. The colored dots trailing along the X-axis 
represent tandem MS for different precursors.   The long trails of colored dots in the 10-
20 and 40-60 represent tandem MS on low abundance contaminants that elute over long 
periods of the LC gradient. In lower complexity samples, these contaminants are 
repeatedly selected for tandem MS due to the absence of other precursors eluting in these 
retention time ranges. In the 20-40 min retention-time range where most glycopeptides 
are found to be eluting in the AGP chromatogram, multiple tandem MS are acquired for 
each precursor. This also allows proper triggering of tandem MS for the precursor to be 
selected at the chromatographic peak apex and results in good quality tandem mass 
spectra. On the other hand, the distribution of precursors in glycoprotein mix 5 and serum 
is clearly very sparse and in most cases only a single tandem mass spectrum is being 
collected per precursor. For a better comparison of the complexity of these samples, in 
Figure 20C, we have compared the average number of tandem MS per precursor for each 
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complexity level. This shows that as the total number of unique precursors increases with 
increasing complexity, the attention or time-spent acquiring MS/MS on each precursor 
diminishes. This becomes a serious limiting factor for low abundance glycopeptide 
glycoforms, which are either not selected for tandem MS or for which poor quality 
tandem MS are acquired. Thus, as the complexity increases, in glycoprotein mixes and 
serum, the mass spectrometer is unable to handle the increase in co-eluting 
peptides/glycopeptides and acquires fewer tandem mass spectra per precursor, resulting 
in poor data quality and lower identification rates. 
The effect of increasing complexity is reflected in the depth of glycoform 
coverage for AGP glycosylation sites as shown in Figure 21.  The most comprehensive 
assignment of glycopeptides comes from the AGP only sample.  As mixture complexity 
increases, the overall scores diminish, resulting in fewer assignments falling above the 
scoring threshold.  This is due to the decreasing number of tandem mass spectra per 
precursor ion resulting from increased mixture complexity and the finite scanning speed 
of the instrument.  The AGP precursor ion abundances decreased with mixture 
complexity.  This is likely due to a combination of ionization effects and the limited 
capacity of the glycopeptide enrichment step, which limits the amount of total 
protein/peptides that are loaded on to the analytical column. Since the bar plots represent 
the sum of fragment ion abundances for all scans matching a glycopeptide, the precursor 
that have the most high-scoring spectral matches also show up as the most abundant 
matches on the bar plots.  
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It was important to integrate data from proteomics and glycomics domains, for 
accurate estimation of the FDR and for setting confidence thresholds for accepting 
matched glycopeptide spectra for all complexity levels, as already shown in Figure 18. 
While a tandem MS may be acquired for all eluting glycopeptides, good spectral quality 
is essential for confident matching above the FDR thresholds. For some of the AGP 
glycosylation sites shown in Figure 21, glycoprotein mix 5 appears to have more 
glycopeptide matches with glycoprotein mix 3. This is generally due to differences in the 
profile of co-eluting contaminating peptides that affect tandem MS acquisition.  
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Figure 21: Grouped bar plots showing identified site-specific AGP glycoforms in samples of different complexity 
levels and in depleted serum 
The different glycoforms for each glycosylation site are listed on the X-axes while the Y-axes indicate summed 
abundances of all fragment ions in the matched glycopeptide spectra. Different colored bars are specific for pure 
AGP, glycoprotein mixtures or depleted serum as indicated in the legend. 
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3.4 Discussion 
For most proteomics and glycoproteomics experiments, multiple sample clean-up 
and fractionation steps are used for reducing complexity before online LC-MS. While 
sample fractionation increases glycopeptide coverage, overall matrix complexity impacts 
the analysis of our molecule of interest. Since, heterogeneity of glycoforms is a major 
challenge in the analysis of glycoconjugates, the problem of defining the correct 
boundaries for data analysis is amplified many fold over non-glycosylated molecules. It 
is therefore important to account for the matrix contribution during data analysis so that 
assumptions about sample purity do not affect confidence in results. A better 
understanding of the matrix comes from integrating different data dimensions and 
prevents erroneous assignment of contaminant data to the analyte of interest, thereby 
lowering the false discovery rates. Since this step helps determine the nature of 
contaminants present in the sample matrix, it also guides choice of the appropriate 
methods required for further sample purification. This can greatly impact successful 
method development in an industry setting for analysis of biologicals [434]. Collectively, 
these results demonstrate the effect of assumptions about sample complexity on the false 
discovery rates and therefore confidence in analyses. Analytical method development 
benefits greatly from proper data analysis and results visualization to identify any issues 
that limit performance.  
While method performance is heavily dependent on instrument hardware and 
software, it is essential to establish standard methods and datasets to use as benchmarks 
for tracking any changes in instrument and method suitability both within an experiment 
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and over long-term use. The human α1-acid glycoprotein is reasonably complex, widely 
available and can be handled by most LC-MS analytical platforms used for 
glycoproteomics. AGP therefore serves as a good standard for method development, 
validation and suitability tracking.  
We demonstrated that predetermination of sample complexity is of utmost 
importance, when dealing with complex biological matrices. In the absence of 
empirically derived information, the multiplicity of molecular forms in glycoproteomics 
can easily overwhelm analytical methods that are not setup keeping sample and matrix 
complexity in mind. The ramifications are even more serious on the informatics end. 
Contaminating proteins, sample processing artefacts, unusual PTMs, mutations and above 
all glycoforms can confound glycoproteomics data and severely inflate false discovery 
rates. Measurement of the proteome of glycoprotein sample constrains the search space 
size by defining the peptide variants actually present.  This allows inclusion of 
contaminating glycoproteins detected in the proteomics data that were not included in the 
naïve search space, while preventing addition of unnecessary contaminants based on 
assumptions about matrix that may not be present in the sample, thus fixing the 
proteomics search space.  In addition, profiling of the released glycans reduces the list of 
glycans present in the sample and efficiently constrains the search space size.  Thus, 
proteomics and glycomics data help develop an efficient search space that prevents over- 
or underestimation of the glycosylated molecular forms present in a sample. We present a 
new glycoproteomics data analysis pipeline GlycReSoft that maximizes informatics 
power by combining glycomics and proteomics data in mining the glycoproteomes. 
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Naïve searches fail to eliminate unreasonable hypotheses because of the 
complexity of real life glycoprotein samples.  As a result, the level of false identifications 
cannot be determined accurately.  Informed searches allow unbiased definition of search 
spaces, thus helping determine confidence levels in assignments, accurately.   
We conclude that sample complexity at which acceptable rates of false 
identifications occur need to be defined using data.  We suggest use of AGP as a 
glycoprotein standard of complexity suitable to test the glycoproteomics workflows. This 
will help harmonize efforts in the glycoproteomics community and enable a better 
comparison of data quality and controls. Further, we suggest controls in which AGP is 
doped into the sample matrix to demonstrate that acceptable rate of false identification 
results. This will help the experimentalists identify and eliminate any flaws in their 
analytical strategies. 
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Chapter 4: Influenza virus glycobiology and structural studies using mass 
spectrometry 
(Part of this work is published in [291]). 
 
4.1 Introduction 
Influenza A virus (IAV) remains a major cause of animal and human mortality 
and morbidity, with no effective broadly neutralizing vaccines available. The IAV 
envelope-glycoprotein hemagglutinin (HA) binds sialic acids on respiratory airway 
surface glycoconjugates and facilitates viral entry into host cells, thereby leading to 
infection.  The envelope-glycoprotein neuraminidase (NA) cleaves sialic acids to allow 
newly formed virions to escape the host cell membrane.   Because the surface proteins 
undergo rapid mutation, it has not been possible to develop broadly neutralizing vaccines 
against IAV. In particular, IAV strains undergo amino acid mutations to accumulate new 
N-glycosylation sequons during seasonal circulation in the human population 
[49,86,546,561]. Thus, based primarily on genetic sequencing evidence [72,225,345], 
glycans appear to shield HA antigenic sites from host antibody recognition, as part of the 
evolutionary antigenic drift [111,118,340,616]. While this putative shielding effect of 
glycans apparently improves the ability of the virus to escape antibody neutralization, the 
virus must compensate for loss in receptor avidity from steric interference caused by the 
glycans proximal to the sialic acid binding sites on the HA head [117,541]. 
T-cells of the adaptive immune system reach the lung approximately five days 
after IAV infection [259]. During this time, viral replication and lung damage is 
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mitigated by the innate immune system. Among the soluble innate immune inhibitors, the 
calcium-dependent lectin inhibitors (known as β-inhibitors) bind to carbohydrates on 
pathogen surfaces. For seasonal IAV strains, surfactant protein-D (SP-D) is the most 
important soluble innate immune factor present in bronchial lavage fluid [215,565]. The 
activity of this lectin depends on the presence of high mannose N-glycans on viral HA; 
IAV strains lacking glycosylation on the HA head region resist neutralization by SP-D. 
These include the pandemic strains of H1N1 1918 and 2009, the H3N2 of 1968 and the 
H2N2 of 1957 [218,274,427]. Thus, the pathogenicity of pandemic IAV correlates with 
ability to escape neutralization by SP-D [215,224,427]. Generally speaking, as seasonal 
strains acquire additional N-glycosylation sequons they show increased susceptibility to 
SP-D, as they circulate in humans. While IAV mutates to avoid antibody neutralization 
by accumulating sequons, the mechanisms whereby viruses maintain fitness despite 
increased binding to SP-D and other lectins of the innate immune system remain poorly 
understood [19,213,214,218,436,516,565]. 
The H3N2 subtype has circulated in humans since 1968 and remains the major 
seasonal IAV health threat. The H1N1 subtype was introduced into the human population 
with the disastrous 1918 pandemic and was supplanted by the H2N2 subtype in 1957. 
The H1N1 subtype was re-introduced into the human population in 1977 and displayed 
several additional N-glycosylation sequons on HA not present on earlier strains [508].  In 
2009, it underwent antigenic shift by incorporation of genetic elements from the swine 
and avian sources to emerge as a new pandemic subtype. The pattern of N-glycosylation 
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sequons of pandemic H1N1 2009 more closely resembled the 1918 pandemic H1N1 
(minimal glycosylation) than that circulating seasonally prior to 2009 [561]. 
Despite the central role of glycosylation in viral evolution, there remains a paucity 
of structural information on HA glycosylation. A recent study of engineered variants of 
the Hong Kong 1968 H3N2 subtype demonstrated that exclusively high-mannose N-
glycans occupy HA sites 165 and 246 [17]. Although genetic sequence analyses identify 
the creation or disruption of N-glycosylation sequons, they provide no information on the 
glycan site occupancy, structure and micro-heterogeneity. In addition, crystal structures 
typically show only the chitobiose core and do not define glycan antennae [487,504,571]. 
We therefore built a predictive model for seasonal IAV fitness and antigenicity that 
incorporates (i) data on changes in site-specific HA glycosylation that occur as the virus 
evolves to escape SP-D neutralization and (ii) the HA structural features that regulate 
glycan microheterogeneity at each site that influence binding to SP-D. We demonstrate 
the value of complete information on the mature glycosylated HA structures to inform 
better understanding of the evolution of IAV in response to immune system pressure. 
In addition to defining changes in site-specific glycosylation on HA in response to 
immune-selection pressures, a parallel study was performed to understand the role of 
sialylated glycans present on porcine SP-D (pSP-D), in potentiating the neutralization of 
Influenza in pigs. It has been shown that pSP-D possesses unique structural features in its 
CRD that result in substantially stronger anti-IAV activity as compared to SP-Ds from 
other animal species that have been characterized to date, including human SP-D (hSP-D) 
[137]. pSP-D is known to have a highly sialylated N-linked glycan on its CRD that 
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generates a dual mechanism of interaction with IAV and that makes pSP-D unique 
amongst all other SP-Ds  in being a β-inhibitor as well as a γ-inhibitor against IAV 
infections. In addition, it was shown that the type of sialic acid (SA)-linkage present on 
pSP-D is important for inhibition of IAV strains that have a corresponding receptor-
binding specificity [538]. The presence of this sialoside on pSP-D makes it a potent 
inhibitor of IAV strains, such as PR-08, that lack glycans on the head of HA and are 
therefore not inhibited efficiently by SP-D from other species, but are inhibited by pSP-D 
since the HA recognizes and binds sialylated glycans on the pSP-D [538]. To better 
understand the mechanisms involved in inhibition of IAV by pSP-D, it is important to 
elucidate the structural features of pSP-D, with a particular focus on the sialylated glycan 
present in the CRD. We performed mass spectral characterization of recombinant porcine 
NCRD (RpNCRD). These data will support a study comparing the structural features and 
binding and neutralization activities of sialylated and asialo pSP-D that is being 
performed at Utrecht University by Dr. Martin van Eijk and coworkers.
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4.2 Experimental procedures 
 
Figure 22: Experimental Workflow for IAV analysis 
A: Integrated-omics: Workflow for acquiring and combining proteomics, glycomics and glycopeptidomics 
information to enable confident assignment of site-specific glycoforms; B: Immunological and biochemical 
assays used for correlating changes in virus glycosylation with bioactivity; C: Modeling and molecular dynamics 
simulations driven by structural information from integrated-omics analyses to understand structural basis for 
host-virus interactions and glycan processing at important sites. Graphic shows ERManI interacting with the 
glycan at Asn 144 on the head region of a Phil-82 hemagglutinin trimer. 
 
All mass spectrometry data were acquired by Kshitij Khatri, and the data 
acquisition and analysis were directed by Prof. Joseph Zaia. Mass spectrometry/Omics 
data were analyzed by Kshitij Khatri and Joshua A. Klein. The IAV preparations used in 
this work were grown by Mitchell R. White. Bioassays were performed by Kshitij Khatri 
and Mitchell R. White, under the guidance of Prof. Kevan L. Hartshorn and Prof. Joseph 
Zaia. Dr. Oliver C. Grant performed the computational glycobiology and molecular 
modeling work under the guidance of Prof. Robert J. Woods. Dr. Erika C. Crouch 
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(Washington University School of Medicine) provided the Surface Plasmon Resonance 
data, shown in Figure 28. Dr. Martin van Eijk at Utrecht University generated the 
RpNCRD used in this work. Prof. D.F. Smith carried out the CFG glycan array analyses 
at the National Center for Functional Glycomics (Emory University School of Medicine) 
funded by the NIH grant P41GM103694. Dr. Michael J. Rynkiewicz and Prof. Barbara 
A. Seaton participated in discussions pertinent to this project and provided helpful 
suggestions in designing IAV and porcine SP-D experiments.  
4.2.1 Virus preparation 
The following IAV strains were used in the study: 
Phil-82: A high growth reassortant of A/Philippines/2/82(H3N2) and A/Puerto 
Rico/8/34(H1N1).  The seed stock was a gift from Dr. E. Margot Anders, University of 
Melbourne. This strain consisted of an H3 hemagglutinin and N2 neuraminidase from 
A/Philippines/2/82, while the remaining virus components were from A/Puerto 
Rico/8/34. 
Phil-BS: A mutant version of Phil-82 that was selected by growing Phil-82 in the 
presence of bovine serum, found to be resistant to neutralization by bovine conglutinin, 
as described previously [19,213,214,435].  The seed stock was from Dr. E. Margot 
Anders, University of Melbourne. 
PR-08: The mouse-adapted A/Puerto Rico/8/34(H1N1) strain.  The seed stock 
was from Dr. Jon S. Abramson, Wake Forest University. 
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All viruses were grown in the chorioallantoic cavity of 10 day old embryonated 
chicken eggs. Allantoic fluid was harvested after incubating for 48 hours and insoluble 
debris were pelleted by centrifugation at 1000x g. The virions were then pelleted at 
135,000x g and the pellets were purified on a sucrose density gradient followed by 
dialysis against phosphate buffered saline (PBS).  
RpNCRD was expressed in and purified from HEK293 cells by Dr. Martin van 
Eijk, as described previously[136].  
4.2.2 Experimental Design and Statistical Rationale for IAV analyses 
As shown in Figure 22, virus samples were subjected to proteolytic digestion. 
Proteolytic samples were divided into three fractions for proteomics, glycomics and 
glycoproteomics. Proteomics and glycomics fractions were subjected to PNGase F 
glycan release. All three fractions for each sample were subjected to triplicate LC-MS 
analyses, as described in sections below. Three technical replicates of LC-MS 
acquisitions were used to calculate mean analyte abundances and standard deviations in 
measurements. Human α1-acid glycoprotein (Sigma-Aldrich, St. Louis, MO), a widely 
studied standard glycoprotein, was used as a control for all sample preparation and 
verifying LC-MS instrument performance. 
4.2.3 LC-MS analyses of IAV 
4.2.3.1 Sample preparation  
Virus preparations were subjected to membrane disruption, reduction, alkylation 
and proteolysis. Virus preparations containing approximately 60 µg total protein were 
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dried down in a centrifugal evaporator and re-suspended in LC-MS grade methanol 
(Fisher Scientific), followed by sonication for 10 minutes in a water bath to disrupt viral 
membranes. Samples were dried and re-suspended in 50% 100 mM ammonium 
bicarbonate and 50% 2, 2, 2-trifluoro ethanol (TFE) (Sigma-Aldrich, St. Louis, MO) (60 
µl). 200mM dithiothreitol (DTT) (2 µl) was added to the samples and heated at 95⁰C for 
30 mins to reduce disulfide bonds.  Iodoacetamide (10 µl, 200 mM in water) was then 
added to the samples and incubated for 1 hour in dark, at room temperature. To quench 
excess iodoacetamide, another (2 µl) of 200 mM DTT was added to the samples and 
incubated for one hour at room temperature. LC-MS water (300 µl) was added to the 
samples to dilute TFE to less than 5% of the total volume and 100 mM ammonium 
bicarbonate (200 µl) was added to raise pH to 7.5. Sequencing grade Trypsin or 
Chymotrypsin (Promega Corp., Madison, WI) were added to the samples and incubated 
overnight at 37⁰C, for proteolysis. Proteolytic peptides and glycopeptides were split into 
aliquots for performing 
16
O-proteomics, 
18
O-proteomics (for site-occupancy analysis) and 
glycoproteomics. 
16
O-proteomics and 
18
O-proteomics samples were deglycosylated using 
PNGase F (New England Biolabs, Ipswitch MA) in H2
16
O or H2
18
O respectively, while 
the glycoproteomics samples were incubated in the deglycosylation conditions without 
PNGase F. Released glycans from deglycosylated samples were isolated using C18 spin 
columns (Pierce Biotechnology, Rockford, IL) and pooled (
16
O and 
18
O) for glycomics 
analyses, and deglycosylated peptides were eluted and collected separately for 
proteomics analyses. As a control for spontaneous deamidation at inherently non-
glycosylated Asparagine residues, the glycosylated samples (no PNGase F treatment) 
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were also analyzed, using the proteomics workflow. Mass spectrometry data were 
acquired on each sample as three technical replicates, unless otherwise stated. 
4.2.3.2 Proteomics analyses 
Deglycosylated peptides were subjected to LC-MS/MS using a Waters™ 
NanoAcquity™ nano-flow chromatograph (Waters Corp., Milford, MA) mounted with a 
Waters™ Xbridge™ reversed-phase column (150 µm x 100 mm) packed with 1.7µm 
BEH C18 resin and a Waters™ trap column (180 µm x 20 mm) packed with 5µm 
Symmetry™ C18 stationary phase. The chromatography was performed online with a  Q-
Exactive Plus™ mass spectrometer (ThermoFisher Scientific™, San Jose, CA), operated 
in positive ion mode. The mass spectrometer was mounted with an Advion NanoMate 
(Advion Inc., Ithaca, NY) source for introduction of the LC eluate by nano-ESI. The 
source was operated at 1.7 kV with transfer-capillary temperature maintained at 250⁰C 
and S-Lens RF level set at 55. Mass spectra were acquired in the Orbitrap mass analyzer 
with 1 microscan per spectrum for both MS and MS/MS. Resolving power for MS and 
MS/MS were set at 70,000 and 17,500, respectively. Tandem MS data were acquired in 
parallel with MS, on the top 20 most abundant multiply charged precursors, with higher 
energy collisional dissociation (HCD) at normalized collision energy of 27V. Precursors 
were isolated using a 1.4 Th window and dynamic exclusion of 10 seconds was enabled 
during precursor selection.  
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4.2.3.3 Glycomics analyses 
Released N-glycans were desalted using a Superdex™ Peptide™ 3.2/30 size 
exclusion column on a Beckman™ Gold chromatograph. Desalted N-glycans were 
analyzed in triplicate using negative mode hydrophilic interaction liquid chromatography 
(HILIC) –MS with a constant acetonitrile post-column make-up-flow on an Agilent™ 
6520 LC-MS system with chip-cube™ nanoESI source, as described previously [496].  
4.2.3.4 Glycoproteomics analyses 
Entire tryptic digests were subjected to triplicate analyses using chip-LC-MS/MS 
with online HILIC enrichment and C18 separation on an Agilent™ 6550 LC-MS system 
with chip-cube™ ionization source as described previously [293] and by C18 LC-
MS/MS without any enrichment on the Q-Exactive Plus™ instrument as described for the 
proteomics samples. Chymotryptic samples were analyzed only using C18 LC-MS/MS 
on the Q-Exactive Plus™. 
4.2.4 Data analysis 
4.2.4.1 Proteomics 
Proteomics data were subjected to PEAKS SPIDER (de novo + database + error 
tolerant PTM) searches in PEAKS [615] Studio 7.5 (Bioinformatics Solutions Inc., 
Waterloo, ON) against a combined Uniprot [346] and Influenza A virus protein database 
[493]. The FASTA sequence database used for searches has been included in the data 
repository. A 50 ppm error tolerance for the precursor (MS
1
) and 0.1 Da mass error 
tolerance for fragment ions (MS
2
) were specified. A maximum of 2 missed cleavages per 
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peptide were allowed for the database search. Trypsin specificity was defined as cleavage 
after Arg and Lys, when not followed by a Pro. Chymotrypsin cleavage specificity was 
after Phe, Leu, Met, Trp and Tyr residues, when not followed by a Pro. Cysteine 
carbamidomethylation was specified as a fixed modification; deamidation (Asn) and 
oxidation (Met) were specified as variable modifications. 
18
O labeling of deglycosylated 
asparagine was also used as a variable modification in case of 
18
O-proteomics samples. 
After a regular database search, an error-tolerant PTM search was also performed 
searching for a larger subset of modifications from Unimod [103] and any amino-acid 
substitutions. The final results were a combination of database search, de novo search and 
the error-tolerant search. False discovery rates (FDR) were calculated using a decoy-
fusion approach in PEAKS 7.5, as described previously [615]. Identified peptide-
spectrum-matches with -10logP value of 15 or higher were kept, at a FDR threshold of 
0.1%.  
4.2.4.2 Site-occupancy analysis 
Site-occupancy analysis was performed on Phil-82 for glycan modeling and 
molecular dynamics. While 
18
O-proteomics was performed to define glycan site-
occupancy, in cases where multiple asparagine and glutamine residues existed on 
peptides containing the N-glycosylation sequons, spontaneous deamidation of these 
residues in presence of H2
18
O, confounded the data. Therefore, 
16
O-proteomics results 
were instead used to define site-occupancy information. 
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From the proteomics search results, peptides spanning glycosylation sites were 
selected and extracted ion chromatograms were integrated to generate chromatographic 
peak areas for paired analyses of unoccupied peptides bearing glycosylation sequon in 
glycosylated samples and the same peptides in PNGase F deglycosylated sample. 
Average peak areas of three replicate analyses were compared after normalization using a 
high-confidence peptide from a different protein identified across runs. Site-occupancy 
for sites 8 and 22 were calculated from proteomics results of chymotryptic digests, while 
for the remaining sites, proteomics results from tryptic samples were used.  
Percent site occupancy was calculated as: 
 
𝑆𝑖𝑡𝑒 𝑜𝑐𝑐𝑢𝑝𝑎𝑛𝑐𝑦 =
𝐴𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 (𝑑𝑒𝑔𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑) − 𝐴𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 (𝑔𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑)
𝐴𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 (𝑑𝑒𝑔𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑)
 
 
Equation 20 
4.2.4.3 Glycomics 
Negative mode HILIC-MS data were deconvoluted and deisotoped using the 
THRASH algorithm in DeconTools/Decon2LS (version 1.0.5501) [244,266]. The 
deconvoluted/deisotoped peaklists were matched against a theoretical composition 
hypothesis containing human and avian N-linked glycans from GlycomeDB [432,433], 
using GlycReSoft [359]. Up to 2 formate adducts were allowed while searching for 
glycan compositions, with a match error tolerance of 20 ppm in the theoretical masses. 
Abundances of different adducted forms were grouped together and reported as mean of 
three technical replicates. 
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4.2.4.4 Glycoproteomics/Integrated-omics  
Glycopeptide LC-MS/MS data were deconvoluted and deisotoped using 
DeconTools [266] for MS
1
 spectra. Data were converted to mzML format [355] using the 
MSConvert tool in Proteowizard (version 3.0.7692) [290] and the MS
2
 spectra were then 
deconvoluted using MasSpike [288]. Deconvoluted data were analyzed using an in-house 
version of GlycReSoft and validated manually. Source code for GlycReSoft is publically 
hosted on GitHub (https://github.com/GlycReSoft2). Naïve and informed glycopeptide 
hypotheses were created for mining glycopeptide data. For naïve hypothesis generation, 
theoretical digests of glycoproteins were generated for combining N-glycosylation 
sequon containing peptides with N-glycan compositions from GlycomeDB [432] glycan 
databases.  
For informed hypothesis generation, proteomics search results exported in 
mzIdentML 1.1 format, were used. Hemagglutinin peptides that contained Asn from the 
N-linked glycosylation sequon, with -10logp values of 20 or higher were included in the 
hypotheses. Peptide variants were combined with glycoforms identified in glycomics 
data, to build the glycoproteomics hypotheses. MS
1
 deconvoluted data were searched 
against glycopeptide hypotheses, using a match error-tolerance of 20ppm. Theoretical 
fragment ions were generated for the MS
1
 matches and then searched against the MS
2
 
deconvoluted peak lists, using a 20 ppm error tolerance. Features searched for in MS
2
 
data of glycopeptides included oxonium ions, peptide backbone ions, peptide backbone 
ions with an attached HexNAc and stub-glycopeptide ions [293]. A glycopeptide 
spectrum match was required to have mono or disaccharide oxonium ions. Automated 
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glycopeptide analysis results have been included in the data repository. MS
1
 scores were 
calculated as described previously [359]. MS
2
 scores are representative of number of 
fragment ions found (peptide backbone and stub ion coverage) [293].  q-values depict 
minimal FDR threshold at which the identification is accepted, as described by Käll et al. 
[281]. For cases, where more than one glycopeptide composition matched a given 
precursor and fragment ion spectrum, only the highest scoring match was retained for 
reporting in the results. Glycopeptide analysis results represent site-specific glycoform 
abundances for glycopeptides assigned confidently based on MS
2
 spectra by GlycReSoft 
and validated manually. Chymotryptic glycopeptide data were manually analyzed for 
resolving glycoforms on Asn8 and Asn22, on Phil-82 and Phil-BS and integrated with 
site-specific glycosylation data from tryptic samples processed using GlycReSoft.  
4.2.5 Bioassays 
Biochemical and immunological assays were performed to correlate changes in 
site-specific glycan distributions in IAV strains with virus fitness and susceptibility 
towards host innate immune system. SP-D is a collectin produced and secreted by lung 
epithelial cells in humans and other mammals. SP-D is also known to inhibit IAV by 
binding its surface glycoproteins HA and NA [215,435,224,531]. For this study, a 
recombinant full length human SP-D (rhSPDII) that exists as dodecamers was prepared, 
as described previously by Nikolaidis et al. [106,397]. In addition to the full-length SP-D, 
recombinant neck and carbohydrate recognition domain (NCRD) from SP-D were also 
used. These NCRDs lack the N-terminal domain and the extended collagen domain 
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present in the full-length SP-D and as a result form homotrimers instead of higher order 
multimers. The wild-type recombinant human NCRD (huNCRD) has been shown to bind 
glycans but lacks antiviral activity due to absence of cooperative binding effect from the 
multiple heads [108,217,397]. Gain-of-function mutants R343V and double mutant 
D325A+R343V (D+R), which have been shown to possess increased virus binding and 
neutralizing activity [106,397,107,109,179], were also used in bioassays. Mutant names 
are indicative of amino-acid substitutions flanking the lectin site in the huNCRD protein.  
4.2.5.1 Hemagglutination assays 
Hemagglutination and Hemagglutination inhibition (HI) assays were performed in 
round bottom 96 well plates, using PBS containing calcium and magnesium (PBS++) as a 
diluent. Viral titers were first measured using hemagglutination assays, performed as 
described previously [216], using type O- red blood cells from human donors. HI assays 
were performed with recombinant SP-D preparations described above. Inhibition or 
disruption of agglutination was measured using serial dilutions of SP-D preparations.  
4.2.5.2 Enzyme-linked immunosorbent assay (ELISA) 
 96-well plates were coated overnight at 4
0
C with 0.1µg/well of Phil-82, Phil-BS 
and PR-08.  Serial dilutions of NCRDs were added to control wells. Wild-type huNCRD 
and mutant version D+R were used. Plates were washed 3x with 100µL of PBS++ (PBS 
containing 0.9mM CaCl2, 0.52mM MgCl2 and 0.16mM MgSO4) and blocked with 
blocking buffer (Superblock, Pierce). To the wells coated with IAV, different doses of 
NCRD, matching those in control wells, were added and incubated for 30 min at 37
0
C. 
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Plates were then washed 3x with wash buffer. To each well, horseradish peroxidase 
conjugated anti-S-protein antibody was added and incubated at 37
0
C. Following 
incubation, plates were washed 3x with PBS++ and 50µL of 1-step ELISA substrate 
(Pierce) was added. After 20 min incubation at room temperature with the ELISA 
substrate, the reaction was stopped by addition of 50ul 1N sulfuric acid. Plates were read 
for absorption at 450nm wavelength with wavelength correction at 540nm.  
4.2.5.3 Fluorescent Focus assay (IAV infectivity assays) 
Infectivity assays were performed using human bronchial/tracheal epithelial 
(BTE) cells (Lifeline cell technology, Walkersville, MD). BTE cell monolayers were 
grown to about 70% confluency in 96 well plates. IAV preparations were pre-incubated 
with SP-D preparations for 30 min at 37⁰C, to allow SP-D binding and inhibition of HA. 
The BTE cell monolayers were infected with these IAV preparations for 45 min at 37⁰C, 
in PBS++. Cells were tested for presence of IAV after 18 hours of virus addition using an 
anti IAV nucleoprotein monoclonal antibody (Millipore) and fluorescence detection, as 
described previously [566].  
4.2.5.4 Surface Plasmon Resonance 
Surface Plasmon Resonance (SPR) experiments were performed as described 
previously by Crouch et al. [109]. Recombinant human SP-D NCRD (Neck and 
carbohydrate recognition domain) preparations were immobilized using N-terminal His 
tags on NiNTA, with the binding domain oriented upward. Binding of Phil/82 and 
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Phil/82/BS B-HA were measured against recombinant wild type huNCRD and double 
mutant D+R.  
4.2.5.5 Glycan array binding 
Intact virions were labeled with Alexa 488 succinimidyl ester conjugated dye 
(Life Technologies/Thermo Fisher Scientific, Carlsbad, CA) using the manufacturer’s 
protocol. Post-labeling, virions were dialyzed against 1x PBS. HA titers were measured 
and the virus preparations were appropriately diluted to adjust for differences in HA titers 
before binding experiments. Glycan array binding was performed using standard 
protocols at the Consortium for Functional Glycomics [51,429,490] Protein-Glycan 
Interaction Core at Emory University, using array version 5.2 
(https://glycopattern.emory.edu/structures/view?version=5.2).  Binding was measured as 
fluorescent units of bound fluorescently labeled influenza virions. 
4.2.6 Computational glycobiology 
4.2.6.1 3D structure generation 
A homology model for the Phil/2/1982 HA trimer was generated in Modeller 
[457,154,144] using PDBIDs  2YP3, 2YP7, 1HA0, 4KVN, 4WE5, 4O58 and 4WA1 as 
templates. In order to decrease the time required to perform a molecular dynamics (MD) 
simulation, a smaller structure was generated from the HA0 trimer that contained only 
residues F83 to D86 of the stalk and D57 to S270 of the head group. Glycans were 
attached to the head group using a customized version of the glycoprotein builder 
available on GLYCAM-Web [297], with the following modifications. When attaching the 
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N-glycan to an Asn sidechain, the χ1, χ2, ψ and φ torsion angles were adjusted to match 
observed rotamers reported for N-linked glycoproteins in the PDB [418]. Any vdW 
overlaps were relieved by adjusting the glycosidic torsion angles within normal bounds 
[400]. In all cases, the Asn sidechain conformation that was observed to be most common 
in the PDB was selected, provided that it could be attached without irreconcilable steric 
overlaps with the protein surface. Man9GlcNAc2 glycans were added to each of the five 
N-glycosylation sites on the HA headgroup; at sites Asn63, Asn126, Asn144, Asn165 and 
Asn246.  
4.2.6.2 System preparation for simulation 
Hydrogen atoms were added to the head group structure, with the protonation 
states of the ionizable side chains being assigned by tleap [73]. The structures were 
placed in a periodic box of approximately 35,000 TIP5P waters [347] to provide an 8 Å 
buffer between the glycan and the edge of the periodic box. 
4.2.6.3 Energy minimization and solvent equilibration 
Energy minimization of all atoms was performed for 20,000 steps (10,000 
steepest decent, followed by 10,000 conjugate gradient). The energy-minimized 
structures were equilibrated at 300 K under nPT conditions for 400 ps, with 5 kcal/mol-
Å
2
 Cartesian restraints on the solute heavy atoms.  
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4.2.6.4 System equilibration and production MD 
After solvent equilibration, the heavy atom restraints were removed, and 1 ns of 
equilibration MD followed by a 500 ns production simulation were performed. The Cα 
atoms of the terminus residues were restrained (5 kcal/mol-Å
2
).  
4.2.6.5 Energy minimization and molecular dynamics (MD) simulations 
All simulations were performed with the CUDA implementation of PMEMD 
[186,458] in the Amber14 software suite [73]. The GLYCAM06-j [297] and Amber14SB 
parameters [73] were employed for the carbohydrate and protein portions, respectively. A 
Berendsen barostat with a time constant of 1 ps was employed for pressure regulation, 
while a Langevin thermostat with a collision frequency of 2 ps
-1
 was employed for 
temperature regulation. A nonbonded interaction cutoff of 8 Å was employed. Long-
range electrostatics were treated with the particle-mesh Ewald (PME) method [115]. 
Covalent bonds involving hydrogen were constrained with the SHAKE algorithm 
allowing a time step of 2 fs [455]. 
4.2.6.6 Post processing  
An ensemble of 1,000 conformations for the glycosylated Phil-2-1982 HA 
glycoprotein were taken at regular 500 ps intervals of the MD simulation using cpptraj 
[443].   
4.2.6.7 Assessment of glycan accessibility to ERManI 
A new crystal structure of ERManI, kindly provided by Dr. Kelley Moremen’s 
laboratory, includes a full high mannose glycan in the binding site. This allowed 
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assessment of the accessibility of the glycan to ERManI by superimposing the ERManI-
bound Manβ1-4GlcNAcβ residues onto each N-glycan on the H3 head group. This was 
performed for each N-glycan over 1,000 snapshots taken at regular intervals from the MD 
simulation. If surface overlaps greater than ~36 Å
2
 (equivalent to a buried Carbon atom) 
were observed, the glycan was deemed to be inaccessible for that particular timepoint of 
the simulation. 
4.2.6.8 Assessment of glycan accessibility to SP-D 
A 3D structure has been determined previously for unliganded human SP-D 
(PDBID 1B08), as well as porcine SP-D in complex with Manα (PDBID 4DN8) [136]. 
Despite structural differences in the carbohydrate binding sites of the porcine and human 
proteins, the relative spacing of the binding sites is identical, with a linear distance of 
approximately 45 Å between each Manα binding site. By monitoring the distances 
between the non-reducing terminal Manα residues in each N-glycan over the course of 
the simulation, it was determined which sets of three N-glycans were positioned for 
trimeric interaction with SP-D (sets that were all 43-47 Å apart for any of the 1,000 
snapshots). 
4.2.7 LC-MS analysis of RpNCRD  
4.2.7.1 Identification of glycosylation site and assessment of glycosylation site-
occupancy on RpNCRD 
Theoretical recombinant porcine SP-D protein sequence: 
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GITALRQQVETLQGQVQRLQKAFSQYKKVELFPNGRGVGEKIFKTGGFEKTFQDAQQVCTQA
GGQMASPRSETENEALSQLVTAQNKAAFLSMTDIKTEGNFTYPTGEPLVYANWAPGEPNNNGGSSGAE
NCVEIFPNGKWNDKACGELRLVICEF 
Glycosite identification and site occupancy determination were performed using 
18
O labeling of the glycopeptide and analysis of the intact glycoprotein. Glycosylation 
site was also confirmed by analysis of intact glycopeptides by LC-tandem-MS. 
Chymotrypsin was purchased from Promega Corporation, Madison WI. PNgase F 
was purchased from New England Biolabs, Ipswitch, MA. 
18
O-Water was purchased 
from Cambridge Isotope Laboratories, Andover, MA. All other chemicals were obtained 
from Sigma-Aldrich, St. Louis, MO, unless otherwise stated.  
RpNCRD samples were subjected to reduction (dithiothreitol, DTT), alkylation 
(iodoacetamide) and chymotryptic digestion in the presence of 2,2,2-trifluoroethanol as 
denaturant.  Reactions were stopped by heating at 95⁰ C for 5 min and addition of 
trifluoroacetic acid to lower the pH.   The masses of the resultant peptides were 
immediately analyzed using a Bruker Ultraflextreme matrix-assisted laser 
desorption/ionization (MALDI) MS (Bruker Daltonics, Billerica, MA) using 2,5-
dihydroxybenzoic acid (DHB) as matrix. The samples were then dried down in a 
centrifugal evaporator.  Chymotryptic RpNCRD peptides were deglycosylated using 
PNGase F in the presence of H2
18
O or H2
16
O.  Aprotinin was then added to the reactions 
to inhibit any residual chymotrypsin activity. Samples were desalted using Pierce C18 
spin columns and analyzed using MALDI MS with DHB as matrix. 
The labeled (deglycosylated) RpNCRD peptide samples were subjected to LC-
MS/MS using a Nano-Acquity™ chromatograph and a Symmetry® 5µm C18 trapping 
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column (180µm x 20mm) and BEH™ 30 C18 analytical column (100µm x 100mm, 
Waters Corporation, Milford, MA), coupled to a Thermo® LTQ-Orbitrap™ via an 
Advion® Nanomate™, nano-ESI robot.  Samples were concentrated on the trapping 
column at a flow rate of 4µL/min for 4 min, with 98% Buffer A, 2% Buffer B (Buffer A: 
99% Water, 1% Acetonitrile, 0.1% Formic acid v/v; buffer B: 99% Acetonitrile, 1% 
Water, 0.1% Formic acid). A linear gradient of buffers A and B was used to elute the 
peptides from the analytical column, starting at 5% buffer B to 40% buffer B over 40 
min, at a flow rate of 0.5µL/min. ESI was performed using the NanoMate, at 1.7kV 
capillary voltage and 150⁰C capillary temperature, for introduction of samples into the 
mass spectrometer. Spectra were acquired in the positive ion mode in the Orbitrap using 
m/z range 300-2000 at a resolution of 60,000. AutoMS/MS was simultaneously 
performed on the top 3 most abundant precursors from the MS1 scan. Multiply charged 
precursors were fragmented in the LTQ, using CID (Collision-induced dissociation) as 
the activation type. Normalized collision energy was set at 30%, with Helium as the 
collision gas and the minimum signal cutoff set at 50000, 30000 and 15000 for the top3 
precursors, respectively. Lock mass was active during all spectral acquisitions. Dynamic 
precursor exclusion was enabled for MS/MS runs to allow only two MS/MS spectra for 
each precursor to be acquired. Three additional analytical replicates were prepared and 
analyzed for both O-18 and O-16 labeled samples, with the same LC-MS setup, where 
tandem MS spectra were acquired in the LTQ instead of the Orbitrap.  
LC-MS/MS data was analyzed using Thermo Xcalibur 2.2 SP 1.48 and Thermo 
Proteome Discoverer 1.3.0.339 (Thermo Fisher Scientific). Protein and peptide searches 
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were performed using an in-house licensed MASCOT server (Matrix Science, Boston, 
MA) against the mammalian subset of Swiss-Prot database (SwissProt_2013_01.fasta, 
version 2.4), allowing a maximum of 5 miscleavages using Trypsin/Chymotrypsin as the 
enzyme, with precursor and fragment mass tolerance set at 10 ppm and 0.8 Da, 
respectively.  Carbamidomethylation was set as fixed modification at Cysteine residues. 
Deamidation (NQ) and Dioxidation (M) were set as dynamic modifications. Custom 
modifications were added to the MASCOT server for identification of the labeled 
deglycosylated peptide after PNGase F N-glycan release for both O-16 and O-18 
modifications. All searches included decoy database search with target False Discovery 
Rate set at 0.01 (strict) and 0.05 (relaxed).  
Precursor ion abundances for the peptides verified with MS/MS were used for 
quantification. Peak areas for extracted ion chromatograms of labeled and unlabeled 
peptides were integrated in Xcalibur and compared to give site occupancy information. 
Considering the possibility for spontaneous deamidation, chromatograms were extracted 
for masses corresponding to both deamidated and non-deamidated forms of the peptides 
(unlabeled) containing the sequon. It was noticed that most of the 
unlabeled/unglycosylated sequon containing peptides had undergone deamidation. To 
confirm this, a deamidation control was analyzed using LC-MS under the same 
conditions, except the mass spectra were acquired in the LTQ. This control sample was a 
chymotryptic digest of RpNCRD, without any PNGase F N-glycan release. The sample 
showed that almost all of the unglycosylated sequon containing peptides were present in 
the deamidated form. 
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A second approach was used to quantify the site occupancy of RpNCRD. The 
RpNCRD was reduced and alkylated using DTT and iodoacetamide and then desalted 
using C18 ZipTips (Millipore). The protein samples were spotted on a ground steel 
MALDI target and spectra were acquired in linear TOF mode at 35% laser power using 
DHB as the MALDI matrix. A total of 4 analytical replicates were analyzed. The 
unglycosylated and the glycosylated protein populations were resolved in the MALDI 
mass spectra as shown in Figure 32. Site occupancy was determined by comparing peak 
areas for spectral peaks corresponding to glycosylated and unglycosylated protein 
species. Peak areas were calculated by pixel counting using image processing software.   
4.2.7.2 Glycan profiling of RpNCRD and determination of the degree of sialylation 
Glycan profiling/composition analysis was performed using LC-MS on released 
N-glycans from RpNCRD. RpNCRD samples were subjected to reduction and alkylation 
followed by tryptic digestion. PNGase F release was performed as described above in the 
presence of aprotinin.  Released N-glycans were fractionated using C18 spin columns 
(Pierce) and then subjected to HILIC (hydrophilic interaction liquid chromatography)-
MS in the negative ion mode using an Agilent® 6520 accurate mass Q-TOF mass 
spectrometer (Agilent Technologies, Santa Clara, CA) coupled with an Agilent 1200 
series HPLC stack capable of delivering micro-flow with a flow-splitter and a chip-cube 
for online LC separation and Nano-ESI sample introduction into the mass-spectrometer. 
A custom-made HILIC-chip was used for chromatography, packed with 5µm TSK-gel 
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Amide 80 HILIC stationary phase (Tosoh Bioscience). The outer valve of the chip was 
used to deliver a make-up-flow as described by Staples, et al [495,496]. 
Data were analyzed manually using Agilent Mass Hunter Qualitative Analysis 
software (Version B.05.00) and glycan compositions were assigned to m/z values using 
an in-house excel based tool, using a 20ppm mass error tolerance. The extracted ion 
chromatograms for monoisotopic m/z values were integrated to get peak areas and 
relative ion abundances for each glycan composition.  Three analytical replicates were 
analyzed and average relative ion abundances were plotted only for the glycans that were 
present in all three replicates. The adducted ion forms and charge states were combined 
for each glycan composition.   
4.2.7.3 Determination of sialic acid linkage on RpNCRD 
 
A chemical derivatization method reported for determination of NeuAc linkage by 
Reiding et al. was used [438]. The chemical reaction leads to formation of different 
products, as shown in Figure 5, depending on the sialic acid linkage and causes specific 
mass shifts in glycan mass, which can be easily detected using LC-MS. 
The chemical derivatization was performed by incubating released N-glycans 
from RpNCRD in 20µl of 0.25M1-ethyl-3-(3-(dimethylamino)propyl)-carbodiimide 
(EDC) and 0.25M 1-hydroxybenzotriazole (HOBt) in ethanol, at 37
○
C for 1 hour. 
Subsequently, 20µL acetonitrile was added to the samples and incubated in -20
○
C for 15 
minutes. Glycan standards with known linkage for NeuAc were purchased from V-Labs 
(Covington, LA) and used as controls for the reaction. EDC and HOBt were purchased 
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from Sigma-Aldrich(St. Louis, MO).  The samples were desalted using PD MiniTrap G-
10 columns (GE Healthcare, Piscataway NJ), as per the manufacturer’s instructions and 
dried in a centrifugal evaporator. Data acquisition and analysis were performed as 
described for native glycans.  
 
4.3 Results and Discussion 
We modeled the changes in HA mature structure that occur as an H3N2 subtype 
evolves during repeated growth in eggs in the presence of bovine serum. This process 
rendered the virus resistant to conglutinin and mannose binding lectin in serum, and to 
SP-D as well [215].   Owing to the error prone nature of virus replication and the 
inclusion of host proteins in the virion structure [262], we acquired deep proteomes of 
H3N2 before and after development of resistance to SP-D.  We then profiled the range of 
glycans present on the virions and used this information to drive determination of 
confident site-specific glycosylation from glycoproteomics data. For HA, the 
combination of peptide proteolytic variants, other PTMs including oxidation and 
deamidation, and glycosylation yield an extremely large number of theoretical structures.  
To address this, we combined proteomics, glycomics and glycoproteomics analyses to 
produce site-specific glycosylation assignments.  
We and others have developed liquid-chromatography-mass spectrometry 
methods with sufficient power for analysis of glycopeptides from complex glycoproteins 
[14,121,241,293,523].  In addition, improvements to software tools further enhance the 
ability to analyze complex glycoproteins [113,580]. We built an exhaustive glycopeptide 
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bioinformatics search-space that made no assumptions regarding peptide backbone, 
proteolytic variants, PTMs, or glycome present in the IAV samples. We then defined the 
mature structures of H3N2 HA and the changes associated with escape from SP-D 
neutralization. We used viral infectivity assays, glycan array binding, lectin binding and 
other biochemical methods to demonstrate the changes in biological interactions and 
activities associated with evolution of glycosylation structure among IAV subtypes and 
strains.   In order to understand how particular glycoforms are generated, we modeled the 
interactions between mature glycosylated HA and ER class I α-mannosidase (ERManI), a 
key enzyme in the glycan biosynthetic pathway.  We then defined the key glycans 
mediating interactions of SP-D with HA using structure modeling and molecular 
simulation studies. 
4.3.1 Proteomics 
Influenza A shows host species-specificity in infection governed by HA binding 
to sialylated glycans present on host cell-surface receptors. Avian-strains prefer binding 
to NeuAc-α-2,3-Gal, while human-strains prefer binding to NeuAc-α-2,6-Gal 
[100,511,503,502].  Minor changes to the protein sequence correlate with a switch in 
sialic-acid binding preferences leading to changes in receptor specificities and altered 
susceptibility towards antibodies and lectins [174,274,445,521].   
We performed deep proteomics on deglycosylated IAV digests. Despite the fact 
that IAV contains only 8 gene segments, corresponding to roughly 11 proteins, the 
virions include host proteins as integral parts of its architecture [262]. In addition, host 
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proteins may co-purify with the virions.  We therefore accounted for all proteins and 
glycoproteins present in the samples in order to maximize the confidence of site-specific 
glycosylation assignments. The error-prone manner of IAV replication allows 
incorporation of mutations in viral proteins that may affect glycosylation sites and 
neighboring residues. Our deep proteomics analyses of virus preparations covered all 
glycosylation sites and identified glycopeptide variants that included other PTMs and 
incomplete proteolytic cleavages.  We therefore used an unbiased bioinformatics search 
space for glycopeptide assignment. 
In addition to identifying peptide backbone variants, we identified a revertant 
population in the Phil-BS sample. The N-glycosylation sequon at Asn165 apparently 
became disrupted due to an acquired mutation leading to conversion of NVTM to NVAM 
in the majority of Phil-BS virion population; however, a small fraction of the population 
contained the wild-type sequon NVTM. Based on extracted ion chromatogram peak 
areas, the revertant corresponded to approximately 2% of the population. We observed no 
reversion at the second disrupted sequon (Asn246 NSTG) mutated in Phil-BS. To check 
for presence of glycosylation at the revertant sequon, we included both Phil-82 and Phil-
BS protein sequences in the Phil-BS search hypothesis.  
A majority of proteins identified were common among the three IAV samples 
(Figure 23D).  Gene ontology analysis performed using STRAP [44], showed similar 
distributions of proteins in terms of molecular functions and cellular localization.  
Functional annotation of the proteins showed close similarity to the results described by 
Hutchison et al [262], showing a wide-variety of host-proteins involved in various 
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structural and molecular roles present in the virions. We observed deamidation (NQ) as 
the most commonly encountered PTM in the proteomics results, followed by non-specific 
carbamidomethylation, oxidation (M), sodium adduction and dehydration.  
We identified 10 and 8 sequons for Phil-82 and Phil-BS respectively, as shown in 
Figure 23. All the peptide variants identified and used to construct our informed 
glycoproteomics bioinformatics hypotheses are shown as part of supplemental 
information in [291]. 
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Figure 23: IAV Proteomics results 
Proteomics coverage of Phil-82 (A), Phil-BS (B) and PR-08 (C) hemagglutinins. Portions of sequence covered are 
highlighted in grey, with colored symbols above the sequence rows representing modifications and mutations. 
Green boxes show N-glycosylation sequons and red boxes indicate mutated/disrupted sequons in Phil-BS; D: 
Total number of proteins including host-proteins identified in proteomics of the three IAV samples. Only IAV 
and chicken (Gallus gallus) proteins identified with 2 or more unique peptides were counted. 
 
4.3.2 Glycan site-occupancy analysis 
For modeling and molecular-dynamics studies, we determined glycosylation site 
occupancy of Phil-82 HA. We evaluated the NetNGlyc server [198] 
(http://www.cbs.dtu.dk/services/NetNGlyc/), used in published studies 
[40,549,275,183,17] to provide a qualitative measure of the likelihood for N-linked 
glycosylation, given the protein sequence; however, we found that NetNGlyc predictions 
inconsistent with our results. Table 5 compares NetNGlyc predictions and site-occupancy 
results from proteomics data for Phil-82. While NetNGlyc predicted no glycosylation at 
sites 38 and 144, we identified glycopeptides containing those two sites with high 
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confidence from glycopeptide tandem MS data. The data showed low site occupancy at 
Asn144 and high occupancy for Asn 38. These results re-emphasize the importance of 
analyzing both deglycosylated peptides and intact glycopeptides to minimize assumptions 
about samples and shifting reliance from prediction tools to empirical evidence. 
 
Site NetNGlyc 
Potential 
NetNGlyc 
Jury 
Agreement 
NetNGlyc 
Results 
Site-occupancy 
calculated from 
proteomics 
8  NSTA 0.7987 9/9 +++ 1.0 
22  NGTL 0.7153 9/9 ++ 1.0 
38  NATE 0.4996 3/9 - 0.99 
63  NCTL 0.6366 9/9 ++ 0.99 
126  NWTG 0.5393 6/9 + 0.73 
144  NNSF 0.4293 6/9 - 0.17 
165  NVTM 0.7626 9/9 +++ 0.99 
246  NSTG 0.5880 7/9 + 0.99 
285  NGSI 0.6716 9/9 ++ 0.95 
483  NGTY 0.5207 8/9 + 0.95 
Table 5: NetNGlyc predictions for glycosylation site occupancy and site-occupancy from proteomics data for 
Phil-82 
 
4.3.3 Glycomics 
We used glycomics profiling to define the range of glycans present on virions 
precisely. The glycan profiling results for Phil-BS (38% high-mannose) showed an 
approximately 10% decrease in relative abundances of high-mannose type N-glycans 
compared to Phil-82 (48%)  (Figure 24A).  PR-08 displayed a very small proportion of N-
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glycans (ca. 6%) occurring as the high mannose type.  Detailed comparison of 
abundances for individual glycan compositions (Figure 24B, C, D) showed a marked 
decrease in the relative abundances of immature Hex9HexNAc2 and Hex10HexNAc2 
glycan compositions in Phil-BS. The glycan topologies shown in Figure 24 are 
speculative. Glycomics profiling using LC-MS provides saccharide compositions only – 
topological/structural information cannot be derived from these experiments. Detailed 
results from glycomics analyses have been included in the data repository. 
From the proteomics results, the primary difference between Phil-82 and Phil-BS 
was the disruption of two N-linked glycosylation sequons at positions 165 and 246. The 
glycomics results implied that a large proportion of the glycans occupying these two 
sequons were high-mannose type. To confirm this theory, we carried out intact 
glycopeptide analysis. 
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Figure 24 : Glycomics results from negative mode LC-MS profiling of released IAV N-glycans 
A: Comparison of the three strains. Stacked bars represent mean composite relative abundances of different 
glycan classes, categorized by HexNAc and Hexose units in the identified glycan compositions (Paucimannose: 
HexNAc = 2, Hexose <= 4; High Mannose: HexNAc = 2, Hexose >= 5; Hybrid: HexNAc = 3; Bi-antennary: 
HexNAc = 4; Tri-antennary: HexNAc = 5; Tetra-antennary: HexNAc = 6 and Penta-antennary: HexNAc = 7). 
Bar plots show individual glycan relative abundances for B: Phil-82; C: Phil-BS; D: PR-08. Colored bars 
represent mean abundances relative to the most abundant composition detected for each sample. Error bars 
represent standard deviation. The most abundant glycoforms in each category are labeled with putative 
topologies using the Consortium for Functional Glycomics glycan representation scheme. 
 
4.3.4 Glycoproteomics 
For confident assignment of site-specific glycoforms, we analyzed intact 
glycopeptides using LC-tandem-MS and mined the data using both naïve and informed 
bioinformatics search space hypotheses, as described in the experimental section. 
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Collisional dissociation of glycopeptides in the gas-phase leads to abundant ions from 
glycosidic bond dissociation; however, provided application of sufficient collision 
energy,  peptide bond dissociation also occurs [293]. Figure 25 compares the features in 
collisional dissociation of glycopeptides using low versus high collision energies.  
 
 
Figure 25: Glycoproteomics analysis data dimensions  
A: Chromatographic separation and associated peak areas of enriched Phil-82 IAV glycopeptides; B. MS1 
profiling and intact mass assignments of Phil-82 hemagglutinin glycopeptide PGDILLINSTGNLIAPR 
glycoforms; Tandem MS of glycopeptide PGDILLINSTGNLIAPR - Hex10HexNAc2 showing product ions 
resulting from lower-energy collisional dissociation (C) and higher-energy collisional dissociation (D). Glycan 
topologies shown are speculative based on inferred glycan compositions. 
 
As seen in Figure 25C, lower-energy collisional dissociation yields abundant ions 
from glycosidic bond dissociation. Higher collision energies (Figure 25D) yield tandem 
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mass spectra that contain glycan oxonium ions, peptide backbone dissociation ions and 
intact-peptide with glycan additions (known as stub-glycopeptides). We used these 
features in our automated data analysis workflow for glycopeptide assignment.  
4.3.5 Integrated-omics 
Analysis of intact glycopeptides is often challenging due to the complexity and 
size of the bioinformatics search space [122,293]. Typically, hypotheses for glycopeptide 
mass spectrometry data analysis are limited by assumptions about the peptide variants 
and glycoforms present in a sample. This limitation has been overcome in proteomics 
analyses with the use of error-tolerant database searches [102,330,509,393], which check 
for modifications [103] and mutations that best explain the data, in addition to those 
specified by the user. This is difficult to perform in case of glycopeptides due to the 
already large number of glycoforms associated with each glycosylation site.  A number of 
software tools have emerged recently that mine only glycopeptide tandem MS 
[180,276,422,440] or perform both proteomics and glycoproteomics searches [43]. 
However, the analyses are limited to the user defined boundaries of proteoforms and 
glycoforms. Use of assumptions while defining these boundaries or search-spaces can 
lead to under or over-estimation of the proteoforms, thus leading to loss of information or 
high false discovery rates, respectively.  
For a glycoprotein as complex as HA, tandem MS can be used to resolve 
ambiguous assignments; however, glycopeptide tandem MS alone does not allow 
adequate depth and confidence in assignment for glycoproteoforms. Additionally, 
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glycoproteomics alone does not account for possible mutations incorporated into viral 
genome as a result of evolutionary pressures. 
To produce the most confident information on influenza glycoproteome, we 
adhered to a lex parsimoniae approach, described here as “integrated-omics”. Proteomics 
and glycomics workflows are well-established and easy to implement.  As a first step in 
the workflow, we performed bottom-up proteomics on PNGase F deglycosylated 
influenza virions. The data were mined using hybrid de novo and error-tolerant 
proteomics database searches, which accounted for all possible PTMs, mutations and 
peptide variants from sample handling. The released IAV N-glycans were analyzed in a 
separate experiment and searched against glycan databases to define the glycoform 
search space. Thus, in an effort to minimize assumptions and efficiently mine 
glycoproteomics data, the glycomics and proteomics information were integrated to 
generate a glycopeptide database, against which the glycopeptide MS and tandem MS 
data were searched. Tandem MS matches were scored based on fragment ion coverage. 
To calculate a confidence score, a decoy database containing reversed target sequences 
was used, where the three residue sequon was maintained in the correct order. For 
example, glycopeptide SVQEIQEIQTFFYFTPN(HexNAc)KTEDTIFLR had a decoy 
LFITDEN(HexNAc)KTPTFYFFTQIEQIEQVSR. Confidence scores (q-values) were 
calculated as described by Käll et al. [281,635]. 
 The tandem mass spectrometric assignment scores for some glycopeptides, such 
as those spanning site 126 (NWTG) were lower than the accepted score threshold, due to 
incomplete coverage and low precursor and product ion abundances. Manual validation 
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helped confirm the assignments and inclusion in the final results. All automated 
glycopeptide assignment results have been included as comma separated text files in the 
data repository. 
 
Figure 26: Integrated-omics results: Site-specific glycan distributions for hemagglutinins 
A. Phil-82; B. Phil-BS; C. PR-08. Stacked bars represent composite mean relative abundances for N-glycan 
compositions categorized by number of HexNAc units, as described above. All stacked bars have been scaled to 
100 percent to represent percentages of individual glycan classes among all glycans identified. Insets show 
individual glycoform relative abundances for sites identified in the interaction with immune-lectins. Error bars 
represent standard deviation in three measurements of glycoform abundances. N.D.: Not Detected. **Revertant 
population at site 165 in Phil-BS. 
 
The site-specific glycosylation plots, shown in Figure 26, represent normalized 
percent relative abundances of different glycoform classes at each glycosylation site for 
the hemagglutinins from three IAV strains. While the plots present results from 
glycopeptide LC-tandem MS analyses, the databases against which glycopeptide LC-
tandem MS data were searched were generated by combining the proteomics and 
glycomics results for respective virions. These results therefore reflect the integration of 
different data domains. Individual glycan compositions contributing to the abundances at 
sites 165 and 246 have been shown in Figure 26 (inset). It is clear from the integrated-
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omics results that glycosylation at Asn165 and Asn246 is lost in the escape mutant Phil-
BS from the selection pressures inflicted by growth in presence of bovine serum. All site-
specific glycan distributions are shown aligned to individual HA monomer models for 
better visualization in Figure 27.  
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Figure 27: Integrated omics results: Site-specific glycan distributions for hemagglutinins aligned to their 
respective 3-D models. A. Phil-82; B. Phil-BS; C.PR-08.  
Glycan compositions are listed as [HexNAc, Hex, dHex, NeuAc, NeuGc]. 
 
Hartley et al. had concluded that Asn246 on Phil-82 and Phil-BS is not occupied 
by a glycan [214]. These conclusions were derived using results from genetic sequence 
analyses and mobility shifts in electrophoresis, showing loss of glycosylation in escape 
mutants.  By contrast, we observed that Asn246 is in fact glycosylated in Phil-82, while 
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Phil-BS loses glycosylation at both Asn165 and Asn246, due to acquired mutations. This 
exemplifies the need for site-specific structural information on glycoproteins, which 
genetic sequencing and classical biochemical methods fail to provide. 
Consistent with the proteomics results, we identified glycopeptides from a 
revertant population only for Asn165 (NVTM); we observed no reversion at Asn246 
(NSTG).  To check what percentage of the total virus population reverted to the intact 
sequon at Asn165, we compared AUC (arbitrary unit counts) from integrated extracted 
ion chromatograms in the proteomics data.  We also calculated site-occupancy for this 
revertant population as described above. In the proteomics analyses, 2% of the total Phil-
BS population contained the intact revertant sequon (NVTM) at Asn165, with a glycan 
site-occupancy of 92%. 
Glycosylation changes were limited to loss of glycosylation at Asn165 and 
Asn246, while that at other sequons remained largely unchanged. Both Asn165 and 246, 
present on the HA head, are accessible to host immune lectins. Any differences observed 
in bioassays could therefore be attributed to differences in glycosylation at these two 
sites. Although, high-mannose glycans dominated at all sites on H3 HA head, the level of 
glycan processing varied. In particular, for Phil-82, we noticed a striking difference in 
extent of high mannose N-glycan processing between Asn165 and 246.  In the early 
stages of biosynthesis, glycoproteins are occupied by glucosylated high mannose 
(Glc3Man9GlcNAc2) N-glycans. The glucose residues are recognized by calnexin and 
calreticulin as a quality-control mechanism for protein folding. The three glucose units 
are removed subsequently in the endoplasmic reticulum by glucosidases. A significant 
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number of glycoproteins are also acted upon by ER mannosidase-I, which removes a 
terminal mannose unit, after which the glycoproteins are transported to the Golgi 
apparatus with a Man9GlcNAc2 or Man8GlcNAc2 glycan. In the Golgi apparatus, the 
mannose residues are trimmed further before becoming extended into complex type 
structures [4,210,226,267,357,494,588]. Both Asn165 and 246 displayed higher 
abundances of relatively immature glycans containing a higher number of hexose units in 
their compositions, as seen in the site-specific glycan distributions (Figure 26 inset). The 
composition Hex9HexNAc2 was the most abundant at both Asn165 and 246 and the 
presence of Hex10HexNAc2 was observed at Asn246 by tandem MS, as shown in Figure 
25(C and D).   
The glycosylation profile on PR-08 contrasted with those of the two H3N2 strains 
in that complex type N-glycans dominated at all sequons. Given that all three viruses 
were grown using the same egg culture conditions, this ruled out the involvement of 
external factors including cell type, growth media and culture system in presence of 
under-processed N-glycans on H3N2 virions. Another recent study has shown similar 
predominance of high-mannose type glycans on the head region of a different H3N2 
strain [17]. While the homologous H3 HAs of the same subtype but different strains show 
similar glycosylation profiles, the H1 HA from PR-08 contains much more highly 
processed N-glycans. This implicates protein backbone and structural features of the viral 
subtypes and strains as the drivers in glycan processing and resulting microheterogeneity.  
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4.3.6 Bioassays 
We used biochemical and virological assays to survey virion binding preferences 
to host glycans and correlate differences in glycosylation with susceptibility of HAs 
towards the immune lectin SP-D (Figure 28). 
 
Figure 28: Results from biochemical, virological and immunological assays 
A: CFG glycan array analysis of three IAV strains. Only glycans where relative binding was greater than 0.1% 
for any one of the three strains have been included in the heat-map. Array glycans are sorted into different 
categories (Y-axis) and the three virus strains are listed on X-axis; B: ELISA results. Bar-charts show dose-
dependent binding to human surfactant protein-D NCRD wild-type (i) and double mutant D+R (ii). X-axis 
shows the concentration of SP-D used and Y-axis shows binding response in fluorescent units measured. Error 
bars represent standard error; C: Hemagglutination inhibition of IAV strains. (i) Comparison of inhibitory 
effect of different lectins on Phil-82 and Phil-BS. (ii) HA inhibitory concentrations of rhSPDII for the three IAV 
strains studied. Error bars represent standard error; D: Surface Plasmon Resonance results. Bromelain cleaved 
hemagglutinin (B-HA) from Phil-82 and Phil-BS, were introduced in the mobile phase and binding towards 
immobilized wild type or mutant NCRDs was measured; E: Infectivity assay results. Infectivity of the three IAV 
strains was compared after pre-incubation with increasing concentrations of (i) rhSPDII and (ii) D+R mutant 
SP-D. Data points show infectivity measured as infectious foci expressing influenza nucleoprotein, relative to 
control (no SP-D pre-incubation). 
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4.3.6.1 Glycan array binding 
In addition to the genetic reassortments that cause antigenic-shift and zoonosis, 
differences in protein backbone and in glycosylation states affect receptor binding 
specificities of influenza A virus [521,529,555,270,520,501,594].  Glycan array results, 
in Figure 28A, show binding affinities of the three fluorescently labeled IAV strains to 
glycans normalized to the strongest binder for each strain. Only glycans where the 
relative binding was found greater than 0.1% of the strongest bound glycan for any IAV 
strain have been included.  A complete list of glycans and fluorescence readouts from 
bound IAV are included in supplemental information for [291]. 
Both Phil-82 and Phil-BS strains showed preferential binding to α-2,6 linked 
sialic acid containing glycans, versus α-2,3 linked for the PR-08 H1N1  subtype (Figure 
28A).  This showed that the reassorted H3N2 virions, generated with A/Puerto Rico/8/34 
backbone, retain the binding specificities on their HAs as expected.  Furthermore, the 
mutations induced by selection pressure leading to loss of two N-linked glycans on Phil-
BS, did not alter its binding preferences for sialylated glycans and therefore host 
specificity. 
4.3.6.2 ELISA 
ELISA results performed at different concentrations of the wild-type huNCRD 
show stronger binding for Phil-82, compared to Phil-BS and PR-08, which show similar 
binding affinities, as seen in Figure 28B(i). The D+R mutant huNCRD has mutations in 
the amino acids surrounding the lectin site that improve hemagglutination activity 
[106,110]. Consistent with previous reports, we observed higher binding for all three 
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strains with D+R mutant huNCRD Figure 28B (ii), the extent of which was substantially 
higher in the case of Phil-82 and Phil-BS than for PR-08. These results correlated well 
with our observed abundances for high-mannose type glycans present on the three strains 
from integrated omics. While Phil-BS had lower abundance of high-mannose type 
glycans compared to Phil-82 due to loss of glycosylation at sites 165 and 246, the 
abundances of immature glycans remained higher than on PR-08, for which mature 
complex type N-glycans predominated.   
4.3.6.3 Hemagglutination inhibition 
Surfactant protein-D plays an important role in inhibition of IAV as part of the 
host innate immune response. SP-D has a carbohydrate recognition domain that binds to 
mannose containing N-glycans on viral hemagglutinin. This presumably inhibits HA 
binding to host cell surface receptors, preventing docking and entry in to the host cell. 
Typical hemagglutination inhibition assays are performed using serum to detect the 
presence and levels of antibodies against HA. Because SP-D prevents IAV interaction 
with host cells, it can be used to inhibit hemagglutination activity, in a dose-dependent 
manner[215,224,179]. 
We first determined the sensitivity of Phil-82 and Phil-BS strains towards SP-D 
lectins.  As seen in Figure 28C(i), rhSPDII (full-length SP-D) was the most effective in 
inhibiting the hemagglutination activity between the three SP-D constructs compared. 
While rhSPDII inhibited both Phil-82 and Phil-BS, the D+R and R343V constructs were 
effective only against Phil-82. Figure 28C(ii) shows the measured inhibitory 
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concentrations of rhSPDII for all three IAV strains. Phil-BS required 8-fold higher 
rhSPDII concentration than Phil-82, while PR-08 could not be inhibited even at the 
highest lectin concentration (1 µg/ml), used in the experiment. PR-08 was also found to 
be insensitive to D+R and R343V (data not shown). We concluded from these ELISA 
and hemagglutination inhibition assay results that the presence of high-mannose type N-
glycans on the virus surface correlates with extent of neutralization of hemagglutination 
by SP-D. 
4.3.6.4 Surface plasmon resonance 
Although HA is almost 10 times more abundant than NA [262], it was important 
to identify the primary contributor to SP-D interactions and changes therein. We 
therefore performed SPR experiments using bromelain cleaved hemagglutinins (B-HA) 
from the wild-type and mutant H3N2 IAV strains. As shown in Figure 28D, both wild-
type and mutant SP-Ds display markedly stronger binding to the Phil-82 B-HA compared 
to Phil-BS B-HA. Thus, differing SP-D binding amongst the tested IAV strains can be 
attributed to changes in the HA.  Therefore, ELISA, hemagglutination inhibition and SPR 
assays established a clear difference in SP-D binding and activity of HA from different 
IAV strains. 
4.3.6.5 Infectivity assay 
We next determined the ability of SP-D to neutralize virus infectivity using 
fluorescent focus assays. For these experiments we used primary human 
bronchial/tracheal epithelial cells to ensure that the results reflected behavior of the 
 
 
192 
 
viruses in non-malignant human respiratory epithelia. Infectivity was measured via 
production of viral nucleoprotein by infected host cells, using an anti-nucleoprotein 
antibody.  Cells were infected using virions pre-incubated without SP-D or with different 
concentrations of full-length rhSPDII and the strong binding NCRD mutant D+R.  Figure 
28E shows infectivity of the three virus preparations relative to cells infected without SP-
D pre-incubation.  With increasing concentration of rhSPDII during pre-incubation, the 
infectivity of Phil-82 declined sharply. By contrast, Phil-BS showed only a slight 
decrease in infectivity at higher lectin concentrations. With trimeric NCRD D+R, Phil-82 
required pre-incubation with higher concentrations of lectin for loss in infectivity while 
no significant loss in infectivity was observed for Phil-BS. PR-08 infectivity was 
insensitive to either lectin preparation. 
These results substantiate the involvement of Asn165 and Asn246 in HA 
interactions with SP-D, a collectin that attenuates viral interactions with host cell surface 
receptors and causes viral aggregation and recognition by immune cells. We concluded 
that the presence of high-mannose type glycans at Asn165 and Asn246 is crucial towards 
recognition by collectins.   
4.3.7 Modeling and molecular dynamics 
The integrated-omics results and bioassays showed reduced glycan processing at 
the two sites involved in immune recognition for Phil-82. The predominance of the 
Hex9HexNAc2 composition at these sites, suggested decreased processing by ERManI. 
The presence of Hex10HexNAc2 at Asn246 also suggested a decreased degree of N-
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glycan processing by other enzymes, including glucosidases.  We therefore performed 
three-dimensional (3D) structural modeling and molecular dynamics (MD) simulations to 
understand the structural basis for the low level of glycan processing at these sites and the 
interactions of these immature glycans with SP-D. 
4.3.7.1 Molecular dynamics simulation 
A 500 ns simulation was performed on the head domain of the H3 trimer, with 
Man9GlcNAc2 attached to each of the 15 glycosites (namely N65, N144, N126, N165 and 
N246 on each protomer). Despite the initial threefold symmetry of the trimer, unique 
glycan-glycan and glycan-protein interactions formed on different protomers, a 
consequence of both the algorithm employed to attach the glycans and of the randomly 
assigned initial atomic velocities. Over the timescale of the simulation the unique 
interactions observed on individual protomers were stable and did not interconvert, 
indicating that interconversion occurs on larger timescales. 
4.3.7.2 Assessment of glycan accessibility to ERManI 
The accessibility of each N-glycan to ERManI was assessed over the course of the 
simulation. The co-complexed N-glycan in the ERManI 3D structure was superimposed 
onto each N-glycan on the H3 head domain. Large surface overlaps between ERManI and 
the H3 glycoprotein indicated that the N-glycan was inaccessible at that particular 
timepoint of the simulation. The accessibility varied depending on the unique structures 
formed by the glycans on each protomer, but the relative percentage of time an N-glycan 
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was accessible to ERManI correlated well with the amount of processing observed 
experimentally (Figure 29B). 
Both Asn165 and Asn246 remained completely inaccessible to ERManI 
throughout the simulation, which agrees with the experimental observation that these 
sites contain only high mannose glycans. Glycans at Asn63 and Asn126, which showed 
some processing to mature glycoforms, become accessible to ERManI over the course of 
the simulation. The most processed site, Asn144, adopts shapes accessible to ERManI for 
the longest amount of time during the simulation. 
These results demonstrate a clear correlation between the percentage of time an 
N-glycan is accessible to ERManI and the degree of processing in the glycoforms 
observed at a site; however, the results indicate that longer simulation times, not feasible 
using present state-of-the art processors, would be required to observe interconversion 
between the conformations adopted at each site. Further, it should be noted that the actual 
value of percentage time available is based on an arbitrary overlap cutoff, and that 
assessment of accessibility does not account for induced fit in ERManI or any of the 
overlapping glycans and protein. Thus it is appropriate to consider only the relative 
values among sites. 
4.3.7.3 SP-D binding to glycosylated HA 
SP-D binds to Manα, which is present in high-mannose N-glycans that coat viral 
surface proteins. As SP-D adopts a trimeric structure with approximately 45 Å between 
each binding site, we hypothesized that sets of N-glycans on the H3 head domain may be 
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positioned such that SP-D could form a multimeric interaction with three N-glycans 
simultaneously, enhancing the interaction strength (see Figure 29B). It is interesting to 
note that HAs also have threefold symmetry and an approximately 45 Å linear distance 
between binding sites. 
We took an ensemble of conformations adopted by the Man9GlcNAc2 
glycosylated H3 from the MD simulation. By monitoring the distances between the non-
reducing terminal Manα residues in each N-glycan over the course of the simulation, we 
determined which sets of three N-glycans were positioned for trimeric interaction with 
SP-D (sets that were 43-47 Å apart). Of the 20 total sets, 18 contained either Asn165 or 
Asn246 (Table 6).  The data imply that removal of Asn165 and Asn246 would greatly 
reduce the potential for trimeric interactions to form between SP-D and the H3 head 
domain. This finding agrees with the experimental assays (Figure 28), where we observed 
that removal of these two glycosites reduced binding of SP-D.  
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 Sets of N-glycan sites (protomer number) 
Site 1 Site 2 Site 3 
N165(1) N126(1) N63(3) 
N246(1) N126(3) 
N165(2) N165(3) N63(1) 
N63(2) N126(3) 
N165(3) N63(1) N126(2) 
N246(1) N126(2) N126(3) 
N165(2) N126(3) 
N165(3) 
N246(3) 
N165(3) N126(2) 
N126(3) 
N246(2) N126(1) 
N63(1) N126(2) 
N246(2) N126(2) N165(3) 
N246(3) 
N63(1) 
N246(3) N126(2) N63(1) 
N63(2) 
N126(2) N63(1) N63(2) 
N63(2) N126(3) 
Table 6:  Sets of N-glycosylation sitesa whose spacing and glycan dynamics allow trimeric interaction with a 
trimeric SP-D 
aSite N144 was excluded from the analysis as it was found to have both low site occupancy and a mature 
glycoform distribution. 
 
We observed that the binding sites of trimeric architecture of SP-D are positioned 
perfectly to interact with glycans on the exposed influenza H3 head domain.  Our 
molecular modeling predicts that the high mannose N-glycan at sites N165 and N246 
play a pivotal role in forming trimeric interactions with SP-D, in agreement with the 
experimental evidence. 
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Enzyme accessibility is only one of the factors that determine the degree of 
glycan processing at a particular site. Residues outside of the traditional N-X-S/T (where 
X ≠ P) sequon can profoundly affect both the rate of glycosylation by 
oligosaccharyltransferase and the predominant glycoform observed [389]. Further, 
mechanisms that govern intracellular proteostasis have been observed to impact the N-
glycosylation pattern of secreted glycoproteins [126].  We note, however, that a clear 
correlation between the relative accessibility of an N-glycan computed from an MD 
simulation and the degree of processing has been observed both here and in previous 
work [210]. 
 
Figure 29: Structure modeling and molecular dynamics results 
A: 3D model of glycosylated Phil-82 hemagglutinin trimer (HA0). One HA monomer is shown in dark grey. 
Glycans at Asn165 and Asn246 are shown in blue and pink, respectively. B: Percentage of simulation time that 
an N-glycan is accessible to ERManI. The values are averaged over each protomer of the H3 trimer. The amount 
of Man9GlcNAc2 at each site is depicted on the upper axis, demonstrating that increased accessibility to 
ERManI correlates with less Man9GlcNAc2 at each site. C: A model of trimeric SP-D (red ribbons) bound to 
three N-glycans on the H3 head domain (light grey surface). The 3D structure of the glycosylated H3 was taken 
from the MD simulation. In this snapshot, Manα residues at sites Asn 246, Asn 165, and Asn 246 on different 
protomers were approximately 45 Å apart, such that SP-D could bind each residue simultaneously. The calcium 
atoms found in each SP-D Manα binding site are shown (dark grey spheres). 
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4.3.8 RpNCRD analysis 
4.3.8.1 Glycosylation site identification and site-occupancy analysis 
Glycosylation site was identified by a mass shift upon release of N-glycans using 
PNGase F. The glycan release was performed in the presence of H2
18
O, allowing 
incorporation of the 
18
O at the site of glycosylation leading to a mass shift approximating 
3 Da, as shown in Figure 30. A representative MALDI-MS showing an 
18
O labeled vs. 
unlabeled chymotryptic peptide is shown in the bottom panel of Figure 30. The formerly 
glycosylated and unglycosylated peptides were identified and differentially quantitated 
using LC-MS/MS. A tandem MS of the intact glycopeptide carrying the sialylated glycan 
is shown in Figure 31. 
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Figure 30: 18O labeling of N-glycosylation sites 
Top: Isotopic labeling of the N-glycosylation site for glycosylation site identification and site occupancy analysis. 
Bottom: Representative MALDI-MS of deglycosylated SP-D peptide LSMTDIKTEGNFTYPTGEPL showing 
incorporation of 18O 
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Figure 31: Tandem mass spectrum for chymotryptic pSP-D precursor m/z 1063.1666(3+) corresponding to 
RpNCRD glycopeptide SMTDIKTEGNF-Hex6HexNAc5dHex1 
Symbolic representation of glycans as specified by Consortium for Functional Glycomics has been used. Glycan 
topology shown is speculative. 
 
Quantification of the EICs (Extracted ion chromatograms) was performed for the 
identified labeled and unlabeled peptides with 2 and 3 miscleavages with peptide 
sequences SMTDIKTEGNFTYPTGEPL and LSMTDIKTEGNFTYPTGEPL, 
respectively. The site occupancy values were corrected for the effective H2
18
O 
concentration in the PNGase F reaction. Effective H2
18
O was only 85% due to presence 
of buffer and enzyme in the reaction. The average site occupancy was determined as 
98.75 ± 0.55% from this data. Data are summarized in Table 7 below: 
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Filename % O18 
labeled 
peptide  
(precursor 
1052) 
SMTDIKTEG
NFTYPTGEP
L 
% O18 
labeled 
peptide  
(precursor 
1109) 
LSMTDIKTE
GNFTYPTGE
PL 
Average Site 
occupancy 
(labeled/ 
glycosylated 
peptide) 
Average Site 
occupancy 
(labeled/ 
glycosylated 
peptide) 
Corrected 
for effective 
H2
18O in the 
reaction   
Std. 
deviat
ion 
SPD_O18_CID_Orbi_
Top3 
83.44
% 
84.10
% 
83.94% 98.75% 0.55% 
SPD_O18_CID_Trap_
Top5 
83.45
% 
84.30
% 
SPD_O18_Quanti_rep
licate1 
83.28
% 
84.77
% 
SPD_O18_Quanti_rep
licate2_a 
83.68
% 
84.49
% 
Table 7: RpNCRD site-occupancy determination from 18O labeling 
 
The average site occupancy from intact protein MALDI-MS was determined as 
90.81 ± 0.73%. Data are summarized in Table 8 below and an example spectrum is 
shown in Figure 32. 
 
Sample Site occupancy (pixels 
in glycosylated/total 
pixels in two peaks) 
Average Site occupancy Std. deviation 
20130412 No enz 35% 90.63% 90.81% 0.73
% 
20130318 No enz 35% 91.57% 
20130409 No enz 1 35% 89.87% 
20130409 No enz 2 35% 91.14% 
Table 8: RpNCRD site-occupancy determination from intact protein MALDI-MS 
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Figure 32: Site occupancy determination from intact protein MALDI-MS 
From the combined results of LC-MS/MS of 
18
O-labeled samples and intact 
protein MALDI, the RpNCRD was found to be more than 90% glycosylated. 
4.3.8.2 Glycan profiling and analysis of degree of sialylation 
Figure 33 shows relative abundances only for glycans that had a relative 
abundance greater than 1% of total abundance from all identified glycans.and the error 
bars represent standard deviation between three analytical replicates.  The numeric code 
refers to the monosaccharides in the glycans as [Hex, HexNAc, dHex, NeuAc, NeuGc]. 
The average percent relative abundance by the number of sialic acids is reported 
in Figure 34. Approximately 50% N-glycans from RpNCRD were found to contain N-
acetyl Neuraminic acid. The presence of NeuAc was confirmed by profiling the release 
N-glycans after neuraminidase treatment. Results are summarized in Table 9. 
Sample % sialylation before 
sialidase treatment 
% sialylation after 
sialidase treatment 
Surfactant protein-D 49.96% +/- 2.84% 1.52% +/- 0.28% 
Transferrin (Control; data 
not shown) 
95.37%  0.90% 
Table 9: Degree of sialylation of N-glycans before and after neuraminidase treatment 
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Figure 33: N-glycan profile of recombinant SP-D showing glycans with relative abundances greater than 1% of 
total identified 
Percent relative abundances are average of three replicates; error bars represent standard deviation. Glycan 
symbolic representation as defined by Consortium for Functional Glycomics is used. Glycan topologies shown 
are speculative. The numeric code refers to the monosaccharides in the glycans as [Hex, HexNAc, dHex, NeuAc, 
NeuGc]. 
 
Figure 34: N-glycan summarized by number of sialic acids (NeuAc) 
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4.3.8.3 Sialic acid linkage analysis 
The results for NeuAc linkage analysis have been summarized in Figure 35. Ions 
were assigned to the different groups shown in the figure based on lowest ppm error 
matches against derivatized glycan compositions. Ions accounting for approximately 12% 
of the total relative abundance from matched ions could not be matched unambiguously 
(had more than one match). Data bars indicate mean % relative abundances and error bars 
represent % standard deviation. 
A majority of the abundance from sialylated N-glycans released from RpNCRD 
was contributed by glycans containing α2-3 linked NeuAc, while a small fraction was 
found to be contributed by those containing α2-6 linked NeuAc or both α2-3 and α2-6 
linked NeuAc. 
 
Figure 35: Composite relative abundances of SP-D N-glycans identified after chemical derivatization of NeuAc 
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4.4 Concluding remarks 
Several recent studies have underlined the importance of HA glycosylation in 
influenza virus pathology [69,263,270,345,374,620].  In addition, a number of groups 
have attempted to trigger a broadly neutralizing antibody response towards influenza 
hemagglutinins, by artificially modulating HA glycosylation [84,339].  Therefore, HA 
glycosylation is a clear indicator of virus fitness and evolution [117,118,374,516]. 
Naturally, the ability to predict the fitness of an IAV strain based on its glycosylation 
profile will help designate strains for vaccine development.  
We identified trends in viral evolution with a focus on changes in glycosylation 
patterns.  Our results detailed the site-specific structural changes in HA glycosylation that 
occur as IAV adapts to immune pressure. We showed that not only the presence or 
absence of glycosylation, but also the level of glycan processing need to be considered 
with regard to prediction of interaction with molecules of the host immune system.   
Most importantly, we demonstrated how comprehensive analysis of site-specific 
glycosylation fills in the gaps between modeling and structural studies.  We demonstrated 
that with detailed site-specific glycosylation information, and computational 
glycosylation modeling, we can identify structural determinants of site-specific 
glycoforms.  Our study describes a new strategy to elucidate IAV-host interactions and 
controlled evolution studies for understanding the effects of selection pressures in virus 
evolution. 
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Chapter 5 Improving glycopeptide and glycan separations and analysis using 
advanced analytical methods 
The advancement of sample preparation methods, online separation, 
fragmentation techniques and high resolution mass spectrometry workflows has been 
central to improving biomolecular analyses. There is a constant push for improving 
speed, sensitivity and accuracy in analytical methods. Any progress made in the different 
steps involved in analytical workflows has a direct impact on the ability to further 
biological assays. This section describes the efforts directed at improvement and 
integration of analytical workflows, for application in biologically relevant studies. 
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5.1 Gas-phase separation of glycans and glycopeptides using ion-mobility 
spectrometry and building a collision-cross-section database 
(This work has been published in [177]). 
5.1.1 Introduction 
Interest in ion mobility spectrometry (IMS) has grown because of its capability to 
separate conformations of gas-phase ions, including biomolecules, explosives, drugs, and 
chemical-warfare agents [101,285]. 
 
In IMS, ions are periodically introduced into a drift 
tube that consists of a chamber filled with a buffer gas that contains a series of 
electrostatic lenses to which a weak uniform electric field is applied. Ions separate in the 
drift tube based on their cross-section-to-charge ratios, as a result of the applied electric 
field and interactions with the buffer gas [54,91,101,285,441]. 
A major benefit of IMS is the timescale of the mobility separation, which enables 
the coupling of a drift tube to a time-of-flight mass spectrometer. With the IMS 
separation occurring on a millisecond timescale and flight times on a microsecond 
timescale, thousands of mass spectra can be collected during each ion mobility 
separation, generating a two-dimensional data array wherein the mobilities and mass-to-
charge (m/z) values of ions are recorded [233]. In addition to the extra dimension of 
separation produced by having IMS prior to mass spectrometry, structural information 
can be obtained with the calculation of collision cross section (CCS, Ω) values, which 
provide information on the orientationally averaged surface area of the ions [356]. 
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IMS has demonstrated its capability for separations of lipids, carbohydrates, and 
peptides, as well as proteins and protein assemblies 
[150,151,171,306,368,369,454,534,573,581,590].  This capability results from 
differences in the CCS values that occur as the mass and/or extension are increased, for 
each of these different classes of biomolecules. Previous work has shown that each class 
tends to fold into particular patterns, dependent on the charge state, degrees of freedom, 
and intramolecular folding forces. IMS also separates charge states into distinct trend 
lines, with ions falling along these lines exhibiting a strong dependence between mobility 
(CCS) and mass. When CCS is plotted as a function of m/z, more compact ions will fall 
below the trend line. This has been displayed previously for the series of biomolecules 
described above [360]. Although GlycoMob, a database for CCS of free glycans, was 
announced recently [66], to date there have been few reports that can provide a database 
that includes glycopeptides, the corresponding released glycans and deglycosylated 
peptides. Such data can be used to determine whether trends in the CCS values of 
glycopeptides follow those determined for peptides or glycans, and whether their 
variation shows some dependence on peptide length and/or glycan composition and 
branching. 
Most eukaryotic proteins are modified by N- and/or O-linked glycosylation 
[27,41]. Cell surface and extracellular matrix proteins may include one or more N-linked 
sites where the glycan is covalently bound to asparagine [185,207,307,338], almost 
always in a consensus sequon Asn-Xxx-Thr/Ser (Xxx ≠ Pro) [38,39,494]. In addition, O-
linked glycans can modify the hydroxyl groups of Ser/Thr and, less frequently, 
 
 
210 
 
hydroxyPro [212,543]. Glycosylation impacts the structure, folding, stability, function, 
and activity of proteins [185,207,307,338]. In particular, glycosylation enables binding to 
modular lectin domains present on many extracellular proteins [132,479]. Aberrant 
glycosylation associated with cancer, neurodegenerative disorders, and genetic 
abnormalities reflects disease physiology [114,133,158] and many infectious agents show 
specificity for particular cell surface glycans [22]. Thus, essential physiological functions 
including cell-cell and cell-matrix recognition [209], cellular adhesion, and inter- and 
intracellular interactions depend on protein-carbohydrate interactions [614]. 
Glycoconjugate glycan expression reflects enzyme-dependent remodeling and 
biosynthetic steps in the endoplasmic reticulum and Golgi apparatus that vary according 
to cell type, development, disease state and species-specific expression of 
glycosyltransferases [159,323]. In addition, the population of glycans present at each site 
reflects the efficiencies of the individual biosynthetic steps as that particular glycoprotein 
is generated and processed. Thus, a given site exists as a set of glycoform variants that 
differ with regard to degree of occupancy, composition, linkage positions and branching 
points [622]. Each glycoprotein is expressed as a set of glycoforms that share a common 
amino acid sequence as the backbone but differ in the localizations, structures and/or 
sequences of carbohydrate units [209]. 
Owing to the large number of possible glycan structures and localizations, 
glycoprotein and even glycopeptide compositions cannot be assigned solely from high 
resolution mass measurements [122]. Tandem MS experiments increase the structural 
detail for glycopeptides; however, statistically rigorous scoring methods for glycopeptide 
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MS/MS data are not yet available. Thus, the confidence level for many glycoproteomics 
experiments remains poorly defined. IMS offers the advantages of providing an 
additional, orthogonal mode for resolving mixture components and CCS data that may be 
used as a feature to improve the depth to which glycopeptides may be reliably assigned, 
provided that there is an understanding of the influence of the glycan structure on 
mobility [122]. 
Here we have measured the mobilities of glycopeptides produced by protease 
digestions of well-characterized glycoproteins and have utilized exoglycosidases to 
generate additional glycoforms, in order to observe how the volume increments that are 
due to individual monosaccharide units affect the CCS values. We are compiling the 
measured values into a database that we are developing for N-linked glycopeptides, 
reduced and permethylated N-glycans, and deglycosylated/deamidated peptides. In 
particular, we observed that the cross section values measured for the [M+3H]
3+
 ions of a 
given glycopeptide or glycan changed linearly as the number of residues of a particular 
monosaccharide at the termini of its antennae was varied, and that the incremental 
differences were dependent on the identity of the monosaccharide. Furthermore, the 
relationships showed little dependence on the peptide structures. This work establishes 
the feasibility of building a database of glycopeptide and glycan mobilities as a function 
of glycan composition that will be useful for mobility-based glycopeptide and glycan 
profiling, which will likely extend to other types of glycoconjugates as well. 
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5.1.2 Experimental 
Sample preparation was carried out by Kshitij Khatri, data acquisition and data 
interpretation were performed by Dr. Rebecca S. Glaskin with help from Kshitij Khatri 
under the guidance of Prof. Joseph Zaia and Prof. Catherine E. Costello. Final data 
integration and figure generation were carried out by Dr. Rebecca S. Glaskin and Prof. 
Catherine E. Costello. 
5.1.3 Glycoproteins, enzymes, solvents and reagents  
Bovine ribonuclease B (RNase B), human transferrin, bovine fetuin and human 
α1-acid glycoprotein (AGP) were obtained from Sigma-Aldrich (St. Louis, MO). 
Sequencing grade trypsin and chymotrypsin were purchased from Promega Corp. 
(Madison, WI). Endoglycosidase F and exoglycosidases were prepared by New England 
Biolabs (Beverly, MA). LC-MS solvents were acquired from Fisher Scientific 
(Pittsburgh, PA). Unless specifically stated, all other reagents were obtained from Sigma-
Aldrich. 
5.1.4 Methods 
5.1.4.1 Glycoprotein reduction, alkylation and protease digestion 
 Each glycoprotein was reduced, alkylated, and subjected to tryptic or 
chymotryptic digestion, as described below. The glycopeptide fraction was enriched with 
a ProteoExtract Glycopeptide Enrichment Kit (EMD Millipore, Billerica, MA), following 
the manufacturer’s protocol. 
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5.1.4.2 Glycopeptide sample preparation, stepwise exoglycosidase digestion, and 
endoglycosidase release of N-linked glycans.  
Tryptic digestion. Each standard glycoprotein was reduced (dithiothreitol), 
alkylated (iodoacetamide), and subjected to overnight tryptic digestion with the use of 
2,2,2-trifluoroethanol (5%) as a denaturant, and ammonium bicarbonate (100 mM) as a 
pH buffer. Trypsin was dissolved in 50 mM acetic acid (1 μg/μL) and added in the ratio 
of 1:20 protease/protein. After digestion, the samples were dried with a centrifugal 
evaporator (Speedvac, Thermo Fisher Savant, Waltham, MA) and glycopeptides that 
resulted from the digestion were individually enriched with a ProteoExtract Glycopeptide 
Enrichment Kit (EMD Millipore, Billerica, MA) following the manufacturer’s protocol.  
Chymotryptic digestion. For digestion with chymotrypsin, 500 μg of transferrin, 
fetuin or AGP were dissolved in 400 μL of water and 100 μL of 100 mM ammonium 
bicarbonate and reduced and alkylated as above. After reduction and alkylation, 100 μL 
of 100 mM Tris-HCl, 10 mM CaCl2 (pH 8) were added to each sample for digestion with 
chymotrypsin. Chymotrypsin was dissolved in 1 mM HCl (1 μg/μL) and added in the 
ratio of 1:20 protease/protein. The chymotryptic digestion products were dried with the 
Speedvac centrifugal evaporator and desalted with Pierce C18 spin columns (Thermo 
Scientific, Rockford, IL). 
Exoglycosidase treatments. Exoglycosidases were used to sequentially remove 
individual saccharide units from the glycan non-reducing termini. The stepwise reactions 
were conducted at 37 °C. First, an aliquot of the zwitterionic hydrophilic interaction 
chromatography (ZIC-HILIC) enriched glycopeptides of a proteolytic digestion of each 
protein was analyzed by LC-IM-MS to determine CCSs for the intact glycopeptides. The 
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remainder of the sample was treated with α2-3,6,8 neuraminidase to remove sialic acid 
from the termini of the bi- or multi-antennary structures. A portion of each product 
mixture was desalted using a C18 spin column prior to analysis by LC-IM-MS, while the 
remainder of the sample was treated with β1-4 galactosidase to remove galactose from 
new non-reducing termini. A portion of the product mixture was desalted and then 
analyzed by LC-IM-MS, while the remainder of the sample was further digested using 
the exoglycosidase β–N-acetylglucosaminidase to remove the newly exposed N-
Acetylglucosamine residues (GlcNAc). Each product mixture was desalted and analyzed 
by LC-IM-MS.  
 A 20-μg aliquot of each glycopeptide-enriched fraction was reconstituted with 
80:20:0.1 water/acetonitrile/formic acid (H2O/ACN/FA) to a concentration of 2 µg/µL; 
these solutions were diluted (with 99:1:0.1 H2O/ACN/FA) to 200 ng/µL prior to C18-
reversed phase separation.  
Another portion of each glycopeptide-enriched fraction (20-40 μg) was 
sequentially treated with three exoglycosidases: α2-3,6,8-neuraminidase, β1-4-
galactosidase, and β–N-acetylglucosaminidase. The products from each step were 
desalted using Pierce C18 spin columns (Thermo Scientific, Rockford, IL) and prepared 
for analysis by LC-IM-MS in 80:20:0.1 H2O/ACN/FA.  
N-glycans were released from glycopeptides using PNGase F. From each of the 
nonenriched tryptic and chymotryptic proteolysis product solutions, 50 μL (2 μg/μL in 
water) was added to 7.5 μL of PNGase F (500,000 units/mL), 5 μL 10x GlycoBuffer, 1 
μL aprotinin (2 mg/mL in water) and the reaction mixtures were incubated overnight at 
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37 °C. The products were desalted using Pierce C18 spin columns and dried with the 
Speedvac. Flow-through and wash fractions contained salts and released glycans. The 
peptides resulting from the PNGase F release were resuspended in 25 µL of 90:10:0.1 
H2O/ACN/FA. For LC-MS, 0.5 µL of each peptide solution was diluted into 4.5 µL of a 
mixture of 99:1:0.1 H2O/ACN/FA; 2.5 µL of the resulting solution was injected by the 
autosampler. 
5.1.4.3 Glycan reduction, permethylation and analysis 
The  glycan pools resulting from endoglycosidase F treatments of RNase B, 
transferrin, fetuin, and AGP, with or without subsequent stepwise exoglycosidase 
treatment,  were each reduced with NaBD4 and then permethylated with a method 
introduced by Ciucanu and Kerek [90] and later modified by Ciucanu and Costello [89]. 
An approximately 50-μg portion of the glycans released from each sample by treatment 
with Endo F, with or without exoglycosidase treatment similar to that used for the 
glycopeptides, was reduced with NaBD4 and the product mixture was suspended in 200 
μL of DMSO/NaOH solution and vortexed for one hour at room temperature. Methyl 
iodide (100 μL) and 100 μL of DMSO/NaOH were added and the reaction mixture was 
vortexed for another hour at room temperature. An additional 100 μL of methyl iodide 
and 200 μL of DMSO/NaOH were added and the reaction mixture was vortexed for 
another hour at room temperature; the procedure was repeated four times. To stop the 
permethylation reaction and extract the permethylated glycans, 1 mL of chloroform was 
added to the reaction mixture. Water (1 mL) was added to dissolve salt from the samples. 
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After the sample tubes were vortexed and centrifuged, the aqueous layer was removed, 
and the organic phase that contained the permethylated glycans was retained. This 
washing cycle was repeated 18-20 times and, finally, the products were dried with the use 
of a centrifugal evaporator. 
 The derivatized glycan products were suspended in 50 µL of 50:50:0.1 
H2O/ACN/FA. For HPLC-MS analysis 1 µL of the RNase B glycans solution was diluted 
1:8 with 90:10:0.1 H2O/ACN/FA; for transferrin, fetuin and AGP, the glycan solution 
was diluted 1:4 with 96:4:0.1 H2O/ACN/FA. For each experiment, an 8-µL aliquot was 
injected. 
5.1.4.4 Instrumentation 
The Agilent 1200 series HPLC-Chip Cube interface equipped with a Polaris-HR-
Chip-3C18 LC chip was coupled to a 6560 Ion Mobility Quadrupole Time-of-Flight (IM-
QTOF) mass spectrometer (Agilent Technologies, Santa Clara, CA). The LC system 
included an autosampler, a binary capillary-flow pump used for loading samples, and a 
nano-flow gradient pump. Tryptic and chymotryptic digests of each reduced and 
alkylated protein were separated using the Polaris-HR-Chip-3C18 (3 µm, 180 Å pore 
size) that had a 360 nL enrichment column followed by a 75 µm × 150 mm 
separation/analytical column.  
For the analysis of glycopeptides and peptides, the gradient was 99% A (99% 
water, 1% acetonitrile, and 0.1% formic acid) and 1% B (1% water, 99% acetonitrile, 
0.1% formic acid) to 60% A for minutes 0 to 25, from 60% to 40% A in minutes 25 to 
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35, from 40% to 5% A in minutes 35 to 36, 5% A from minutes 36 to 41, 5% to 99% A in 
minutes 41 to 42, and 99% A from minutes 42 to 55. The flow rates for the capillary-flow 
and nano-flow pumps were 1.50 μL/min and 0.25 μL/min, respectively. For the analysis 
of deutero-reduced, permethylated glycans, the gradient was 90% A and 10% B for 
minutes 0 to 5, 90% to 35% A for minutes 5 to 40, 35% to 5% A for minutes 40 to 50, 
5% A for minutes 50 to 55, 5% to 90% A for minutes 55 to 60, and 90% A for minutes 
60 to 65. For the nanoflow and capillary-flow pumps, the flow rates were 0.25 μL/min 
and 2.00 μL/min, respectively. 
The HPLC chip was held at a DC bias of 1950-2250 V above the ion source 
entrance aperture, which is followed by a dual ion funnel interface into the 6560 IM-
QTOF analyzer. IMS separation took place in the ~80-cm long drift tube, operated at 
18.5 V/cm (temperature, 30.5-33.5 °C; pressure, 3.91 to 4.04 Torr nitrogen). Ions exiting 
the drift tube are refocused in a rear ion funnel prior to entering the mass analyzer. The 
dual ion funnel interface and rear ion funnels were operated at 100 and 120 V peak-to-
peak, respectively. For the Agilent tune mix, the typical values were: drift resolution, 50; 
mass resolution, 30,000; mass error, 2 ppm. The tune mix was infused during LC-MS 
runs and mass calibration was corrected based on its signal at m/z 1221.  As discussed 
below, likely due to linkage and conformational heterogeneity, the values observed 
during sample measurements were lower: drift resolution, 15-60; mass resolution, 24,000 
– 32,000; mass error, 1-10 ppm.  
LC-IMS-MS data files were extracted and deconvoluted using DeconTools [266]. 
Our software package GlycReSoft [359] was used to match the deconvoluted peak lists 
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against theoretical peptide and glycopeptide neutral mass lists, with mass tolerance 20 
ppm. 
All measurements were made in triplicate. Measured CCS values were plotted vs. 
m/z. Linear fits were applied, unless noted otherwise. The results are presented in the 
figures that follow. 
5.1.5 Results and Discussion 
5.1.5.1 Analysis of RNase B Glycopeptides 
Previous reports on IMS-MS of the high mannose (Man) glycans of RNase B 
have analyzed the glycans released after tryptic digestion of the glycoprotein 
[411,569,632]. The Clemmer group, utilizing a one-meter drift tube coupled to a linear 
ion trap, detected four isomeric structures for doubly sodiated Man7 [632]. The Bowers 
and Harvey groups used a home-built drift tube and a Synapt G2-S instrument (Waters 
Corporation, Manchester, U.K.) [569]. Pagel and Harvey later used both unmodified and 
modified Synapt HDMS instruments (Waters Corporation, Manchester, U.K.) to analyze 
these glycans [411]. Their experiments distinguished the high Mannose N-glycan isomers 
based on drift time and determined their absolute CCS values. IM-MS studies of the 
proteolytic glycopeptides obtained from the proteins analyzed here (including RNase B) 
have not been reported, nor have the IM-MS properties been determined for the shortened 
glycoforms of the peptides or for the released, reduced and permethylated glycans.  
In our experiments, we first studied the RNase B tryptic glycopeptide 
34
N*LTK
37
 
(where N* = occupied glycosylation site). Figure 36 displays a 2-D plot of m/z vs. drift 
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time over the drift time range during which the Man5-9 [M+2H]
2+
 ions were observed. 
These results are comparable to those obtained previously by Bowers and Harvey for the 
released glycans. 
 
Figure 36: A two-dimensional plot displaying m/z as a function of drift time represented with a false color scale 
(least intense features in blue; most intense in red) for the RNase B tryptic glycopeptide 34N*LTK37.  
To the left and above the 2-D plot are the mass and drift time spectra, respectively, for Man5-9 [M+2H]
2+ 
glycopeptide ions. 
 
For the Man5-9 glycoforms observed in Figure 36, the extracted drift time 
distributions are plotted in Figure 37A. The drift time distributions for the [M+2H]
2+
 ions 
display multiple peaks for Man6-8, consistent with separation of the known multiple 
isomeric structures.  
Here and elsewhere, the observations of lower drift time resolution (with respect 
to the data obtained for polyfluoroalkoxyphosphazine standards) and multiple peaks at 
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given m/z values are likely due to the presence of multiple conformers of individual 
isomers as well as branching isomers, some of which overlap in their drift times. 
 
Figure 37: RNAse B glycopeptide IMS-MS 
A) Extracted drift time distributions for the Man5-9 [M+2H]
2+ ions observed for the tryptic glycopeptide 
34N*LTK37 from RNase B. B) CCS values were plotted as a function of m/z for the high mannose glycoforms. 
Error bars: standard deviations obtained from triplicate measurements. 
 
CCS values calculated from the drift times obtained for the [M+2H]
2+
 ions of the 
Man5-9 glycoforms ranged from 400 to 500 Å
2
 (Figure 37A). The measured CCS values 
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were plotted as a function of m/z (Figure 37B). Two distinct linear trends can be observed 
as the number of Man units on the glycopeptide varies, one corresponding to the compact 
conformations (peaks falling along the blue line in Figure 37A) observed for Man5-9, and 
the other, to the elongated conformations (peaks falling along the red line in Figure 37A) 
of less highly branched glycoforms of Man6-8.  
5.1.5.2 Analysis of Transferrin Glycopeptides 
Transferrin has two N-linked glycosylation sites, each carrying a complex 
biantennary structure [211,289,293]. The transferrin glycopeptides were analyzed using 
procedures similar to those described above. However, unlike RNase B, abundant shorter 
glycoforms of transferrin do not occur naturally (except in the case of disease or 
metabolic disorders). We therefore used exoglycosidases to sequentially remove 
individual saccharide units from the termini of the biantennary structures, in order to 
produce convenient quantities of the shorter glycoforms.  
Figure 38 displays the results obtained for tryptic glycopeptides corresponding to 
the two known glycosylation sites of transferrin, after modification by 
carbamidomethylation (Cam) at cysteine, 
421
C(Cam)GLVPVLAENYN*K
433
 and 
622
QQQHLFGSN*VTDC(Cam)SGNFC(Cam)LFR
642
. Figure 38A and D, B and E, and C 
and F display the CCS plotted vs. m/z for the glycoforms that varied in their content of 
sialic acid (NeuAc), galactose (Gal), and N-acetylglucosamine (GlcNAc), in that order, 
after these residues were stepwise removed from the non-reducing termini.  
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In Figure 38A, the CCS values obtained for the [M+4H]
4+
 and [M+3H]
3+
 ions of 
the biantennary glycopeptide 
421
C(Cam)GLVPVLAENYN*K
433
 are plotted vs. m/z for 
the species containing NeuAc0-2. Unique linear trendlines can clearly be distinguished for 
the two observed charge states, as a result of the increased force experienced by ions in 
the higher charge state during travel through the gas-filled drift tube. Linear trends were 
also observed for the biantennary glycoforms with Gal0-2 (Figure 38B) and then GlcNAc0-
2 (Figure 38C) at the non-reducing termini. 
 
Figure 38: Plots displaying CCS vs. m/z for the two biantennary complex N-linked tryptic glycopeptides from 
transferrin.  
The left and right columns correspond to variations in the number of each type of terminal saccharide unit on 
421C(Cam)GLVPVLAENYN*K433 and 622QQQHLFGSN*VTDC(Cam)SGNFC(Cam)LFR642, respectively, after 
each round of treatment with exoglycosidase. A) and D) display CCS measurements for products with 
incremental changes in the number of NeuAc residues; B) and E) show changes in Gal; and C) and F) vary the 
number of GalNAc. Blue diamonds: compact [M+4H]4+ ions; red squares: elongated [M+4H]4+ ions; green 
triangles: [M+3H]3+ ions. Error bars: standard deviations from triplicate measurements.  
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Figure 38D shows plots of CCS vs. m/z for the [M+4H]
4+
 and [M+3H]
3+
 ions 
observed for the species with NeuAc0-2 on the biantennary structure of the glycopeptide 
at the second glycosylation site, 
622
QQQHLFGSN*VTDC(Cam)SGNFC(Cam)LFR
642
. 
Figure 38E presents the results obtained for the series Gal0-2 resulting from subsequent β-
galactosidase treatment of the desialylated glycoforms. Both compact and elongated 
conformations were observed for the [M+4H]
4+
 and [M+3H]
3+
 ions. Figure 38F shows 
that, after further treatment with β–N-acetylglucosaminidase, the [M+3H]3+ ions of the 
GlcNAc0-2 glycoforms also exhibited a linear trend.  
A parallel set of IM-MS analyses was carried out after the digestion of transferrin 
with chymotrypsin, to determine if the changes in the observed CCS were primarily 
dependent on the glycan composition or were influenced by the length of the peptide 
(Data not shown). 
5.1.5.3 Analysis of Fetuin Glycopeptides 
 Complex N-glycans of bovine fetuin have been previously studied by MS [205]. 
Here, we analyzed peptides corresponding to one of the three occupied glycosylation 
sites. The procedures for sequential exoglycosidase treatments followed those above.  
In Figure 39, CCS was plotted vs. m/z for full-length tryptic glycopeptides from 
bovine fetuin and their products after two stepwise glycosidase treatments, 
145
LC(Cam)PDC(Cam)PLLAPLN*DSR
159
 and its analog that contains one missed 
cleavage site, 
144
KLC(Cam)PDC(Cam)PLLAPLN*DSR
159
. These exhibited similar 
trends. For each set, we observed [M+5H]
5+
, compact [M+4H]
4+
, elongated [M+4H]
4+
, 
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and [M+3H]
3+ 
ions. Although the CCS vs. m/z plots showed similar slopes for the 
[M+3H]
3+
 ions as the number of monosaccharide units varied, the [M+4H]
4+
 ions did not 
exhibit a linear trend. 
 
Figure 39: Plots of the CCS as a function of m/z for the triantennary complex N-linked glycopeptides resulting 
from the tryptic digestion of Fetuin and further exoglycosidase treatments. 
Similar experiments were performed on the fetuin triantennary glycopeptides. 
These trends followed those described above for the biantennary transferrin 
glycopeptides. Figure 39 shows plots of CCS as a function of m/z for the triantennary 
complex N-linked glycopeptides resulting from the tryptic digestion of fetuin after 
sequential treatments with α2-3,6,8 neuraminidase, β-1-4-galactosidase and β–N-
acetylglucosaminidase. 
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Fetuin was also digested with chymotrypsin. The results obtained as the numbers 
of A) NeuAc and B) Gal residues varied
 
for the triantennary chymotryptic glycopeptide 
156
N*DSRVVHAVEVAL
168
 are shown in Figure 40. These results exhibited no 
significant difference in the variance of CCS upon change in the number of NeuAc 
residues present on two glycopeptides containing the same sequon and the same inner 
glycan structure but composed of different numbers of amino acids, the tryptic peptide 
145
LC(cam)PDC(cam)PLLAPLN*DSR
159
 and the chymotryptic peptide 
156
N*DSRVVHAVEVAL
168
. As the number of NeuAc residues changed, the two sets of 
glycoforms exhibited the same slope for the plot of CCS vs. m/z for the triply charged 
species. For the [M+4H]
4+
 ions, the slope of the line corresponding to variation in the 
number of NeuAc residues differed significantly for this pair of glycopeptides (0.33 vs. 
0.22) (Figure 40A). It is likely that the excess charge on the [M+4H]
4+
 ions increases the 
extension of the overall structure as compared to [M+3H]
3+
 ions; the increased flexibility 
of the [M+4H]
4+
 ions which have a more elongated structure due to increased Coulombic 
repulsion is also reflected by the difference in the slopes for the [M+4H]
4+
 ions, whereas 
the slopes for the [M+3H]
3+
 ions are almost identical. Figure 39B shows the incremental 
changes due to variation in the terminal Gal residues on the asialo glycoforms observed 
for [M+3H]
3+
 ions of glycopeptides resulting from tryptic and chymotryptic digestions. 
Here again, the situation was reversed: the slopes observed for CCS vs. m/z were: tryptic 
glycopeptides, 0.26; chymotryptic, 0.31.   
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Figure 40: Plots displaying the CCS vs. m/z for variations in the number of terminal A) NeuAc and B) Gal 
residues on the triantennary structure of the glycopeptides 156N*DSRVVHAVEVAL168 and 
145LC(Cam)PDC(Cam)PLLAPLN*DSR159, resulting from proteolytic digestion of fetuin with trypsin (solid 
symbols) or chymotrypsin (open symbols)  
Blue diamonds: [M+4H]4+ ions; green triangles: [M+3H]3+ ions. Error bars: standard deviations obtained from 
triplicate measurements. 
 
Values measured for the NeuAc0-3 series of the [M+4H]
4+
 and [M+3H]
3+
 ions of 
the triantennary glycopeptide 
98
AN*C(Cam)SVRQQTQHAVE
111 
and similar plots for 
the triantennary chymotryptic glycopeptide 
98
AN*C(Cam)SVRQQTQHAVEGDC(Cam)DIHVL
119
, analyzed for sequential variances 
in the numbers of A) NeuAc, B) Gal, and C) GlcNAc residues. For NeuAc0-3, [M+4H]
4+
 
and [M+3H]
3+
 ions both displayed linear trends. The slope for the line for CCS vs. m/z 
observed for the [M+3H]
3+
 ions with NeuAc0-3 was 0.26, the same value observed for the 
[M+3H]
3+
 ions of 
98
AN*C(Cam)SVRQQTQHAVE
111
 with NeuAc0-3. A linear trend was 
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determined for the [M+4H]
4+
 and [M+3H]
3+
 ions for Gal0-3 and for [M+3H]
3+
 ions with 
GlcNAc0-3. (Data not shown) 
5.1.5.4 Analysis of α1-Acid Glycoprotein Glycopeptides 
 Parallel analyses were carried out for human AGP, a glycoprotein that contains 
five N-linked glycosylation sites [292,293,530]. For AGP, tryptic glycopeptides exhibited 
zero, one, or two missed cleavage sites. Both tetra-antennary and triantennary structures 
were observed for most of the AGP glycopeptides discussed here. 
For the glycoforms of the AGP tryptic glycopeptide 
87
QNQC(Cam)FYN*SSYLNVQR
101
 differing in the numbers of A) NeuAc, B) Gal, and 
C) GlcNAc residues, CCS was plotted vs. m/z, for (Figure 41). Figure 41A displays the 
glycoforms containing NeuAc0-4 observed as [M+5H]
5+
 ions and clearly distinguished 
from the [M+4H]
4+
 ions.  
 
 
228 
 
 
Figure 41: CCS plotted vs. m/z for glycoforms that vary in the numbers of non-reducing terminal NeuAc, Gal 
and GlcNAc residues on the multiantennary structures of the listed AGP glycopeptide. 
Both tetra-antennary and triantennary structures for the [M+4H]
4+
 ions fall along 
the same diagonal with similar slopes, 0.35 and 0.37, respectively. For the [M+4H]
4+
 ions 
of tetra-antennary and triantennary glycoforms with Gal0-4, compact and elongated 
structures were observed, with comparable trendlines. (Figure 41B) The values 
determined for the [M+3H]
3+
 ions for the structures shown in Figure 41B overlap along 
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the same diagonal and display linear trends for the plots of CCS vs. m/z, with slopes of 
0.29 (tetra-antennary structures) and 0.27 (triantennary). Figure 41C displays a plot of 
CCS vs. m/z with a linear trendline applied for the [M+3H]
3+
 ion series corresponding to 
tetra-antennary structures with GlcNAc0-4.   
Both tetra- and triantennary structures were observed for glycoforms of the AGP 
peptide 
98
NVQREN*GTISRY
109
. Linear trends were found for CCS plotted vs. m/z 
(Figure 42A); the observed slopes were tetra-antennary [M+4H]
4+
 ions, 0.37; triantennary 
[M+4H]
4+
, 0.40; tetra-antennary [M+3H]
3+
, 0.26; triantennary [M+3H]
3+
, 0.30.  
In Figure 42B, CCS was plotted vs. m/z for the series NeuAc0-3 on the triantennary 
structures of [M+3H]
3+
 ions of the tryptic and chymotryptic AGP glycopeptides 
102
EN*GTISR
108
 and 
98
NVQREN*GTISRY
109
. The slopes for CCS vs. m/z were tryptic 
glycopeptides, 0.29; chymotryptic, 0.30. As discussed above for fetuin, the observed 
changes in CCS were similar for the pair of glycopeptides with the same sugar attached, 
independent of the difference in peptide lengths.  Here again, it appeared that the slope in 
the correlation of CCS with incremental changes in glycan depended on sugar 
composition and was independent of peptide length. 
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Figure 42: A) Display of the change in CCS with incremental changes in the number of NeuAc residues present 
on the [M+4H]4+ and [M+3H]3+ ions of tetra-antennary and triantennary glycoforms of the AGP chymotryptic 
glycopeptide 98NVQREN*GTISRY109, with CCS plotted vs. m/z.  
Solid and open blue diamonds correspond to [M+4H]4+ ions of the tetra-antennary and triantennary structures, 
respectively. For the [M+3H]3+ ions, solid and open green triangles correspond to the tetra-antennary and 
triantennary structures, respectively. B) A plot displaying CCS vs. m/z for [M+3H]3+ ions in the series of NeuAc0-
3 glycoforms of the triantennary glycopeptides from AGP 
102EN*GTISR108 (tryptic peptide, open green 
triangles) and 98NVQREN*GTISRY109 (chymotryptic peptide, solid green triangles). Error bars: standard 
deviations resulting from triplicate measurements. 
 
Analyses similar to those described above were conducted on additional 
glycopeptides resulting from tryptic and chymotryptic digestion of AGP and sequential 
treatment with the exoglycosidases (results not shown). 
For the tetra- and triantennary glycoforms of 
87
QDQC(Cam)IYN*TTYLNVQR
101
 
with varying number of NeuAc (Figure 43A), the slopes resulting from the linear fits 
applied to the [M+5H]
5+
 ions deviated more than those observed for the compact and 
extended forms of the [M+4H]
4+
 and [M+3H]
3+
 ions, suggesting that increased 
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Coulombic repulsion allows the antennae to adopt more elongated and flexible structures. 
The values obtained for the [M+3H]
3+
 ions overlapped along a comparable diagonal; the 
slopes in the plots of the CCS values for NeuAc0-4 were tetra-antennary, 0.26; 
triantennary, 0.29.  
For glycoforms with terminal Gal0-4 on tetra- and triantennary structures of this 
glycopeptide, the compact and elongated conformations observed for [M+4H]
4+
 ions of 
both sets of structures displayed linear trends, with deviations in their slopes (Figure 
43B). The [M+3H]
3+
 ions of these structures exhibited comparable diagonals (tetra-
antennary slope 0.20; triantennary, 0.17). 
 
Figure 43: Plots of CCS values vs. m/z for glycoforms that differ in the number of NeuAc and Gal residues, 
present at the termini of multiantennary structures for AGP glycopeptides listed.  
Results for the AGP tryptic glycopeptide 
58
SVQEIQATFFYFTPN*K
73
 were 
similarly analyzed (Figure 43C); CCS values were plotted vs. m/z for [M+3H]
3+
 to 
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[M+5H]
5+
 ions. [M+5H]
5+
 ions were observed for the tetra-antennary structure. CCS vs. 
m/z plots for the [M+4H]
4+
 ions fall along similar diagonals (tetra-antennary slope 0.32; 
triantennary, 0.26) with variation in NeuAc. The [M+3H]
3+
 ions exhibited similar 
behavior (tetra-antennary slope, 0.25; triantennary, 0.26). 
For the triantennary glycoforms of the AGP tryptic glycopeptide 
52
NEEYN*K
57
 
(NeuAc0-3), both compact and elongated structures were observed for the [M+4H]
4+
 ions 
(Figure 43D). Compact ions showed a quadratic trend for CCS vs. m/z, whereas elongated 
ions followed a linear trend. Compact ions for this particular charge state may exhibit 
tighter folding for glycoforms having fewer NeuAc residues. CCS of the [M+3H]
3+
 ions 
displayed a linear trend.  
5.1.5.5 Analysis of Deutero-Reduced Permethylated N-glycans and 
Deglycosylated/Deamidated Peptides 
 The same type of analysis was carried out for the deutero-reduced permethylated 
N-glycans and the corresponding deglycosylated/deamidated peptides. Linear trends were 
observed when CCS values of the derivatized glycans were plotted vs. m/z (Figure 44). 
For the derivatized high mannose N-glycans (Figure 44A), the CCS values were 395 - 
538 Å
2
, with a slope of 0.27 in the line for CCS vs. m/z. The CCS values of the 
derivatized complex N-glycans and the shortened glycans obtained via glycosidase 
digestions were also measured. [M+3H]
3+
 ions were observed for both tetra- and 
triantennary structures. The slopes in the plots for CCS vs. m/z with variation in NeuAc 
residues were similar to slopes observed for the glycopeptides (tetra-antennary, 0.34; 
triantennary, 0.39) (Figure 44B). For the [M+2H]
2+
 ions of the tri- and biantennary 
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structures, the slopes for the lines reporting CCS vs. m/z were 0.20 and 0.25, respectively. 
As the number of terminal Gal residues varied, the CCS values changed at rates similar to 
those observed for the glycopeptides.  For ions corresponding to structures that differed 
in the number of Gal residues (Figure 44C), the observed slopes were: tetra-antennary 
[M+3H]
3+
 ions, 0.40; triantennary 0.39; and, for [M+2H]
2+
 ions, were tetra-antennary, 
0.24; triantennary, 0.27; biantennary, 0.23. The deglycosylated/deamidated peptides did 
not exhibit significant conformational heterogeneity and yielded well-defined, narrow 
CCS distributions. 
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Figure 44: Plots of CCS values vs. m/z for deuteron-reduced and permethylated high-mannose (A) and complex 
glycans (B & C). 
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5.1.5.6 Combination of Glycopeptides, Deutero-Reduced Permethylated N-Glycans, 
and Deglycosylated/Deamidated Peptides 
 To enable visualization of the characteristic separations of the three classes of 
biomolecules, we assembled these data and plotted the CCS values vs. m/z, as shown in 
Figure 45. For charge states [M+2H]
2+
 and [M+3H]
3+
, it appears that the average 
densities differ in the order: glycopeptides > peptides > permethylated glycans. The 
differences in CCS values between the classes of biomolecules are due to class-specific 
structural folding (dependent on the particular intramolecular folding forces). Although 
both the deutero-reduced permethylated glycans and the glycopeptides may possess 
highly branched structures, the deutero-reduced permethylated glycans have larger CCS 
values than the glycopeptides with similar m/z values, probably because the peptide 
portions of the latter serve as the major reservoirs of charge localization, and thus the 
glycan structure does not need to expand its cross section quite so much to accommodate 
the higher charge states. It is also possible that the attachment of the glycan to the peptide 
causes compaction of the glycopeptide, and therefore the resulting CCS values for the 
glycopeptide and corresponding glycan moiety were found to be similar. 
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Figure 45: CCS plotted as a function of m/z for three classes of biomolecules: deutero-reduced, permethylated 
glycans, deglycosylated/deamidated peptides, and glycopeptides  
A) [M+2H]2+ ions and B) [M+3H]3+ ions. Solid green triangles: tryptic glycopeptides; open green triangles: 
chymotryptic glycopeptides. Error bars: standard deviations obtained from triplicate measurements. 
5.1.6 Conclusions 
With coupled IM-MS, we determined CCS values for glycopeptides resulting 
from tryptic or chymotryptic digestion of a set of well-characterized glycoprotein 
standards (bovine RNase B, human transferrin, bovine fetuin and human α1-acid 
glycoprotein), the deutero-reduced permethylated derivatives of the N-linked glycans 
released from these sources, and the corresponding deglycosylated/deamidated peptides. 
Multiple charge states and conformations were observed for the glycopeptides and 
derivatized glycans. We calculated CCS values for the glycopeptides generated by 
proteolysis, the deglycosylated/deamidated peptides and deutero-reduced permethylated 
glycans, including shorter glycoforms that occur naturally or that resulted from stepwise 
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application of exoglycosidases. We determined a linear dependence for all [M+3H]
3+
 ions 
and for a majority of [M+4H]
4+
 ions, when the CCS values were plotted vs. m/z for 
glycoforms that differed from one another by known increments. The most highly 
consistent result was the overlapping linear fits observed for the complete [M+3H]
3+
 
series for glycoform sets constructed from a given glycopeptide or deutero-reduced 
permethylated N-glycan. For some sets of glycoforms in [M+4H]
4+
 and [M+5H]
5+ 
charge 
states, quadratic curves were observed. Our results from analysis of the [M+3H]
3+
 ions 
indicate that the rate of change in CCS upon increments of individual saccharide units is 
independent of peptide length. The monosaccharide incremental changes in CCS values 
for both [M+3H]
3+
 and [M+4H]
4+
 glycopeptide ions were 22 to 30 (±5) Å
2
 per NeuAc 
residue, 11 to 19 (±5) Å
2
 for Gal, and 13 to 15 (±5) Å
2
 for GlcNAc. For both [M+2H]
2+
 
and [M+3H]
3+
 deutero-reduced permethylated glycans, the monosaccharide incremental 
change in CCS value was 32 to 49 (±7) Å
2
 per NeuAc residue, 23 to 28 (±2) Å
2 
for Gal, 
and 19 to 44 (±9) Å
2 
for Man. Future work will utilize reference glycans with specific 
linkages and additional proteases, and will examine the behavior of O-linked 
glycopeptides and released O-glycans, as well as negative ions, and will refine the results 
by incorporating tandem MS data and, when possible, molecular dynamics calculations. 
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5.2 Electron-activated dissociation (ExD) of glycans and glycoconjugates 
5.2.1 Introduction 
Electron-based activation of glycans and glycoconjugates yields informative 
product ions that provide information critical to confident assignment of detailed 
structures and site-specific post-translational modifications. The application of these 
methods to biological samples has primarily been limited by instrument costs, sensitivity 
and speed. Instrument development and workflow development need to go hand in hand 
for efficient application and dissemination of these methods. We developed and tested 
approaches for standardization of sample preparation and ExD analysis of glycans and 
glycopeptides that are not characterized efficiently using collisional-dissociation 
methods. These efforts have helped identify the key features in ExD of these biopolymers 
and also generated data that are being used for development of bioinformatics software.  
A particular problem with analyzing glycopeptides using collisional dissociation 
is the loss of information on the glycan moiety. For singly glycosylated peptides, this 
does not pose a problem because the glycan composition can be inferred from the total 
mass of the precursor ions, once the peptide backbone has been identified. However, 
when analyzing multiply glycosylated peptides, the loss of saccharide from peptide 
backbone fragments prevents assignment of site-specific glycosylation. In addition, CAD 
does not produce good peptide backbone fragmentation for multiply N-glycosylated 
peptides. This limits the applicability of this method to analysis of heavily glycosylated 
peptides such as O-glycosylated peptides, which contain stretches of serine and threonine 
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residues with multiple glycans attached, or long peptides with more than one N-
glycosylation sequon. In some cases, it may be possible to separate the multiple sites of 
glycosylation by using a combination of proteolytic enzymes; however, this limitation of 
CAD prevents its application to intact protein and glycoprotein analysis. 
When analyzing in a bottom-up fashion, we lose the information concerning how 
different pieces of a molecule exist together in the intact molecular structure and are thus 
unable to differentiate among the many forms that are present as part of the population 
that we analyze. For example, there may be a range of glycan structures present at each 
site on a multiply glycosylated protein. When we analyze using a bottom-up method, we 
are able to determine the range of glycan forms that are present at each site but we are 
unable to establish what combinations of glycans appear together on multiple sites of a 
complete protein. Thus, we are always building back to a molecular form that is an 
average of all molecules in a measured population. This hampers the ability to fully 
understand the interactions between specific molecular forms and to identify the forms 
that are relevant to a particular biological response or disease.  
To overcome this barrier, methods are being developed to study proteins using a 
“top-down” approach, which means the intact molecule is analyzed instead of studying 
smaller portions and building back. This requires ExD fragmentation combined with 
high-resolution and high-sensitivity mass spectrometers. These methods are primarily 
being applied to non-glycosylated proteins at present. The problem is that the addition of 
glycans to proteins multiplies the total number of molecular forms many-fold due to the 
added heterogeneity of this second biopolymer. The number of protein-glycan 
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combinations increases exponentially with an increase in the number of glycosylation 
sites. As a result, for large glycoproteins with multiple glycosylation sites only a “middle-
down” approach is conceivable, where moderately-sized pieces of protein that contain 2-
3 sites of glycosylation can be studied [67,156,314,420,500]. We evaluated the 
performance of different fragmentation modes for analysis of bottom-up and middle-
down glycopeptides from standard glycoproteins including Human Transferrin and 
Human α1-acid glycoprotein (AGP). 
For glycan dissociation, CAD is known to produce abundant glycosidic bond 
fragments with little to no cross-ring fragmentation. It is therefore important to utilize 
electron-based activation for detailed structural characterization [3,208,257,575,605,634]. 
To date there is a paucity of high-quality oligosaccharide ExD data. ExD of glycans 
generates very complex tandem mass spectra that are very tedious to interpret manually. 
Because the availability of ExD data is limited, automated spectral interpretation tools 
that can handle such data are not well-developed. Our work included generation of CAD 
and ExD data on chemically defined standards to compare the characteristics of these 
fragmentation modes and to make available high-quality data on oligosaccharide 
standards for development of bioinformatics pipelines.  
5.2.2 Materials and methods 
5.2.2.1 Sample preparation 
For bottom-up glycopeptide analysis, human transferrin and human AGP (Sigma- 
Aldrich, St. Louis, MO)  were denatured by heating in presence of 2,2,2-trifluoroethanol. 
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Samples were then reduced with dithitreitol (DTT), alkylated using iodoacetamide (IAM) 
and digested with Trypsin (Promega Corp., Madison, WI) in presence of 100mM 
ammonium bicarbonate (Sigma- Aldrich, St. Louis, MO) as buffer.  Detailed digestion 
protocol has been described previously [291,292,293]. Glycopeptides were enriched 
using ZIC-HILIC glycopeptide enrichment kit (EMD Millipore, Billerica, MA), as per 
the manufacturer’s protocol. Samples were desalted, where necessary, using Pierce 
Pepclean C18 spin columns (Thermo Fisher Scientific, Pittsburgh, PA).  
For middle-down glycopeptide analysis, AGP was denatured, reduced, alkylated 
and digested using AspN endproteinase (Promega Corp., Madison, WI). Middle-down 
glycopeptides were enriched by fractionation on the AspN digest using a Superdex 75 
(3.2/300) (GE Healthcare, Pittsburgh, PA) on a Beckman Gold HPLC system (Beckman 
Coulter, Inc, Indianapolis, IN). 25mM ammonium formate (pH 4.5) with 10% acetonitrile 
was used as mobile phase for the separation at an isocratic flow rate of 50µL/min. 
Fractions were collected manually based on UV absorbance at 230nm and further 
fractionated using a Vydac C18 reversed-phase HPLC column (W.R. Grace & Co., 
Columbia, MD) on an Agilent 1200 series chromatograph (Agilent, Inc., Santa Clara, 
CA), fitted with an automated fraction collector. 
Where indicated, for both bottom-up and middle-down analyses, samples were 
also desialylated using α-2,3,6,8 Neuraminidase (New England Biolabs, Ipswitch, MA), 
prior to LC-MS or nanoESI-MS to reduce glycoform heterogeneity. 
Chemo-enzymatically synthesized glycan standards were used for glycan ExD 
and CAD experiments. The standards were kindly donated by Chemily, LLC (Atlanta, 
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GA). Glycan samples were first reduced using sodium cyanoborodeuteride (Sigma-
Aldrich, St. Louis, MO); excess borate salts were removed by repeated resuspension and 
drying in methanol. Deutero-reduced glycan alditols were permethylated using the 
protocol described by Cicuanu and Costello [89,90]. Following liquid-liquid extraction of 
permethylated glycan alditols, desalting was performed using C18 spin columns. 
5.2.2.2 Data acquisition 
Bottom-up glycopeptide samples were either directly infused for analysis using 
the Advion Nanomate alone or analyzed by online LC-MS using LC-MS at nanoliter 
flow-rates on a Bruker Solarix 12T hybrid Q-FTICR mass spectrometer mounted with an 
Advion Nanomate nanoESI source (Advion Inc., Ithaca, NY). A Waters™ 
NanoAcquity™ nano-flow chromatograph (Waters Corp., Milford, MA) mounted with a 
Waters™ Xbridge™ reversed-phase column (150 μm × 100 mm) packed with 1.7 μm 
BEH C18 resin and a Waters™ trap column (180 μm × 20 mm) packed with 5 μm 
Symmetry™ C18 stationary phase, was used for online LC-MS. Glycopeptides were 
analyzed by collisional-dissociation on a Thermo-Fisher Scientific Q-Exactive Plus mass 
spectrometer (Thermo Scientific, San Jose, CA), using a similar LC-MS setup, as 
described previously [291]. Bottom-up Transferrin glycopeptides were also analyzed 
using CAD on an Agilent 6550 Q-TOF mass spectrometer using online HILIC 
enrichment combined with reversed-phase separation, as described previously [293]. 
Middle-down glycopeptide fractions from C18 LC separation were analyzed by 
nanoESI-MS using a Bruker Solarix 12T FTICR-MS mounted with an Advion Nanomate 
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source. ETD and EThcD (Electron Transfer Dissociation with supplemental collisional 
activation) experiments were performed on ZIC-HILIC enriched and unfractionated 
bottom-up and middle-down glycopeptide samples in collaboration with Dr. Rosa Viner 
at Thermo-Fisher Scientific (San Jose, CA) by LC-MS using an EASY-nLC 
chromatograph with an EASY-Spray C18 LC column on a Thermo Orbitrap Fusion 
instrument. The instrument was set to perform HCD-triggered EThcD, which allowed 
EThcD to be performed only on precursor ions that generated saccharide oxonium ions. 
Permethylated glycan alditols were resusupended in 1:1 methanol:water with 
0.1% formic acid and infused via nano-ESI (Advion Nanomate) into a Bruker Solarix 
12T FTICR-MS for ExD experiments or into a Thermo Fisher Scientific Q-Exactive Plus 
mass spectrometer for CAD (HCD) experiments. Sodium metal adduction was achieved 
by addition of sodium hydroxide to the samples and glycan EED was performed as 
described previously [605]. 
Experiments on the Bruker Solarix FTICR-MS were performed in collaboration 
with Dr. Yi Pu. For data acquisition on the Solarix by LC-MS/MS, precursor ions of 
interest were isolated using a front-end quadrupole mass-filter and accumulated in the 
collision-cell for 100 to 1000 ms prior to MS/MS analyses. hECD was performed by 
irradiating trapped ions in the ICR-cell with 12-14 eV electrons, for up to 1 s. Cathode 
current was set at 1.5 A and the cathode bias was set between -12 and -14 V. Summed 
spectra were used to improve signal-to-noise ratio. LC-MS/MS experiments were 
performed by data-dependent precursor selection of the most-abundant parent ion or 
using a targeted inclusion list.  
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5.2.2.3 Data analysis 
Glycopeptide data analysis was performed manually or in a semi-automated 
manner using python scripts developed in-house, using the GlyPy library [300] 
(https://pypi.python.org/pypi/glypy/0.0.5rc2) developed by Joshua A. Klein and with help 
from Prof. Cheng Lin and Dr. Yi Pu, at Center for Biomedical Mass Spectrometry, 
Boston University. Glycan tandem MS data were deconvoluted using the SNAP 
algorithm version 2.0 in the Bruker DataAnalysis software, using a quality factor 
threshold of 0.01, signal-to-noise ratio of 2, relative intensity threshold of 0.01% and a 
peptide averagine model for isotope fitting [244,308]. Deconvoluted peaklists were 
annotated using GlyPy and a prototype version of GlycoDeNovo (Prof. Pengyu Hong, 
Brandeis University). The data are being used for further development of these software 
pipelines.  
5.2.3 Results and Discussion 
5.2.3.1 Glycopeptide analysis by different dissociation methods 
As described previously, glycopeptide fragmentation by collisional-dissociation 
causes dissociation of the labile glycosidic bonds, leading to loss of the carbohydrate 
before the peptide backbone can be fragmented. This complicates assignment of the 
glycosylation sites for multiply glycosylated peptides. For bottom-up N-glycopeptide 
analysis, peptide backbone fragments often retain a HexNAc since the amide bond 
between the asparagine residue and HexNAc is stronger than the glycosidic bonds and 
survives CAD. Further, for multiply glycosylated peptides, CAD is generally unable to 
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resolve site-specific glycosylation. Therefore, ExD becomes necessary in cases where 
multiple glycans are attached to the peptide to keep the glycan moieties intact, while 
fragmenting the peptide backbone. 
5.2.3.2 Comparison of dissociation modes for bottom-up glycopeptide tandem-MS 
To compare the dissociation characteristics of different dissociation modes, we 
acquired tandem MS of the same transferrin glycopeptide 
(QQQHLFGSNVTDCSGNFCLFR – Hex5 HexNAc4 NeuAc2) using CAD, ETD and 
ECD. Figure 46 shows the tandem MS results using CAD. As expected [293], extensive 
dissociation of the glycan is seen leading to generation of abundant oxonium ions. The 
intact peptide ion without any glycans attached and a glycan Y1 ion are also seen, which 
confirm the intact peptide and glycan mass. A series of peptide backbone ions are also 
seen that have relatively low abundances. In addition to the bare peptide backbone ions, 
peptide fragment ions with an attached HexNAc (nx/Y1) are also observed. Together 
these features allow unambiguous assignment of the peptide sequence and the glycan 
composition can be inferred from the residual precursor mass. The same precursor was 
also fragmented using CAD on the FTICR MS. While similar CAD dissociation patterns 
were observed, fewer peptide backbone fragments were observed, owing to the lower 
sensitivity of the FTICR MS compared to the Q-TOF.  
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Figure 46: CAD Tandem MS of a Transferrin glycopeptide ([M+4H]4+, m/z 1180.7328) on a Q-TOF instrument 
An ETD spectrum for the same precursor, generated on the FTICR instrument, is 
shown in Figure 47. It was interesting to see that ETD generated few, if any, peptide 
backbone fragmentation for this precursor, while some glycan fragmentation was 
observed from vibrational excitation, probably induced by ion transfer in the optics. The 
intact precursor and abundant charge-reduced species were observed in the ETD 
spectrum, indicating an ETnoD (Electron Transfer with no Dissociation) phenomenon, 
where the electron is transferred to the precursor leading to charge reduction but no 
fragmentation takes place [195,272].  
Contrastingly, ECD of the same precursor generated extensive glycopeptide 
fragmentation on the FTICR MS (Figure 48). We observed abundant c and z-type peptide 
backbone ions with the intact glycan attached in the range m/z 1600-2400. In the lower 
m/z range, peptide backbone fragments not containing the glycosylation site were 
observed. A few b/y-type peptide ions and some peaks resulting from glycan 
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fragmentation (oxonium ions and saccharide losses from the precursor) were also 
observed, indicating slight vibrational excitation. 
 
 
Figure 47: ETD Tandem MS of a Transferrin glycopeptide ([M+4H]4+, m/z 1180.7328) on an FTICR-MS 
instrument 
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Figure 48: ECD Tandem MS of a Transferrin glycopeptide ([M+4H]4+, m/z 1180.7328) on an FTICR-MS 
instrument 
 
While ECD of the 4+ precursor of the transferrin glycopeptide generated 
abundant peptide backbone product ions, a triply charged precursor of the same 
glycopeptide led to Electron Capture with no Dissociation (ECnoD) and therefore did not 
yield useful tandem MS (data not shown but presented in [425]). Further experiments 
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were performed in an attempt to understand and alleviate this problem of charge-state 
dependence.   
To improve glycopeptide fragmentation for lower-charge precursors by ECD, we 
first desialylated the transferrin glycopeptide samples using α-2,3,6,8 Neuraminidase. 
Desialylation was performed to collapse the overall glycan microheterogeneity for the 
same, thereby increasing precursor ion abundances and to eliminate any intramolecular 
interactions of the sialic acids preventing efficient dissociation of the odd-electron 
species. However, increased precursor abundance and removal of sialic acids did not 
seem to improve ECD performance for lower-charge precursors (Figure 49). Only 
charge-reduced species were observed in addition to low-abundance oxonium ions, 
confirming presence of ECnoD. To circumvent the problem of charge-state dependence, 
we tested hECD for the same precursor. hECD yielded abundant glycopeptide fragments 
for the same triply charged precursor that could not be fragmented by ECD (infusion-
hECD data not shown).  
 
 
Figure 49: ECD Tandem MS of an asialo Transferrin glycopeptide ([M+3H]3+, m/z 1379.9068) on a FTICR-MS 
instrument 
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The ExD fragmentation modes tested so far all used static nanoelectrospray on the 
FTICR instrument. Practical application of these analytical methods requires their 
implementation for LC-scale experiments to allow efficient characterization of the 
glycoproteome. Owing to the high fragmentation efficiency of hECD, we decided to 
implement this method with online LC-separation for fragmentation of Transferrin 
glycopeptides. Figure 50 shows the LC-hECD results for enriched glycopeptides from a 
Transferrin tryptic digest. Comprehensive glycopeptide structural information was 
generated by hECD in a single tandem-MS scan, where the peptide backbone was 
covered by both c/z- and b/y-type ions. In addition, many secondary cleavages were 
observed in the tandem-MS. While the increased electron energy caused some glycan 
dissociation, many peptide backbone fragments with intact glycan attached, were 
observed. Overall, hECD generated the most complete glycopeptide fragmentation 
among all ExD modes evaluated. While CAD is still more efficient for bottom-up 
glycopeptide fragmentation, its applicability to peptides with more than one glycosylation 
site is limited due to the loss of glycan linkage information in vibrational excitation, 
which prevents assignment of site-specific glycan compositions.  
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Figure 50: LC-hECD of enriched tryptic glycopeptides from human Transferrin 
 
However, hECD can only be performed on FTICR-MS instruments to improve 
fragmentation of glycopeptides, when ECD or ETD fragmentation is not efficient. 
FTICR-MS instruments suffer from the lack of sensitivity and speed prohibiting their use 
in large-scale glycoproteomics studies. While FITCR MS is well suited for targeted 
analyses, the most successful implementation of ExD for large scale studies has been 
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possible on hybrid Orbitrap instruments capable of performing ETD 
[370,486,548,567,619]. Many groups have demonstrated further improvement in the 
efficiency of ETD fragmentation on Orbitrap instruments by use of supplemental 
collisional activation [78,161,331,512]. 
We evaluated collisional dissociation (HCD) (Figure 51) and EThcD (ETD with 
supplemental collisional activation) (Figure 52) of an AGP glycopeptide on a Thermo 
Orbitrap Fusion instrument. As expected, collisional dissociation of the precursor by 
HCD primarily generated peptide backbone fragments while the glycan was reduced to 
mono-, di- and tri-saccharide oxonium ions. In addition to bare peptide backbone ions, y-
type ions with an attached HexNAc can be observed. Also, an intact peptide ion with a 
HexNAc (Glycan Y1 ion) is seen in the spectrum. EThcD is performed by first allowing 
the precursor ions to react with the electron donating radical anion, which leads to 
formation of the odd-electron species. In many cases, this reaction leads to formation of a 
charge-reduced species. The ETD reaction takes place in the LTQ, after which these ions 
get transferred to the HCD cell, where they are subjected to gentle collisional activation 
that facilitates efficient dissociation of the peptide backbone by disrupting non-covalent 
interactions, while keeping the glycan largely intact. As seen in Figure 52, EThcD of an 
AGP glycopeptide generates extensive coverage with c-type ions and a few b-ions. The z7 
ion is observed with the intact glycan attached. Additionally, Y1 and Y2 ions, saccharides 
losses from the precursor and oxonium ions are seen due to collisional-activation but 
their abundances are much lower relative to backbone ions as compared to HCD spectra. 
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Figure 51: HCD of a Human AGP glycopeptide on Orbitrap-MS (m/z: 1195.9939, [M+4H]4+) 
 
Figure 52: EThcD of a Human AGP glycopeptide on Orbitrap-MS (m/z: 1195.9939, [M+4H]4+) 
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Supplemental activation can also be performed prior to electron-based activation 
by photodissociation methods such as IRMPD, as shown by the Coon group 
[446,366,442]. Supplemental activation using collisional and photodissociation methods 
generally decreases the charge-state dependency of ETD and ECD and has been shown to 
improve fragmentation for both bottom-up and top-down analyses [56,78,480]. 
From our evaluation of the different dissociation modes for bottom-up 
glycopeptide fragmentation, CAD based fragmentation was found to be the most efficient 
in terms of speed and sensitivity. However, when considering the level and quality of 
information generated, CAD suffered from poor abundance of peptide backbone 
fragment ions and inability to resolve multiple glycans attached to the same peptide.   
EThcD and hECD generated abundant peptide fragments, while keeping the glycan 
moiety intact during the fragmentation process, thus indicating potential for application in 
the analysis of middle-down glycopeptides with multiple glycosylation sites.  
5.2.3.3 Method development for middle-down glycopeptide analysis 
Bottom-up glycoproteomics has matured to the point where we can measure site-
specific glycosylation in very complex biological matrices. For our purposes, bottom-up 
glycopeptide analysis refers to tandem mass spectral analysis of glycopeptides with one 
glycosylation site. Bottom-up analyses determine the distributions of glycosylation at 
specific sites but not relational information among the glycans that exist on different 
sequons on a mature glycoprotein simultaneously. As a result, we are able to model 
complete glycoprotein structures with glycan distributions at each site [291] but are 
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unable to generate structures of fully-glycosylated proteoforms present in a 
heterogeneous mixture. This hampers the complete biological characterization of 
glycoproteins in terms of identifying the most functionally relevant glycoforms. Middle-
down glycoproteomics is a relatively new technique involving analysis of large 
glycopeptides with two or more glycosylation sites. By analyzing multiple glycosylation 
sites connected together, we can assign relationships between glycosylation sites and 
assess the interplay of glycosylation and structural features on the overall glycosylated 
proteoform.  
The greatest challenge in glycopeptide analysis is the heterogeneity of 
glycoforms. As the number of glycosylation sites occurring together on a glycopeptide 
increases, the glycan heterogeneity multiplies thereby increasing the number of possible 
glycoform combinations exponentially. This extreme heterogeneity has prevented the 
development of efficient top- and middle-down glycoproteomics methodologies. Our 
efforts described in this section have focused on the development of offline and online 
separation methods and mass-spectral dissociation methods for middle-down 
glycopeptidomics.  
 
 
 
256 
 
 
Figure 53: SEC-MS/MS (CAD) of Human AGP digested with AspN, showing separation of glycopeptides and 
peptides based on size and number of glycans attached 
We selected the human AGP for middle-down methods development, which we 
and others have characterized in detail using bottom-up mass spectral methods 
[292,293,319,530]. AGP has 5 N-glycosylation sites, each with a variety of complex-type 
N-glycans. Furthermore, AGP occurs as a mixture of two protein isoforms (AGP1 and 
AGP2) [292,406]. Digestion of AGP using endoproteinase AspN generates multiple 
peptides with two N-linked glycosylation sequons. Therefore, AGP is an ideal 
glycoprotein for development and evaluation of methods for middle-down glycopeptide 
analysis. Since, glycan microheterogeneity poses the greatest challenge in analysis of 
peptides with multiple glycosylation sites; we decided to reduce glycan heterogeneity by 
trimming them from the non-reducing end. We used α-2,3,6,8 Neuraminidase to remove 
NeuAc residues from the AGP AspN digests. The resulting mixtures after proteolysis 
contained unglycosylated peptides and glycopeptides with 1, 2 or 3 glycosylation sites. 
To resolve glycopeptides with 2 glycosylation sites from those with fewer or greater 
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number of sites, we used a size exclusion chromatography fractionation step, as shown in 
Figure 53 and described above. SEC provided more specificity in enrichment of 
glycopeptides with 2 glycosylation sites over HILIC SPE techniques, such as those used 
for bottom-up sample preparation.  
After further C18 fractionation of the SEC fractions containing two glycosylation 
sites, the glycopeptides were analyzed by FTICR-MS. We compared the different ExD 
modes available on the FTICR-MS for middle-down glycopeptide analysis. As expected, 
ETD of middle-down glycopeptides only produced charge-reduced species, similar to 
bottom-up glycopeptides and while ECD produced a few fragments covering the ends of 
the peptide, no fragmentation between the glycosylation sites was observed (data not 
shown). Middle-down glycopeptides were then irradiated with higher energy electrons to 
achieve hECD. We analyzed a few examples of hECD spectra to assess the ability of this 
fragmentation mode to resolve glycan compositions on the two N-glycosylation sites. 
As shown in Figure 54, comprehensive fragmentation of a middle-down 
glycopeptide from AGP could be achieved using hECD. Predominantly c-type ions were 
seen in the tandem-MS. Overall, better coverage was observed along the peptide portions 
not carrying glycosylation, while peptide backbone coverage between the two 
glycosylation sites was sparse. Nevertheless, a few c-type fragment ions carrying the 
intact glycan could be identified. Vibrational excitation also led to generation of three 
peptide b-ions that still had intact glycans attached to them. A few z-ions were also 
observed in the tandem-MS complementing the information from the c-ion series. This 
example had the same glycan composition present at the two glycosylation sites. Another 
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middle-down glycopeptide tandem-mass spectrum is shown in Figure 55, where two 
different glycan compositions were identified at the two glycosylation sites. In this case, 
abundant c- and z-type ion series were observed again covering the N- and C-termini of 
the peptide, along with presence of y-type ions from vibrational excitation. Coverage 
between the two glycosylation sites was again poor with only one fragment ion each of c- 
and z-type identified.  
 
Figure 54: Tandem MS (hECD) of an AGP AspN glycopeptide with two glycosylation sites on FTICR-MS (m/z: 
1802.1786, [M+5H]5+) 
Our results for hECD fragmentation of middle-down glycopeptides with two 
glycosylation sites indicated that although overall the peptide backbone was reasonably 
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well-covered, coverage between the glycosylation sites needed improvement. Despite the 
poor coverage between glycosylation sites, we show that presence of as few as one or two 
fragment ions between the glycosylation sequons is sufficient to discriminate the exact 
glycan compositions simultaneously occupying the glycopeptide. Data acquisition on the 
FTICR-MS for middle-down glycopeptide tandem-MS was performed using static nano-
ESI and could not be coupled to online LC-separations.  
 
Figure 55: Tandem MS (hECD) of an AGP AspN glycopeptide with two glycosylation sites on FTICR-MS (m/z: 
1437.4571, [M+6H]6+) 
Since, the hybrid Orbitrap instruments had shown promising results for online 
LC-MS/MS of bottom-up glycopeptides using EThcD, we evaluated the performance of 
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this method for middle-down glycopeptides. HILIC SPE-enriched glycopeptides were 
subjected to online C18 LC-MS on an Orbitrap Fusion instrument. Similar to bottom-up 
glycopeptide separation, middle-down glycopeptide resolution on the reversed-phase 
column was peptide-centric leading to clustering of the different glycoforms for the same 
glycopeptide in the LC-elution profile. An example MS1 spectrum showing a distribution 
of co-eluting middle-down glycopeptide glycoforms is shown in Figure 56. The higher 
speed and sensitivity of Orbitrap-MS made data-dependent LC-tandem-MS more feasible 
on this instrument, compared to FTICR-MS.  
 
Figure 56: A MS1 spectrum showing glycan heterogeneity for an AGP middle-down glycopeptide with two 
glycosylation sites 
While Orbitrap-MS was able to sample many more precursors for tandem-MS 
during the data-dependent acquisition experiment, only a few middle-down glycopeptides 
generated fragments suitable for resolving glycosylation site microheterogeneity. As 
shown in Figure 57, the terminal regions of the peptide backbone are well covered in the 
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tandem-MS but coverage for fragment ions carrying the glycan moieties was again 
sparse, similar to EThcD results. A z-ion series was predominant for this glycopeptide, 
with only two ions covering the N-terminal region of the peptide. Supplemental 
collisional activation also generated y-type fragment ions and glycan oxonium ions. The 
two z-type ions with intact glycan attached, covering region between two glycosylation 
sites provided adequate confidence in assigning the glycan compositions at the two sites. 
From our evaluation of methods for middle-down glycopeptide analysis, it is clear 
that front-end separation plays a crucial role in managing the extreme heterogeneity of 
glycoforms. Even with a combination of different enrichment, fractionation and online 
separation methods, the glycopeptide complexity extended far beyond what is typically 
seen for bottom-up glycopeptides. Another level of complexity comes from the presence 
of glycoform combinations that are isobaric due to presence of glycosylation site 
positional isomers. Such isobaric compositions can’t be resolved using liquid-phase 
separation methods and generate chimeric tandem-MS due to co-isolation in the mass 
spectrometer. Gas-phase separation methods such as ion-mobility might be useful in 
separating such molecules prior to fragmentation. Thus, successful middle-down 
glycopeptide analysis would require a combination of analytical tools. 
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Figure 57: Tandem MS (EThcD) of an AGP middle-down glycopeptide on an Orbitrap Fusion instrument 
(precursor m/z: 1308.2788, [M+7H]7+) 
Our pilot study focusing on method development for middle-down glycopeptide 
analysis has helped identify features in different types of analytical methods and their 
suitability for separation and analysis. We have also generated a dataset, which would 
enable development of bioinformatics strategies. The data discussed here were analyzed 
using a combination of manual interpretation and programmatic data analysis tools 
prototyped written using Pyteomics [182] and GlyPy [300] 
(https://pypi.python.org/pypi/glypy/0.0.5rc2) Python libraries. It is clear from these 
analyses that middle-down glycopeptide analyses alone are not sufficient for efficient 
bioinformatics and defining glycosylation site relationships would require a combination 
of bottom-up and middle-down information sets. Our proposed workflow would require 
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integration of the two data domains for efficient and comprehensive data analysis, as 
shown in Figure 58.  
Further development of analytical methods is necessary to enable acquisition of 
high-quality middle-down glycopeptide tandem MS. While hECD and EThcD have 
shown promising results in the analysis of multiply glycosylated peptides, the sensitivity 
and speed of these methods remains mediocre. Several recent studies have underlined the 
value of combining collisional and photo-activation modes with electron-based activation 
methods [61,239,344,366,442,512]. At the same time, electron-based activation modes 
are now being implemented on faster, more sensitive instruments [551,552,553]. 
Technology development in these areas will play a key role in advancing top- and 
middle-down workflows and dissemination of these methods in the glycol-analytics 
community.   
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Figure 58: Proposed workflow for combining bottom-up and middle-down glycoproteomics 
 
5.2.3.4 N-glycan ExD and HCD data generation for bioinformatics development 
A major factor affecting glycan data interpretation is the lack of high-quality 
training data. Glycans from biological sources generally occur as mixtures of isomeric 
forms and are generally limited in quantities, which makes it difficult to obtain pure 
glycan structures for ExD experiments. While our group has developed and applied 
electron-based dissociation methods, such as EED, for detailed characterization of 
glycans, the extent of these applications has remained limited to relatively simple glycans 
[605]. We recently obtained chemo-enzymatically synthesized glycan standards from 
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Chemily, LLC, containing larger, branched oligosaccharides with N-glycan like 
structures. We generated collisional (HCD) and electron-activated (EED) tandem-MS 
data on nine (9) different glycan structures shown in Figure 59, with their identifiers for 
correlating with data files. All glycans were deutero-reduced and permethylated before 
analyses and precursors with different charge states for sodiated ions were analyzed by 
MS/MS. HCD data were acquired using a range of different collision energies. These 
data are being used to support the development of GlycoDeNovo, a de novo glycan data 
analysis program being developed in collaboration with Prof. Pengyu Hong at Brandeis 
University (Waltham, MA) and for mining features and development of in-house glycan 
data interpretation tools like GlyPy (https://pypi.python.org/pypi/glypy/0.0.5rc2).  
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Figure 59: Pure glycan standards analyzed by EED and HCD for bioinformatics development 
Exploratory data analysis was performed on HCD and EED data for N002 and 
N014, using the GlyPy machinery. Theoretical fragment ions were generated for both 
structures and matched programmatically against deconvoluted and deisotoped peaklists. 
Glycans subjected to CAD and ExD yield different fragment types. Initial tests for 
fragmentation using ETD and ECD of sodium adducted permethylated glycan alditols 
primarily resulted in charge reduction with poor fragmentation. EED resulted in extensive 
fragmentation of the permethylated glycan alditols. CAD (HCD) generated abundant 
glycosidic bond fragments at lower collision energies but with increase in collision 
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energies, cross-ring cleavages were apparent in the spectra. However, fragments from 
both dissociation modes had multiple ambiguous matches in a theoretical fragment 
database necessitating the use of more sophisticated bioinformatics approaches along 
with complementary analytical techniques for confident assignment of glycan fine 
structure. 
5.2.4 Summary 
In summary, we made significant advancement in analytical methodologies for 
middle-down glycopeptide analysis and compared the characteristics of different 
dissociation modes for both bottom-up and middle-down glycopeptide analysis. This 
work will contribute towards development of a comprehensive workflow for middle-
down glycopeptide analysis and the training data generated will be used toward 
development of informatics strategies for both glycan and glycopeptide mass spectral 
data. 
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5.3 Improved analysis of sulfated oligosaccharides using size-exclusion 
chromatography-ion-suppressor-high resolution mass spectrometry 
(This work has been published in [611]) 
5.3.1 Introduction 
Pharmaceutical heparin is a sulfated, linear polysaccharide prepared from porcine 
intestinal mucosa. Consisting of repeating uronic acid-glucosamine disaccharide units 
modified with an average of 2.3 sulfate groups, unfractionated heparin has an average 
molecular weight of 17,800 Da with a high degree of polydispersity [388]. 
Pharmaceutical heparin, used as an anticoagulant in surgical suites, is neutralizable with 
protamine and requires constant patient monitoring.  Heparin-induced thrombocytopenia, 
a serious risk of heparin treatment, results from an immunological reaction against a 
complex between heparin and platelet factor 4 [42,379]. Low molecular weight heparins 
(LMWH) were developed in order to minimize such risks to allow administration as an 
outpatient anticoagulant.   LMWH are produced from unfractionated heparin by limited 
chemical or enzymatic cleavage [328] to produce a biopolymer with average molecular 
weight of 4000-6000 Da, depending on the preparation [188]. The chemical structure and 
pharmacological activities of LMWH depend on the method used for partial 
depolymerization [328] (see Figure 60).   
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Figure 60: General structures for dalteparin and enoxaparin saccharides. X = H or SO3H, Y = Ac or SO3H 
Since their introduction, LMWH have captured a large share of the US heparin 
market.  This has driven effort to develop biosimilar heparins, the first of which for the 
enoxaparin LMWH was approved by the Food and Drug Administration in 2010 [642].  
Because the complexity is vast, it is not possible to characterize every molecular species 
in LMWH preparations; thus, the FDA approval was based on the ability to reverse 
engineer LMWH using analytical and pharmacologic assay data representative of the 
preparation.  Such biosimilars development depends on the demonstration of acceptably 
low risk for use of the biosimilar heparin.  The ability to demonstrate acceptable risk 
improves with increases in analytical capability. 
Molecular weight distributions for unfractionated heparin and LMWH have been 
measured traditionally using size exclusion chromatography with refractive index 
detection [386,387,388].   In order to increase the detail of the chromatographic LMWH 
separations we and others have analyzed LMWH fractions using hydrophilic interaction 
chromatography (HILIC)-MS [326,497].  While the chromatographic resolution of 
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HILIC is higher than that of SEC, the ability to interpret the mass spectral data is limited 
by the presence of abundant ammonium adducted forms of the LMWH oligosaccharide 
ions.  This adduction results from pairing of ammonium cations with deprotonated 
oligosaccharide anions, resulting in proton transfer reactions that decrease the magnitude 
of ion charge.  Thus, abundant ions with low degree of charge and high degree of 
ammonia adduction are observed.  As a result it is not possible to extract neutral masses 
from LMWH saccharides larger than degree-of-polymerization (dp) 20 using LC-MS.  
Similar problems limit the use of MS to detect LMWH eluting from a SEC column since 
ammonium ions must be included in the mobile phase. 
Tinzaparin LMWH was analyzed using 6 µm particle size SEC columns [228].  
These investigators used a self-regenerating cation exchange column to remove 
ammonium salts prior to the MS source.  Chromatographic resolution was modest but 
they reported ability to identify ions corresponding to Tinzaparin oligomers up to dp18.  
The availability of ultraperformance SEC columns with 1.7 µm particles greatly 
improved the chromatographic resolution for LC-MS separation of LMWH [617].  
Again, the LMWH extracted mass spectra suffered from ammonium adduction, limiting 
the ability to interpret data for >dp 18. 
In this work, we solved this ammonium adduction problem for SEC-MS of 
LMWH by using an on-line ion suppressor to exchange remove ammonium ions for 
protons, dramatically reducing the abundances of ammonium adducted LMWH ions.  
This allowed us to measure mass profiles for LMWH up to dp30, essentially the complete 
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LMWH biopolymeric range.  We developed a specialized bioinformatics approach to 
interpret the data. 
5.3.2 Experimental Section 
5.3.2.1 Materials 
The United States Pharmacopeia standard for enoxaparin sodium was purchased 
from Sigma Aldrich (St. Louis, MO). Dalteparin sodium as Fragmin was obtained from 
Pharmacia Corporation (Kalamazoo, MI).   
Stock solutions of enoxaparin sodium and dalteparin sodium were prepared at 10 
nmol/µL in water. They were then desalted by dialysis against 50 mM ammonium 
formate (pH 6.8) in methanol:water (20:80) using 500 Da molecular weight membranes 
(The Nest Group, Southborough, MA).  
5.3.2.2 SEC LC-MS Analysis with Ion Suppressor 
Size exclusion chromatography-ion suppressor-mass spectrometry (SEC-IS-MS) 
analyses were performed  using Tandem Acquity UPLC BEH columns (4.6 mm × 150 
mm and 4.6 mm × 300 mm, Waters Corp., Milford, MA) were used to separate the 
LMWH preparations using conditions similar to a published method[617].  The mobile 
phase contained 50 mM ammonium formate (pH 6.8) in methanol:water (80:20). The 
constituents were eluted in 90 min at a flow rate of 75 µL/min. The analyses were 
initiated and performed in part by Dr. Yuewei Sheng.  
The LC column was connected to a chemically regenerated ion suppressor (ACRS 
500, 2 mm, Thermo Fisher Scientific/Dionex, San Jose, CA) for online desalting. The ion 
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suppressor exchanged ammonium salts to their corresponding organic acids, thereby 
eliminating the problem of ammonium adduction of the saccharide ions.  A solution of 
100 mM sulfuric acid was used to regenerate the suppressor. The suppressor effluent was 
connected to the standard ESI source of a Q-Executive Plus mass spectrometer (Thermo 
Fisher Scientific, San Jose, CA). The mass spectra were acquired using the negative 
ionization mode at resolution 75,000 and m/z range 200-2000 Th with three microscans. 
The source parameters for the analyses were optimized to minimize sulfate loss and 
included a spray voltage of 3.8 kV, a capillary temperature of 280 ºC, a sheath gas flow 
of 10, and an S-lens RF level of 40.  
5.3.2.3 Data Deconvolution 
The acquired spectra were manually examined and averaged over retention time 
ranges using the Xcalibur software (version 3.0.63, ThermoFisher Scientific, San Jose, 
CA). The combined spectra were auto-deconvoluted by an in-house software, developed 
by Joshua A. Klein and Dr. Yuewei Sheng, GAGdecon 
(https://github.com/BostonUniversityCBMS/gagdecon).  GAGdecon uses a database 
search algorithm for structural assignment at the MS level. It maps the isotopic 
distribution of theoretical species using a python implementation of the BRAIN (Baffling 
Recursive Algorithm for Isotopic distribution calculations) [128,246] available at 
(https://github.com/BostonUniversityCBMS/brainpy) to the experimental data. The data 
processing and validation was performed together with Joshua A. Klein and Prof. Joseph 
Zaia. 
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GAGdecon works by constructing a combinatorial database of GAG 
compositions, computing their theoretical monoisotopic mass at a range of user specified 
charge states. The composition includes the number of monosaccharide species: HexN, 
HexA, HexNAc, dHexA, ManN, as well as substituents and adducts: Ac, Na, K, Ca, and 
Li. The disaccharide pattern was extrapolated from the user input GAG species, and the 
counts of each monosaccharide scale with chain length (degree of polymerization, dp), 
which may either be a range, or a fixed value.  GAGdecon can process either centroid or 
profile data, using a Lorentzian peak shape fit to calculate the centroids for profile peaks.  
Once the input spectra have been preprocessed, database search is carried out by 
searching each theoretical GAG composition and charge state, generating a theoretical 
isotopic cluster based on the elemental composition of the theoretical molecular 
composition, including the first 95% of the isotopic pattern. Each theoretical isotopic 
pattern was fitted to the peak list, producing a score of the form: 
 
𝐺 = 2 ∑
𝑂𝑖
∑ 𝑂𝑗𝑗
log (
𝑇𝑖/ ∑ 𝑇𝑗𝑗
𝑂𝑖/ ∑ 𝑂𝑗𝑗
)
𝑖
 
 
Equation 21 
𝑂𝑖 is the abundance of the ith observed peak and 𝑇𝑖 is the abundance of the ith 
theoretical peak. Optimal fits minimize𝐺. Each fit with a score below a parameterized 
threshold is reported to the user. 
 5.3.3 Results and Discussion 
We analyzed the two most widely used LMWH in the US, dalteparin and 
enoxaparin, the general structures for which are shown in Figure 60. 
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5.3.3.1 SEC-MS of dalteparin   
Dalteparin is produced by limited nitrous acid depolymerization of unfractionated 
heparin, resulting in chains that range from 5600-6400 Da (European Pharmacopeia 
range)[188] that terminate with an anhydromannitol residue at the reducing end [482].  
Notably, a side reaction occurs in that corresponds to GlcN ring contraction without chain 
cleavage (Figure 61) [196].  SEC-MS of a synthetic heparin saccharide (Arixtra) in the 
absence of an ion suppressor results in abundant ammonium adducted ions that 
complicate the assignment of exact masses and saccharide compositions.  Use of a post-
column ion suppressor results in observation of deprotonated ions with an absence of 
ammonium adducts (Figure 62).   
 
Figure 61:  Top: deaminative cleavage of heparin using nitrous acid, pH 1.5.  Bottom: ring contraction side 
reaction that occurs with deaminative cleavage, equivalent to loss of NH[196] 
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Figure 62: SEC-MS extracted mass spectra for Arixtra 
Top: mass spectrum with no ion suppression, showing abundant ammonium adducts for the 2– 
charge state. Bottom: use of an online ion suppressor results in deprotonated ions with no 
ammonium adducts. 
 
Figure 63a shows the total ion chromatogram (TIC) for SEC-ion suppressor (IS)-
MS of dalteparin.  Distinct chromatographic peaks are observed corresponding to 
saccharides ranging from dp6-30 as labeled in the figure.  The extracted mass spectrum 
for dp16 saccharides obtained using the ion suppressor is shown in Figure 63b in which 
deprotonated ions are observed without ammonium adducts.  This absence of adduction 
greatly facilitates interpretation of the mass spectral data; ammonium adducts increase 
the incidence of overlapping isotopic clusters and limit the size of heparin saccharides 
that yield interpretable mass spectra.  We noticed several pairs of isotope clusters 
separated by 15.0 Da in the data.  We reasoned that this resulted from deamination of 
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heparin chains without chain cleavage, resulting from the nitrous acid depolymerization 
reaction used in the formulation of dalteparin [196].   This corresponds to the substitution 
of an amino group with a proton for a net loss of NH (15.01 Da) (Figure 61).  This 
pattern of paired isotopic clusters differing by NH units was observed throughout the 
SEC-IS-MS dataset on dalteparin. The extracted mass spectrum of dp26 saccharides 
(Figure 63c) show absence of ammonium adducts that allow unambiguous assignment of 
compositions. Saccharides resulting from NH loss were too low in abundances to be 
assigned. 
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Figure 63: SEC-IS-MS of Dalteparin 
(a) SEC-IS-MS total ion chromatogram for Dalteparin. The oligomer size (degree-of-polymerization) is shown 
for each chromatographic peak, (b) extracted mass spectrum for 43.6–44.7 min, and (c) extracted mass 
spectrum for 39.9–40.4 min. 
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In previous work, we used hydrophilic interaction chromatography (HILIC) MS 
for analysis of heparins [256,326,497].  In these studies we used Horn deconvolution 
[244,266,359] to convert mass spectra data to neutral masses.  As shown in Figure 64, the 
decrease in abundances of the monoisotopic ions for LMWH saccharides that occur as 
molecular weight increases poses a serious problem for identification of monoisotopic 
ions for dp >18.   For the dp14 and dp18 saccharides, the monoisotopic peak is readily 
identifiable.  This identification becomes more difficult for larger saccharides as shown 
by the dp26 and dp30 examples because of the lower abundance of the monoisotopic 
peak.  By overlaying the calculated isotopic patterns (shown in orange), we found that it 
was possible to assign dalteparin saccharides accurately through dp30.    
 
Figure 64: Dalteparin mass spectra – theoretical vs. observed 
Expanded m/z ranges for (a) dp 8 [7,6,16,1,1,0] 6–, (b) dp 18 [9,8,22,1,1,0] 8–, (c) dp 26 [13,12, 31, 2, 1, 0] 10–, 
and (d) dp30 [15,14,35,2,1,0] 11–. Compositions are given as [HexA, HexN, SO3, Ac, aMan, NH loss]. 
Experimental data (blue) overlay theoretical isotope patterns (orange). Theoretical isotopic distributions were 
calculated using IsoPro 3.1 at 40 000 resolution. 
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In order to determine the LMWH compositions, it is essential for the algorithm to 
assign charge states correctly.  Horn deconvolution seeks to identify the monoisotopic 
peak using a molecular averagine.  This task becomes increasingly difficult as the 
LMWH oligomer size increases, to the point that it cannot easily be determined even by 
manual inspection (see examples for dp26 and dp30 in Figure 64).  We therefore 
developed a bioinformatics algorithm (GAGdecon) to accomplish the task of isotopic 
pattern matching and scoring for LMWH datasets.  For this, the algorithm generated 
theoretical dalteparin compositions and exact isotope patterns, provided with 
supplemental data of the published article[611].  
As described in the methods section, exact masses for LMWH saccharides were 
assigned by fitting calculated isotope patterns.  The compositional profile aggregated for 
all observed charge states for dalteparin dp16 saccharides is shown in Figure 65a.   
Scores were higher (poorer) for saccharides with NH losses, owing to the lower 
abundances and correspondingly greater difficulty in matching isotope clusters.   For 
dp30 saccharides (Figure 65b) it was possible to assign only the compositions without 
NH losses with acceptable confidence. The complete set of compositional profiles are 
shown in the supplemental information for the published article[611].  These 
compositional profiles show a small degree of incorrect compositions for low abundance 
saccharides due to incorrect charge state assignments at half the correct value. This is due 
to multiple well-scoring interpretations of the signal which share peaks. These cases are 
uncommon, requiring that the isotopic pattern of one composition be similar on a relative 
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scale to the overlapped components of another composition. Often, a difference in scores 
can be used to discriminate the correct fit. 
 
Figure 65: Compositions, scores, and abundances of dalteparin saccharides 
(a) retention time 43.6–44.6 min, corresponding to dp16 and (b) retention time 38.8–39.4 min, corresponding to 
dp30. Ring contraction is given as NH loss in the compositions. The lowest score values reflect the greatest 
confidence. 
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In order to validate that the assignment of saccharide compositions was correct, 
we plotted the average saccharide chain length versus elution time.  The resulting plot 
(Figure 66a) shows that average chain length diminishes with elution time as expected.  
This is consistent with overall correctness of assignment of saccharide compositions.  
Instances of incorrect assignments would skew this trend.   This plot also demonstrates 
that charge state assignments were generally correct.  We next calculated the number of 
sulfation per saccharide chain length across the SEC elution profile (Figure 66b).  This 
showed that the number of sulfate groups ranged from 1.10 to 1.14, indicating a relatively 
narrow distribution of sulfation per saccharide across the elution profile.  This 
corresponds to an average of 2.3 sulfate groups per disaccharide unit for dalteparin, in 
close agreement with the expected value [388]}.  We also plotted the number of acetate 
groups per dalteparin disaccharide unit as shown in Figure 66c.  This plot showed that the 
number acetate groups per disaccharide unit diminished as the dalteparin chain length 
diminished.  This is expected since nitrous acid cleavage occurs at N-sulfated 
glucosamine residues to produce anhydromannitol, requiring the absence of acetate from 
the reducing terminal residue.   
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Figure 66: (a) Plot of dalteparin chain length as a function of SEC retention time. The shaded regions 
surrounding the trend lines indicate standard deviation of the mean at each point. (b) Plot of number of sulfate 
groups per unit chain length. The shaded region for the relationships indicate the confidence interval of the 
coefficient for the sample. (c) Plot of number of acetate groups per unit chain length. The shaded regions 
surrounding the trend lines indicate standard deviation of the mean at each point. 
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5.3.3.2 SEC-IS-MS of enoxaparin 
Enoxaparin is produced by alkaline hydrolysis of heparin benzyl esters [328].  
The package insert for the commercially available Lovenox® formulation states that 20% 
of the molecular weight distribution is below 2000 Da, 68% between 2000 and 8000 Da 
and 15% above 8000 Da[640].  The European Pharmakopeia range is listed as 3800-5000 
Da[188]}.   In comparison with that of dalteparin (Figure 63a) the SEC-IS-MS total ion 
chromatogram (TIC) of enoxaparin (Figure 67a) shows more abundant dp4 saccharides.  
The 43.7-44.7 min retention time window (Figure 67b) shows a range of enoxaparin dp16 
saccharides in three compositional forms.  The fully saturated saccharides correspond to 
enoxaparin containing the original saturated non-reducing HexA residue of the parent 
heparin chains.  The saccharides showing one water loss correspond to chains cleaved by 
alkaline hydrolysis in which a Δ4,5-unsaturated uronic acid (ΔHexA) is present on the 
non-reducing chain ends.  Saccharides of the same mass would be produced by cyclic 
ester formation at the reducing end.  The saccharides showing two water losses 
correspond to saccharides with Δ-unsaturated non-reducing ends and a cyclic ester 
formed from the reducing end glucosamine (also known as a cyclic acetal).  These 
compositions are given as [HexA, GlcN, SO3, Ac, H2O-loss] in the figure.  Fully 
saturated enoxaparin dp16 saccharides (0 water losses) were low in abundances (Figure 
67b).  The assignments for a summed mass spectrum for the 39.9-40.4 min retention time 
range, corresponding to dp30 are shown in Figure 67c.  As shown in Figure 68a for dp16, 
abundances for enoxaparin saccharides fully saturated, with one water loss and with two 
water losses, respectively, fall in the order 1>2>0.  The same order is observed for dp30 
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saccharides (Figure 68b).  As shown by the shading (darker shade indicating lower 
confidence), the confidence of assignments for dp30 saccharides of low relative 
abundances is low due to the difficulty of assigning isotopic patterns for isotope clusters 
with low signal-to-noise ratios. 
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Figure 67: SEC-IS-MS of enoxaparin  
(a) total ion chromatogram, (b) summed mass spectrum for the 43.7–44.7 min retention time window, 
corresponding to dp16, (c) summed mass spectrum for the 39.9–40.4 min retention time window, corresponding 
to dp26–28. Compositions are given as [ΔHexA, HexA, GlcN, SO3, Ac, H2O-loss ]. 
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Figure 68: Compositions, scores and abundances of enoxaparin saccharides 
(a) Retention time 43.5–44.5 min, corresponding to dp16. (b) Retention time 38.5–39.3 min, corresponding to 
dp30. The lowest score values reflect the greatest confidence. 
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As with dalteparin, we plotted the average chain length versus SEC elution time 
(Figure 69a).  This plot showed that as expected the average chain length for enoxaparin 
diminished with time indicating that GAGdecon identified enoxaparin compositions 
correctly.  We plotted the sulfation divided by saccharide chain length to determine the 
density of sulfation of enoxaparin per unit chain length (Figure 69b).  We found that 
sulfation of enoxaparin saccharides diminished with decreasing chain length.  This trend 
is consistent with less sulfated regions of the precursor chains being of increased 
likelihood to undergo alkaline hydrolysis.  We next plotted the number of acetate groups 
per enoxaparin saccharide chain length (Figure 69c).  This showed that the number of 
sulfate groups per unit chain length varied to a small degree for the range of saccharides 
detected in the SEC-IS-MS runs.  This is consistent with acetylated glucosamine playing 
little influence on the alkaline hydrolysis reaction.     
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Figure 69: (a) Plot of enoxaparin chain length as a function of SEC retention time. The shaded regions 
surrounding the trend lines indicate standard deviation of the mean at each point. (b) Plot of number of sulfate 
groups per unit chain length. The shaded region for the relationships indicate the confidence interval of the 
coefficient for the sample. (c) Plot of number of acetate groups per unit chain length. The shaded regions 
surrounding the trend lines indicate standard deviation of the mean at each point. 
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5.3.4 Conclusions 
The United States Food and Drug Administration has defined five criteria for 
demonstrating sameness for LMWH abbreviated new drug applications [642].  Among 
these, improvements in physical and chemical methods that occur over time were 
recognized to increase the ability to characterize sameness of LMWH preparations.  
While the establishment of sameness impacts both the development of abbreviated new 
drugs for LMWH, and LMWH batch release criteria, the identification of contaminants 
remains a critical need.  This was shown by the 2007-2008 heparin contamination crisis 
in which criminal adulteration of the heparin severely impacted the global heparin 
supply[189,190,332,461].   
We demonstrate the ability to produce exact mass values on the entire polymeric 
distribution of LMWH preparations using SEC-IS-MS.  This capability adds a dimension 
to traditional SEC analysis of LMWH distributions by enabling calculation of elemental 
compositions for each detected LMWH species.  We assert that this new capability will 
impact the ability to characterize the compositions of LMWH preparations in the global 
market favorably. 
The components used in this first time SEC-IS-MS method for LMWH profiling 
are commercially available.  It was necessary, however, to develop specialized 
bioinformatics to assign the compositions of the LMWH preparation.  This involved 
assigning elemental compositions from theoretically calculated values.  Using this 
approach, we defined the distribution of saccharides present in the LMWH preparations.  
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We suggest that this approach will be useful for analyzing LMWH as part of drug 
development and quality control efforts.   
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5.4 Microfluidic Capillary Electrophoresis-Mass Spectrometry of Glycans 
and Glycopeptides 
This work has been submitted as a manuscript to the journal Analytical Chemistry and is currently 
under peer review. 
5.4.1 Introduction 
With improvements in mass spectrometer speed, sensitivity, analysis time, and 
depth, effectiveness of omics characterizations depends largely on front-end separation 
methods [481]. Liquid chromatography (LC) remains the preferred separation mode for 
online interface with mass spectrometry (MS), due to mature interfaces, solvent 
compatibility and a variety of available chromatography modes. Glycosylation increases 
the number of molecular forms of proteins (proteoforms) and thus the complexity of a 
biological sample. CE offers high peak capacity for glycoform resolution because the 
separation is based on charge, size and shape [34,83,304,373]. In contrast to LC and 
nano-LC, CE systems have lacked convenient interfaces for mass spectrometers, and this 
situation has limited their utilization for applications in large-scale glycomics and 
glycoproteomics studies. Due to recent developments in technology, microfluidic CE 
systems with integrated nano-electrospray ionization interfaces are commercially 
available for easy coupling to mass spectrometers [77,375,437]. The compact scale of 
these CE devices improves sensitivity and facilitates analysis of small sample quantities. 
As stated above, a key factor affecting the implementation of CE-MS to 
biomolecule analysis has been the development of interfaces for mass spectrometry 
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coupling. One challenge has been the low liquid flow-rates in CE that are insufficient for 
ESI. Introduction of a coaxial sheath liquid by Smith and coworkers provided for mixing 
of a sheath liquid with CE effluent to increase overall flow rates, thereby enabling online 
coupling of CE to a mass spectrometer [491]. The sheath flow interface is easy to 
implement but suffers from low sensitivity due to sample dilution and chemical noise 
from the sheath liquid. Sheathless-flow interfaces were also developed around the same 
time [403] and modified versions of this interface were later introduced [147,363]; 
however they suffered from problems in spray-stability and reproducibility. A liquid-
junction interface, implemented by many groups, enables partial disconnection of the CE 
and ESI components.  This makes it possible to optimize CE and ESI individually 
because the flows from the two components are combined at a junction to produce a 
stable electrospray  [155,476,477,556].  
The use of bare fused-silica capillaries compromises separation efficiencies due to 
interactions with the analyte [430]. It also deteriorates migration time reproducibility, 
which is critical to proteomics analyses. To prevent such interactions, the use of surface 
coatings is common [260]. A number of groups have evaluated a polyamine-based 
coating, PolyE-323, that adheres to glass through ionic interactions with silanol groups 
and produces a net positive charge on the coated surfaces under neutral to acidic 
conditions [375,536]. The authors reported efficient separation for tryptic peptides using 
capillaries with this coating.  The coating also provided a stable anodal electroosmotic 
flow (EOF), thus enabling stable ESI on the microfluidic device. Therefore, a variety of 
neutral or positively-charged coatings have been explored to counteract unfavorable 
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surface interactions for proteomics applications [74,138,470]. These coatings include a 
monoquaternarized piperazine compound, polybrene-poly(vinyl sulfonate) and an N-
methylpolyvinylpyridinium cationic polymer. 
CE was widely adopted for glycan analysis after its coupling to a laser-induced 
fluorescence detector (LIF). This method requires derivatization of the glycans with a 
fluorophore, with aminiopyrene trisulfolane (APTS) being the most commonly used tag 
[199,200,510]. Optical detection allows identification only of molecules for which 
standard migration times have been determined. Gennaro and colleagues evaluated 
aminonapththalene trisulfolane (ANTS) as a derivatization reagent for CE-MS of 
glycans, along with a low molarity (20 mM) 6-aminocaproic acid CE separation buffer 
[166]. APTS and ANTS both impart negative charge to the labeled glycans and make 
negative ion mode analyses more efficient by improving ionization efficiencies 
[166,200,460]. Gennaro and Salas–Solano demonstrated the use of online CE-LIF-MS 
for APTS-labeled glycans on a CE system with PVA-coated capillaries and a running 
buffer of 40 mM aminocaproic acid and 0.02% hydroxypropylmethylcellulose [167].  
Monosaccharide analysis is commonly performed using gas chromatography-
mass spectrometry (GC-MS). This method requires derivatization (generally 
peralkylation) of monosaccharides to generate hydrophobic derivatives that can be 
resolved by gas chromatography [384]. Partially methylated alditol acetates can be used 
for linkage analysis by GC-MS [227]. Isobaric monosaccharides are differentiated based 
on the retention time differences measured for purified standards. A method for 
monosaccharide analysis using CE was developed by Guttman, who has described the 
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separation of APTS-labeled monosaccharides and AMAC-labeled sialic acids coupled 
with LIF detection [201]. This setup used 25 mM lithium tetraborate buffer in the 
separation channels. This method has been adopted by many laboratories but employs 
buffers incompatible with mass spectrometry. 
Guttman also described sample preparation and separation methods using CE with 
optical detection for analysis of oligosaccharides [199,200,402,510,514].  These methods 
are incompatible with mass spectral analysis due to their running buffers.  More recently, 
a study described the characterization of N- and O-linked glycopeptides from human 
erythropoietin using CE-MS [173]. This study utilized bare fused-silica capillaries with 
an electrolyte solution containing a mixture of acetic and formic acid, with 50% 
isopropanol used for sheath flow.  Váradi et al. used isotopically coded 2-
aminobenzamide for glycan labeling and analysis by CE-MS. This method enabled 
duplex analysis of glycan samples [539].  The aminoxy TMT (tandem mass tag) reagents 
have been used for efficient labeling and multiplexing of glycans in CE-MS/MS 
experiments [626,629]. This reagent facilitates fast and efficient labeling of glycans with 
minimal post-labeling cleanup required and enables straightforward tandem-MS based 
quantification and sample multiplexing. 
The CE-MS setup used in this work integrates a microfluidic separation system 
with a nanoESI source on a single piece of hardware [375] that works as a removable 
interface for mass spectrometers.  As shown in the schematic in Figure 70, sample 
injection, background electrolyte and ESI solution are controlled independently in a 
manner similar to the liquid-junction interface described above. The microfluidic setup 
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minimizes gaps, dead volume, sample dilution, and band broadening, to maintain speed 
and sensitivity in analyses. The separation capillary surfaces are coated with an 
aminopropyl silane reagent to minimize EOF, as described previously [36].  
We developed a CE-MS method for analysis of monosaccharides, 
oligosaccharides and glycopeptides to enable comprehensive glycoprotein analysis. The 
method uses the same electrophoresis solutions for all three compound classes, greatly 
simplifying the task of glycoprotein characterization. We used the aminoxy TMT regent 
to improve electrophoretic migration of neutral saccharides and to enable multiplexing in 
tandem-MS experiments. We also used a sialic acid derivatization method to prevent 
interaction of the negatively charged carboxyl groups with the positively charged 
capillary surface coating and discriminate sialic acid linkages. In summary, we present a 
CE-MS method using a convenient mass spectrometry interface for glycan, 
monosaccharide and glycopeptide analysis. 
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Figure 70: Overview of workflow for analysis of monosaccharides, oligosaccharides and glycopeptides using 
microfluidic CE-ESI-MS  
Chip schematic on the right shows sample reservoir “S”, background reservoir “B”, ESI pump “P” and sample 
waste “SW”.  
 
5.4.2 Materials and methods 
All experiments were performed on a ZipChip capillary electrophoresis-
electrospray ionization interface (CE-ESI) (908 Devices, Boston, MA), using a high-
resolution chip with capillary length 22 cm, coupled to a Q-Exactive Plus mass 
spectrometer (Thermo Scientific, San Jose, CA).  A CE voltage of 20 kV was applied 
with a shield potential set at 500 V. ESI voltage varied between 2200-2700 V for the 
different samples and chips. A background electrolyte (BGE) and ESI solution containing 
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50% methanol, 48% water and 2% formic acid was used for all experiments. Pressure-
assisted CE, a feature of the CE-MS interface, was used for oligosaccharide sample 
analysis to speed analysis times. Pressure-driven injection allows transient 
isotachophoresis for the analyte but dilutes the sample solution in cases where low 
sample volumes are loaded in the sample well. All MS data were acquired in the positive-
ion mode. Released glycans and monosaccharides were derivatized with aminoxy-TMT 
prior to analysis. Sialic acid derivatization was performed using the method described by 
Reiding et al.[438].  
Glycopeptide and oligosaccharide sample preparation and data acquisition were 
carried out by Kshitij Khatri. Monosaccharide samples were prepared by John R. 
Haserick and the data were acquired by John R. Haserick and Kshitij Khatri. 
Oligosaccharide and glycopeptide data analysis was carried out by Kshitij Khatri and 
Joshua A. Klein and monosaccharide data were analyzed by John R. Haserick. Prof. 
Mark E. McComb supervised all CE-MS method development and data acquisition. Data 
interpretation and figure generation was carried out with guidance from Prof. Joseph 
Zaia, Prof. Catherine E. Costello and Prof. Mark E. McComb.  
5.4.2.1 Glycopeptide sample preparation and data acquisition 
The glycoprotein standards, bovine ribonuclease B (RNase B), human transferrin 
(transferrin) and human alpha-1-acid glycoprotein (AGP), were purchased from Sigma-
Aldrich (St. Louis, MO). Approximately 250µg of each glycoprotein was subjected to 
reduction and alkylation, using dithiothreitol and iodoacetamide, followed by proteolysis 
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using trypsin (Promega Corp., Madison, WI), as described previously [293]. Tryptic 
digests were desalted using C18 spin columns (Thermo Pierce) and then dried down 
using a centrifugal evaporator. Dry peptide/glycopeptide samples were resuspended in 
50µl of the background electrolyte (BGE) containing 100 mM ammonium acetate, to 
improve conductivity and sample stacking via isotachophoresis. MS1 spectra were 
acquired over the range m/z 665 - 2000, with 1 microscan per spectrum at a resolution of 
70,000. A high starting m/z was used to avoid interference from abundant siloxane peaks 
that were coming from the CE-ESI source. Siloxane peaks corresponding to m/z 667.1764 
and 741.1952 were consistently present in the spectra and were used as lock masses for 
internal mass calibration. The automatic-gain-control (AGC) target set at 1e6
 
and a 
maximum ion injection time of 110 msec. Data-dependent tandem MS were acquired on 
the top 10 precursors with charge states ranging between 3 and 6 using (higher energy 
collisional induced dissociation) collisional-dissociation at a normalized collision energy 
(NCE) of 27 eV. Tandem mass spectra were acquired with 2 microscans per spectrum at 
a resolution of 35,000 and an AGC target set at 5e5. Peaks for migrating glycopeptides 
were between 15-30 seconds wide. A minimum intensity threshold of 1.4 e5 was used for 
precursor selection and following a tandem MS precursors were dynamically excluded 
for 1 sec from being selected again. Source capillary temperature and RF level were set at 
320⁰C and 55, respectively. 
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5.4.2.2 N-glycan sample preparation and data acquisition 
N-linked glycans were released from 100µg of standard glycoprotein tryptic 
digests using PNGase-F (New England Biolabs, Ipswich, MA). The released glycans 
were separated from the peptides using a C18 spin column, as the unbound fraction. 
Glycan samples were dried and then subjected to reducing-end labeling using Aminoxy-
TMT
131
 (Thermo Scientific) reagent as per the manufacturer’s protocol. Labeled glycans 
were desalted using PD Minitrap G10 columns (GE Healthcare, Marlborough, MA). 
Desalted glycan samples were dried in vacuo and resuspended in 20µL of background 
electrolyte containing 100mM ammonium acetate.  
Glycan MS1 spectra were acquired over the range m/z 600 – 2000, with 1 
microscan per spectrum at a resolution of 70,000, with the AGC target set at 1e6
 
and a 
maximum ion injection time of 110 msec. Siloxane peaks with m/z 610.18416, 667.1764 
and 741.1952 were used as lock-masses. Data-dependent tandem MS were acquired on 
the top 5 precursors with charge states of 2 or 3, using collisional-dissociation at a 
stepped NCE of 25 and 30 eV. While glycan compositions were assigned based on MS1 
only, a low minimum intensity threshold of 5.5 e3 was used for precursor selection in 
data dependent tandem MS to confirm that the migrating peaks were glycans and 
following a tandem MS precursors were dynamically excluded for 1 sec from being 
selected again. Tandem mass spectra were acquired with 2 microscans per spectrum at a 
resolution of 35,000 and an AGC target set at 2e4 to enable tandem MS of low 
abundance glycoforms. Source capillary temperature and RF level were set at 320⁰C and 
55, respectively.  
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5.4.2.3 Monosaccharide sample preparation  
5.4.2.3.1 Preparation of TMT-labeled Monosaccharide Standards 
Monosaccharide Monosaccharide standard pentoses (D-xylose, D-ribose, D-
arabinose), deoxyhexoses (L-fucose, L-rhamnose), hexoses (D-glucose, D-galactose, D-
mannose), N-Acetyl-hexoses (N-acetyl-D-glucosamine, N-acetyl-D-galactosamine, N-
acetyl-D-mannosamine), and a sialic acid, N-acetylneuraminic acid, were purchased from 
Sigma Aldrich. Aqueous solutions of each monosaccharide were made at a concentration 
of 20 mg/mL in ddH2O. One microliter of each was added to three separate tubes, in 
groups, to be labeled with the aminoxyTMT
6
-127, aminoxyTMT
6
-128, and 
aminoxyTMT
6
-130 tags. The monosaccharides were grouped in the following manner: 
aminoxyTMT
6
-127 (Xyl, Fuc, Gal, GlcNAc), aminoxyTMT
6
-128 (Rib, Rha, Man, 
GalNAc), and aminoxyTMT
6
-130 (Ara, Glc, ManNAc, Neu5Ac). Prior to labeling, the 
three mixes were dried under vacuum and then reactions were performed according to the 
manufacturer’s protocol, excluding quenching with acetone. Briefly, the entire contents 
of a packet of aminoxy-TMT reagent (0.8 mg) was re-suspended in 200 μL of 95% 
methanol/ 0.1% acetic acid, and added to one of the tubes containing dry monosaccharide 
samples. The tubes were then vortexed vigorously, and allowed to sit for 10 minutes at 
ambient temperature. The solvents were removed with a centrifugal evaporator. Then, 
200 μL of 95% methanol was added; the samples were vortexed and allowed to sit for 10 
min. at room temperature, and dried using the centrifugal evaporator. After drying, the 
three mixes were stored at -20°C until analyzed.  
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Just prior to analysis, the three standard monosaccharide mixes were reconstituted 
with 50:50 methanol:water, and each solution was mixed with an equal volume of 50:50 
methanol:water containing 200 mM ammonium acetate to yield a final concentration of 
100 mM ammonium acetate for CE-MS analysis.  
5.4.2.3.2 AGP monosaccharide preparation 
A 1 mg quantity of AGP was treated with PNGase-F overnight at 37 ⁰C. The 
released N-glycans were separated from the protein using C-18 Sep-Pak cartridges 
(Waters Corporation, Milford, MA), as described previously 
2,3
. The released, purified N-
glycans were placed into a conical vial and subjected to acid hydrolysis using 2 M 
trifluoroacetic acid at 110 ⁰C, for 30 min. The resulting monosaccharide mixtures were 
dried down in a centrifugal evaporator and labeled with aminoxyTMT
6
-127 as described 
above. The labeled sample was dried and re-suspended for analysis in 50 µL of 50:50 
methanol:water. A 1:200 dilution was made in 50:50 MeOH/H2O containing 100 mM 
ammonium acetate and this solution was used for CE-MS analysis. 
5.4.2.3.3 CE-MS of Monosaccharides 
MS1 alternating with all-ions fragmentation (AIF) was performed (MS/AIF). For 
MS, the chosen parameters were resolution 17,500, AGC target 2e5, maximum injection 
Time 40 ms, scan range m/z 440 - 640 For AIF, the chosen parameters were NCE 35 eV, 
resolution 17,500, AGC target 2e5, maximum injection time 40 ms, scan range m/z 440-
640. Lock masses used were, m/z 445.12003, 519.13888 and 610.18416. Source capillary 
temperature and RF level were set at 320⁰C and 55, respectively. 
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5.4.2.4 Data analysis 
Data were analyzed manually using Thermo XCalibur data analysis software and 
using in-house data analysis tools for generation of extracted ion electropherograms 
(EIEs), as described below. 
5.4.2.4.1 Database Construction 
The database of theoretical glycan compositions was generated using a 
combinatorial algorithm considering every combination of Hex between 3 and 9, 
HexNAc between 2 and 8, Fuc between 0 and 4, and NeuAc between 0 and 5. The 
number of NeuAc residues was constrained to be ≤ (# HexNAc – 1) and the number of 
fucose were constrained to be ≤ (# HexNAc) residues. Each composition was considered 
with and without a tandem mass tag (Mass Shift Formula: C10 C[13]5 H28 N4 O2). For 
each composition containing NeuAc, each NeuAc was considered in three forms, 
underivatized, dimethylaminated, or lactonized. 
The glycopeptide database was constructed by combining this same list of glycan 
compositions without derivatization or tandem mass tags with a list of common tryptic 
peptide sequences around sequons of interest. 
5.4.2.4.2 Migration Profile Reconstruction 
Each MS1 scan for each sample was processed by a deisotoping and charge state 
deconvolution algorithm using an N-glycan-specific averagine[473] formula C7 H11.83 
N0.5 O5.17, using the BRAIN [128] algorithm to generate isotopic patterns for the 
interpolated experimental composition. Extrapolated neutral mass monoisotopic peaks 
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were aggregated into migration profiles by mass using a 10 parts-per-million error 
tolerance to collect peaks across scans. Profiles which contained gaps greater 250 
milliseconds wide were split into separate migration profiles, corresponding to separate 
events. Migration profiles were expected to conform to a bi-Gaussian shape after 
Gaussian smoothing (𝜎 = 1). Un-gapped multimodal profiles were partitioned at valleys 
and evaluated independently. The bi-Gaussian fit for each smoothed profile was 
computed using non-linear least squares and the residual-sum-of-squares (RSS) for this 
fit was recorded, called the “shape fit RSS”. Each migration profile was also compared 
against a null model which assumed that the distribution of signal over time was random, 
using a horizontal line at the average intensity across the migration profile to calculate the 
“null model RSS”. Profiles for which  1 −
shape fit RSS
null model RSS
> 0.4  were considered well 
resolved. 
For glycomics data, reconstructed electropherograms were searched against a 
database of theoretical glycan compositions by neutral mass, using a 10 parts-per-million 
error tolerance to assign putative compositions. Under the conditions used, ammonium 
adducts were expected, and a second round of searches was performed using a mass shift 
corresponding to one or two ammonium adducts.  The results which matched overlapping 
migration profiles of different adduct types were summed.  These summed profiles were 
also evaluated following the above shape rules. Glycopeptide electropherograms were 
reconstructed in the same fashion; however, adducts were not considered. 
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5.4.2.4.3 Migration Profile Visualization 
All migration profile figures were produced by applying the same Gaussian 
smoothing described above to the matched raw profile data. 
5.4.3 Results and Discussion 
5.4.3.1 N-glycan analysis 
Zhong et al. have shown the utility of aminoxy-TMT tags in quantitative analysis 
of released glycans by CE-MS [626]. The TMT tags also improve ionization efficiency 
and thus the sensitivity of sialylated glycans in the positive-ion mode. The aminoxy TMT 
group imparts a positive charge to labeled neutral glycans in acidic buffers, thereby 
enabling electrophoretic migration. Further, TMT-based multiplexing has been shown to 
provide robust quantitative results for paired glycomics samples in both LC-MS and CE-
MS [626,629]. We therefore used aminoxy-TMT labeling for analyses of released 
glycans by CE-MS.  
The migration and separation of neutral glycans appeared to be dependent on the 
size and number of monosaccharide units, as shown in EIEs in Figure 71 for pauci- and 
high-mannose N-glycans (left panel) observed from a sample consisting of a mixture of 
released glycans from ribonuclease B, human transferrin and AGP. The EIEs for asialo 
complex-type glycans in the mixture are shown in the right panel. Glycan compositions 
are reported as [HexNAc; Hex; dHex; Total NeuAc; Esterified NeuAc; lactonized 
NeuAc] in the text and figures. Migration for high-mannose-type N-glycans shows a clear 
correlation with increasing size; however, multiple peaks are observed for paucimannose 
 
 
305 
 
glycans (HexNAc2Hex3-4) [2;3;0;0;0;0] – [2;4;0;0;0;0]. The earliest migrating peaks 
indicate the existence of these two glycans in solution prior to the CE-MS analysis.  In 
addition, the data show that [2;3;0;0;0;0] and [2;4;0;0;0;0] EIEs contain signal from MS-
induced breakdown products of larger high-mannose type glycans. MS-induced 
breakdown products in the EIEs for larger glycans also exist but are difficult to visualize 
due to the scale of the Y-axis and the presence of data-dependent tandem MS, which 
decreases the number of data points per electropherogram. 
The extracted mass spectra showed protonated analyte ions with varying degrees 
of ammoniated, sodiated and potassiated ions forming due to presence of ammonium 
acetate in the sample loading solution and other salts that may be present in the sample 
matrix or introduced from sample preparation.  The abundances of adducted ions ranged 
from 5-20% abundance relative to protonated ions and generally decreased with the size 
of the glycan.  The EIEs were plotted for protonated ions only.  Complex-type asialo 
glycans showed similar increasing migration times with added monosaccharide units and 
branching. The right panel in Figure 71 shows EIEs for bi-, tri- and tetra-antennary 
complex-type N-glycan compositions, with or without a fucose residue.  
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Figure 71: Neutral glycans – stacked EIEs showing high-mannose N-glycans from bovine RNAseB (left panel) 
mixed with complex glycans from human transferrin and AGP 
Glycan compositions are represented as [HexNAc; Hex; dHex; Total NeuAc; Esterified NeuAc; Lactonized 
NeuAc]. 
 
We next analyzed the behavior of N-glycans containing neuraminic acids 
(NeuAc) in their compositions. Figure 72 shows stacked EIEs for sialylated glycan 
compositions, with a TMT label on the reducing end.  While neutral glycans migrated 
through the separation capillary within the first 15 minutes of the CE-MS run, their 
sialylated counterparts migrated more slowly. The retardation of sialylated glycoforms 
was proportional to the number of sialic acids present in the glycan compositions. 
Additionally, we detected split peaks or multiple peaks for multiply sialylated 
glycoforms. For  compositions including [5;6;0;3;0;0], migration time differences 
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between peaks were as high as 14 minutes. While CE has been shown to resolve isomeric 
glycans, such large differences in migration times for the same glycan composition were 
not expected [626]. We hypothesized that the increased migration times and elution in 
multiple peaks was related to a combination of increased glycan net negative charge, 
increased hydrodynamic radius and non-specific interactions of acidic glycans with the 
positively charged capillary coating. 
Methyl esterification stabilizes sialic acids for MALDI- and LC-MS analyses 
40,41
. 
Recently, Wuhrer and colleagues described a MALDI-MS method for analysis of 
sialylated glycoforms by sialic acid stabilization that allows facile discrimination of sialic 
acid linkages by ethyl esterification [438]. Using this approach, α2,6-linked NeuAc 
residues are esterified and α2,3-linked NeuAc form cyclic lactones. To eliminate any 
non-specific interactions of the sialylated glycoforms, we employed their ethyl 
esterification strategy to derivatize the NeuAc residues.. 
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Figure 72: Sialylated glycans – EIEs showing sialylated glycan with underivatized sialic acids, from human 
transferrin and AGP 
Glycan compositions are represented as [HexNAc; Hex; dHex; Total NeuAc; Esterified NeuAc; Lactonized 
NeuAc]. 
The ethyl-esterification step allowed us to track the migration characteristics of 
TMT-labeled glycans without the influence of the sialic acid carboxyl groups. We 
identified N-glycans with completely and partially derivatized sialic acids, as shown in 
Figure 73. As expected, fully derivatized N-glycans shifted to migration times of 20 
minutes or less, while populations of partially derivatized glycans with one or more sialic 
acids left underivatized eluted in multiple peaks with longer migration times.  
Additionally, the mass shifts induced by ethyl esterification versus lactonization allowed 
characterization of sialic-acid linkages.  
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In most cases, the differently linked sialosides displayed the same electrophoretic 
mobility.  In some cases, migration times of different compositions overlapped.  For 
example, [4;5;1;2;0;2],  overlapped with [4;5;1;2;1;1] and [4;5;1;2;2;0]. A relatively 
wide, bimodal peak was also observed for [5;6;1;1;1;0], indicating isomer separation. 
Peak shoulders and tailing were also observed for sialylated glycans with unoccupied 
non-reducing end Gal residues.  It thus appears that NeuAc positional isomers exist on 
these glycans. The presence of abundant underivatized glycans necessitates the 
improvement of derivatization method to achieve higher efficiency. Several methods for 
sialic acid derivatization have been published, indicating that this is an ongoing and 
challenging problem [50,82,85,168,202,203,240,334,394,394,399,423,431,438,472]. 
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Figure 73: Derivatized sialylated glycans – EIEs showing sialylated glycan with derivatized sialic acids, from 
human transferrin and AGP 
Glycan compositions are represented as [HexNAc; Hex; dHex; Total NeuAc; Esterified NeuAc; Lactonized 
NeuAc]. 
5.4.3.2 Glycopeptide analysis 
Capillary electrophoresis separates analytes based on both charge and size. The 
size of glycans on peptide backbones has a significant influence on their electrophoretic 
mobilities. Thus, glycosylated peptides migrate more slowly through the separation 
capillary compared to their non-glycosylated counterparts [173]. Alpha-1-acid 
glycoprotein contains five glycosylation sites with a wide-ranging distribution of 
complex-type N-glycans [530,464,293,292]. In addition, the protein has two isoforms that 
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add variability in protein sequence in the region spanning the glycosylation sites. This 
allowed us to generate and study the migration characteristics of a variety of peptide 
backbone sequences with combinations of glycoforms using a tryptic digest of human 
AGP. Figure 74 shows a total-ion electropherogram (TIE) for an AGP tryptic digest 
stacked over the EIEs for oxonium ions indicating presence of HexNAc (middle) and 
NeuAc (bottom) on the precursor ions selected for tandem MS. As indicated by the 
overlay of oxonium ions, the non-glycosylated peptides in an AGP tryptic digest elute in 
the first 10 minutes, while the majority of glycosylated peptides elute after 8 minutes. All 
the peaks selected using data-dependent acquisition of tandem mass spectra after 8 min 
migration time were glycopeptides. The migration positions for two glycoforms of the 
peptide LVPVPITNATLDR are indicated in the TIE. Figure 75 and Figure 76 show HCD 
tandem mass spectra confirming the assignments. Note that addition of a single sialic acid 
resulted in a migration time difference of more than 5 minutes between the two 
glycoforms. Overall, most glycosylated peptides with neutral (asialo) glycans appeared 
prior to 14 minutes, while the sialylated glycoforms were slower migrating.  
. 
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Figure 74: Total ion electropherogram of a tryptic digest of AGP, analyzed by CE-MS, overlaid with extracted 
ion electropherograms for HexNAc and NeuAc oxonium ions, showing migration characteristics of glycosylated 
and non-glycosylated peptides 
 
Figure 75: Tandem MS of an asialo AGP glycopeptide from data dependent CE-MS/MS 
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Figure 76: Tandem MS of an asialo AGP glycopeptide from data dependent CE-MS/MS 
In a manner similar to the released glycans, glycopeptide migration through the 
separation capillary depended on size. Figure 77 compares the migration profiles of 
glycopeptides grouped according to peptide backbone by overlaying different peptide 
backbones with the same glycan composition on the same plot. Figure 78 compares the 
overlaid migration profiles of glycopeptides with the same peptide backbone but different 
glycoforms. Migrations times increased with both the peptide length and the glycan size. 
Further, the trend in migration of neutral vs. sialylated glycoforms, as seen in released 
glycans, persisted in glycopeptides. All asialo glycopeptides had migration times of 15 
minutes or less. With increase in the number of sialic acids, broader and multiple peaks 
were observed. While these factors increase the density of the data, the overall separation 
of different glycoforms is useful for deeper characterization of site-specific glycan 
microheterogeneity. The value of this separation will become more apparent for complex 
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biological samples where multitudes of glycosylated peptides and their numerous 
glycoforms are present. Although CE separates non-glycosylated peptides from 
glycosylated peptides, employment of a prior enrichment step such as HILIC would 
greatly enhance the loading capacity and allow a better use of the instrument speed and 
dynamic range.  
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Figure 77: Glycopeptide migration by peptide backbone 
Each electropherogram overlays the extracted ion traces for different peptide backbones of the same glycoform. 
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Figure 78: Glycopeptide migration by glycan composition 
Each electropherogram overlays the extracted ion traces for different glycan compositions decorating the same 
peptide backbone. 
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To eliminate the effects of sialylated glycoforms on migration times, we also 
explored derivatization schemes similar to those used for released glycans. The Wuhrer 
group has reported a  derivatization method for sialic acid stabilization and linkage 
discrimination in glycopeptide MALDI-MS, similar to their ethyl esterification procedure 
which we used for glycan derivatization [202]. This reaction converts α-2,6 linked sialic 
acid to dimethylamide, and α-2,3 linked sialic acid to a cyclic lactone with the adjacent 
galactose. We explored this derivatization method for CE-MS of sialylated glycopeptides 
from AGP. Although it did stabilize the sialic acids, the reaction introduced multiple 
modifications along the peptide backbone. This, combined with ammonium adduction 
from the ammonium acetate present in the stacking buffer, divided the signal from each 
glycopeptide into many channels, lowering the overall signal-to-noise ratio and making it 
extremely difficult to identify the glycopeptide compositions. This derivatization scheme 
necessitated the use of an additional HILIC-enrichment or cleanup step prior to CE-MS 
analysis because the reagents used for the derivatization were not soluble in aqueous 
solvents, and thus could not be removed via reversed-phase cleanup. To simplify the 
analysis, data were acquired using transferrin tryptic glycopeptides, which have only two 
glycosylation sites and a narrow glycoform distribution [187,293]. Methyl esterification 
of the glycopeptides using the method of Powell and Harvey was also attempted [423]. A 
few methyl esterified glycopeptides could be identified by de novo sequencing of the 
peptide backbone, but the problem of multiple backbone modifications persisted. 
. 
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5.4.3.3 Monosaccharide analysis 
Monosaccharide analysis provides insight into the overall variety of saccharide 
constituents in a sample. The monosaccharide compositions of unknown samples are 
identified and quantitated based on the retention/migration times of standards.  Following 
analysis of the standard monosaccharide pools that had been derivatized with aminoxy 
TMT-127, TMT-128 or TMT-130, for which the results are shown in Figure 79, a 
mixture of monosaccharides, obtained from AGP by acid hydrolysis and derivatized with 
TMT-127, were analyzed by CE-MS. The monosaccharide identities were assigned using 
a table of migration times established for standard monosaccharides, as shown in Figure 
80. As expected, AGP monosaccharides included fucose, mannose, galactose, N-acetyl 
glucosamine and sialic acid. The peak apex and peak width corresponding to hexoses 
indicated presence of mannose and galactose but no glucose (see Figure 81). 
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Figure 79: Monosaccharide standards multiplexed using the TMT reagent to enable identification of isomers by 
tandem MS 
 
Figure 80:  Extracted ion electropherograms for monosaccharides derived from AGP.  
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Figure 81: Overlaid traces for hexose standards and monosaccharides derived from AGP showing that AGP 
contains a mixture of mannose and galactose but no glucose 
This workflow for monosaccharide analysis allows easy estimation of the 
monosaccharide composition of a sample. Even though some the HexNAc 
monosaccharide isomers are incompletely resolved by CE, using our testing conditions, 
baseline separation was achievable between the pentoses, deoxyhexoses, hexoses, 
HexNAcs, and the sialic acid. With the exception of the HexNAcs, separation was broad 
enough, and the retention time reproducible, such that each monosaccharide can be 
identified when compared to a standard mix. The use of TMT multiplexing offers the 
flexibility to develop this method to provide a better monosaccharide identity. For 
example, internal standards could be included in the analyte, which are labeled with a 
different TMT-tag, to not only provide internal RT calibrants, but enable the possibility 
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of quantification. Similarly, this method could be developed further to compare N-glycan 
monosaccharide compositions, and O-glycan compositions within the same protein 
sample, by differential release of O- and N-glycans, labeling with different TMT-tags, 
and analyzing simultaneously to have a quantifiable comparison.  The ease of TMT-
labeling and high-throughput capability of CE-MS makes monosaccharide analysis 
accessible to most with basic laboratory equipment.  
5.4.4 Conclusions 
The ZipChip CE-ESI device allowed easy interfacing of the CE separation 
capabilities with mass spectral detection. The integrated sprayer obviated the need for 
complex ESI source setups on CE-MS systems and delivered stable nanoESI for all 
experiments. Our methods utilized the same mass spectrometer friendly buffer system for 
glycopeptides, released glycans and monosaccharides. We showed that the same CE 
conditions allow analysis of three different analyte classes, thus eliminating the need for 
switching among different CE methods and capillary chemistries.  The CE device 
delivered rapid separation and sensitive detection of oligosaccharides, with the sialic acid 
derivatization procedure allowing identification of sialic acid linkages. 
Aminoxy TMT reagent was used to fix a positive charge to improve 
electrophoretic migration of small, neutral glycans. This reagent has been shown to be 
useful for relative quantitation and multiplexing of biological samples [626,629]. 
Sialylated glycoforms in oligosaccharides and glycopeptides that retained a negatively 
charged functional group under the experimental conditions appeared to interact with the 
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coated capillary surface, thereby causing band broadening. We used chemical 
derivatization to neutralize the acidic monosaccharides and eliminate this interaction for 
both oligosaccharides and glycopeptides. This derivatization induced linkage-specific 
mass-shifts for sialylated glycans, which were used for linkage-discrimination in complex 
mixtures. All sialic acid derivatized oligosaccharides eluted in less than 20 minutes, 
considerably reducing analysis times over commonly used LC modes. Glycopeptides in 
tryptic digests of glycoproteins were well-separated from non-glycosylated peptides, 
thereby reducing the need for enrichment prior to mass spectrometry analysis. 
Glycopeptide glycoforms were resolved based on glycan size and composition showing 
glycoform resolution much higher than observed using liquid chromatography separation. 
Monosaccharide standards were derivatized using TMT tags and analyzed using 
CE-MS to establish migration times, followed by analysis of monosaccharides derived 
from a standard glycoprotein. Isomeric monosaccharide standards were multiplexed using 
TMT to generate different reporter ions allowing discrimination between co-migrating 
isobars. Different types of monosaccharides found on mammalian N-glycans were easily 
separated. 
Glycopeptide separation by CE-MS opens avenues for improved resolution and 
analysis of these analytes in complex biological samples. While separation of 
glycopeptides from peptides obviates the need for pre-enrichment, an added enrichment 
step would increase loading capacity of glycopeptides and enable better tandem MS of 
low-abundance glycoforms. 
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The development of newer capillary coatings will increase compatibility with 
acidic analytes and improvements in hardware and availability of reversed polarity will 
enable analysis of acidic oligosaccharides and other polyanionic compounds. Because the 
separation mechanism is orthogonal to commonly used chromatography modes, our CE-
MS method is attractive separation mode to combine with offline chromatographic 
fractionation. 
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Chapter 6: Conclusions and future perspectives 
The work presented in this dissertation describes the development of analytical 
methods for analysis of glycans and glycoconjugates, with a focus on mass spectrometry 
and hyphenated methods such as LC and CE for separation of analytes online with mass 
spectral analysis. The majority of these methods were developed to tackle the challenges 
in analysis of complex glycoproteins in Influenza virions but all methods have wide 
applicability in the field of glycoprotein and glycan analysis. In addition, a bioinformatics 
workflow has been described that was developed to enable high-throughput and detailed 
analysis of the large glycoproteomics and glycomics datasets. 
The first chapter summarizes the state-of-the art in glycan and glycoprotein 
analysis using mass spectrometry and related methods. This chapter reviews the most 
widely-used methods for chemical derivatization, front-end liquid-phase separation and 
mass spectrometry, including an overview of MS hardware and dissociation modes.  
Our study of Influenza glycoproteins allowed us to elucidate site-specific 
glycosylation on hemagglutinins from three different IAV strains. This enabled direct 
comparison of changes in glycosylation on a wild-type and a mutant strain, which had 
very different sensitivities to inhibition by immune lectins as shown by our biochemical 
and binding assays. Using this information, we identified the sites involved in 
interactions of the virions with the immune molecule SP-D. We also utilized our glycan 
macro- and micro-heterogeneity information to perform modeling and simulations studies 
to pinpoint the structural determinants for interactions of HA with SP-D and for glycan 
processing at the sites involved in these interactions. This is the first IAV study that 
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combines site-specific glycosylation data with binding assays and in silico structural 
studies, in a systematic manner. The resolution of our multidimensional analyses is clear 
from our results. Our analytical and informatics workflows are now ready for analysis of 
a series of IAV strains where glycosylation sequons have been systematically mutated. 
The phenotypic information combined with bioassays and structural studies, as detailed 
in Chapter 4, will help identify the structural features that impart virulence and fitness to 
IAV and help build a model for prediction of IAV fitness based on its site-specific 
glycosylation profile. Together, these analyses can be used for rapid classification of 
emerging virus strains that can help select the best prophylactic and therapeutic 
interventions. These methods in general are applicable to study of glycosylation in any 
complex biological system. 
Our informatics pipeline, GlycReSoft, takes advantage of proteomics and 
glycomics data to maximize the depth in analysis of glycopeptides without wasting 
resources on unnecessary assumptions about sample search space. Using empirically 
defined search spaces makes data analyses both more efficient and more confident. This 
pipeline was used in the analysis of data from IAV samples and also a series of increasing 
complexity samples containing serum glycoproteins to demonstrate the value of this 
approach.  
Chapter 5 describes efforts in method development for glycan and glycoconjugate 
analysis. The first part describes development and application of a novel IM-MS 
workflow for adding a gas-phase separation step to biopolymers. Using this approach, we 
have cataloged the CCS values for scores of glycans and glycopeptides. This information 
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will be integrated into our data analysis pipeline using machine learning to add even more 
confidence to the information already delivered by our LC-MS/MS analyses. 
Furthermore, this approach can help resolve structural isomers and conformers to help 
identify structural features in biomolecules. The value of combining IMS with ExD 
modes has already been demonstrated by our group on an FTICR-MS system [425,426]. 
Recent developments in instrumentation have paved way for such applications on 
instruments that are capable of delivering higher scan speed that can be combined with 
LC-scale omics experiments [550,551,552]. While it may take some time to combine 
IMS and ExD on instruments that deliver high acquisition speed and sensitivity, such 
combinations on home-built and prototype instruments can now be realized, as 
demonstrated recently [99,178]. Further, we have compared the features in different 
collisional and electron-based dissociation modes for analysis of glycans and 
glycopeptides, including middle-down glycopeptides. The data from these experiments 
will enable development of bioinformatics strategies that are not currently available due 
to paucity of training data.  
Also described in Chapter 5 is the application of a microfluidic CE-ESI interface 
for MS analysis of monosaccharides, oligosaccharides and glycopeptides. This is an 
important development in glycan and glycopeptide front-end separations, which often 
suffer from peak capacity limitations in chromatography modes that are unable to resolve 
glycoforms. While CE-MS methods have existed for a long time, the development of this 
interface has made it extremely easy to couple this orthogonal separations method with 
high-resolution mass spectrometry. Future work would include testing alternative 
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capillary coatings to minimize EOF for sialylated and sulfated glycans and different 
buffer conditions to improve electrophoretic separation. Further, combining CE 
separations with IMS-MS and with ExD would enable separation of isomeric glycans and 
identification of the isomers.  
In addition to analysis of N-glycans, we have also developed methods for 
separation of extremely complex mixtures of linear sulfated polysaccharides of heparan 
sulfate. This method utilizes UPLC SEC separations and eliminates a major limitation of 
salt-based buffer systems in chromatography modes by online removal of salt-adducts by 
using an ion-suppressor system. The method was applied for profiling the complete 
molecular weight range of pharmaceutical preparations of low-molecular-weight 
heparins. The work also describes a novel data analysis workflow that takes into account 
the isotopic patterns for the elemental compositions of individual matches. This system is 
now ready for application to complex mixtures of polysaccharides from biological 
samples. The ion-suppressor system can be used with any chromatography mode such as 
HILIC or PGC, thereby extending its applicability to analysis of other glycan classes. 
Further, this system can be combined with ExD methods for detailed GAG structure 
analysis that have been developed by our group [247,257]. 
When analyzing proteins in a bottom-up fashion, we lose the information 
regarding how different parts of a molecule exist together in the intact molecular 
structure and are thus unable to differentiate between the many forms that are present as 
part of the population that we analyze. For example, there may be a range of glycan 
structures present at each site on a multiply glycosylated protein. When we analyze using 
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a bottom-up method, we are able to determine the range of glycan forms that are present 
at each site but we are unable to establish what combination(s) of glycans appear together 
on multiple sites of a complete protein. Thus, we are always building back to a molecular 
form that is an average of all molecules in a measured population. This hampers the 
ability to fully understand the interactions between specific molecular forms and to 
identify the forms that are relevant to a particular biological response or disease.  
Together, the new methodologies that we have developed both in liquid- and gas-
phase separations in mass spectral analyses and our unique informatics approach will 
enable realization of middle-down glycoprotein analyses. A middle-down methodology 
would enable us to pinpoint individual glycoproteoforms of HA and NA that interact 
differently with immune molecules and we can correlate these information sets to 
understand the relationship and effects of glycosylation that occurs simultaneously at 
different protein sites. Such information will allow production of better recombinant 
vaccines that will generate a potent and broadly neutralizing antibody response, by 
replicating the exact interaction of mature glycoprotein structures present on the most 
infectious virions with host molecules. Middle-down analyses and definition of detailed 
structural features in mature glycoproteoforms will require all our analytical tools and 
informatics strategies in both bottom-up and middle-down domains to work in concert, as 
shown in Figure 82.  
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Figure 82: Extending the bottom-up analytical workflow by adding information from CE, IMS and ExD 
 
In summary, this dissertation describes significant advancements made to 
methods in mass spectrometry for application to glycan and glycoprotein analysis in 
biological systems. While method development is pivotal to analytical technology, 
without real application the value of these methods remains limited to conjecture. The 
resolution of our methods is evident from our studies of influenza virus glycobiology and 
the wide-applicability of these methods will allow easy adaptation to other biological 
projects. It is incontrovertible that a single method or technique is not sufficient for 
detailed analysis of glycans and glycoproteins; for complete structural analysis, a 
combination of methods is necessary. We therefore conclude that bioinformatics is 
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crucial in logical integration of information from different analytical methods and 
informatics development must therefore be a concerted effort with analytics. 
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APPENDIX 
 
In addition to the projects that were completed as part of this dissertation, some 
exploratory work was done on projects that remain incomplete at the time of writing this 
dissertation. This section provides an overview of the progress made on these projects 
and provides an outlook for the future of these projects.  
 
Using Click-chemistry to probe specific glycan motifs in complex biological 
samples 
Introduction 
Glycan structures contain specific motifs that play important roles in biological 
processes. The presence and absence of certain motifs and linkages is often indicative of 
altered biological state. It is therefore of interest to probe biological systems for such 
glycans and stratify the biomolecular environment using glycans as sensitive biomarkers. 
Since glycan biosynthesis is regulated by enzymes that only act on substrates that contain 
the correct structural features and intermediate states, it is conceivable to use the 
enzymatic machinery to identify glycans that contain the structural features of interest 
and use these features as handles to isolate the glycans and glycoconjugates of interest 
from complex mixtures for detailed analysis. 
Wu and colleagues have demonstrated the ability to probe sialosides using 
sialyltransferases to add monosaccharide analogs containing an azido group [583]. The 
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azido group can be used for azido-alkyne cycloaddition. Azido-labeled monosaccharide 
analogs are generally incorporated into glycans using metabolic labeling, followed by 
subsequent enrichment and analysis of the modified glycans or glycopeptides, as 
previously shown by the Bertozzi group [59,578]. Labeling using metabolic methods 
cannot be controlled except by modifying the genetic expression of certain glycosylation 
enzymes and can be performed only in samples derived from cell culture systems. Thus, 
these labeling approaches are not representative of the actual biological systems that one 
might want to study. The enzymatic labeling as described by Wu et al., allows labeling of 
any glycoprotein derived from any biological sample.  
Methods 
Our initial efforts in enzymatic labeling of specific glycan structures entailed 
desialylalation of bovine fetuin glycoprotein using a non-specific sialidase (New England 
Biolabs, Ipswich MA). Asialo fetuin was then probed with recombinant sialyltrasferase 
(R&D systems, Minneapolis, MN) specific to adding Galα1-6NeuAc in presence of 
azido-CMP-sialic acid. Following the reaction, labeled fetuin was digested using trypsin 
as previously described [291,292,293]. Labeled glycopeptides were then reacted with an 
alkyne-functionalized TMT reagent, shown in Figure 83. Labeled samples were cleaned 
up using C18 spin columns and analyzed by data-dependent LC-MS/MS on a Q-Exactive 
Plus mass spectrometer using methods described previously [291]. 
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Figure 83: Alkyne-functionlized TMT reagent 
 
Results 
The TMT reagent and the modified sialic acid generated specific reporter ions in tandem 
MS that could be used to identify the precursors that were labeled by the sialyltransferase 
and TMT, as shown in  
 
Figure 84: Overlaid chromatograms showing presence of azido-sialic acid from enzymatic labeling and click-
conjugated TMT on fetuin glycopeptides 
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Spectra containing reporter ions were analyzed manually to identify the labeled 
glycopeptides, as shown in Figure 85. As shown in the figure, low mass reporter ions 
were present and confirmed the presence of azido-NeuAc and TMT-labeling. Other 
oxonium ions, stub-glycopeptide ions and peptide backbone ions were used to confirm 
the identity of the glycopeptide. 
 
Figure 85: MS and tandem MS of a fetuin glycopeptide labeled with azido sialic acids and probed using alkyne 
functionalized TMT 
Conclusions and future perspectives 
The click-chemistry approach provides an unbiased method for specifically labeling and 
identifying glycan structural motifs in a site-specific manner from complex biological 
matrices. The TMT labeled glycopeptides can be enriched using an anti-TMT antibody 
that is available from Thermo Scientific. Alternatively, alkyne functionalized biotin can 
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be used to label, followed by affinity purification using streptavidin. The TMT labeling 
provides an advantage in the ability to analyze paired biological samples using 
multiplexing. In this pilot study, we used a sialyltransferase for labeling, but a variety of 
glycosyltransferases are available from R&D systems that can be used for labeling 
specific linkages and motifs, as needed. 
A major limitation of this approach is the yield of the labeling reaction using the 
glycosytransferases. Application to biological samples would require consistent and high-
labeling efficiencies both for the enzymatic addition of azido-monosaccharides and for 
subsequent click-conjugation. Further experiments will evaluate labeling efficiencies and 
approaches to improve yields in these reactions. 
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